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ABSTRACT
T he B H 3-only  B C L -2  protein  B ID  is thought, in som e cases, to be responsib le fo r the initiation o f 
cytochrom e c release from  m itochondria  during  apoptosis. In  o rder to  study this process in an in vitro  
system , the ra t B id gene w as cloned, recom binant B ID  purified , and truncated  B ID  (tB ID ) produced. 
A dditionally , reliable p rocedures w ere developed fo r the isolation o f in tact m itochondria  from  a rat 
neu rob lastom a cell line and fo r assay o f cy tochrom e c release from  the iso lated  m itochondria.
T he involvem ent o f the perm eability  transition  (w idely regarded  as a m echanism  for m itochondrial 
perm eabilisation  and/or rem odelling  during cy tochrom e c release) w as investigated. H ow ever, using 
m itochondrially  entrapped  fluorophores and agents that prom ote the transition  (C a2+, overexpression o f 
m itochondrial cyclophilin  D), B ID -induced cytochrom e c release w as in fact found to be independent 
o f  perm eability  transition. N evertheless, C SA , a potent inh ib ito r o f  cyclophilins and the perm eability  
transition , did inhibit cy tochrom e c release.
T o resolve the action o f  C SA , a kinetic m odel of tB ID -induced cy tochrom e c release w as form ulated 
from  first principles. T his considered  tB ID -induced oligom erisation  and au to-oligom erisation  o f the 
B A K  protein into B A K  pores and efflux o f cytochrom e c via these pores. T he m odel w as based on 
prev iously  published data and the presence o f B A K , but not B A X , in the iso lated  m itochondria. 
A nalysis according to this m odel indicated  that the form ation o f pores, rather than efflux  through pores, 
w as inhibited by C SA . D irect m easurem ents o f tB ID -induced change in B A K  conform ation (an 
essen tia l step in o ligom erisation) by trypsin  cleavage confirm ed that C SA  inhibited this step.
A s potential targets o f  C SA , the iso lated  m itochondria contained both cyclophilin  D (m itochondrial 
m atrix ) and residual cyclophilin  A (a cytosolic enzym e). H ow ever neither cyclophilin  D 
(overexpression) nor cyclophilin  A (addition  o f  recom binant enzym e) stim ulated  cy tochrom e c release. 
M oreover, D B25, a C SA  analogue tha t inhibits the catalytic activity  o f  both cyclophilins, but does not 
allow  interaction w ith dow nstream  targets such as calcineurin, w as ineffective, and instead had a 
stim ulatory  effect on cytochrom e c release. It appeared therefore that the cyclophilin-C SA  com plex 
m ay be the inhibitory species. H ow ever inhibition w as not a ttributable to  calcineurin  inhibition, as 
ju d g ed  by 32P labelling and the effects o f C a2+. It is concluded that the cyclophilin -C SA  com plex m ay 
inh ib it B A K  conform ational change by  a novel m echanism .
T w o  o ther novel findings arose in the course o f the study, nam ely a 54 kD pro line-rich  cyclophilin  D 
b ind ing  p ro tein  (identified by pull-dow ns and m ass spectrom etry) and phosphory lation  o f a (non­
iden tified) 17 kD  protein in cyclophilin  D overexpressing m itochondria.
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CHAPTER 1 : BACKGROUND
[1.1]Overview
T he aim  o f this p roject w as to investigate the process o f cytochrom e c release from  m itochondria. 
C ytochrom e c release is a key step  in the progression o f apoptosis, and as such there is considerable 
in terest in the  m echanism s by w hich it occurs, and also in the reasons w hy it e ither fails to  occur, or 
occurs in a deregulated  m anner, in conditions such as neoplasias, ischaem ic injury and 
neurodegenerative disease.
Specifically , this p roject considered  the process o f B ID -induced release o f cytochrom e c from  isolated 
m itochondria , and the effects on this process o f cyclophilins and cyclosporin  A. T his introduction will 
first give som e general background on the cellu lar m echanism s o f apoptosis. Follow ing this, som e o f 
the specifics o f the process relevant to this study will be considered: the nature and role o f the 
perm eability  transition pore; the role o f B C L2 proteins; the structure and function o f  BID ; the role of 
cyclophilins and cyclosporin  A; the role o f m itochondrial fission and fusion; and finally the role o f 
p ro tein  phosphorylation.
[1.2]Apoptosis
[1.2.1]Definition
A poptosis, or ‘program m ed cell dea th ’ is the process by w hich cells are induced, by intrinsic or 
extrinsic signals, actively to  shut them selves dow n and rem ove them selves from  the body. A poptosis is 
an essential process in m etazoans, p laying a num ber of im portant physio logical roles, including the 
rem oval o f redundant cells during developm ent, counterbalancing cell d iv ision  in tissue hom eostasis 
and the rem oval o f diseased or dam aged cells [1].
[1.2.2]lntrinsic and extrinsic pathways
Follow ing  its original description by K err and co-w orkers in 1972 [2], intensive research  in this field 
ov er the last thirty years has defined m any o f  the critical m orphological and b iochem ical features of 
apoptosis. T w o m ajor signalling pathw ays have been delineated: firstly  the extrinsic pathw ay, 
ac tiva ted  by ligation o f death-dom ain-contain ing cell-surface receptors o f the tum our necrosis factor 
recep to r superfam ily ; and secondly the intrinsic pathw ay, induced by in tracellu lar stim uli such as D N A  
dam age or oxidative stress. The intrinsic pathw ay is characterised  by the release o f pro-apoptotic 
factors from  the interm em brane space o f m itochondria.
T he tw o pathw ays converge on the activation o f caspases, a fam ily o f in tracellu lar pro teases that m ake 
use o f  a ca ta ly tic  cysteine residue to cleave a w ide range o f substrates after aspartate residues. 
C aspases ex is t as inactive zym ogens in the cytosol, and upon induction  o f apoptosis are proteoly tically  
cleaved  to  form  active heterodim eric enzym es [3]. A ctive caspases can cleave o ther caspases, resulting 
in a proteo ly tic  cascade w ith the executioner caspases-3, -6 and -7 at the distal end. These executioner 
caspases c leave cellu lar substrates, resulting  in the typical b iochem ical and m orphological hallm arks of 
apoptosis and u ltim ately  leading to death and phagocytosis o f the cell.
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T here is c ross-ta lk  betw een the tw o pathw ays -  w hilst som e extrinsic signals are sufficient to activate 
the caspase cascade d irectly , in m any cases activation  o f  proxim al caspases fo llow ing death  receptor 
ligation  brings the m itochondrial loop into play in order to am plify  the apoptotic signal. T he intrinsic 
and extrinsic pathw ays are show n d iagram m atically  in Figure 1.
Scaffidi and co-w orkers [4] have identified  tw o distinct cell types. Type 1 cells (e.g. SK W 6.4 and H9 
cells) rely  exclusively  on the extrinsic pathw ay to initiate apoptosis fo llow ing death  receptor ligation -  
there is a rapid, high level o f caspase 8 p rocessing , leading directly  to caspase 3 activation  and caspase 
cascade. In  type 2 cells (e.g. Ju rkat and C EM ) there is very little im m ediate p rocaspase 8 processing. 
T he sm all am ount o f active caspase 8 is, how ever, sufficient to initiate the m itochondrial pathw ay, and 
this leads to  caspase 3 activation  via cy tochrom e c release, thus am plify ing  the apoptotic signal. 
O verall there is no  d ifference in suscep tib ility  to apoptosis betw een the tw o cell types.
[1.2.3]Role of cytochrome c in the intrinsic pathway
O ne o f the critical m itochondria-derived  pro-apoptotic factors is cytochrom e c, a 12-kD haem - 
con ta in ing  redox carrier protein, norm ally  responsib le for transferring  elec trons betw een com plexes III 
and IV o f the resp irato ry  chain. U pon activation  o f the m itochondrial (in trinsic) apoptotic pathw ay, 
cy tochrom e c is transported  across the outer m itochondrial m em brane into the cytosol. O nce released 
in to  the cytosol, cy tochrom e c induces the form ation o f the apoptosom e, consisting  o f caspase-9 , A paf- 
1 (apoptotic protease-activating  fac to r-1), dA T P or A TP and cy tochrom e c [5]. The apoptosom e is 
h ighly  active in processing  and activating  caspase-9  and o ther in itiator caspases, thus p ropagating  the 
apoptotic response.
[1.2.4]Loss of outer membrane integrity
A s part o f the intrinsic pathw ay o f  apoptosis, a num ber o f p roapoptotic factors are released from  
m itochondria  along w ith cy tochrom e c [6]. These include A IF  (a DNA  cleavage factor), endonuclease 
G  (responsible for nuclear D N A  fragm entation), pro-caspase 3 (an effecto r caspase), O m i (a serine 
p ro tease) and SM A C /D IA B L O  (a repressor o f the IA P caspase inhibitor p roteins, thereby potentiating  
caspase  activation). These factors are norm ally  located in the in term em brane space, and so a necessary 
step  in their release is perm eabilisation  o f  the outer m itochondrial m em brane.
Several com peting  theories, d iscussed in m ore detail below , have been proposed to  account for the loss 
o f  ou ter m em brane integrity. For exam ple, B C L-2 fam ily proteins m ay form  channels in the outer 
m em brane [7,8]; channels m ay form  from  resident m itochondrial proteins [9,10]; channels m ay form  
from  m is-fo lded  m itochondrial proteins [11]; im pairm ent o f  A D P/A T P exchange m ay lead to matrix 
sw elling  and ou ter m em brane rupture via an increase in inner m em brane potential [12]; lipidic pores 
m ay be responsib le  for m em brane perm eabilisation [13]; or finally , open ing  o f  the perm eability  
transition  (PT ) pore m ay lead to osm otic sw elling o f m itochondria  and outer m em brane rupture [14] 
(rev iew ed in [15]).
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Figure 1 - The intrinsic and extrinsic apoptotic pathways.
The extrinsic pathway is initiated by death receptor ligation, and leads to caspase 
activation via formation of the Death Inducing Signalling Complex (DISC). The intrinsic 
pathway is activated by intracellular stimuli, and involves the release of proapoptotic 
factors from the mitochondrial intermembrane space. Cross-talk between the pathways is
mediated by caspase 8 and tBID.
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[1.2.5]Availability of inter-membrane space proteins for release through the outer membrane 
It has been suggested  that ou ter m em brane perm eabilisation  p e r  se is not sufficient to release som e or 
all in term em brane space proteins to the cytosol during apoptosis. E lectron tom ography studies suggest 
that the traditional textbook view o f m itochondrial substructure is incorrect. R ather than being 
com posed  of sim ple baffle-like folds, the inner m em brane is distorted  into com plex tubular regions and 
ex tended  internal com partm ents. U nder som e conditions, these com partm ents represent highly 
sequestered  areas, separated  from  the IM S by narrow  cristae junctions [17,18].
T hese structural features are predicted  to inhibit free diffusion o f proteins and m etabolites around the 
in term em brane space [19], so that alterations in m itochondrial substructure are likely to influence 
p ro foundly  the rate o f release o f proapoptotic factors during apoptosis. Furtherm ore, conversion 
betw een  alternative substructural states (for exam ple betw een the m atrix-contracted  and matrix- 
expanded  states observed in respiring and non-respiring m itochondria, respectively) is not possible by 
passive folding and unfolding, but requires m em brane fission and fusion events. A ctive regulation of 
substructural state through m odulation o f fission and fusion rates is therefore a possible m echanism  by 
w hich  cells m ight regulate apoptotic progression during the intrinsic pathw ay [20].
In the case of cytochrom e c, the m ajority  o f stores are thought to be sequestered  within the cristae; 
functional estim ates suggest only about 10-15 % is present in the interm em brane space (IM S) close the 
ou te r m em brane [21]. Scorrano and co-w orkers have suggested that a m ajor part o f the action of 
B C L -2 pro-apoptotics involves re-m odelling  these cristae to m obilise cytochrom e c stores for release 
through the outer m em brane [17].
In addition to the above-m entioned barrier to free diffusion o f m itochondrial inter-m em brane space 
proteins, cytochrom e c is physically  associated  w ith the outer leaflet o f the inner m itochondrial 
m em brane, through tw o m echanism s. Firstly, there are strong elec trostatic interactions o f cytochrom e 
c w ith the negatively-charged m em brane surface (cytochrom e c has a p i o f 9.3, and carries a net 
charge  o f +8 [22,23]). Secondly, an ‘ex tended lipid anchorage’ tethers cy tochrom e c to the m em brane, 
w hereby  one acyl chain of a m em brane phospholipid protrudes out of the m em brane and intercalates 
into a hydrophobic channel in cytochrom e c, w hile the other chain rem ains in the bilayer [22,23],
In non-apoptotic cells, these associations are thought to increase the efficiency w ith w hich cytochrom e 
r  can transfer electrons betw een the m em brane-bound respiratory com plexes; how ever they m ust be 
breached  during apoptosis. O tt and co-w orkers suggested that cytochrom e c release during apoptosis 
p roceeds by a tw o-step process; solubilisation of cytochrom e c by breaching o f the electrostatic and 
lip id-based  interactions w ith the inner m em brane is a necessary first step prior to release o f cytochrom e 
c across the ou ter m em brane [24],
[1.3]The permeability transition pore (PT pore)
[1.3.1 [Overview
C alcium - and inorganic phosphate- induced changes in the perm eability  characteristics o f the inner 
m itochondrial m em brane w ere first observed in the 1960s [25]. In the late 1970s, H aw orth and H unter 
further characterised  this ‘perm eability  transition ’ as a non-specific increase in m em brane perm eability ,
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uncoupling o f oxidative phosphorylation  and loss of respiratory control, and suggested that it may be 
due to a transm em brane channel [26]. Poly(ethylene glycol) perm eability  studies suggested that the 
m echanism  w as the induction of a large pore o f discrete size, perm eable to solutes up to around 
1500 Da [27]. T his observation  w as confirm ed by direct m easurem ent o f the ratios o f perm eation of 
l4C -labelled  so lu tes of d ifferen t sizes, and is consistent w ith a pore of 2 -  3 nm  diam eter [28],
[1.3.2]Structure
T he m inim al structure o f the PT  pore is generally  accepted to com prise the voltage dependent anion 
channel (V D A C ) in the ou ter m em brane, the adenine nucleotide translocase (A N T) in the inner 
m em brane and cyclophilin  D in the m atrix [29], H ow ever A N T alone m ay also  form  the pore under 
ex trem ely  high [C a2+], as show n in reconstitu tions w ith purified A N T [30], It is certain ly  also the case 
that o ther proteins m ay be associated w ith the m inim al pore com ponents under som e conditions. 
N otab le  am ong these other proteins are BCL-2, BAX, the peripheral benzodiazepine receptor and a 
num ber o f kinases including hexokinase and glycerol kinase (review ed in [31]). It has also been 
suggested  from knockout studies that perm eability  transition is possible in the absence o f A N T  [32], 
and that other m itochondrial proteins may form the pore [11].
[1.3.3]Pore activity
Pore opening is dependent on several factors besides calcium . M agnesium  ions were found to inhibit 
open ing , presum ably by com petition  with calc ium  for a binding site [26], Pore opening requires the 
absence of adenine nucleotides and is stim ulated by inorganic phosphate; the presence of exogenous 
adenine nucleotides prevents calc ium -induced pore opening in isolated m itochondria [33]. C ellular 
redox state is also im portant, the oxidation  state of intram itochondrial pyridine nucleotides apparently  
being  a key indicator o f this; as long as the pyridine nucleotide pool is m aintained in a sufficiently  
reduced  state, pore opening is inhibited. The cross-linking of C y sl6° and C ys257 on the m atrix side of 
A N T  is thought to stabilize the ‘c ’ conform ation, enhance cyclophilin  D binding, antagonise A D P 
binding, and strongly sensitise the PT pore to C a2+-induced opening [34,35]. O ther pore effectors 
include the cyclophilin  D inhibitors cyclosporin  A (CSA ) and sanglifehrin  A [36], cG M P ([37]; via the 
action  o f protein kinase G) and the A N T  ligands carboxyatracty losidc and bongkrekate [38]. 
In terestingly , the F iF0 A TP synthase inhibitor oligom ycin has also been show n to inhibit pore opening 
under certain  conditions [39], Finally, several ubiquinones have been show n to m odulate pore activity 
[40], T hree classes have been defined, w hich either stim ulate, inhibit or have no effect on the pore. 
W alter and co-w orkers suggest that quinines m odulate pore activity through b inding to a com m on site 
on a pore com ponent, rather than through oxidation-reduction  reactions [41 ].
C alc ium -induced  perm eability transition is highly dependent on m itochondrial energy state and 
substrate u tilisation  [42]. Thus energisation w ith FA D H -linked succinate results in increased 
suscep tib ility  to  PT pore opening com pared to energisation w ith N A D H -linked  glutam ate plus malate. 
B locking  o f e lec tron  flow w ith inhibitors inhibits perm eability  transition , and susceptibility  can be 
restored w ith artificial electron donors. Isenberg and co-w orkers report that rotenone inhibits the PT 
pore [43], and C hauvin  and co-w orkers have confirm ed this result [44], identifying electron flux 
through com plex  I as a key regulator of PT  pore activity.
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[1.3.4]Physiological and pathological function
C learly, sustained PT  pore opening is likely to be severely detrim ental to cell viability, resulting as it 
does in d issipation  o f the proton m otive force, A TP hydrolysis, loss of m itochondrial m etabolites and 
deregulation  o f ion hom eostasis in the m itochondria. On these grounds it was first proposed that the 
perm eability  transition  is instrum ental in necrotic cell death associated  w ith oxidative stress and 
cellu lar calc ium  overload [45]. It has, how ever, been suggested that transient PT  pore opening m ight 
play a useful physiological role, resulting  in efflux from the m itochondria o f excess m etabolites, 
especia lly  calcium  [46], A dditionally , calcium -induced calcium  release from  m itochondria via 
transien t PT  pore opening has been suggested to be involved in in tracellu lar signal propagation via 
elec trical and/or calcium  transients [47], Pore opening does indeed tend to be transient at physiological 
calc ium  concentrations, w ith openings from  a few m illiseconds to seconds occurring  w ith a frequency 
dependen t on matrix free [C a2+] [48,49], A ccordingly, m itochondria exposed to low levels o f calcium  
will slow ly accum ulate sucrose w hilst apparently  m aintaining an intact inner m em brane potential as a 
population , due to transien t pore flicker in a sm all proportion of m itochondria [50]. N evertheless, it 
does seem  unlikely for the cell to utilise PT pore opening physiologically . The basic function o f matrix 
[Ca~+] regulation is to contro l the citric acid cycle and A TP production; but m odulation o f matrix 
[C a2+] by pore opening (an event leading to disruption of the proton m otive force and loss of 
m itochondrial m etabolites) w ould disrupt the very process (A TP generation) that the cell is trying to 
contro l [50],
R O S induce PT pore opening [45]. Skulachev and co-w orkers propose a m echanism  w hereby transient 
pore opening acts as a protection m echanism  follow ing excessive ROS production [5 1 ]. In their m odel, 
pore opening w ould reduce ROS production  by tw o m echanism s; firstly stim ulation o f respiration due 
to  uncoupling w ould low er cellu lar [ 0 2]; and secondly dissipation  o f the m em brane potential would 
ensure m axim al oxidation o f electron carriers such as coenzym e Q w hich can o therw ise act as one- 
e lec tron  reducers of 0 2 leading to ROS production. Follow ing an adequate reduction in ROS levels, 
the pore w ould close.
[1.3.5]lnvolvement of the PT pore in apoptosis
Sustained  opening o f the PT pore allow s free exchange o f ions and m etabolites across the 
m itochondrial m em brane. In vitro  at least, this results in osm otic sw elling o f the m itochondrion, and 
since the surface area of the convoluted inner m em brane is far greater than that o f the outer m em brane, 
this rapid ly  leads to outer m em brane rupture [52]. It is possible that this m ight be the m echanism  of 
apoptotic cy tochrom e c release in som e cases. For exam ple, follow ing transient cardiac ischaem ia, in 
addition  to the central core of necrosis, a surrounding region o f cells is seen to die by apoptosis. In the 
necrotic region, PT  pore opening on reperfusion has presum ably  led to uncontrolled m etabolite 
exchange and A TP loss, thus causing cell death. A hypothetical m odel suggests that in the surrounding 
apoptotic region, a sm all am ount of transient pore opening (insufficient to dissipate the proton motive 
force and exhaust A TP supplies) has led to cytochrom e c release via outer m em brane rupture which, in 
the presence o f  a m aintained A TP supply, has initiated the cytosolic apoptotic pathw ay via apoptosom e 
form ation [28],
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In addition to this involvem ent in “sub-necrotic” apoptosis, K roem er has suggested that the PT pore 
m ight be involved m ore generally  in apoptosis, being induced by m ultiple apoptotic stim uli and thus 
acting as a signal in tegrator at the level o f the m itochondrion, leading to cytochrom e c release [ 14|.
[1.3.6]Evidence against permeability transition as the root mechanism of apoptosis
If cy tochrom e c release via sw elling-induced rupture of the outer m em brane fo llow ing opening o f the 
PT  pore is a more general m echanism  of apoptosis, then m em brane potential loss should certainly 
occur p rio r to cytochrom e c release. H ow ever W igdal and co-w orkers show ed in 2002 that, in m ouse 
cerebellar granule neurons, cytochrom e c release is in fact substantially  com plete p rior to m em brane 
potential loss. Furtherm ore they dem onstrated  by electron m icroscopy that m itochondria are not 
obv iously  sw ollen during cy tochrom e c release [53]. Sim ilarly, von A hsen and co-w orkers 
dem onstrated  that m itochondrial structure as well as protein im port function is m aintained even after 
com plete  cytochrom e c loss induced by recom binant BID or BAX [54], and a num ber o f o ther reports 
have placed cytochrom e c release upstream  o f m em brane potential loss and/or sw elling [55-57], In 
som e cases, though, it seem s that m em brane potential loss does occur concurrent w ith, or prior to, 
cytochrom e c release (e.g. B A X -induced cytochrom e c release [56[). A lso, G ogvadze and D istelhorst 
show ed recently that sm all-am plitudc sw elling, sufficient to release cy tochrom e c, can leave 
m itochondria substantially  intact and functionally  active [58]. In sum m ary, although the occurrence of 
transien t PT pore opening during apoptosis is not ruled out, it seem s that sustained opening o f the pore 
and disruption of m itochondrial hom eostasis is not a necessary step in the progression of apoptosis in 
all system s.
E vidence against PT pore involvem ent in apoptosis also com es from  experim ents w ith cyclophilin  D 
knockouts. N akagaw a and co-w orkers generated knockout mice, and show ed that, although 
m itochondria isolated from  these anim als were unable to undergo perm eability  transition, there was no 
d ifference  in their response to apoptotic stim uli [59], B aines and co-w orkers have obtained sim ilar 
resu lts [60], indicating that perm eability  transition is not required for apoptotic cell death.
[1.3.7]Organisation of cytochrome c by PT pore components
Several reports have suggested that cytochrom e c is organised into localised clusters by PT pore 
com ponents (e.g. [61]). V yssokikh and co-w orkers show ed that 10 - 20 % of cytochrom e c was 
associated  w ith contact sites, and that cytochrom e c rem ained attached to V D A C -A N T  com plexes that 
w ere reconstitu ted  in phospholipid vesicles [62],
[1.4JBCL-2 Proteins
[1.4.1 [Overview
The key regu lators of the m itochondrial steps in the apoptotic pathw ay are proteins o f the BCL-2 
fam ily. B C L -2 itself w as first described in follicular lym phom a, w here the t( 14; 18) chrom osom al 
translocation  fuses the bcl-2  gene to the im m unoglobulin  enhancer [63]; consequent over-expression  of 
bcl-2  p ro tects the B lym phocyte from  apoptosis. Subsequently , a total o f sixteen B CL-2 fam ily 
m em bers have been described [15]. These fall into three categories, based on sequence hom ology
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w ithin the four conserved dom ains found in BCL-2, designated BCL-2 H om ology (B H ) 1 to BH4. 
Firstly, B H 1-4 proteins such as BCL-2 and B C L -X l , w hich share all four conserved dom ains with 
BCL-2, act p redom inantly  as death inhibitors. N ext, BH1-3 proteins such as BAX  and BAK , which 
share only three dom ains w ith BCL-2, prom ote apoptosis in m ost cellu lar contexts. F inally  B H 3-only 
proteins such as BID and BIM , w hich share only the BH3 dom ain w ith B C L-2, function invariably as 
death agonists [64]. Figure 2 show s the dom ain arrangem ent in the sixteen B C L -2 fam ily proteins.
[1.4.2]The pro-apoptotic BH1 - 3  domains
T he first three BH dom ains (BH1 -  3) are thought to be involved in hom o- and hetero-dim erisation  of 
these proteins. BAX is capable o f hom o- and hetero- d im erisation w ith other B CL2 proteins even 
w hen the BH1 and B H 2 dom ains are rem oved, revealing the BH3 dom ain as the only part o f BAX 
critical for dim erisation  [65,66]. B H 3-m utants o f BAX are inactive in prom oting  cell death in 
m am m alian  and yeast cells [65,66], On the other hand it is the B H l and BH 2 dom ains o f  BCL-2 that 
are necessary for B A X -B C L-2 interaction [67].
[1.4.3]The BH4 domain
T he am phipathic helical BH4 dom ain is found exclusively in BCL-2 fam ily m em bers displaying anti- 
apoptotic activity. It has been suggested that the BH4 dom ain is involved in protein-protein 
interactions with pro-apoptotic BCL-2 fam ily m em bers, thus neutralising their function.
T he BH4 dom ain can be exchanged betw een the antiapoptotic proteins BCL-2 and BCL-Xi w ithout 
loss of function, but residue substitution or deletion o f all or part of B C L -2’s BH 4 dom ain  im pairs 
function [68], This is despite the fact that the m odified protein is still able to bind strongly to 
proapoptotic fam ily m em bers such as BAK, BIK, BIK, BAD and BIM , suggesting association with 
death  agonists p er  se is not sufficient for cell survival function.
A lthough the prim ary function o f the B CL-2 proteins is thought to be in regulating  the m itochondrial 
pathw ays o f apoptosis, Rosse and co-w orkers have show n that cells overexpressing BCL-2 can survive 
w ith significant am ounts o f cytochrom e c in the cytoplasm  [69], thus dem onstrating  that BCL-2 can 
a lso  protect cells from apoptotic death dow nstream  of m itochondrial involvem ent.
[1.4.4]The rheostat model
O ne m odel o f apoptosis regulation by the BCL-2 fam ily holds that, under norm al c ircum stances, pro- 
and anti- apoptotic proteins titrate each other in roughly equal stoichiom etry. A cell can set itself to a 
strongly  ‘p n > surv ' val’ state by up-regulating the am ount o f anti-apoptotic protein, so that a large 
increase in anti-apoptotic protein levels is required to tip the balance tow ards cell death. C onversely, a 
cell can render itself more sensitive to apoptosis by adjusting the balance c loser to parity, so that only a 
sm all increase in pro-apoptotic protein level will lead to an excess o f pro-apoptotic proteins and cell 
death  [70],
By generating  sm all-m olecule inhibitors o f B H 3-dom ain interaction betw een B C L-2 fam ily m em bers, 
D egterev  and co-w orkers confirm ed that one o f the key functions o f anti-apoptotic BCL-2 proteins is to 
bind and sequester pro-apoptotic proteins, thus neutralising their activ ity  [71 ].
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Figure 2 - The BCL-2 protein family.
The family is divided into three groups, based on domain structure -  BH1-4, BH1-3 and 
BH3-only. BH1-4 proteins act predominantly as death inhibitors, whereas BH1-3 and 
BH3-only proteins function as death agonists.
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This fits well w ith the observation  that cell types w hich are inherently m ore sensitive to death by 
apoptosis tend to show  a h igher ratio o f pro- to anti- apoptotic BCL-2 proteins than those w hich tend to 
be m ore resistant; for exam ple non-progenitor cells in the adult m ouse show  a h igher BAX / BCL-2 
ratio  than em bryonic cells [72].
[1.4.5]Membrane association
The m ajority  o f BCL-2 fam ily m em bers are m em brane-associated, e ither constitu tively  or follow ing 
activation. Several o f the proteins carry a trans-m em brane dom ain (see F igure 2). In 2003, K aufm ann 
and co-w orkers described the targeting  sequence present in B C L -X l w hich d irects it to the outer 
m itochondrial m em brane to be the C -term inal 20-residue trans-m em brane dom ain  present in m any 
other B C L -2 proteins, flanked at both ends by at least tw o basic residues [73], A com parable sequence 
targets B A K  to m itochondria [74], BAX also carries a sim ilar C -term inal m em brane association 
dom ain , but this dom ain is folded back into a pocket form ed by the BH1, 2 and 3 dom ains and is 
unavailab le  for m em brane binding before it is released during protein activation in apoptosis [751- The 
basic residues arc lacking in BCL-2, w hich therefore associates w ith several other intracellular 
m em branes in addition to the m itochondrial outer m em brane.
[1.4.6]Ion channel activity
D eterm ination  o f the 3D structure o f B C L -X l  by M uchm ore and co-w orkers in 1996 revealed a striking 
s im ilarity  to the pore-form ing dom ain o f bacterial toxins, in particular diphtheria toxin and the colicins 
176], Following this d iscovery it was dem onstrated  that several BCL-2 proteins display pore-form ing 
activ ity  in vitro [7,77-80], H ow ever, the pore size in these cases was only dem onstrated  to be large 
enough  for the passage o f sm all m olecules or ions, and not necessarily  for the efflux o f proteins such as 
cy tochrom e c.
In vitro  channel form ation by the pore form ing dom ains o f both colicins and diphtheria toxin depends 
on the presence of negatively charged lipids in the m em brane (> 10 % mole fraction), a negative-inside 
m em brane potential and a pH o f less than 4.0. U nder these conditions both BCL-Xi and BCL-2 also 
induce solute efflux from K C l-loaded vesicles [81]. In addition, several B CL-2 proteins have been 
show n to exhibit channel-form ing activity at physiological pH. In all cases there is a requirem ent for 
acid ic lipids in the mem brane.
[1.4.7]A direct BAX /BAK pore
T he d irect involvem ent o f BCL-2 proteins in outer m em brane perm eabilisation w as First suggested as a 
result o f the observation  that pro-apoptotic BAX, BID and BAD translocate to m itochondria early in 
apoptosis [82], A ntonsson and co-w orkers show ed that BAX  is capable o f form ing B C L -2-inhibitable 
channels in lipid m em branes through which liposom e-entrapped carboxyfluorescein  can be 
released [7]. Eskes w ent on to show  that addition o f BAX  to isolated m itochondria resulted in 
cytochrom e c re lease that could not be blocked by PT  pore inhibitors [83], suggesting an autonom ous 
B A X  pore m ight be responsible for cytochrom e c release during apoptosis. M ore recently, Pavlov and 
co-w orkers dem onstrated  by patch-clam ping experim ents a m itochondrial apoptosis-induced channel 
(M A C ) o f d iam eter (4 nm ) sufficient to allow  the passage o f cytochrom e c, w hose existence correlated
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w ith the presence o f BAX  in the outer m em brane [84], G uo and co-w orkers confirm ed by electro- 
physiological m ethods that cy tochrom e c was able to interact w ith the pore [85].
A num ber o f w orkers have confirm ed in cell-free experim ents the ability o f BAX to form  large 
channels. K uw ana and co-w orkers show ed that tBID  could activate m onom eric BAX to form large 
openings in a vesicular m em brane, sufficient to release dextran m olecules o f up to 2000 kD a [86]. 
S im ilarly  T errones and co-w orkers en trapped fluorescein iso th iocyanate-labeled  dextrans o f various 
sizes in pure lipid vesicles, and show ed that tB ID  and BAX  w ere able to induce the release of 
m olecules o f sizes up to around 70 kD [87].
In 2005, D ejean and co-w orkers show ed that M A C  activity was blocked by im m unodepletion  of BAX 
[88], T hey w ent on to show  that M A C  w as associated w ith oligom eric rather than m onom eric BAX; 
that M A C  channel activ ity  w as m odified by cytochrom e c, consistent w ith entry  o f cytochrom e c into 
the pore; that recom binant BAX  channels and M AC isolated from  apoptotic H eLa cells have sim ilar 
single-channel electrical behaviour; and that M AC activity is absent in B A X /B A K  double-knockout 
cells (but not in BAX single knockouts). T he above results strongly suggest that BAX or BAK  arc 
capable o f oligom erising to form  a large pore in the m itochondrial outer m em brane able to release 
cytochrom e c during apoptosis. Several other groups have show n that the presence o f either BAX or 
B A K  is essential for m itochondrial apoptosis [89,90], The specific region o f BAX necessary for pore 
form ation has been m apped to alpha helices 4 and 5; neither the transm em brane dom ain nor the BH3 
dom ain  are essential, these regions presum ably  being involved only in activation and targeting 19 1 1. 
C handra  and co-w orkers investigated the effects o f knocking out BAX and BAK proteins on apoptosis 
in H CT116 cells [92], They observed that BAX and BAK are, to an extent, functionally  redundant, 
a lthough BAX(-) cells are less susceptible to apoptosis than BAK(-) cells (w hich are only slightly  less 
susceptib le than W T cells).
[1.4.8]BH3-only proteins as afferent receptors of apoptosis
T he B H 3-only family o f B C L -2 proteins appear to act as the afferent receptors o f apoptosis, integrating 
pro-apopto tic  signals from  a diverse range o f stim uli and propagating the signal dow nstream  via a 
single pathw ay -  B A X /B A K -m ediated m itochondrial cytochrom e c release. Thus BID is activated 
dow nstream  of the Fas/Fas-L  pathw ay [93]; BAD is negatively regulated by the A kt/PK B  survival 
pathw ay [94]; and BID, N OX A  and PU M A  are regulated by p53 [95-98],
[1.4.9]BH3-only proteins as activators of multi-domain proapoptotic proteins
D esagher and co-w orkers dem onstrated a B ID -induced conform ational change in the pro-apoptotic 
BAX  protein  [99], They suggested that, during apoptosis, BID translocates to m itochondria and 
activates BA X  by this m echanism , this then being follow ed by cytochrom e c release. K orsm eyer and 
co-w orkers confirm ed this view , show ing the induction by tBID  o f a 22 A tetram eric BAX pore 
capable o f translocating  cytochrom e c [8], R uffolo and co-w orkers identified the tB ID -induced change 
to be the induction  o f an ‘open’ conform er of BAX or B A K , w ith the N -term inus exposed. This 
conform er induces conversion o f other ‘c losed’ B A X /B A K  m olecules to the ‘open ’ conform ation, thus 
initiating a cascade o f B A X /B A K  auto-activation into ‘open’ m olecules capable o f oligom erising  to 
form  the pore [100]. In this m odel, the prim ary role o f anti-apoptotic B CL-2 proteins is to bind the
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'o p e n ’ B A X /B A K  conform er, thus inhibiting the activation cascade, rather than inhibiting B H 3-only 
action directly.
This ‘B A X /B A K  pore’ m odel is supported by experim ents with knock-out anim als, in w hich it was 
show n that BID  is incapable o f inducing cytochrom e c release in the absence o f BAX or BAK 
[8,89,90,101,102]. There have, how ever, been som e reports suggesting that tBID  alone is capable of 
form ing a pore for cytochrom e c efflux [103].
[1.4.10]Release of sequestered multi-domain proapoptotic proteins by BH3-only proteins 
Several o ther B H 3-only proteins, how ever, are unable directly  to activate m ulti-dom ain  proapoptotic 
p roteins to induce m itochondrial dam age [104,105]. M oreau and co-w orkers have suggested a model 
w herein  the prim ary function o f the B H 3-only fam ily is to antagonise the anti-apoptotic effect of the 
B H 1-4 proteins. These B H 1-4 proteins are suggested constitu tively  to bind BH1-3 proteins, 
neutralising  their function. B H 3-only proteins com pete for the sam e binding site on the B H 1-4 
proteins, thus releasing the proapoptotic factors [106]. U sing a B A X -dependent m em brane 
perm eabilisation  assay, K uw ana and co-w orkers show ed that several peptides derived from the BH3 
dom ain  o f BH3-only proteins relieved BAX inhibition caused by B CL-X | or Mcl-1 ] 107]. This 'd e ­
rep ression ’ function was accom panied by the ability  o f som e peptides (derived from  BID and BIM ) to 
activate  BAX directly [ 1.4.9],
[1.5]Relationships between BCL2 proteins, mitochondrial membrane proteins and 
apoptosis
[1.5.1JVDAC
Shim izu  and co-w orkers show ed in 1999 that cytochrom e c release from m itochondria induced by 
B A X  or BAK was com pletely  inhibited in m itochondria isolated from  a VDAC-1 deficient yeast 
strain  [9]. They w ent on to show  B A X /B A K -dependent, BCL-X[ -inhibitable release of cytochrom e c 
from  V D A C -1-containing liposom es, and hence suggested that V D A C  itself w as the cytochrom e c 
re lease channel. Sim ilarly, Sugiyam a and co-w orkers dem onstrated  B IM -V D A C  interaction and a 
B IM -dependent enhancem ent o f V D A C  activity, and show ed V D A C -dependent apoptosis induced by 
BIM  [ 108]. C apano and co-w orkers have dem onstrated a B A X -V D A C  interaction using a G FP-B A X  
pull-dow n assay [109]. Shim izu and co-w orkers have also observed that BAX interacts with V DA C, 
and that B A X -induced apoptosis is inhibited when this interaction is prevented by blocking 
an tibodies [110], H ow ever they observe no effect o f these antibodies on B ID -induced cell death or 
B ID -induced  cytochrom e c release form  isolated m itochondria. These findings have been challenged 
by R ostov tseva et ul, w ho were unable to detect any interaction betw een BAX and V D A C. In contrast, 
these authors observed tB ID -dependent closure  o f the V D A C  channel, and suggested  that disruption of 
m itochondrial m etabolite exchange by this m echanism  m ight lead to m itochondrial dysfunction and 
apoptosis [111]. Shim izu and co-w orkers were unable to detect any interaction betw een BID and 
V D A C, nor any effect of BID on liposom e-incorporated V D A C [56],
C heng and co -w orkers have identified a difference in role betw een the tw o V D A C  isoform s present in 
m am m als. V D A C -2-deficien t cells w ere show n to be more susceptible to apoptotic death, and
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V D A C -2 overexpression inhibited the m itochondrial apoptotic pathw ay [112]. The effect is suggested 
to be m ediated  by V D A C -2 sequestration of BAK  in an inactive conform ation , preventing activation. 
B H 3-only m olecules such as tBID , BIM  and BAD were show n to d isplace V D A C 2 from  BAK, leading 
to hom o- and hetero- o ligom erisation  o f BAK and apoptosis. Loss o f the more abundant VDAC-1 had 
no effect on apoptosis.
[1.5.2JANT
A N T  exists as tw o isoform s in the inner m em brane. Peripheral inner m em brane contains both 
isoform s, w hereas the cristae m em brane contains only A N T-2 [113]. ANT-1 has a h igher affinity for 
cyclophilin  D, consistent w ith the location o f PT pore com plexes exclusively  in the peripheral inner 
m em brane. Bauer and co-w orkers show ed that overexpression o f the ANT-1 isoform  led cells to die by 
apoptosis [114]. The authors w ent on to show , by m utagenesis, that A D P/A T P transport activity w as 
not necessary for this effect. M achida and co-w orkers show ed in 2002 that the A N T  inhibitor MT-21 
w as able to induce m agnesium -dependent cytochrom e c release and apoptosis w ithout causing 
m itochondrial sw elling, suggesting that A N T  can m odulate apoptotic progression other than via its role 
in the PT pore [115],
[1.5.3]The relation between BAX and the PT pore
BAX  is norm ally cytosolic (75 ]. De G iorgi and co-w orkers have suggested that the signal for BAX 
translocation  to the m itochondrial outer m em brane is provided by the PT pore. This group loaded 
m itochondria in whole cells with tetram ethylrhodam ine methyl ester (TM R M ), and used fluorescence 
im aging both to m easure m em brane potential and to induce transient PT pore opening via free radical 
re lease from excited TM R M . They observed that this PT pore “ flicker” did not affect m itochondrial 
volum e or m orphology, but instead appeared to signal the redistribution o f  BAX and the form ation o f 
B A X  m ultim ers, thus leading to cy tochrom e c release [116]. H ow ever they w ere unable to show  that 
this BAX  redistribution w as not sim ply a secondary effect resulting from  disruption o f m itochondrial 
A T P production follow ing m em brane potential dissipation. This w ould be expected  to raise the 
ce llu lar A M P/A TP ratio and thus activate A M P-activated protein kinase (A M PK ) (review ed in [ 1171). 
A s show n by Capano and C rom pton [118], A M PK  activation leads to BAX translocation, via a 
pathw ay involving p38 M A P kinase.
In con trast to the work o f De G iorgi, N arita and co-w orkers have show n BAX - or BAK - dependent PT 
pore activation , dependent on interaction w ith V D A C, that w as inhibited by B C L -X l or BCL-2 [119]. 
A lso  Pasto rino  and co-w orkers have dem onstrated either transient or sustained PT pore opening 
induced by d ifferen t concentrations o f BAX (125 -  1000 nM ) [120]. Pastorino and co-w orkers have 
generated  a stably  transfected Jurkat T-cell line, in which bax  expression w as inducible by m uristerone 
A [121]. T hey show ed that cell death follow ing induction o f bax  expression  w as inhibited by a 
com bination  o f  C SA  and aristocholic acid (A rA ) but not by caspase inhibitors, and concluded that 
BAX  causes cell death via the PT pore.
W ieckow ski and co-w orkers reconstituted an in vitro  system  for B A X -induced m em brane 
perm eabilisation  o f liposom es or outer m em brane vesicles, and show ed that the presence o f the PT pore 
com plex w as a p rerequisite  for cytochrom e c release in both these system s [122], N otably, how ever,
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they were only able to dem onstrate release o f a sm all proportion of entrapped cytochrom e c under all 
conditions, and could  not show  release o f another entrapped protein (adenylate kinase), questioning the 
relevance o f their m odel in vivo.
[1.5.4]lnduction of the PT pore by BID
Zam zam i and co-w orkers developed a system  to study induction o f m em brane perm eabilisation  by BID  
and tB ID , both in intact cells and in a cell-free system . They show ed that B ID -induced 
perm eabilisation  of the m itochondrial outer m em brane could  be inhibited by three inhibitors o f the PT  
pore, nam ely  CSA, N -m ethyl-4-V al-C SA  and bongkrekic acid. Furtherm ore they show ed that tBID  
w as able to perm eabilise A N T -contain ing lipid bilayers, and w ent on to suggest that tB ID  exerts its 
action at least in part by functional interaction w ith the PT pore via A N T [123],
[  1.6]Role of tBID
[1.6.1 [Structure
BID  w as first identified as a death agonist by W ang and co-w orkers in 19%  (124], D espite having 
lim ited  sequence hom ology with other BCL-2 proteins (other than w ithin the BH3 dom ain) BID shares 
the sam e overall fold [125], containing eight alpha-helices, w ith tw o central hydrophobic helices 
surrounded by six am phipathic ones. As m entioned above, this fold resem bles that of pore-form ing 
bacterial toxins.
[1.6.2]Expression and location
B ID  is one of the m ost w idely expressed B H 3-only proteins [ 126], being strongly expressed throughout 
developm ent and also in a range o f m ature tissues. Im m unohistochem istry revealed especially  strong 
B ID  staining in short-lived and/or apoptosis-sensitive tissues such as neurons, germ inal centre B cells 
and peripheral blood granulocytes [127], and BID is also present in brain, spleen and liver [124,128], 
B ID  expression is found to be altered in several types o f cancer (e.g. [ 129]).
H aving  no m em brane targeting dom ain, BID is a predom inantly cytosolic protein [ 124]. H ow ever BID 
does associate to some extent w ith intracellular m em branes, depending on lipid com position , bilaycr 
cu rvature  and osm otic pressure [126], Upon activation during apoptosis BID translocates to the 
m itochondrial outer m em brane [82,99,130-132],
[1.6.3]Activation
Like o ther proapoptotic BCL-2 proteins, BID is norm ally present in the cytosol in an inactive state. In 
1998 Luo and co-w orkers published a sem inal paper revealing BID  cleavage by caspase 8, generating 
the active fragm ent tBID , to be the critical step in propagation o f the apoptotic signal from  cell surface 
death recep tors to the m itochondrial outer m em brane [93], The full length protein (197 residues; 
20 kD) is c leaved  at aspartate 59, after a consensus caspase cleavage site 56L Q T D 59. C leavage exposes 
an N -term inal glycine residue, which is post-translationally  N -m yristoylated , presum ably to enhance 
m em brane targeting  [133]. The C- and N- term inal fragm ents are thought to rem ain associated 
follow ing cleavage [125,134], BID cleavage is regulated by phosphorylation by casein kinases I and II,
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w ith the phosphory lated  form  being insensitive to cleavage 1135]. C leavage significantly  changes the 
surface charge and hydrophobicity  o f BID , aiding the change in subcellular localisation [ 136],
Slee and co-w orkers have identified an additional pathw ay o f BID activation, w herein BID  is cleaved 
by caspase 3 dow n-stream  o f cytochrom e c release, in a B C L 2-inhibitable m anner [137], This pathw ay 
represents a feedback loop for the am plification of m itochondrial cytochrom e c release induced by 
som e stim uli; i.e. a sm all am ount o f caspase 3 activation can lead to BID activation and therefore to 
substantial release of cytochrom e c.
Finally, V alen tijn  and co-w orkers f 138] have identified an alternative pathw ay o f BID  action, active in 
anoikis, in w hich B ID  cleavage does not occur. In this case full-length BID  translocates to 
m itochondria, and appears able to induce cytochrom e c release w ithout association w ith B A X  or BAK.
[1.6.4]Targeting and the mechanism of membrane association
BID  is thought to localise to specific regions o f the outer m itochondrial m em brane. Luttcr and co­
w orkers show ed by im m unogold labelling and electron m icroscope tom ography that tB ID  localises to 
contac t sites betw een the inner and outer m em brane [ 139]. Kim and co-w orkers how ever show ed that 
a sm all proportion o f tBID  can also bind to other sites on the outer m em brane (140], These authors 
w ent on to show by m ass spectrom etry that tBID  interacts w ith cardiolipin in a process requiring alpha 
helices 4 -6 , but not the BH3 dom ain. A dditionally , by dem onstrating inhibition o f apoptosis by 10-N- 
nonyl acridine orange (a cardio lip in-specific dye that prevents tB ID -cardio lip in  interaction) they 
suggested  that tB ID -cardiolip in  interactions arc essential for apoptosis. Hu and co-w orkers recently 
identified helix 6  as necessary, though not sufficient, for m itochondrial targeting, and subsequently  
identified  a 33-residue stretch spanning helices 6  and 7 as the m inim um  dom ain sufficient for binding 
[141]. Liu and co-w orkers have confirm ed the interaction of tBID  w ith cardiolip in  (or 
m onolysocardiolipin), and go on to suggest that this association is the driving force for d issociation of 
the inhibitory N -term inal fragm ent from  tB ID  follow ing cleavage [ 142],
B ased on studies of tB ID -induced pore form ation in liposom es, Yan and co-w orkers proposed that, on 
reach ing  the m itochondrial outer m em brane, tBID inserts deep into the hydrophobic core o f the 
m em brane (143]. This view has recently  been challenged by G ong and co-w orkers, w ho perform ed 
N M R  studies on m em brane-associated tB ID  [144]. These authors show ed that association  w ith lipid 
m em branes induces a unique conform ation of tBID , in which its helices are parallel with the m em brane 
surface, w ith no trans-m em brane helix insertion. E lectron param agnetic resonance (EPR) spectrom etry 
confirm ed  that tBID  binds to the bilayer w ithout adopting a trans-m em brane orientation  [145].
[1.6.5]Lipid transfer
B ID  has hom ology  to plant lipid transfer proteins [146], and lipid transfer activ ity  o f BID has been 
reported  [131]. G oonesinghe and co-w orkers have show n that full-length BID  has the ability  to insert 
selected lyso lip ids into the m em brane bilayer [147], The authors suggest this as the m echanism  of 
action o f fu ll-length  BID (as opposed to cleaved, activated tB ID ); insertion o f  these lipids into the 
m itochondrial outer m em brane would ‘p rim e’ the m em brane for insertion o f other pro-apoptotic 
proteins (includ ing  tB ID ), and for channel formation.
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[1.6.6]Cytochrome c redistribution
Scorrano and co-w orkers suggested in 2002 that tBID  was responsible for inducing a striking 
rem odelling  o f m itochondrial sub-structure, so that cytochrom e c stored in m itochondrial cristae was 
redistributed  to the peripheral inter-m em brane space, thus being prim ed for release across the outer 
m em brane [17]. The authors estim ated that approxim ately 85 % o f cytochrom e c stores are norm ally 
unavailable for rapid release as a consequence of their in tra-m itochondrial location. T hey also propose 
the tB ID -induced  redistribution  to be independent o f B A K  but inhibited by CSA , thereby im plicating 
the PT  pore in this process.
[1.7]Role of cyclophilins
[1.7.1 [Introduction
T he cyclophilins are a fam ily o f  peptidyl- prolyl- cis-trans isom erases (PPIases), present in several 
ce llu lar com partm ents. T he first m em ber was identified in 1984 as a binding target o f the 
im m unosuppressive fungal peptide cyclosporin A (CSA ) [148], C yclophilins w ere subsequently  
discovered  to catalyse the cis-trans isom erisation o f peptidyl-prolyl bonds and w ere nam ed 
PPI-ases 1149], The fam ily com prises more than eight m em bers in hum ans [150], including 
cyclophilin  A (a cytosolic protein, and the m ost abundant isoform ); cyclophilins B and C (located in 
the ER); cyclophilin D (m itochondrial); and cyclophilin-40 (a larger cytosolic isoform , o f 40 kD, in 
con trast to cyclophilins A - D which are 18-20 kD).
A s proline isom erases, cyclophilins have a role in protein folding, catalysing the conversion o f nascent- 
chain  proline am ide bonds to their native state. Recently, a num ber of other functions have been 
revealed, including regulation of the perm eability  transition pore; regulation  of T-cell function and 
inflam m ation; pathogenesis of vascular disease and rheum atoid arthritis; and hum an im m unodeficiency 
virus infection (review ed in [151]).
[ 1.7.2]The role of cyclophilin D in the PT pore
C yclophilin  D is known to be a core com ponent of the PT pore [ l .3.2], Based on the observation that 
C SA  blocks pore activity at concentrations sim ilar to those needed to inhibit PPIase activity, it has been 
suggested  that PPIase activity is a necessary step in pore opening [ 15 2 ,153], H ow ever, the binding of 
cyclophilin  D to A NT is not disrupted by CSA , at least when the tw o proteins are already 
associated  [29], and diethylpyrocarbonate (D PC; another inhibitor o f PPIase activity) does not inhibit 
pore opening  [ 154], These results suggest that the activity of cyclophilin  D tow ards the PT  pore m ight 
be m ediated  o ther than by its PPIase activity.
[1.7.3]The role of cyclophilin D in cell death
Lin and L ech le iter show ed that cyclophilin D overexpression protects cells from  tert-butyl peroxide- 
(t-B uO O H -) and staurosporine- induced m em brane potential collapse, and in fact that the resting 
m em brane potential w as h igher in these cells [155]. The authors w ent on to show , by m utagenesis 
experim ents, that the PPIase activity  o f cyclophilin  D was required for these effects, although the active 
site m utants w ere still capable o f binding to ANT. S im ilarly, Schubert and G rim m  show ed that
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cyclophilin  D w as able to specifically  repress A N T -1-induced apoptosis, and also that cyclophilin  D 
w as upregulated  in a num ber o f hum an tum ours, suggesting that inhibition o f apoptosis by cyclophilin  
D is a relevant m echanism  in vivo 1156]. In contrast to the work o f Lin and Lechleiter, how ever, these 
authors suggest that cyclophilin  D ’s antiapoptotic activity is independent o f its catalytic activity. 
R ecently , Li and co-w orkers show ed that cyclophilin  D overexpression strongly stim ulated PT pore 
opening; this resulted in inhibition o f apoptosis, but enhanced necrosis, indicating that perm eability  
transition is a necrotic, but not an apoptotic m echanism  [157].
N akagaw a and co-w orkers generated cyclophilin  D knock-out m ice, and investigated the response o f 
cells and m itochondria to various apoptotic and necrotic insults [59]. The authors observed no 
d ifference in response to apoptotic stim uli, but found protection from  necrotic death induced by 
reactive oxygen species and calcium  overload. C yclophilin  D (-) m itochondria w ere also unable to 
undergo perm eability transition. Sim ilarly , Baines and co-w orkers show ed that cyclophilin  D(-) 
m itochondria are resistant to sw elling and perm eability  transition in vitro, and also that cyclophilin  D ; 
cells are largely resistant to calcium  overload and ox idative-stress-induccd necrotic cell death 160]. In 
agreem ent w ith the w ork o f N akagaw a and co-w orkers they also observed no difference in response to 
apoptosis induced by staurosporine or TN Fu.
Finally , Schin/.el and co-w orkers have also investigated the role o f cyclophilin  D in apoptotic cell death 
by generating cyclophilin  D knockout mice and inducing apoptosis using a num ber o f different 
stim uli [158]. These authors observed no difference in mouse em bryonic fibroblast (M EF) apoptosis in 
response to etoposide (a topoisom erase II inhibitor) or staurosporine (a broad-spectrum  kinase 
inhibitor), both o f w hich induce the intrinsic m itochondrial pathw ay o f caspase activation. S im ilarly, 
there was no difference in response fo llow ing treatm ent w ith thapsigargin (w hich inhibits the C a“+ A TP 
pum p), tunicam ycin (w hich inhibits N -linked glycosylation), or brefeldin A (w hich inhibits ER-G olgi 
transport), all of w hich induce apoptosis via an ER stress response resulting  from  accum ulation  o f mis- 
fo lded proteins. C yclophilin  D -deficient M EFs were also equally  susceptible to death receptor-induced 
apoptosis (TN F or TRA IL). H ow ever, cyclophilin  D -deficient M EFs w ere found to be significantly  
less susceptible to apoptosis induced by H 2 0 2, specifically im plicating cyclophilin  D in the apoptotic 
signalling  pathw ay induced by oxidative stress.
[1.7.4]The role of proline isomerisation in ‘switching’
Isom erisation  o f proline residues has been proposed as a regulatory m echanism  in som e proteins. 
Pappenberger and co-w orkers have show n that prolyl isom erases are able to efficiently  catalyse native- 
state isom erisation  reactions, in som e cases at least [159], O ’Neal and co-w orkers suggested in 1996 
that an im m unophilin  such as FK 506-binding protein (FK B P) m ight regulate the activity  o f the 
prolactin  recep to r by proline isom erisation [160], Johnson and co-w orkers observe that a proline 
residue plays a crucial role in a conform ational change in d iphtheria toxin, leading to m em brane 
insertion [161]. Sim ilarly, Schinzel and co-w orkers have identified a proline residue in an unstructured 
loop o f B A X  to be critical for apoptotic activity [75]. The authors suggest that this residue som ehow  
regulates re lease o f the C -term inal trans-m em brane dom ain from  an internal binding pocket, allow ing 
translocation  o f  B A X  to the m itochondrial outer m em brane and subsequent cytochrom e c release.
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[  1.8]The actions of CSA
[1.8.1]Inhibition of cyclophilins
C yclosporin A was first isolated as a m etabolite o f the prokaryote Tolypocladium  inflaturns  [ 162], 
initially as an im m unosuppressive agent. C SA  was subsequently  found strongly to inhibit the PPIase 
activity  o f cyclophilins; the K j varies depending on cyclophilin  isoform , from  around 2 nM for 
cyclophilin  B up to approxim ately  300 nM  for cyclophilin  40 [163,164], T hrough its inhibition of 
m itochondrial cyclophilin  D, C SA  inhibits opening o f the PT pore induced by a num ber o f stim uli 
([165]; although pore opening induced by certain  stim uli is CSA- and cyclophilin- insensitive [154]). 
T he m echanism  o f PT pore inhibition is unclear, but m ay involve C SA -induced dissociation o f 
cyclophilin  D from the pore com plex [152], Som e w orkers have show n the cyclophilin  D -A N T  
interaction  to be d isrupted  by CSA  [36,166]; how ever som e have found that this interaction is 
preserved even in the presence o f C SA  [29]. The difference may be due to the order o f binding, w ith 
C SA  able to prevent association with A N T  w hen pre-incubated w ith cyclophilin  D, but unable to 
disrup t an existing interaction.
[1.8.2]Effects on other cellular targets
C SA  has been show n to have other in tracellu lar effects, in addition to its inhibition o f cyclophilins. For 
exam ple, CSA induces up-regulation o f the vasopressin type 1A receptor, apparently  via stim ulation of 
superoxide production [ l 67]. CSA  inhibits transport activity and surface expression o f the N a+-C a2+ 
exchanger N C X l, albeit at rather high doses (2 -2 0  pM ) [168], CSA also m odulates activity  of the 
m ulti-drug transporter P-glycoprotein [168],
C SA  has a num ber o f effects on cellu lar calcium  hom eostasis. In addition to its effects on the PT pore, 
C SA  is reported to inhibit the calcium  uniporter [169] and also to stim ulate activity  of the sarco- 
endoplasm ic reticulum  C a2+-A TPase (SE R C A ) [170],
T he effects o f CSA on respiration are unclear. On the one hand, CSA  has been show n to induce a 
hyper-m etabolic state in hepatocytes [171]; the effect is proposed to be due to stim ulation of 
prostag landin  E2 production by K upffer cells. H ow ever, H okanson and co-w orkers have dem onstrated 
inhib ition  o f respiration by C SA  in skeletal m uscle cells [172],
In terestingly , CSA can inhibit sterol processing in m itochondria (e.g. 27-hydroxylation of 
cholesterol [173,174], and 25-hydroxylation of vitam in D3 [175]). The effect has been found to be 
m ediated  via non-com petitive inhibition o f the m itochondrial 27-hydroxylase (cytochrom e P -45027) 
[174,175], perhaps due to inhibition o f substrate binding. On the other hand, C SA  activates sterol 
regu lator e lem en t binding protein-2 (SR EB P-2) via increased m essenger RNA  (m R N A ) levels, leading 
to an increase in cholesterol biosynthesis and V LD L triglyceride production [176],
CSA  is also reported  to inhibit m em brane fusion events [177], through an effect on the bilayer-to  
hexagonal phase transition propensity o f m em brane lipids.
[1.8.3]Gain-of-function effects of CSA
CSA  is able to  m ediate gain-of-function effects via its interaction w ith cytosolic cyclophilin  A [178]. 
C yclophilin  A is norm ally unable to interact w ith the protein phosphatase calcineurin, but, w hen bound
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to CSA , the cyclophilin  A -C SA  com plex can bind and inhibit calcineurin. This is the m echanism  by 
w hich C SA  exerts its m edically  im portant im m unosuppressive effects; calcineurin  inhibition blocks 
activation o f the N FA T, JN K  and p38 signalling pathw ays, inhibiting T-cell activation.
[1.8.4]Effects on cell death
T he effects o f CSA  on cell death, and on apoptosis in particular are w idely reported (review ed in 
[164]). C SA  is able to protect cells against necrotic and apoptotic death induced via PT -dependent 
m echanism s, but the specific effect o f CSA  on apoptotic m itochondrial cy tochrom e c release is unclear. 
A lthough BID - or BIK- induced cytochrom e c release from  isolated m itochondria is C SA -insensitive in 
som e system s [56], other groups have show n inhibition by C SA  of BAX - and/or B A K -induced 
cy tochrom e c release [119,121,179], and Scorrano and co-w orkers [17] have show n inhibition o f the 
analogous process induced by tBID.
[  1.9]Mitochondrial fission and fusion
[1.9.1 [Mechanism and significance
T he first ‘m ito-fusion’ to be identified w as the fuzzy onions (fzo) gene in D rosophila , fzo encodes a 
large predicted m em brane G TPase that was show n to be responsible for m itochondrial fusion during 
sperm atogenesis [180 |. Subsequently  H erm ann and co-w orkers dem onstrated  the yeast hom ologue, 
F z o lp , to be a m itochondrial integral m em brane protein, making contacts w ith both m em branes, that 
w as responsible for m itochondrial fusion events [1 8 l[. Sesaki and co-w orkers have show n U g o lp  to 
be another yeast protein, also w ith hom ology to fzo, which m ediates m itochondrial fusion events 1182], 
A dditionally , M gm lp , a self-assem bling G TPase, present in the inter-m em brane space, is proposed to 
coord inate  fusion o f the inner and outer m em branes, through interactions w ith both m em branes as well 
as w ith F z o lp  and U g o lp  [ 183]. T w o proteins, M fnl and M fn2 have been show n to m ediate 
m itochondrial fusion events in m am m als [184],
In yeast, D n m lp  and M g m lp  have been identified as fission factors [185], and Sm irnova and co ­
w orkers have identified the protein D rp l as a hum an hom ologue [ 186]. These proteins have hom ology 
to dynam in, the prototypic m em brane fusion protein, know n to catalyse G T P-dependent m em brane 
‘b u d d ing ’ and fission events, through a self-assem bly m echanism  [ 187-189].
D ynam ic fission and fusion appears to be im portant for m itochondrial function. Thus M fn l 7 or M fn 2 7 
em bryonic  fibroblasts display fragm ented m itochondria that are unable to m aintain m em brane 
potential, and these em bryos die in m id-gestation [184], H ow ever, by observing the frequency o f 
transcom plem entation  of tw o defective m itochondrial genes to be extrem ely  low, E nriquez and co­
w orkers have suggested m itochondrial fusion events to be very rare in m ost cell types [ 190].
[1.9.2]Relation to apoptosis
M itochondrial fragm entation is frequently observed in apoptosis [191,192], Frank and co-w orkers 
have show n that the D rp l translocates to m itochondria during apoptosis, w here it localises to potential 
sites o f  organelle  d ivision and catalyses this process [191]. These authors also show that inhibition of 
D rp l blocks cell death  by apoptosis. B reckenridge and co-w orkers report that caspase 8  activation
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leads to cleavage o f the integral ER m em brane protein BAP31 [193]. One o f the cleavage products 
(p20) induces recruitm ent o f D rp l to m itochondria, leading to fission o f the m itochondrial netw ork, 
and a strong sensitisation  to cytochrom e c release. Intriguingly, BAX appears to translocate to sites on 
m itochondrial that subsequently  becom e scission sites during apoptosis [194]. BAX is associated with 
D rp l and M fn2 at these foci. K arbow ski and co-w orkers have show n that the block o f m itochondrial 
fusion observed during apoptosis occurs w ithin the sam e tim efram e as BAX  translocation  to 
m itochondria and m em brane perm eabilisation, and have suggested the block m ight be a result o f BAX 
activation  [192].
T he link betw een m itochondrial fission and susceptibility  to cytochrom e c release is unclear. 
A lterations in m em brane lipid com position are likely to be involved in m em brane fusion events [ 195], 
and these changes m ay prom ote binding o f proapoptptic proteins, or facilitate pore form ation. 
A lternatively , fission events m ay be involved in the m obilisation o f cy tochrom e c stores for efflux 
1196], In relation to this, an intriguing link has been suggested betw een alterations in m itochondrial 
substructure and the fission/fusion m achinery: M g m lp  has been im plicated as an up-stream  regulator 
o f A TP synthase assem bly, w hich in turn is suggested to regulate cristac m orphology and cytochrom e c 
sequestration 1197],
[1.9.3]The link between cyclophilins and mitochondrial fission/fusion
G aligniana and co-w orkers have show n cytosolic cyclophilin  A to associate w ith dynein via dynam itin, 
in a PPIase-dom ain-dependent m anner (although PPIase activity is not required for com plex 
form ation) [198]. T chaicheeyan and co-w orkers have suggested the intriguing possibility that proline 
isom erisation m ight be involved in the m echanism  o f chem o-m echanical coupling in motor 
p roteins [ 199], perhaps explain ing the function o f cyclophilin  A association  w ith m otor protein 
com plexes. Since m itochondrial fission and fusion events depend on hom ologous m otor proteins, it is 
possib le that cyclophilin D m ight be involved in these processes.
[1.10] Phosphorylation
[1.10.1JBCL-2 proteins
T he activ ity  o f BID is know n to be regulated by phosphorylation. D ephosphorylation  o f a num ber of 
sites in an unstructured loop betw een helices 2 and 3 unm asks the caspase 8  clevage site, allow ing 
processing  to form  the active tBID  [ 135], A dditionally, dephosphorylation  is reported to enhance BID 
b inding to PA C S-2, resulting in transloaction to m itochondria [200].
B A D  is a lso  regulated by phosphorylation; dephosphorylation by calcineurin activates BAD  [201,202], 
In terestingly , these authors also report that rotenone is able to induce BAD  dephosphorylation  via the 
calc ineurin  pathw ay.
Finally, recom binan t BAX  is a substrate for serine/threonine kinases [203]; how ever the relevance of 
this process in vivo  is unknown.
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[1.10.2]Mitochondrial proteins
The regulation of various m itochondrial enzym es by phosphorylation is w ell know n - for exam ple, 
pyruvate dehydrogenase and branched-chain a-oxoacid  dehydrogenase [204,2051. V arious cA M P- 
dependent and independent protein kinases have been found in the inner m em brane and in the 
in term em brane space o f  m itochondria [206-211], and phosphorylation  o f several m em brane-bound 
proteins (6.5, 18 and 29 kD a), has been show n [209,212,213], R ecently, A zarashvili and co-w orkers 
suggested a connection betw een phosphorylation o f subunit c of the F 0 F, A TPase and the PT 
pore [214], w hereby dephosphorylation  was prom oted by calcium -induced perm eability  transition and 
inhibited  by CSA. The authors also raised the possibility  that this protein is part o f the PT pore. The 
sam e group w ent on to show  regulation o f phosphorylation o f a num ber o f o ther m itochodrial proteins 
(3.5, 17 and 23 kD) by calcium  levels, possibliy  m ediated by the PT pore and also by calm odulin  [215].
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CHAPTER 2 : MATERIALS AND METHODS
[2.1]Chemicals
U nless o therw ise stated, all chem icals and reagents were from Sigm a-A ldrich  U nited  K ingdom , and 
w ere reagent-grade.
General DNA Methods
[2.2]Polymerase chain reaction (PCR)
[2.2.1 ]Primer design
Prim ers were designed to include the follow ing features: 4 base spacers at the 5 ’ end; restriction sites 
included as necessary; at least 1 2  bases com plem entary  to the target sequence; annealing  tem perature 
betw een 60 -  70 °C; annealing  tem peratures o f up-stream  and dow n-stream  prim ers m atched to w ithin 
5 °C; m inim al potential for secondary structure form ation; and m inim al in ter-prim er com plem entarity . 
P rim ers were sourced from  Sigm a-G enosys.
[2.2.2]Enzyme
P fu  DNA polym erase (S tratagene) was used throughout. Pfu polym erase has high 5 ’ to 3 ’ DNA 
polym erase activity as well as a proof-reading 3 ’ to 5 ’ exonuclease activity to im prove copying fidelity.
[2.2.3]Reactions
50  pi PCR reactions typically  had the follow ing com position : 5 p i o f 10X Pfu  buffer, 1 -  20 ng of 
D N A  tem plate, 35 pm ol o f upstream  prim er, 35 pm ol of dow nstream  prim er, 250 pM  each dN TP, 
2 m M  M gCE, 2.5 units o f Pfu  polym erase, and dH 20  q.v.. Pfu buffer contained 200 mM  Tris-H C l, 
pH 8 .8 , 100 mM  (N H 4 ) 2 S 0 4, 100 m M  KC1, 1 % Triton X-100, 1 m g/m l bovine serum  album in (BSA). 
PC R  constitu ted  35 cycles o f  denaturing  at 96 °C for 45 secs, annealing at 5 °C below  the low est prim er 
m elting  tem perature for 45 secs, and extension at 72 °C for 1 min per kilobase, follow ed by a final 
10 min extension at 72 °C.
[2.3]Agarose gel electrophoresis
A garose (type V) was dissolved w ith heating in 40 mM  Tris-C l, 0.12 % (v/v) glacial acetic acid, 1 mM  
E D T A , pH 8.0 (TA E) to 0.8 -  1.2 %, depending on the size of fragm ents of interest. The gel was 
a llow ed to cool to 50 °C. 2 ,7 ,-D iam ino-10-ethyl-9-phenyl-phenanthrid ium  brom ide (ethidium  
brom ide) w as added to 0.5 pg/m l, and the gel was cast in a plastic tray. 6  X loading buffer 
(0.25 % (w /v) brom ophenol blue, 0.25 % (v/v) xylene cyanol FF, 15 % (v/v) Ficol 400) was added to 
D N A  sam ples, w hich were then inroduced into the wells. G els w ere run at 100 V in T A E  in a H orizon 
11.14 unit (G ibco) until the dye front reached the end o f the gel. B ands were visualised and 
photographed under UV light using the G eneG enius system  (Syngene).
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[2.4]DNA purification from agarose gels
D N A  was extracted  from  excised  gel slices using the G eneC lean II kit (Q -B io  gene) according to the 
m anufactu rer’s instructions.
[2.5]DNA quantitation
D N A  sam ples w ere dilu ted  to 1 ml in dH 2 0 .  A bsorbance was m easured at 260 and 280 nm. The A 2 6 0  
value gives D N A  concentration  by the relationship:
[ds DNA] (m g/m l) = 50 x A 2 6 0
T he value A 260/A 28o gives a m easure o f  D N A  purity, with values below  1.8 indicating protein 
contam ination .
[2.6]Plasmid generation
[2.6.1 [Double digestion
1 pg  of plasm id was added to a 1/3 m olar am ount o f insert, in 1 0 0  p i o f the appropriate restriction 
enzym e buffer. T w o 10 pi aliquots w ere rem oved, and 1 unit o f single restriction enzym e added to 
each tube. 8  units o f both enzym e was added to the rem ainder o f the digest mix, and all three tubes 
w ere incubated at 37 °C for 2 hr. Enzym es w ere inactivated by heating to 70 °C for 10 mins, and 
digestion  products w ere checked by agarose gel electrophoresis [2.3] to confirm  com plete cleavage by 
both enzym es. All restriction enzym es and buffers w ere obtained from N ew  England Biolabs.
[2.6.2]Phenol-chloroform extraction
A n equal volum e of 1:1 phenol:chloroform  was added to the digest mix, vortexed for 1 min and 
centrifuged  in an E ppendorf 3200 bench centrifuge for 2 mins at 13,000 g. The upper layer was 
rem oved, and 1/10 volum e o f 4 M sodium  acetate pH 5.2 was added, follow ed by 3 volum es o f 70 % 
e thanol. T he m ixture was vortexed for 1 min, left for 1 hr at -2 0  °C and centrifuged (E ppendorf 3200 
bench centrifuge; 13,000 g) for 10 m ins at 4 °C. The supernatant was rem oved, and 3 volum es of 
100 % ethanol carefully layered onto the pellet. A fter 30 mins at -2 0  °C the m ixture w as centrifuged 
for 10 m ins at 4 °C, the supernatant rem oved and the pellet dried for 10 mins at 50 °C.
[2.6.3]Ligation
T he D N A  pellet w as resuspended in 7.5 p i o f dH 2 0 .  1 p i of 10X T4 D N A  ligase buffer (N ew  England 
B iolabs; 330 m M  Tris-A cetate, pH 7.8, 660 mM  potassium  acetate, 100 m M  m agnesium  acetate, 5 mM 
D L -dith io threito l (D TT)) was added, along with 0.5 pi 10 m M  A TP. 0.5 p i pre-ligate was rem oved. 
1 p i (400 U) T 4 D N A  ligase (N ew  England B iolabs) was added, and the ligation reaction was allow ed 
to  p roceed for 15 m ins at room  tem perature. T he enzym e was inactivated  by heating to 70 °C for 
10 mins. 0.5 p i o f post-ligate was run alongside the 0.5 p i of pre-ligate on an agarose gel [2.3] to 
confirm  ligation.
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[2.7]Generation of bacterial cell lines
[2.7.1]Preparation of competent cells
10 ml o f N utrient B roth (O xoid; No. 2) was inoculated w ith a single isolated colony from  a freshly 
m ade agar p late o f the appropriate strain. E. coli D H 5a w as routinely used (genotype F ,  
08Od/acZAM 15, A(/£icZKA-argF)U169, deoR , recA  1, endAX, h sd R X l(rk \ m k+), phoA , supE 44, X , th i-1, 
gyrA 96, relAX). The culture w as incubated overnight at 37 °C w ith shaking, and then added to 200 ml 
o f fresh N utrient B roth. T he culture w as grow n w ith shaking to an optical density  at 600 nm (O D 600) of 
0.5 -  0.6, and cells w ere then sedim ented by centrifugation for 5 m ins at 5000 g. The pellet w as gently 
resuspended  in 40 ml o f ice-cold 75 m M  C aC l2, 15 % (v/v) glycerol, and then re-sedim ented  for 5 m ins 
at 5000 g in the sam e rotor. The pellet w as gently resuspended in 5 ml o f ice-cold 75 m M  C aC l2, 15 % 
(v/v) glycerol, and div ided into 250 pi aliquots. A liquots w ere rapidly frozen on dry ice and stored at 
-70 °C.
[2.7.2]Preparation of agar plates
2.5 % granulated agar (D ifco laboratories) w as added to 500 ml o f N utrient B roth (O xoid; No. 2), and 
autoclaved. The m ixture was allow ed to cool to 50 °C, and antib io tics w ere added as appropriate 
(am picillin  to 100 p.g/ml, kanam ycin to 20 p.g/ml or chloram phenicol to 30 p.g/ml). 20 ml fractions 
w ere poured into sterile 85 mm petri dishes (S terilin) and allow ed to cool.
[2.7.3]Transformation
A n aliquot of com petent cells [2.7.1] w as thaw ed on ice. 100 ng o f plasm id w as added, and the cells 
incubated  on ice for 40  mins. The cells w ere heated to 37 °C for 10 m ins, and then added to 5 ml of 
nu trien t broth, pre-w arm ed to 37 °C. T he culture was incubated at 37 °C for 2 hr w ith shaking, and 
then centrifuged at 4500 g for 5 m ins. The cell pellet was gently resuspended in 150 pi o f nutrient 
broth, and plated on a freshly prepared agar plate [2.7.2]. P lates w ere incubated overnight at 37 °C.
[2.7.4]Blue-white colour selection
A gar plates w ere prepared as above [2.7.2], except 40 pg/m l 5-brom o-4-chloro-3-indolyl-()-D - 
galac toside (X -G al) and 1 m M  isopropyl-p-D -thiogalactopyranoside (IPTG ) w ere added together with 
the an tib io tics. IPTG -induced (1-galactosidase production results in a blue co lour due to release o f the 
5 -brom o-4-chloro-3-indolyl m oiety in cells carrying an intact LacZ gene (non-transform ants). 
T ransfo rm an t colonies, carrying a disrupted LacZ  gene, rem ain w hite.
[2.7.5]PCR Screening
C olonies w ere screened for presence o f insert by PCR. A single isolated colony from  the overnight 
p late w as inoculated  into 200 pi nutrient broth, w ith the appropriate antibiotic. The culture w as 
incubated  at 37 °C for 4 hr, after which 2 p i was used as tem plate for a PC R  reaction [2.2], using the 
appropriate p rim ers. C ultures giving a PC R  product (indicating presence o f the insert) were streaked 
onto  freshly p repared  agar plates, containing the appropriate antibiotic. The tem plate for the negative 
control w as from  a culture o f non-transform ed cells.
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[2.8]Gene cloning using the pPCR-Script vector
[2.8.1 [Background
T he pPC R -Scrip t clon ing  kit (S tratagene) w as used for blunt-end ligation o f PCR products into the 
pPC R -Scrip t vector. The pPC R -Scrip t cloning technique utilises a unique ligation strategy, based on 
the uncom m on restriction site o f the enzym e S r / I .  As show n in Figure 3, the ligation m ixture contains 
S r f l l  in addition  to the pPC R -Scrip t vector, insert and T4 D N A  ligase. C leavage o f the S r f  I site 
generates linear vector, w hich inter-converts w ith the closed form  through the opposing action o f T4 
ligase. Insertion  of the PC R  fragm ent, how ever, disrupts the S r f  I site, trapping the vector in the closed 
state w ith insert. Insertion of the fragm ent also disrupts the LacZ gene carried  by the vector, allow ing 
b lue-w hite  selection o f positive transform ants.
[2.8.2]Vector generation
10 p i reactions had the follow ing com position: 10 ng o f pPC R -Scrip t A m p SK (+) V ector, 1 p.1 o f PCR- 
Scrip t 10 X reaction buffer, 0.5 mM  A TP, 70 X m olar excess PCR product (-1 5  ng), 5 units o f S r f  I 
restriction  enzym e, 4 units of T4 D NA  ligase and w ater q.v.. The reaction m ixture w as incubated for 
1 hr at room  tem perature, and then heated to 65 °C for 10 mins to inactivate the enzym es.
[2.8.3]Transformation
40  pi of X LIO-G old Kan ultracom petent cells (Stratagene) were thaw ed on ice. 1.6 p i of 
(Tm ercaptoethanol w as added, and the cells incubated for 1 0  mins on ice w ith gentle m ixing. 2  p i of 
the ligation mix was added, and the cells incubated on ice for 30 mins. The cells w ere heat-pulsed by 
heating  to 42 °C for exactly  30 sec, and then incubated on ice for a further 2 mins. 450 p i of pre­
w arm ed N utrient B roth (O xoid No. 2) was added to the cells, w hich w ere then incubated for 1 hr at 
37 °C w ith shaking. 200 pi o f the transform ation mixture was plated on a freshly prepared X -Gal / 
IPT G  / agar plate [2.7.2], contain ing am picillin  (100 pg/m l). P lates were incubated overnight at 37 °C 
and positive transform ants (w hite colonies) picked.
[2.9]Preparation of plasmid DNA from bacteria
Plasm id D N A  w as extracted from  bacterial cultures using the M iniPrep or M axiPrep  kits (Q iagen) 
accord ing  to the m anufacturer’s instructions.
[2.10]DNA sequencing
D N A  sequencing  was carried out by U CL scientific support services, using the d i-deoxy m ethod of 
Sanger and co-w orkers [216] as developed by R uiz-M artinez and co-w orkers [217], on a Beckm an 
C oulter C E Q  8000 genetic analysis system.
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T4 DNA ligase
T4 DNA ligase
Figure 3 - The pPCR-script cloning strategy (Stratagene).
Inter-conversion of closed and open vector through the opposing actions of T4 ligase and 
Srf I maintains a pool of open vector. Insertion of the PCR fragment disrupts the Srf I 
site and traps the vector in the closed state with insert. Figure taken from Stratagene
pPCR-script manual.
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[2.11]Preparation of glycerol stocks
10 ml o f nutrient broth (O xoid No. 2) w as inoculated w ith a single isolated colony from  a freshly made 
agar plate [2.7.2], The culture was incubated overnight at 37 °C w ith shaking, and cells were then 
sedim ented by centrifugation  for 10 mins at 4500 g. The pellet w as resuspended in 0.5 ml of sterile 
20 % glycerol, frozen rapidly on dry ice and stored at -7 0  °C.
Protein Methods 
[2.12]Fast protein liquid chromatography (FPLC)
FPLC  w as carried out on a Pharm acia LK B system , using the follow ing colum ns, at a flow  rate of 
l m l/m in:
Function Column Gradient species Buffer
Anion exchange l ml M ono Q HR 5/5 C f(N a C l) 20 mM  Tris-C l, pH 7.4
Cation exchange l ml M ono S HR 5/5 N a+ (NaCl) 10 mM K -H EPES, pH 7.0
H ydrophobic
interaction
l ml phenyl Superose 
HR 5/5 (N H 4 )2 S 0 4 20 mM  Tris-C l, pH 7.4
Gel filtration 25 ml Superdex 75 
HR 10/30 -
100 mM NaCl, 
20 m M  Tris pH 7.4
[2.12.1]Calibration of gel filtration column
T he colum n was calibrated using 250 p i o f a mixture of blue dextran (3 m g/m l), alcohol dehydrogenase 
(2 m g/m l), BSA (4 m g/m l), carbonic anhydrase (4 m g/ml), u-chym otrypsin  (4 m g/m l), cytochrom e c 
(1.5 m g/m l) and aprotinin (4 m g/m l), as show n in Figure 4 and Figure 5.
[2.13]Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE)
T he m ethod used was a m odification o f Laem m li [2 18].
[2.13.1 JReagent preparation
50%  A cry lam ide Solution (32:1) contained 48 % (w /v) acrylam ide, 1.5 % (w /v) m ethylene-bis- 
acrylam ide. G el buffer contained 3 M Tris, 0.3 % (w/v) sodium  dodecyl sulphate (SD S), pH 8.5. 
A m m onium  persulphate (A PS) was 10 % (w /v), and w as made im m ediately  before use and stored on 
ice. A node buffer was 200 mM  Tris, pH 8.9. C athode buffer was 100 m M  Tris, 100 mM  Tricine, 
0.1 % (w /v) SD S, pH 8.2.
[2.13.2]Gel composition
Stacking and reso lv ing  gels w ere made as follow s. A crylam ide percentage was chosen according to the 
m ass o f proteins o f  interest.
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2 1 9  2 2 7
Chart distance/ Elution volume
Figure 4 - Gel filtration of protein standards.
A mixture of blue dextran, alcohol dehydrogenase, BSA, carbonic anhydrase, u- 
chymotrypsin, cytochrome c and aprotinin was applied to a Superdex 75 gel filtration 
column and eluted with 100 mM NaCl, 20 mM Tris pH 7.4 at 1 ml per min. A trace was 
recorded using a chart recorder running at 10 mm/min. The distance of peak centres 
from the point of sample application is indicated in mm.
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Ve/V0
Figure 5 - Calibration graph deriving from gel filtration of protein standards.
The distances indicated on Figure 4 were used to calculate values of Ve/V0 (distance to
peak centre divided by distance to centre of blue dextran peak; assuming blue dextran to
be completely excluded from the column). As expected, Ve/V0 shows a linear relation to
log(relative molecular mass) (log(Mr)).
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8% 10% 12% 18% Stacking (4%)
50% Acrylamide 32:1 4.8 6.0 7.2 10.8 1.0
Gel buffer 10.0 10.0 10.0 10.0 3.1
Glycerol 3.2 3.2 3.2 3.2 0.0
dH2Q 12.0 10.8 9.6 6.0 8.4
Gel so lu tions w ere degassed using a vacuum  pum p w hilst w arm ing in a 50 °C w ater bath for 10 mins. 
Im m ediately  before casting, N, N, N \  N ’ -  tetram ethylethylene-diam ine (TE M E D ) and 10%  APS 
w ere added to 1.1 p l/m l and 11 p l/m l respectively, to induce polym erisation. G els w ere cast using the 
SE  250-M ighty  Sm all II electrophoresis unit (H oeffer Scientific Instrum ents, San Francisco).
[2.13.3]Protein sample preparation
1 volum e o f 2 X sam ple loading buffer (10 mM  T ris-C l, 6  % (w/v) SDS, 2 mM  ED TA , 20 % (v/v) 
g lycerol, 0.025 % (w /v) brom ophenol blue, pH 6 .8 ), and 2 % (v/v) 2-m ercapto  ethanol w as added to the 
protein sam ples. Sam ples w ere heated at 90 °C for 10 mins.
[2.13.4]Electrophoresis
T he gel was electrophoresed at 20 mA until the dye front had m oved into the resolving gel, after which 
the current was raised to 30 -  50 mA until the dye front reached the bottom  o f the gel. The anode 
buffer was 200 mM  T ris-C l, pH 8.9 and the cathode buffer was 100 mM Tris-C l, 100 mM  Tricine, 
0.1 % (w /v) SDS, pH 8.2.
[2 .14]Coomassie staining
[2.14.1]Standard
A fter electrophoresis [2 .13], protein gels were washed three times for 5 m ins w ith 100 ml o f dH 2 0 .  
T he gel was stained w ith 20 ml o f S im ply Blue SafeStain (Invitrogen) for 1 hr w ith gentle shaking, and 
then w ashed tw ice for 30 mins with 100 ml o f dH 2 0 .
[2.14.2]Colloidal
A fter e lectrophoresis [2.13] the gel was fixed overnight in 200 ml o f 50 % (v/v) e thanol, 2 % (v/v) 
H 3 P 0 4. T he gel was washed three tim es for 30 mins with 200 ml o f dH 20  and placed in 34 % (v/v) 
m ethanol, 17 % (w/v) (NH 4 )2 S 0 4, 3 % (v/v) H 3 P 0 4. A fter 1 hr, C oom assie Blue G -250 was added to 
0.7 m g/m l and the gel was stained for 3 - 4  days.
[2.15]Silver staining
Silver sta in ing  o f  protein gels was carried out using the S ilver Stain P lus kit (B ioR ad) according to the 
m anufactu rer’s instructions.
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[2.16]Western blotting
[2.16.1 [Blotting
Filter paper (W attm an 3M M  C hr) and nitrocellulose (0.45 pm  pore size, Schleicher & Schuell) were 
cut to size and soaked in transfer buffer (50 mM  Tris, 40  mM  glycine, 1.5 % (w /v) SD S, 20 % (v/v) 
m ethanol, pH 8.5) for 30 mins. A fter SD S-PA G E  [2.13] the gel sandw ich was prepared, and proteins 
w ere transferred  to the nitrocellu lose using a constant voltage o f 30 V for 1 hr in an XCell II blot 
m odule (Invitrogen).
[2.16.2]Probing
B lots w ere blocked using either pow dered m ilk (M arvel; 10 % in phosphate buffered saline (PBS)), 
BSA  (10 % in PBS) or 1 X O dyssey®  blocking buffer (L iC or biosciences) for 1 hr at room  tem perature 
w ith gentle shaking, and then w ashed for 5 m ins in PBS plus 0.1 % T w een-20 (PB S-T). The blot was 
then incubated for 1 -  24 hr at room  tem perature with prim ary antibody, dilu ted  to the appropriate 
concentration  in either pow dered m ilk (M arvel; 4.5 % in PBS-T), BSA (3 % in PB S-T) or O dyssey®  
blocking buffer (L iC or biosciences; 0.5 X in PBS-T). Blots w ere w ashed three tim es for 5 mins in 
PB S-T  and then incubated for 1 hr at room  tem perature in the appropriate secondary antibody, in the 
sam e solution as for the prim ary antibody. Blots w ere w ashed four tim es for 5 mins in PBS-T.
T he follow ing antibodies and dilutions w ere used: m onoclonal anti-cytochrom e c (C albiochem , 
A P1030, 1/1500), m onoclonal anti-B A K  (U pstate, 06-536, 1/2000), m onoclonal anti-B A X  N 20 (Santa 
C ruz, sc-493, 1/1500), m onoclonal an ti-V D A C  (C albiochem , 529532, 1/1500), polyclonal anti-A IF  
(S tratagene, B 12000, 1/1500), polyclonal anti-cyclophilin  D (A bCam , ab3567, 1/2000), polyclonal 
anti-cyclophilin  A (U pstate, 07-313, 1/1500), polyclonal anti-A N T  (produced in-house, 1/1500), 
fluorescent anti-m ouse secondary (800 nm, Rockland, K FB002, 1/5000), fluorescent anti-rabbit 
secondary  (680 nM, Invitrogen, A 21076, 1/5000), H RP-conjugated anti-rabbit secondary (Sigm a, 
A 0545, 1/5000).
[2.16.3] Detection
For fluorescent secondary antibodies, bands were detected and quantified  using the L i-C or O dyssey 
system . A lternatively, for H R P-conjugated secondary antibodies, blots w ere incubated w ith ECL 
D etection  R eagents (A m ersham ), and then exposed to Super RX M edical X -R ay film  (Fuji). For 
quan tification , the developed film was scanned, and bands analysed using the Scion im age program  
(Scion C orporation).
[2.17]Protein assays
Three protein  assays were used, according to the requirem ent e ither for speed, accuracy or sensitivity.
[2.17.1] Biuret assay
The B iuret assay w as used to quantitate protein sam ples from  0.5 to 50 mg/m l. The m ethod w as that of 
K roger and K lingenberg  [219]. 167 pi of sam ple (diluted w ith w ater as appropriate) was added to 
67 pi o f 4%  (w /v) sodium  cholate, 667 pi of 10% (w/v) N aO H  and 100 p i o f 1% (w /v) C u S 0 4. The
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reactions w ere m ixed well, left to stand for 1 0  m ins and transferred to 1 ml plastic cuvettes. 
A bsorbance w as m easured at 540 nm  and converted  to protein concentration  using a BSA  standard 
curve.
[2.17.2]Lowry assay
The L ow ry assay was used to quantitate protein sam ples from  0.01 to 20 m g/m l. The m ethod was that 
o f H arring ton  [220]. Im m ediately  before use, solution A (0.4 % (w /v) N aO H , 2 % (w /v) N a 2 C 0 3, 
0 .16 % (w /v) sodium  tartrate, 1 % (w /v) SD S) was m ixed w ith 1/100 volum es o f 4 % (w /v) C u S 0 4. 
750 p i o f this solution w as added to 250 p i o f protein sam ple and left to stand at room  tem perature for 
20  m ins. Folin -C iocalteu’s phenol reagent [221] v/as diluted 1:1 w ith dH 2 0 ,  and 75 pi added to the 
sam ples, w hich w ere then left to stand for an additional 45 m ins, in the dark. A bsorbance w as 
m easured  at 750 nm and converted  to protein concentration using a BSA standard curve
[2.17.3]Fluorescence assay
T he fluorescence assay w as used to rapidly  determ ine the approxim ate protein concentration  of 
m itochondrial preparations. 3 ml o f 395 mM  sucrose, 10 mM K -H EPES, 0.5 mM  EG TA , pH 7.4 
(SH -E ) was added to a fluorim eter cuvette. F luorescence was m easured on a Perkin-E lm er LS-5B 
fluorim eter using excitation  at 280 nm and em ission at 320 nm. A sm all volum e o f the m itochondrial 
p reparation  (5 -  10 p i; 20 -  40  pg) w as added to the cuvette and m ixed thoroughly, and the 
fluorescence m easurem ent repeated. [R eading -  B ackground] was converted  to protein concentration 
using a standard curve, prepared using parallel assays on a typical m itochondrial preparation by the 
B iuret method.
[2 .18JGST affinity precipitation
[2.18.1]Preparation of Fusion Protein-GSH-Agarose resin
2.5 ml o f  a sm all overnight culture o f E. coli D H 5a, harbouring the plasm id o f interest, was diluted 
10 -fold in fresh nutrient broth, contain ing  the appropriate antibiotic. C ells w ere grow n at 37 °C to an 
O D 6 0 0  o f 0.6 -  0.8 (typically around 2 hr). Expression was induced by adding IPTG  to 40  pg/m l, and 
cells w ere grow n overnight at room  tem perature. C ells w ere sedim enled by centrifugation  at 4500 g 
for 10 m ins, and the pellet resuspended in 4 ml of 100 mM  N aCl, 20 m M  T ris-C l, 0.5 mM  EDTA , 
pH  7 .4  con tain ing  10 mg/ml hen egg w hite lysozym e. A fter a 1 hr incubation  on ice, cells were 
son ica ted  for 4  x 30 secs with a 30 sec cooling period in a Sanyo Soniprep 150 sonicator at 10 pm  
deflection , using a 6  m m  probe. C ells w ere spun for 15 mins at 13,000 g at 4 °C, and the supernatant 
collected . M eanw hile, 20 mg reduced glutathione- (G SH -) agarose was sw elled overnight in dH 2 0 ,  
and pipetted  in to  a glass colum n (Pierce; No. 20055, 8  m m  I.D. x 152 m m , 40  pm  pore disc). The 
colum n w as equilib rated  w ith lysis buffer and the supernatant contain ing  recom binant protein w as 
applied  to the colum n in three passes. T he colum n w as w ashed w ith 7 x 2 ml o f PB S-T, follow ed by 
3 x 2 ml o f  the buffer to be used in the pull-dow n experim ent. The buffer depended on the extract to be 
used (sub-m itochondrial particles (SM Ps), total protein, or soluble protein) -  com positions are given 
below  [2.27]. The resin was w ashed out of the colum n, centrifuged for 1 min at 100 g, and
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resuspended in approxim ately  500 pi o f buffer, to m ake a 1:1 agarose/buffer m ixture. All steps were 
carried  out at 4 °C.
[2.18.2]Pull-down of mitochondrial proteins
1400 p i o f m itochondrial extract (SM Ps, total protein or soluble protein, as specified in the text) [2.27] 
w as incubated  w ith 60 p i o f fusion protein-G SH -agarose resin [2.18.1] in a 1.5 ml E ppendorf tube, for 
10 m ins at 4  °C on a rotary shaker. Tubes w ere spun for 5 secs in a bench-top  centrifuge and the 
supernatan t rem oved. 1450 p i o f the appropriate buffer w as added (again, depending on the extract 
used; [2 .27]), and the tubes incubated for another 5 mins at 4 °C on the ro tary  shaker. These w ash steps 
w ere repeated  tw o to four tim es. Fusion protein and m itochondrial proteins bound to it w ere eluted by 
add ing  3 x 40 p i of 50 m M  G SH  in the sam e buffer. The tubes w ere centrifuged after each addition, 
and the supernatants rem oved and com bined. For experim ents w ith inhibitors, the fusion protein-G SH - 
agarose resin was preincubated  w ith inhibitor for 5 mins at 4 °C before addition  o f m itochondrial 
ex tract.
[2.19]Protein sequencing
[2.19.1]Trypsin digestion
E xcised gel bands w ere w ashed three tim es w ith 200 pi o f 50% acetonitrile  (A C N ) in 5 mM N H 4 H C O 3 , 
pH 8.0, and dried in a rotary vacuum  evaporator (Savant SpeedV ac). 150 pi o f 10 m M  D TT in 5 mM 
N H 4 H C O 3 pH 8.0 was added to the gel pieces, w hich were then incubated for 45 m ins at 50 °C. The 
D T T  solution was rem oved, and replaced w ith 150 p i o f 50 mM  iodoacetam ide in 5 mM N H 4 H C O 3 , 
pH  8.0. Gel pieces w ere incubated for 1 hr at room  tem perature in the dark, w ashed tw ice with 200 pi 
o f  50%  ACN in 5 mM N H 4 H C O 3 , pH 8.0, and dried in the rotary vacuum  evaporator. 5 pg/m l trypsin 
in 15 p i of 5 mM N H 4 H C O 3 , pH 8.0 was added to the gel pieces, w hich w ere then left overnight at 
37 °C. The gel pieces w ere centrifuged  and the supernatant rem oved. 150 pi o f 5 0 %  A CN , 5 % 
trifluoroacetic  acid in 5 m M  N H 4 H C O 3 , pH 8.0 was added to the gel pieces, w hich w ere agitated gently 
and then centrifuged. The supernatant w as rem oved, and this last step repeated once more. The 
com bined  supernatants w ere evaporated  to dryness in the rotary vacuum  evaporator and stored at 
-20 °C.
[2.19.2]Mass spectrometry
L iquid  chrom atography  tandem  mass spectrom etry (LC -M S-M S) w ere carried  out at the Proteom ics 
U nit o f the W olfson Institute of B iom edical R esearch, U CL. Peptide m ass m atching against the NCBI 
database w as carried  out using the M ascot search engine (M atrix Science) [318],
[2.20f2P labelling
B 50 cells w ere g row n to 90 % confluence. C ells were w ashed tw ice w ith 20 ml o f ice-cold PBS and 
scraped in to  5 ml o f 395 m M  sucrose, 10 mM  K -H EPES, 0.5 m M  EG TA , pH 7.4 (SH -E), containing 
18 pg /m l phenyl m ethyl sulphonyl fluoride (PM SF), 7 pg/m l pepstatin  A, 4 pg/m l leupeptin, 1.5 pg/m l 
antipain, 0.25 pg /m l chym ostatin  as protease inhibitors. M itochondria w ere isolated [2.26], and
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resuspended in SH -E  + 5 pM  rotenone at approxim ately 2 mg/m l. M itochondria w ere divided into 
250 p g  aliquots and centrifuged for 3 mins at 13,000 g to give a m itochondrial pellet. The supernatant 
w as rem oved and the pellet resuspended in the follow ing buffer: 125 m M  KC1, 2 m M  EG TA , 5 mM 
K -succinate, 10 m M  K -H EPES, 2 mM  M gC l2, 5 mM  N a 2 H P 0 4, 5 pM  rotenone, 50 pC i/m l 1 2 P„ pH 7.0. 
In som e experim ents A D P w as added to 0.1 mM . O ther additions w ere m ade as appropriate. The 
reaction m ixture w as incubated at 30 °C for 90 mins to allow  labelling o f m itochondrial proteins. 20 pi 
o f sam ple loading buffer w as added, and the sam ples were im m ediately  heated to 90  °C for 10 mins to 
stop the labelling reaction and denature proteins. 2 0 0  pg  o f m itochondrial protein per lane w as run on 
SD S -PA G E  [2.13], and transferred  to n itrocellulose by W estern blot [2.16.1]. Blots w ere air-dried and 
then w ashed w ith 50 ml o f PBS for 1 hr, three tim es. B lots w ere again air-dried, and the m em brane 
w as exposed either to Super RX M edical X -R ay film (Fuji) or to a phosphorim ager screen for 
1 2 - 9 6  hr. Film w as developed using an X ograph C om pact X4 developer, and phosphorim ager plates 
read using a FujiFilm  FL A -2000 im ager.
[2.21]lmmunoprecipitation using protein G-agarose beads
Cell or m itochondrial protein extract [2.27] was incubated with antibody against the target protein 
(approxim ately 0 .1 pg  antibody per mg o f protein) for l hr at 4 °C using a rotary shaker. 30 pi of 
protein G -agarose beads were added to the reaction m ixture, which was incubated for a further l .5 hr at 
4 °C. Beads w ere collected by centrifugation  (1000 g, l m in) and the supernatant rem oved. Beads 
w ere washed 3 tim es w ith 0.75 ml o f buffer, and then resuspended in 30 p i o f sam ple loading buffer.
[2.22]Coupling antibody to CarboLink resin (Pierce)
C arboL ink C oupling G el (P ierce) is an affin ity  support for im m obilizing antibodies via a hydrazine 
linkage to c A-glycol groups in sugars o f polysaccharide m oieties. Since antibodies only carry these 
m oieties on the Ft portion, they are properly oriented when bound, w ith their antigen-binding sites 
unobstructed.
10 p g  o f antibody was resuspended in 100 p i o f 100 mM  N a 2 H P 0 4, pH 7.0. Sodium  m etaperiodate 
w as added to 15 mM , and the reaction incubated in the dark at room  tem perature for 30 mins, to 
ox id ise  c7.s-glycol groups. The reaction mixture w as diluted to 3 ml w ith 100 mM N a 2 H P 0 4, pH 7.0, 
and then concentrated to 50 p i using a centrifugal concentration unit (C entricon). The dilution / 
concentration  procedure was carried out 4 tim es in total, low ering the sodium  m etaperiodate 
concen tration  to less than 3 nM. The final oxidised antibody solution w as dilu ted  to 300 p i, and added 
to 100 p i C arboL ink resin. The m ixture was incubated for 5 hr at room  tem perature using a rotary 
shaker. B eads w ere then sedim ented by centrifugation (lOOOg, 1 m in), w ashed tw ice w ith 100 mM 
N a 2 H P 0 4, pH 7 .0 and resuspended in 80 pi o f 100 m M  N a 2 H P 0 4, pH 7.0.
[2.23]Pull-down using CarboLink-coupled antibody
Cell or m itochondrial protein extract [2.27] was incubated w ith C arboL ink-coupled antibody against 
the target pro tein  (approxim ately  0.1 pg  antibody per m g o f protein) for 1 hr at 4 °C using a rotary 
shaker. B eads w ere collected by centrifugation (1000 g, 1 min) and the supernatant rem oved. Beads 
w ere w ashed 3 tim es w ith 0.75 ml o f buffer, and then resuspended in 30 p i o f sam ple loading buffer.
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[2.24]Cross-linking
D isuccinim idyl suberate (D SS) w as used to cross-link  cellu lar or m itochondrial proteins. DSS w as 
dissolved in d im ethy lsu lphoxide (D M SO ) to 50 m M  im m ediately before use. M itochondria were 
suspended in 395 m M  sucrose, 10 m M  K -H EPES, 0.5 m M  EG TA , pH 7.4 (SH -E ) contain ing  18 pg/m l 
PM SF, 7 pg /m l pepstatin  A, 4 pg/m l leupeptin, 1.5 pg/m l antipain, 0.25 pg /m l chym ostatin  as protease 
inhibitors, at approxim ately  2 m g o f protein/m l, and DSS w as added from  the D M SO  stock, to the 
desired  concentration. The reactions w ere incubated for 15 -  30 mins at 25 °C, and m ixed gently  every 
ten m ins. T o stop the reaction, 1/10 volum e o f 1 M T ris-C l, pH  7.0 w as added, and the reaction 
incubated  for an additional 10 mins at 25 °C.
Mitochondrial Methods 
[2.25]Isolation of mitochondria from rat liver or heart
M itochondria were prepared by differential centrifugation, using a m odification o f the m ethod of 
Pederson and co-w orkers [222]. Sprague-D aw ley rats (150 -  200 g body w eight) w ere killed by 
cervical dislocation. The heart or liver w as rem oved and im m ediately placed into an ice-cold solution 
o f  210 mM m annitol, 70 m M  sucrose, 10 mM  T ris-C l, 1 mM  EG TA , pH 7.2 (M STE), with protease 
inhibitors (18 pg/m l PM SF, 7 pg/m l pepstatin  A, 4 pg/m l leupeptin, 1.5 pg/m l antipain, 0.25 pg/m l 
chym ostatin). The tissue w as finely chopped using scissors, transferred to a 30 ml centrifuge tuhe and 
hom ogenised for approxim ately  15 secs using a Polytron hom ogeniser on setting 5. The probe was 
pre-cooled  to 4 °C. The d isrupted tissue w as centrifuged  for 5 mins at 1200 g (liver) or 800 g (heart) at 
2 °C, to pellet unbroken cells and nuclei. The supernatant was further centrifuged for 10 mins at 
16,000 g to pellet m itochondria. M itochondria w ere w ashed by gently  resuspending in 30 ml of 
210 m M  mannitol, 70  mM  sucrose, 10 m M  Tris-C l, pH 7.2 (M ST), and re-sedim ented by centrifuging 
for 10 mins at 16,000 g. T he final pellet was re-suspended in M ST (1 ml (heart) or 5 ml (liver), giving 
a concentration  of approxim ately 1 0  m g m itochondrial protein per ml), kept on ice and used w ithin 
tw o hr.
[2.26]lsolation of mitochondria from B50 cells
T ypically , B 50 cells from 200 cm 2  o f culture area [2.38] were w ashed three tim es w ith ice-cold 
phosphate  buffered saline (PBS), gently scraped into 10 ml o f 395 mM  sucrose, 10 mM  K -H EPES, 
0.5 m M  E G T A , pH 7.4 (SH -E) and centrifuged for 5 m ins at 1000 g. T he cell pellet w as resuspended 
in 2.5 ml o f SH -E , supplem ented with protease inhibitors (45 pg  PM SF, 18 p g  pepstatin  A, 10 pg  
leupeptin , 3.8 p g  antipain, 0.63 pg  chym ostatin). 0.5 ml fractions w ere passed through a 21-gauge 
needle five tim es, using the equipm ent show n below  [Figure 6 ] to deliver a constant driving pressure. 
U nder standard  conditions finally adopted, a pressure o f 120 kPa w as used, giving a flow rate through 
the needle o f 30.6 m/s. A fter breaking, the disrupted cells w ere taken to a volum e of 15 ml w ith SH -E 
and cen trifuged  for 5 mins at 1000 g at 2 °C to pellet unbroken cells and nuclei. The supernatant w as 
then cen trifuged  for 10 m ins at 16,000 g at 2 °C. T he m itochondrial pellet was resuspended in 200 pi 
o f  SH -E. A flow chart o f the procedure is show n in Figure 7.
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F ix ed  p ressu re  air 
so u rce
V alv e
P is to n
C ell su sp en sio n
S y rin g e
N eedle
4 ---------►
Figure 6 - Apparatus for disrupting B50 cells.
The cell suspension is driven from the upper chamber into the lower by a constant- 
pressure air source. The suspension is then gently returned to the upper chamber. 
Sheer forces rupture cells as they pass through the narrow-gauge needle.
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Scrape and W ash Cells
I
Resuspend in isotonic sucrose m edium
I
Pass through needle 
1
Low speed spin
Supernatant
Pellet Pellet Supernatant
(U nbroken cells) (M itochondria) (C ytosol)
Figure 7 - Strategy for isolating mitochondria from B50 cells.
Cells were suspended in isotonic sucrose medium and disrupted by passage through a 
21-gauge needle. Differential centrifugation subsequently separated a mitochondria- 
enriched fraction from unbroken cells and cytosol. During development of the protocol, 
KCI was added to the low-speed supernatant to detach electrostatically bound 
cytochrome c from the surface of mitochondria.
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[2.27]Preparation of mitochondrial and cell extracts
[2.27.1 ]Total protein
C ells [2.38] or m itochondria [2.26] w ere sedim ented for 10 mins at 1000 g or 16,000 g, respectively, 
and resuspended in 50 m M  Tris-C l, 150 mM  N aCl, 1 % (v/v) N onidet P40, 0.25 % (w /v) deoxycholate, 
1 m M  E D T A , 0.1 % (w /v) SDS, pH 7.4 (R IPA  buffer). For som e experim ents, R IPA  buffer was 
supplem ented w ith 1 m M  N aF, 1 m M  sodium  orthovanadate, 10 m M  [I-glycerophosphate, to inhibit 
protein dephosphorylation  by phosphatases. To activate sodium  orthovanadate before use, the pH o f a 
200 m M  solution o f sodium  orthovanadate w as adjusted to 10.0 w ith N aO H  or HC1. The solution was 
boiled until it becam e colourless, and cooled to room  tem perature. The pH w as readjusted to 10.0, and 
the procedure repeated until the pH w as stable at 10.0 after boiling. This procedure depolym erises the 
vanadate, converting it into a more potent inhibitor o f protein tyrosine phosphatases [223],
[2.27.2]Sub-mitochondrial particles (SMPs)
M itochondria were sedim ented for 10 mins at 16,000 g and resuspended in SH -E  at 2 mg protein/m l. 
D igitonin was dissolved at 60 m g/m l in 50 % ethanol by sonication. W hilst sw irling the m itochondrial 
preparation continuously on ice, digitonin w as slow ly added drop-w ise to a final concentration of 
0.12 mg per mg o f m itochondrial protein. T he preparation was sw irled on ice for a further 10 mins, 
and then diluted w ith 1 volum e o f ice-cold SH -E. M itochondria were then sedim ented by centrifuging 
at 16,000 g for 10 mins, and resuspended in SH-E. This treatm ent w ith digitonin rem oves adherent 
pro teases [224]. The m itochondrial preparation was then sonicated for 10 x 30 secs, w ith a 30 sec 
cooling period, in a Sanyo Soniprep 150 sonicator at 10 pm  deflection using a 6  mm probe. The 
preparation was centrifuged at 20,000 g for 15 m ins at 4 °C to pellet SM Ps. The supernatant was 
rem oved and the pellet w ashed once w ith SH -E, before re-suspending in R IPA  buffer.
[2.27.3]Matrix
M itochondria were treated as above [2.27.2], Follow ing the first centrifugation  step after sonication, 
the supernatant (containing m atrix proteins) was rem oved and retained.
[2.28]Calcein release assay
[2.28.1 [Introduction
R elease o f m atrix-entrapped calcein is a very sensitive m ethod to m onitor even very short periods of 
transien t PT  pore opening. Isolated m itochondria were initially loaded w ith calcein  by incubating with 
calcein-A M  [Figure 8 ], This m olecule is highly lipophilic due to the acetoxym ethyl groups, and can 
rapidly  perm eate into the matrix through the m itochondrial m em branes. The acetoxym ethyl group is 
subsequently  c leaved by m atrix esterases, trapping the tetra-acid fluorophore in the matrix.
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Figure 8 - Calcein acetoxymethyl ester (Calcein-AM).
The molecule is lipophilic, and is accumulated rapidly by mitochondria, where matrix 
esterases cleave the AM groups, trapping the molecule in the matrix. Calcein fluoresces 
strongly at 494 nm excitation. The AM derivative is not fluorescent.
H3COCOH2COOC
H3COCOH2COOC^ c o o c h 2o c o c h ;
c o o c h 2o c o c h :
CH;
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M itochondria w ere then incubated in respiration buffer, during w hich tim e any PT  pore opening will 
rapidly release calcein  from  the m atrix (at 680 Da, calcein is sufficiently  sm all to pass through the PT 
pore, w ith a m olecular w eight cu t-o ff of approxim ately 1600 Da). M itochondria are then separated 
from  the assay m ixture by centrifugation , and calcein assayed fluorim etrically.
[2.28.2]Method
M itochondria w ere isolated from  B50 cells as described above [2.26] and resuspended in SH -E at 
approx im ately  3 m g protein/m l. C alcein acetoxym ethyl ester (C alcein-A M ) w as added to 10 pM , and 
cells incubated  in the dark at room  tem perature for 30 mins. A fter loading, m itochondria w ere diluted 
w ith 10 volum es o f SH -E and then sedim ented by centrifuging at 13,000 g for 3 mins. M itochondria 
w ere resuspended in 125 mM  KC1, 5 mM  K -succinate, 10 m M  K -H EPES, 2 mM  M gC l2, 5 mM  
N a 2 H P 0 4, 5 pM  rotenone, pH 7.0, w ith further additions as appropriate. A liquots w ere rem oved at 
various times, centrifuged for 3 mins at 13,000 g, and the supernatant diluted to 0.5 ml w ith 10 mM 
K -H EPES, pH 7.0. C alcein concentration was determ ined by m easuring fluorescence with the 
w avelength pair 487 nm / 520 nm, on a Perkin-E lm er LS-5B fluorim eter. Total calcein was m easured 
using an aliquot that was not centrifuged. (The hypotonic dilution m edium  results in osm otic lysis of 
m itochondria and release o f all entrapped calcein into the m edium .)
[2.29]Membrane potential measurements
[2.29.1 [Principle
T he presence o f a potential across the m itochondrial inner m em brane (A4* ) provides a driving force for 
the accum ulation by m itochondria o f positively charged species. At equilibrium  the distribution o f a 
freely perm eable species C is given by the N ernst equation :
w here R is the universal gas constant, T  is the absolute tem perature, F is the Faraday constant, z is the 
charge o f the species C, and [C], and [C]() are the internal and external concentrations of C respectively.
[2.29.2]Choice of cation
C ations m ust be lipophilic in order to fulfil the criterion o f free perm eability  across the inner 
m em brane. The tetra-phenyl phosphonium  (T PP+; Figure 9) ion’s positive charge is delocalised over 
the phenyl n  system  and the ion is hence sufficiently lipophilic to cross the m em brane.
[2.29.3]Construction of TPP* electrode
The construction  o f the T PP+ electrode and cham ber is show n in Figure 10. The T PP + electrode was 
constructed  as described by K am o and co-w orkers [225].
55
f r  ~ 
i ( )
(  )
Figure 9 - The tetra-phenyl phosphonium (TPP+).
The positive charge is delocalised over the phenyl n system and the ion is hence 
sufficiently lipophilic to cross the membrane. TPP+ is thus accumulated by mitochondria 
according to the magnitude of the inner membrane potential.
A g .A g C l referen ce e lectrod e
A g .A g C l w ire e lectrod e
W ater ja ck et
T P P + sen sit iv e  m em brane
M agn etic  stirrer
Figure 10 - Set-up of TPP+ electrode
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[2.29.4JExperimen tal
B50 m itochondria [2.26] were suspended in 600 pi 125 mM  KC1, 10 mM  K -H EPES, 2 mM M gC l2, 
5 pM  rotenone, pH 7.0 at approxim ately 1 m g protein/m l. The instrum ent was calibrated  by adding 
sequential sm all am ounts o f T PP +, to a final concentration o f 1.5 pM . M itochondrial respiration w as 
started by addition o f 5 m M  N a-succinate, and follow ed using an am plifier and chart recorder to 
m easure the potential d ifference betw een reference and test electrodes.
[2.30]Mitochondrial swelling assay
B 50 m itochondria [2.26] w ere suspended at 1 m g protein/m l in 0.5 ml of the follow ing buffer at 30 °C, 
in a spectrophotom eter cuvette: 125 m M  KC1, 2 mM  EG TA , 5 m M  K -succinate, 10 mM  K -H EPES, 
2 m M  MgCU, 5 mM  N a 2 H P 0 4, 5 pM  rotenone, pH 7.0. A dditions w ere m ade as appropriate. To 
m onitor sw elling, absorbance was recorded at 540 nm on a Perkin-E lm er 124 spectrophotom eter with 
chart recorder. A decrease in absorbance corresponded to m itochondrial sw elling (decrease in light 
scattering).
Enzyme and cytochrome c release methods
[2.31]Protocol for assaying BID-induced cytochrome c release
[2.31.1] Buffer
M itochondria were isolated as described above [2.26]. 3.5 pi o f m itochondrial suspensions
(approxim ately 20 pg  protein) w ere pipetted into F ppendorf tubes, containing 20 pi o f the follow ing 
buffer: 125 mM KCl, 2 m M  EGTA , 5 mM K -succinate, 10 mM  K -H EPES, 2 mM M gC l2, 5 mM 
N a 2 H P 0 4, 5 pM  rotenone, pH 7 .0  (respiration buffer), plus BID or tBID  as indicated in the figure 
legends. tBID  was generated as described below  [2.49] or bought (Sigm a; purified caspase 8 -cleaved 
recom binant BID).
[2.31.2]Technique
R eactions w ere incubated for varying periods at 30 °C, and then stopped by centrifugation  at 13,000 g 
for 3 m ins. The supernatant was rem oved using a fine-tipped pipette, and the pellet resuspended in a 
volum e o f reaction buffer equal to the volum e of supernatant rem oved. C ytochrom e c in the pellet 
and/or supernatan t fraction was analysed by W estern blot [2.16], A flow chart of the technique is 
show n in F igure 11.
[2.32]Preincubation with cytochrome c
For cy tochrom e c preincubations, a m itochondrial pellet contain ing approxim ately  0.5 mg of 
m itochondrial p rotein  [2.26] was resuspended in 250 p i of SH -E contain ing 1 pM  cytochrom e c (beef 
heart). Follow ing 15 m ins incubation at 4 °C, m itochondria w ere pelleted by centrifugation, w ashed 
once w ith SH -E , and then resuspended in SH -E at around 4 mg/ml.
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Prepare reaction buffer w ith /  w ithout caspase 8
A dd BID  to reaction  buffer
Incubate 2 hr at 20 °C for 
caspase 8  cleavage
Mix solutions w ith / w ithout BID to give a range o f final BID concentrations
I
A dd m itochondria to BID solutions
I
Incubate 30 mins at 30 °C
I
C entrifuge 2 mins at 13,000 g
R esuspend pellet Rem ove and retain supernatant
i  i
Assay pellet and/or supernatant for cytochrom e c by W estern blot 
Figure 11 - Procedure for assaying BID-induced cytochrome c release.
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[2.33]Peptidyl- prolyl- cis-trans isomerase (PPIase) assay
[2.33.1] Rationale
In contrast to all o ther am ino acids, w hose peptide bonds exist alm ost exclusively  in the trans 
conform ation , an appreciable fraction o f proline peptide bonds exist in the cis conform ation, due to 
p ro line’s unique im ide structure. D epending on the environm ent, around 15 % o f bonds are in the cis 
conform ation . Isom erisation occurs slow ly in aqueous solvents, but is cata lysed by the PPIase fam ily 
o f enzym es. The assay for cis-trans  isom erase activity  m akes use o f the stereo-specificity  o f 
chym otrypsin  in cleavage o f a test peptide to release a chrom ophore. C hym otrypsin  w ill only cleave 
the trans conform er; the 85 % o f test peptide initially in this conform ation is rapidly cleaved, and after 
this new trans conform er is slow ly generated from  the cis state. Thus the rate o f chrom ophore release 
in this second stage reflects the rate o f cis-trans  isom erisation.
[2.33.2]Protocol
The test peptide, yV-succinyl-ala-ala-pro-phe-/?-nitroanilide, was dissolved to 5 mM  in an anhydrous 
solution o f 470 mM LiCl in trifluoroethanol [226], C hym otrypsin was d issolved to 25 m g/m l in 
100 mM  NaCl, 10 mM K -H EPES, pH 7.2 (NH buffer). 3 ml of NH buffer w as added to a glass cuvette 
and cooled to 12 °C. 20 p i o f PPIase enzym e (approxim ately 5 nM final concentration) was added to 
the cuvette, follow ed by 20 pi chym otrypsin and 12 pi o f test peptide. The cuvette contents were 
rapidly  mixed, and absorbance was recorded at 395 nm on a Perkin-E lm er 124 spectrophotom eter with 
chart recorder. For assays w ith PPIase inhibitors, PPIase enzym e and inhibitors were prc-incubated in 
the cuvette for 5 mins before addition o f chym otrypsin  and test peptide. This is necessary because the 
conform ation  of bound C SA  is m arkedly  different to that of CSA free in solution [227], and the 
transition  betw een the tw o during  binding is slow [228].
[2.33.3]Derivation of rate constants
W hen the chym otrypsin reaction is not rate-lim iting, the isom erisation reaction (production o f trans 
isom er) is pseudo-first order w ith respect to the cis  isomer. Thus
d[cis] . = —k ■ [as ]  
dt
and so, by integration, at some tim e t after beginning m easurem ents
[cis], = [cis]0 ■ e~k '
w here [cA ]t represents the concentration o f cis isom er at tim e t, and [c7.v] 0  is the initial concentration of 
cis isom er. If  additionally  [C*]t and [C*]«, represent the concentration  of chrom ophore at time t and at 
infinite tim e, respectively  (the chrom ophore being form ed im m ediately  from  the trans isom er by the 
chym otrypsin  reaction) then
[cis], =[C*L ~[C*] t
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and
Thus
and so
[«4> = [C ’L - [ C -]„ 
[C*L-[C*], =([C'L-[C*]0)-e -k '
In
A[C *L-[C ‘], 
JC*L-[C*]oy
Since absorbance A is proportional to [C*] we have
— - k - t
(
In K ~ A t 
4 . - A )
A
— - k t
and so a graph of In
A - A .
A _ - A ,
against tim e will have gradient -k. Since the isom erisation reaction
o y
proceeds even in the absence o f catalysis by cyclophilins, the enzym e rate constant w as calculated as
k  — k. — k,enzyme apparant background
[2.33.4]Derivation of percentage inhibition
For the experim ents w ith cyclophilin  inhibitors, percentage inhibition I was calculated as
/  = 100x
k  - kenzyme enzyme+inhiblor
kenzvme
[2.34]Monoamine oxidase (MAO) assay
M A O  assays were carried out using the A m plex Red m onoam ine oxidase assay kit (M olecular Probes). 
Sam ples were added to the follow ing m ixture: 50 mM  N a 2 H P 0 4, 1 m M  benzylam ine, 0.2 mM 
10-acetyl-3,7-dihydroxyphenoxazine, 1 U/ml H orseradish peroxidase, pH 7.4. M A O  activity generates 
H 2 0 2 from the substrate (benzylam ine). H 2 0 2  reacts w ith the non-fluorescent 10-acetyl-3,7- 
d ihydroxyphenoxazine to generate 7-hydroxyphenoxazin-3-one (resorufin), w hich can be detected 
fluorim etrically  using excitation at 563 nm  and erm ssion at 587 nm. C ontinuous m easurem ents were 
taken over 10 m ins at 30 °C, and a reaction rate obtained. A background rate w as calculated  by pre­
incubating  sam ples for 20 mins at 4 °C with 1 pM  clorgyline (M A O -A  inhibitor) and 1 pM  pargyline 
(M A O -B  inhibitor). This rate was subtracted from  the rate in the absence o f inhibitors to give M AO 
activ ity  in the sam ple.
[2.35JCaspase assays
C ells w ere incubated  with or w ithout 400 nM staurosporine to induce apoptosis. At various time- 
points, a cy toso lic  extract was made by incubating cells in 20 m M  K -H E PE S, 2 mM  EDTA , 5 % (w/v) 
C H A PS, 5 m M  D TT, pH 7.2, 1 mM  PM SF and 10 pg/m l each o f pepstatin , leupeptin and aprotinin. 
C aspase assays on these extracts w ere carried  out in 1 ml o f 100 m M  K -H EPES, 20 % (v/v) glycerol,
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0.5 mM  ED TA , 5 mM  D TT, pH 7.0. A 7-am ino-4-trifluorom ethyl coum arin  (A FC )-conjugated 
substrate w as added (V E ID -A FC  for caspase 6  or LEH D -A FC  for caspase 8 ), and fluorescence was 
follow ed w ith excitation  at 400 nm and em ission at 505 nm in a Perk in-E lm er 124 fluorim eter. The 
A FC group fluoresces only w hen cleaved from  the peptide m oiety by caspase activity. Results were 
calibrated  by m easuring the fluorescence o f a standard AFC solutions.
[2.36]BAK digestion assay
M itochondria  were incubated in respiration buffer [2.31.1], A t various tim e-points, a 25 p i volum e was 
rem oved, added to 5 p i of a pre-cooled trypsin solution and incubated on ice. U nder standard 
conditions, trypsin was present at 0.05 m g/m l, and the d igestion carried  out for 10 m ins. M itochondria 
w ere then isolated by centrifugation. A fter SD S-PA G E  [2.13] and W estern blotting [2.16], BAK 
digestion  was assayed by probing w ith the anti-B A K  N T antibody (U pstate).
Cell culture, transfection and imaging methods 
[2.37]Preparation of cover-slips
24 mm cover-slips (B D H ; thickness no. 1) w ere autoclaved, and w ashed in 70 % ethanol. A fter drying, 
cover-slips were covered w ith 250 p i o f 15 pg/m l poly-L-ornithine and left for four hr. C over-slips 
w ere washed with sterile dH 2 0 ,  covered with 250 pi o f 20 pg/m l lam inin in PBS and left for 3 hr. 
C over-slips were then w ashed with sterile dH 20  and seeded w ith cells im m ediately.
[2.38]B50 cell culture
B 50 cells from a rat neuronal cell line (European Collection o f Cell C ultures, Salisbury, W ilts, U .K.) 
w ere m aintained under C O :/air (1:19) at 37 °C in D ulbecco’s m inim al essential m edium  (D M EM ) with 
10 % (w /v) foetal calf serum  (FCS), and 50 pg/m l gentam ycin. C ells w ere typically  grow n to 90 % 
confluence  in 200 ml plastic flasks (Sterilin; 200 cm 2 culture area per flask ). To detach adherent cells, 
p re-w arm ed PBS containing 1 mM EDTA  was added to the culture m edium , and cells incubated for 
10 m ins at 37 °C.
[2.39]Transient transfection
To transfect cells on cover-slips or 35 mm plates, D NA  was diluted to 10 pg /m l in 100 pi O PTI-M EM  
(G ibco-B R L ), and left to stand for 20 mins. L ipofectam ine 2000 (Invitrogen) was diluted to 50 pg/m l 
in 100 p i O PTI-M E M , added to the D NA  solution and allow ed to stand for 2 hr. Cells were washed 
tw ice w ith PB S, after which the 200 pi o f transfection mix w as diluted to 1 ml w ith foetal ca lf serum 
(FCS) and added to the culture dish. Cells were incubated for 5 hr in a C 0 2  incubator, after which the 
transfection  m ixture was rem oved. 3 ml o f fresh FCS was added to the culture dish, and cells were 
incubated in a C 0 2  incubator, typically for 24 -  48 hr.
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[2.40] Cel I fixing and permeabilisation
C overslips of transfected  cells [2.39] were fixed in freshly prepared 4 % paraform aldehyde, 4 % 
sucrose in PB S, for 15 mins. Cells w ere w ashed tw ice for 5 m ins in PB S, and then perm eabilised for 
7 m ins in 0.25 % Triton-XlOO. C ells w ere w ashed three tim es for 5 m ins in PBS before antibody 
probing.
[2.41] Cel I staining and imaging
Perm eabilised  cells [2.40] w ere b locked using 10 % B SA  in PBS for 40  m ins at room  tem perature. 
A fter w ashing tw ice for 5 m ins w ith PBS, cells w ere incubated w ith prim ary  antibody (anti-FL A G  or 
anti-A N T ) diluted to the appropriate concentration  (typically 0 .1 -  l pg/m l, in 3.5 % BSA  in PBS), for 
3 hr at room  tem perature. C ells w ere w ashed tw ice for 5 mins w ith PBS, and incubated for l hr with 
the appropriate secondary antibody (typically  0 .1 pg/m l, in 3.5 % BSA  in PBS) - either fluorescein- 
labelled anti-m ouse IgG (Invitrogen) for detection o f FLA G  or Texas red-labelled anti-rabbit IgG 
(EM D  biosciences) for detection  o f ANT. C ells were w ashed four tim es for 5 mins w ith PBS before 
im aging. For staining w ith M itoTracker, cells were incubated for 10 m ins w ith 10 ng/m l M itoT racker 
red (M olecular probes) prior to fixation. C ells were im aged using an O lym pus IX 70 fluorescent 
m icroscope fitted w ith a cooled C CD  cam era (M icroinax 14 0 IE; Princeton instrum ents). Excitation 
w as via band-pass filters for excitation of fluorescein (490 nm), T exas red (570 nm) or M itoT racker red 
(570 nm). F luorescent light was collected on a polychroic beam  splitter and a tw o band-pass em ission 
filter in the filter cube (530 nm, 625 nm). The appropriate em ission band w as then selected by band­
pass filters in the em ission light path.
[2.42]Generation of cyclophilin D(+) cell line
A cyclophilin  D(+) cell line w as generated previously in the lab by Li and co-w orkers [ 157]; this cell 
line carries the pcD N A  3 .1 plasm id (Invitrogen) [Figure 12] containing the cyclophilin  D coding 
sequence. pcD NA  3.1 is an expression  vector carrying the C ytom egalovirus early p rom oter for strong 
expression  in m am m alian system s. K ozak described a consensus sequence for m axim um  efficiency of 
translation  efficiency [229], The rat cyclophilin  D gene does not conform  to this consensus sequence, 
as show n in Figure 13. Thus the second codon of the gene was altered from C TA  to GTA  (Leu to Val 
substitu tion) in order to incorporate the consensus sequence, to increase translation efficiency. The 
N -term inal pre-sequence is rem oved upon im port to m itochondria, so the m ature protein sequence is 
unaltered.
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ssaliiiilssSU
pcDNA3.1 (+)
5428/5427 bp
P c m v  -  C ytom egalovirus early  prom oter
BGH pA  -  BGH polyadenylation signal
F I ori -  f l  origin o f replication
SV 40 ori -  SV 40 early  p rom oter and origin o f
replication
N eom ycin -  N eom ycin  resistance gene 
SV 40 pA  -  SV 40 polyadenylation  signal 
PU C ori -  pU C origin o f replication 
A m picillin -  A m picillin  resistance gene
Figure 12 - The pcDNA 3.1 (+) plasmid.
G
Kozak Consensus Sequence A N N G
Cyclophilin D Translation Start Site : G C G A T G C
Modified cyclophilin D Sequence : G C G A T G G
Figure 13 - The translation start site of the cyclophilin D gene does not conform to the
Kozak consensus sequence.
The required G at position + 4 is in fact a C in the cyclophilin D sequence. This 
nucleotide was thus replaced by a G during the generation of the cyclophilin D expression 
plasmid. The resulting Leu -> Val substitution does not affect protein function, since it is 
part of the N-terminal pre-sequence which 'S removed following mitochondrial import.
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Methods fo r  expression and purification o f recombinant proteins
[2.43]Extraction of total RNA from rat liver
Total RN A  w as extracted  from tissue using the H igh-Pure RNA tissue kit (R oche), according to the 
m anufactu rer’s instructions. B riefly, a 150 g male Sprague-D aw ley rat w as killed by cervical 
dislocation , and the liver rem oved. A pproxim ately 60  mg o f tissue w as hom ogenised in an 
ethanol/guanidine hydrochloride- based denaturing buffer using a D ounce hom ogeniser, and 
centrifuged  to pellet cellu lar debris. The supernatant was applied to a H igh-Pure filter tube, containing 
a glass fibre fleece to bind RNA . R esidual D N A  was rem oved by the addition o f deoxyribonuclease I 
(D N A se I), follow ed by 15 mins incubation at room  tem perature. The colum n w as w ashed three tim es 
in a h igh-salt ethanolic w ash buffer to rem ove low -M r contam inants. Total R N A  w as then eluted by 
addition of a low -salt buffer.
[2.44]First-strand cDNA synthesis
First-strand com plem entary D NA  (cD N A ) was produced using a 1st strand cD N A  synthesis kit 
(R oche). 20 pi reactions contained the follow ing com ponents: 10 mM  T ris-C l, 50 mM KC1, 5 mM 
MgCla, 1 mM each o f dA TP, dC TP, dT TP and dG TP, 1 pM  prim er, 50 units o f ribonuclease (RN ase) 
inhibitor, 20 units of A M V  reverse transcriptase, 1 p g  RNA tem plate (total RNA ; [2.43]), ddH 20  q.v., 
pH 8.4. The reaction was incubated for 10 mins at 25 °C to anneal the prim er, and then for 60 mins at 
42 °C to synthesise cD N A . The reverse transcriptase enzym e was denatured by heating to 95 °C for 
5 m ins, before cooling to 4 °C.
[2.45]Expression of BID
B acterial cells carrying the B id  expression plasm id [2.7] w ere grow n to m id-log phase (O D w,o = 0 .6 ) at 
37 °C and expression induced with 1 mM IPTG. C ells w ere harvested after 3 hr by centrifugation  at 
5000 g for 15 mins, and resuspended in 100 mM N aCl, 20 m M  T ris-C l, 1 m M  ED TA  (lysis buffer) 
con ta in ing  protease inhibitors (18 pg/m l PM SF, 7 pg/m l pepstatin  A, 4 pg/m l leupeptin, 1.5 pg/m l 
antipain , 0.25 pg/m l chym ostatin). C ells were broken by lysozym e (10 m g/m l for 1 hr at 0 °C) 
fo llow ed by sonication (5 x 30 secs w ith a 30 sec cooling period in a Sanyo Soniprep  150 sonicator at 
10 p m  deflection , using a 6  mm probe). The lysate was centrifuged for 15 mins at 13,000 g, and the 
so luble (supernatant) and insoluble (pellet) fractions retained.
[2.46]Nickel affinity chromatography
10 m M  im idazo le  was added to the protein solution to prevent non-specific binding. The solution was 
then applied  to a nickel-N TA -agarose colum n at approxim ately 2 mg fusion protein per ml of resin. 
T he colum n w as w ashed ten times w ith 20 mM  T ris-C l, 150 m M  N aCl, 35 m M  im idazole, pH 7.4, 
using 10 ml per ml o f resin. Protein was eluted using 4 x 0.5 ml of 20 m M  T ris-C l, 150 m M  NaCl, 
250 m M  im idazole, pH 7.4. T ypically  85 % o f the fusion protein w as eluted in the second and third 
fractions.
64
[2.47]Removal of poly-histidine tag from recombinant BID
BID (1m l; approxim ately  1 mg) w as diluted 10-fold w ith 20 m M  T ris-C l, 150 mM  N aCl, 2.5 m M  
CaC E, pH 8.4 and 0.5 units o f throm bin added to cleave the poly-histidine tag. T he reaction w as 
incubated for 3 hr at room  tem perature.
[2.48]Buffer exchange of BID
A fter ion exchange chrom atography, the BID buffer was exchanged to 20 m M  K -H E PE S, 15 % 
glycerol, pH 7.4. First, B ID  w as concentrated  approxim ately 10 tim es using a C entricon centrifugal 
filter (A m icon). BID w as then diluted 10-fold in 20 m M  K -H EPES pH 7.4, and again concentrated  by 
centrifugal filtration. This procedure w as repeated 3 tim es in total, and glycerol w as then added to 
15 %. T he preparation was stored in aliquots at -7 0  °C.
[2.49]Generation of tBID
R ecom binant BID w as incubated w ith recom binant caspase 8  (C albiochem ) to produce tB ID  in vitro. 
1 -  2.5 units of C aspase 8  w as added to 300 pi of respiration buffer [2.31.1] contain ing  0.5 p g  BID. 
T he reaction was incubated at 20 °C for 30 m ins -  24 hr. For cytochrom e c release experim ents, 
varying quantities o f this tB ID  preparation w ere m ixed w ith respiration buffer to give 20 p i reaction 
volum es containing the desired  concentration o f tBID  protein.
[2.50]Expression of recombinant cyclophilin A
[2.50.1]GST-cyclophilin A
A pG EX -cyclophilin A plasm id, encoding hum an cyclophilin  A w ith an N -term inal G ST tag, w as 
available in the lab. An overnight culture o f E. coli D H 5u, harbouring this plasm id, w as diluted 
10-fold to 500 ml w ith fresh nutrient broth. A fter grow ing to an O D 60() o f 0.6, IPTG  was added to 
40  pg /m l. Cells were grow n for 10 hr at room tem perature, and harvested by centrifuging for 15 mins 
at 4500  g. The pellet was resuspended in 15 ml o f 100 mM  N aCl, 20 m M  T ris-C l, 0.5 mM EDTA , 
pH 7.2, containing 18 pg/m l PM SF, 7 pg/m l pepstatin A, 4 pg/m l leupeptin, 1.5 pg/m l antipain, 0.25 
pg /m l chym ostatin  as protease inhibitors, plus 1 0  m g/m l hen egg w hite lysozym e, and incubated on ice 
for 1 hr. C ells were sonicated for 10 x 40 secs with a 30 sec cooling period, in a Sanyo Soniprep 150 
son icator at 10 pm  deflection, using a 6  mm probe. T riton X -100 was added to 1 %, and cell debris 
rem oved  by centrifuging for 15 mins at 13,000 g. The supernatant was passed three tim es over GSH- 
agarose beads, in a glass colum n, w hich were then w ashed with 10 x 2 ml o f PB S-T . Bound fusion 
protein  w as elu ted  w ith 7 x 0.5 ml o f 150 mM  N aCl, 20 m M  T ris-C l, 2.5 m M  C aC l2, 50 mM  GSH, 
pH  8.5.
[2.50.2]Cleavage of GST tag
The G ST  tag w as cleaved from the fusion protein (3.5 ml; above) by incubating overnight at 4 °C w ith 
30 units o f throm bin. The reaction m ixture was diluted to 25 ml w ith 10 mM  K -H EPES, pH 7.0, and 
dialysed overn igh t against this buffer. The protein was applied to a M ono-S cation exchange colum n, 
and eluted w ith a g radient o f  0 -  250 m M  N aCl in 10 mM  K -H EPES, pH  7.0. The elution profile is
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show n in Figure 14. The un-cleaved G ST-cyclophilin  A fusion protein co-elu ted  w ith cyclophilin  A, 
and so this contam inant w as rem oved by passing over G SH -agarose beads. The final cyclophilin  A 
preparation was concentrated  using a C entricon centrifugal filter (A m icon), and stored at 5 m g/m l at 
-70 °C in 10 m M  K -H EPES pH 7.0. Figure 15 show s the protein species present at each stage o f the 
purification.
[2.51]Generating epitope-tagged cyclophiiin D constructs
[2.51.1 ]Choice of tag
T hree alternative tags w ere used, having the follow ing am ino acid sequences: Y PY D V PD Y A  (H A  tag); 
D Y K D D D D K  (FLA G  tag) or D Y K D H D G D Y K D H D ID Y K D D D D K  (3xFL A G  tag). The triple-flag 
(3xFL A G ) tag was reported to give a ten-fold increase in detection sensitivity  over the single FLAG  
epitope on W estern blot [230]. H ow ever, it was possible that the high negative charge o f this tag (net 
charge -7 )  might interfere w ith protein tertiary structure and/or protein-protein  interactions. The 
single-flag tagged construct w as thus also prepared as a precaution.
[2.51.2] Vector
T he pcDNA 3 .l(+ ) plasm id [Figure 12| was used to generate the tagged cyclophilin  D vectors. The 
pcD N A  vectors are suitable for one-step gene cloning, having an am picillin  resistance gene and pUC 
replication origin for selection and propagation in E. coli as well as sequences for gene expression in 
m am m alian cell culture.
[2.51.3]Template
T he rat cyclophilin D gene has previously been cloned in our lab [2311, and an expression vector 
cod ing  for full-length cyclophilin  D was available. This was used as a tem plate for preparing the 
cyclophilin  D inserts by PCR.
[2.51.4] Primers
T he follow ing prim er sequences w ere used to generate the HA and FLA G  tagged constructs. Tags 
w ere all C -term inal, since the N -term inal pre-sequence o f cyclophilin  D is cleaved follow ing im port 
into m itochondria. A Kozak translation initiation sequence was included around the initiator ATG  
codon [229].
HA
F o r w a r d  -  5 '  AAAA GGATCC ACC ATGCTAGCTCT
BamHl C o d i n g
B a c k 5 '  AAAA GAATTC TTA AGCGTAATCCGGAACATCGTATGGGTA GCTCAACTGGC
E c o R l  S t o p HA T a g C o d i n g
6 6
m M  N aC l
m M  Algo 
N aCl
250 0.20
Amo
_  125 0 .10
0 0.00
Figure 14 - Cyclophilin A elution profile.
Cleaved GST-cydophilin A was applied to a mono-S column, and eluted with a linear 
gradient from 0 to 250 mM NaCl.
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k D
Figure 15 - Purification of cyclophilin A.
Lane 1 -  Insoluble fraction from expression cells; Lane 2 -  Soluble fraction from 
expression cells; Lane 3 -  GSH-agarose flow-through; Lane 4 -  First GSH-agarose wash 
with PBS-T; Lane 5 -  Fifth GSH-agarose wash with PBS-T; Lane 6 -  Tenth GSH-agarose 
wash with PBS-T; Lane 7 -  Markers (Odyssey; [12.1.1]); Lane 8 -  GST-agarose eluate; 
Lane 9 -  Final 0.5 ml of GST-agarose eluate; Lane 10 -  Products of overnight thrombin 
cleavage reaction; Lane 11 -  Final cyclophilin A preparation; Lane 12 -  Mono-S elution
fraction
6 8
FLAG
F o r w a r d  -  5 '  AAAA GGATCC ACC ATGCTAGCTCT 
BamHl  C o d i n g
B a c k  -  5 '  AAAA GAATTC TTA CTTATCGTCGTCATCCTTGTAATC GCTCAACTGGC 
E c o R l  S t o p  FLAG T a g  C o d i n g
3xFLA G
T he length of the 3xFLA G  tag coding sequence is too long for a single prim er to be used due to the 
potential for secondary structure form ation and/or dim erisation. The 3xFL A G  construct w as thus 
generated using a tw o-step procedure, using the follow ing prim ers:
F o r w a r d  -  5 '  AAAA GGATCC ACC ATGCTAGCTCT 
BamHl  C o d i n g
1st b a c k  -  5 '  AAAA TGATCTTTATAATCACCGTCATGGTCTTTGTAGTC GCTCAACTGGC
3xFLAG T a g  C o d i n g
2 nd b a c k  -  5 '  AAAA GAATTC TTA CTTGTCATCGTCATCCTTGTAATCGATATCATGATCTTT 
E c o R l  S t o p  3xFLAG T a g
[2.51.5] Vector production
T he cyclophilin D gene w as successfully  am plified by PC R  [2.2], yielding from 2.5 pg  (3xFLA G  
construct) to 17 pg  (HA construct) o f product of the expected size (655 -  685 base pairs (b.p.)), as 
show n in Figure 16. The constructs and vector w ere digested w ith B am H l and E co R l, and ligated 
w ith T 4 DNA  ligase [2.6], as show n in Figure 17.
D H 5u com petent cells were transform ed w ith the vectors and grow n on agar plates with am picillin 
selection  [2.7], Several isolated colonies were picked, and plasm id D NA  prepared by m ini-prep [2.9], 
P lasm id D N A  was digested with B am H l and E coR l to confirm  insert presence, as show n in Figure 18. 
The cyclophilin  D constructs were verified by DNA sequencing [2.10]. All had the expected  sequence.
[2.51.6] Expression
B 50 cells w ere transiently  transfected w ith the three expression plasm ids [2.39]. C ells were grow n for 
48 hr.
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Figure 16 - The cyclophilin D gene was successfully amplified by PCR.
Lane 1 -  HA construct. Lane 2 -  FLAG construct. Lane 3 -  GeneRuler DNA Ladder Mix 
(Fermentas; [12.1.2]). Lane 4 -  3xFLAG construct -  1st round. Lane 5 -  3xFLAG 
construct -  2nd round.
S
W  i w f i  2
Figure 17 - The cyclophilin D constructs were ligated into pcDNA 3.1 (+).
Lanes 1 and 2 -  HA construct pre- and post- ligate (respectively). Lane 3 -  GeneRuler 
DNA Ladder Mix (Fermentas; [12.1.2]). Lanes 4 and 5 - FLAG construct pre- and post- 
ligate (respectively). Lanes 6 and 7 -  3xFLAG construct pre- and post- ligate
(respectively).
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1 2  3 4 5 6 7
Figure 18 - An insert of the expected size can be excised from the plasmid constructs. 
Lane 1 -  GeneRuler DNA Ladder Mix (Fermentas; [12.1.2]). Lane 2 -  HA construct PCR 
product for size comparison. Lanes 3 and 4 -  HA plasmid pre- and post- digest. Lanes 5 
and 6 -  FLAG plasmid pre- and post- digest. Lane 7 -  3xFLAG construct post- digest.
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[2.51.7]Assessment of transfection efficiency
T ransfection  efficiency was assessed for the 3xFLA G  construct. C overslips w ere seeded w ith B50 
cells, transfected with 1, 2 or 4 p g  o f vector, and grow n for 48 hr [2.37]. C ells w ere fixed and 
perm eabilised  [2.40] and probed w ith an anti-FLA G  antibody follow ed by a fluorescein-labelled  an ti­
m ouse IgG secondary antibody (Invitrogen) [2.41]. N uclei were stained using propidium  iodide 
(50 pg /m l in PBS).
Miscellaneous methods
[2.52]Calculating the free calcium concentration in EGTA buffers
There are three H + associations and tw o C a2+ associations to be considered. pK a values for these are 
given in Table 1. First the apparent m etal ion stability constants at the pH of interest are calculated :
K  =  _,______________________ ^ 4 _______________________
4 ” ' w  (l+ k , [ / /+]+ k {k 2[ h +]~ + a:, Ar2Ar3[// +  ]3)
K  = _____________ h _____________
^~“PP f  , X
T hen the apparent com bined stability constant for C a2+ binding, ktomb is calculated :
^ c o m b  ^  4 -u p p  ^ 5 - a p p
N ow , if [C a]f is the free calcium  ion concentration, and [Ca], is the initial calcium  concentration, and 
w e define:
X = { K r,mh( E - [ C a ],)}+ 1
Then:
T c t fornb
2 - K ~
Since the association  constant (K a) for other divalent cations is orders o f m agnitude low er than that for 
calcium  (e.g. pK a for the First metal ion association -10.97 for calcium  com pared w ith -5.19 for 
m agnesium ), the effect o f these other ions can be ignored for practical purposes if  their concentration is 
com parab le  to that o f calcium .
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Association constant Association equation pKa
K, Ca.EGTA / EGTA + Ca -10.97
k2 Ca.H.EGTA / H.EGTA + Ca -5.30
k3 H.EGTA / EGTA + H -9.47
k4 H2.EGTA/H.EGTA+ H -8.85
k5 H3. EGTA/H2. EGTA+ H -2.66
Table 1 - EGTA pKa values for H+ and Ca2+. 
Data taken from [232].
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CHAPTER 3 : CLONING AND EXPRESSION OF BID
[3.1]lntroduction
[3.1.1]Choice of BID
B ID  is one o f the less well characterised B CL-2 proteins. M ultiple m echanism s have been suggested to 
explain its m echanism  of action in initiating m itochondrial outer m em brane perm eabilisation. These 
m echanism s are based on a num ber o f reported properties o f clear relevance to apoptotic signalling in 
m itochondria, including cleavage by caspases [93,135]; catalysis o f o ligom erisation  o f m ulti-dom ain 
pro-apoptotics in m itochondria [8 ,102,233,234]; pore-form ing ability [80,143]; and lipid transfer 
activity [131,146].
Several groups have purified native or recom binant BID for use in in vitro studies. BID was originally  
purified as a cytochrom e c releasing factor by Luo and co-w orkers [93], These authors used a series of 
gel filtration and ion exchange chrom atography steps to purify approxim ately  10 pg  o f BID from 3 g of 
H eLa cell extract. The sam e authors subsequently expressed recom binant hum an BID as a 
6 xH is-tagged fusion protein in E. coli.
[3.1.2]Choice of specie
BID am ino acid sequence is not well conserved across species. Figure 19 show s a m ultiple alignm ent 
o f the human, rat and m ouse sequences. The m ouse and hum an sequences show  only 65 % identity, as 
com pared to an average value of around 85 % for orthologous genes across these tw o species [235]. 
T here is only 60 % identity  betw een all three sequences.
T hus the choice o f specie from  w hich to clone B id  was im portant. Previously available in the lab w ere 
a selection of B 50 cell lines (a rat neuroblastom a cell line) o f various different genotypes. 
A dditionally , rats provide a plentiful source o f m itochondrial protein for in vitro  studies. Thus it was 
decided  to work entirely w ith rat system s, and therefore to clone the rat B id  gene.
[3.2]Generation of expression plasmid
[3.2.1 [Production of first-strand cDNA from rat liver
Total R N A  was extracted from rat liver using a com m ercial kit [2.43], The extract was analysed by 
agarose gel electrophoresis [2.3] [Figure 20], As expected, the 28S and 18S ribosom al RNA bands 
w ere clearly  visible, with the 28S band approxim ately tw ice the intensity  o f the 18S band. H ow ever 
there w as som e sm earing, potentially indicating RN A  degradation. The absorbance ratio A 2 6 0  /  A 2 8 0  of 
the ex tract w as m easured. RNA absorbs at 260 nm, so that A 2 6 0  is proportional to [RN A ], and protein 
absorbs at 280 nm, so that A 2 8 0  is proportional to [protein]. Protein contam ination  of RNA sam ples 
thus low ers the ratio  A 2 6 0  /  A 280; a value above 1.8 indicates the RN A  is free from protein 
contam ination . The value for this RN A  preparation w as 2.01, indicating no protein contam ination.
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Rat MDSEVSNGSGLGAEHITNLLVFGFLR-NNDRDFHQELEVLGQELPVQV-YLEGDREDELQ 58
Mouse MDSEVSNGSGLGAEHITDLLVFGFLQ-SSG-CTRQELEVLGRELPVQA-YWEADLEDELQ 57
Human MDCEVNNGSSLRDECITNLLVFGFLQSCSDNSFRRELDALGHELPVLAPQWEG— YDELQ 58
★ * >* * _ * * * >* * * * . * * * * * * * .  _ *•*.*★** * ****
Rat TDGSRASRSFYHGRIEPDSESQDEVIHNIARHLAQAGDELDHSIQPTLVRQLAAQFMNGS 118
Mouse TDGSQASRSFNQGRIEPDSESQEEIIHNIARHLAQIGDEMDHNIQPTLVRQLAAQFMNGS 117
Human TDGNRSSHSR-LGRIEADSESQEDIIRNIARHLAQVGDSMDRSIPPGLVNGLALQLRNTS 117
* * * . . * . *  **** ***■ ** . . . * . *★** *• ** * ** . * .  * * * * ** * .  * *
Rat LSEEDKRNCLAKALDEVKTSFPRDMENDKAMLIMTMLLAKKVASHAPSLLRDVFRTTVNF 178
Mouse LSEEDKRNCLAKALDEVKTAFPRDMENDKAMLIMTMLLAKKVASHAPSLLRDVFHTTVNF 177
Human RSEEDRNRDLATALEQLLQAYPRDMEKEKTMLVLALLLAKKVASHTPSLLRDVFHTTVNF 177
*★** • * * _ * * . . .  . .I* * * * * ..* .* * . . . .* * * * * * * * * .* * * * * * * * .* * * * *
Rat INQNLFSYVRDLVRNEMD 196
Mouse INQNLFSYVRNLVRNEMD 195
Human INQNLRTYVRSLARNGMD 195
* * * * *  . * * *  *  * *  * *
Figure 19 - Multiple se q u en ce  alignm ent o f rat, m ouse and human BID proteins by the
ClustalW tool.
Alignment of th e  three se q u en ce s  with ClustalW [236] sh ow s that th e  proteins have only 
60%  seq u en ce  identity. * = Identical residue, : =  Conserved residue,
. = Sem i-conserved residue.
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Figure 20 - Extraction of rat liver total RNA.
Total RNA was isolated from 60 mg of rat liver [2.43]. 2 %  of the extracted RNA (5 pi) 
was run on a 0.8 % agarose gel containing ethidium bromide (1 pg/ml) and visualised 
under UV illumination [2.3]. Lane 1 -  GeneRuler DNA Ladder Mix (Fermentas; [12.1.2]),
1.5 pg total DNA. Lane 2 -  Extracted RNA
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First-strand cD N A  w as produced from  the total RNA  using AM V reverse transcriptase and a 
com m ercial kit [2.44], The follow ing prim er was used, w hich is com plem entary  to the 3 ’ end o f the 
BID  gene :
5' - T T T T T GG A T C C  TC A G T C C A T C T C  A T T T C T A A C C  A - 3 '  
BamHl Stop Coding.....................................................
T he product of 1st strand synthesis is show n in Figure 21. A band of the expected  size (612 b.p. plus 5 ’ 
untranslated region = approxim ately 640 b.p.) was generated.
[3.2.2]Generation of BID fragment for ligation into expression vector
The B id  cD NA  was used as a tem plate for PCR [2.2], using the follow ing prim ers. The prim ers were 
com plem entary to the 5 ’ and 3 ’ ends o f the BID gene, with the addition o f N del and B am H l cleavage 
sites.
5' Primer
5 '- T T T T T C A T A T G G A C T C T G A G G T C A G C A A C G G - 3 '
Ndel Coding.........................................................
Start
3' Primer
5' - T T T T T G G A T C C T C A G T C C A T C T C A T T T C T A A C C A - 3 '
B a m H l Stop  C o d in g .......................................................................................
The product of the PCR reaction is show n in Figure 22. A band of the expected size (612 b.p.) was 
generated .
[3.2.3]Choice of expression vector
The pE T -15b vector (Invitrogen) was chosen for expression. This is an E. coli expression vector in 
w hich the m ultiple cloning site is located im m ediately dow nstream  o f transcription/translation 
initiation sequences, follow ed by coding sequence* for a poly-histidine tag and a throm bin cleavage 
site. This a llow s production of an N -term inal 6 xH is-tagged fusion protein  w hich can be purified by 
nickel affin ity  chrom atography. Since the 6 xHis tag can interfere w ith protein function, it is desirable 
to rem ove it after purification; this can be achieved by cleavage of the fusion protein w ith throm bin.
[3.2.4]Ligation into pET-15b
Insertion o f the B ID  fragm ent into the pET-15b vector was attem pted by standard restriction enzym e 
digestion and ligation  [2 .6 ],
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Figure 21 - Production of Bid first-strand cDNA. 
cDNA was generated from total RNA by RT-PCR, using AMV reverse transcriptase and a 
commercial kit [2.44]. 5 % of the reaction product (5 pi) was run on a 0.8 % agarose gel 
containing ethidium bromide (1 pg/ml) and visualised under UV illumination [2.3]. 
Lane 1 -  DNA Ladder Mix (Fermentas; [12.1.2]), 1.5 pg total DNA. Lane 2 -  cDNA
synthesis reaction.
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Figure 22 - Generation of BID cDNA by PCR.
Bid DNA was amplified from the first-strand cDNA by PCR [2.2]. 5 % of the reaction 
product (5 pi) was run on a 0.8 % agarose gel containing ethidium bromide (1 pg/ml) 
and visualised under UV illumination [2.3]. Lane 1 -  Ladder Mix (Fermentas; [12.1.2]),
1.5 pg total DNA. Lane 2 -  PCR reaction
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H ow ever, despite repeated attem pts, this was unsuccessful, and no positive transform ants w ere 
generated. This was possibly due to inefficient cleavage of the PCR product by the restriction enzym es 
due to the cleavage sites being too close to the fragm ent end.
To overcom e this problem , the PCR fragm ent was blunt-end ligated into the pPC R -Scrip t vector 
(S tratagene). This vector utilises a unique ligation strategy, based on the uncom m on restriction site of 
S rf l. As described above [2.8], the ligation m ixture contained S r f  I in addition to the pPC R -Script 
vector, insert and T4 D N A  ligase. C leavage o f the S r f  I site generates linear vector, w hich inter­
converts w ith the closed form  through the opposing action o f T4 ligase. Insertion  o f the PC R  fragm ent, 
how ever, disrupts the S r f  I site, trapping the vector in the closed state w ith insert. Insertion of the 
fragm ent also disrupts the LacZ  gene carried by the vector, allow ing b lue-w hite selection o f positive 
transform ants [2.7.4].
Positive transform ants w ere generated using this strategy. P lasm id D N A  was isolated from one o f the 
clones by m ini-prep [2.9], The BID fragm ent was excised by digestion w ith B am H l and N del, as 
show n in Figure 23. The expected 612 b.p. fragm ent {Bid  D N A ) was excised  w hen both restriction 
enzym es w ere used to digest the vector. This was the B id -coding fragm ent w hich contained the tw o 
sticky-ended restriction sites generated by the tw o restriction enzym es, N de l and B am H l. An 
additional band o f 650 b.p. was generated by digestion with B am H l alone, due to the presence of a 
B am H l site in the pPC R -Script vector sequence upstream  o f the N del cleavage site. In the double 
digest, the predicted extra 38 b.p. N d e l-B am H l fragm ent was not recovered.
T he excised B id  D NA  was purified from an agarose gel fragm ent [2.3] using a com m ercial kit [2.4], 
The pET-15b vector w as digested w ith B am H l and N del to generate sites for insertion o f the BID 
D N A  [2.6.1], and the purified BID fragm ent was ligated into the vector w ith T4 DNA ligase [2.6.3], 
L igation was confirm ed by agarose gel electrophoresis [2.3], as show n in F igure 24.
D H 5u com petent cells w ere transform ed with the plasm id [2.7]. A stock o f the expression plasm id was 
m ade from an overnight culture by m iniprep [2.9], and the sequence o f the B id  gene confirm ed by 
D N A  sequencing [2.10].
[3.3]Expression
[3.3.1 [Development of expression conditions
The expression plasm id was used to transfect tw o cell types [2.7.3]: firstly E. coli D E3 cells, and 
secondly E. coli DE3 cells carrying the pLysS plasm id. The pLysS plasm id directs production of T7 
lysozym e, a natural inhibitor o f the T7 RNA polym erase used in the pE T -15 expression system. 
D E3 pLysS cells thus have more stringent prom oter control and low er background expression levels. 
This can help in establishing stable transfectants in cases w here the recom binant protein is toxic to 
E. coli (given that BID  has pore-form ing activity [80], toxicity w as a potential problem ). Figure 25 
show s the resu lt o f transfecting the tw o cell types.
B id  w as poorly  expressed in the DE3 pLysS strain, but w as well expressed in DE3 cells follow ing 
induction, and w as the m ajor protein in the soluble fraction. E xpression was repeated with grow th at 
30 °C, in o rder to increase the proportion o f protein present in the soluble com pared to the insoluble 
fraction. H ow ever, the effect was m arginal [not shown].
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Figure 23 - Excising BID DNA from the pPCR-Script vector.
500 ng of plasmid DNA was digested with BamHl (lane 2), Ndel (lane 3) or both BamHl 
and Ndel (lane 4). Products were run on a 0.8 % agarose gel containing ethidium 
bromide (1 pg/ml) and visualised under UV illumination [2.3]. The band at 650 b.p. in 
lane 2 results from a BamHl cleavage site in the vector DNA sequence. Lane 1 -  DNA 
Ladder Mix (Fermentas; [12.1.2]), 1.5 pg total DNA.
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Figure 24 - Ligation of BID DNA into pET-15b.
Vector DNA was digested with BamHl and Ndel and the BID fragment ligated into the 
cloning site using T4 DNA ligase [2.6]. 80 ng of the pre-ligate (lane 2) and post-ligate 
(lane 3) was run on a 0.8 % agarose gel containing ethidium bromide (1 pg/ml) and 
visualised under UV illumination. Lane 1 -  DNA Ladder Mix (Fermentas; [12.1.2]), 1.5 pg
total DNA.
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Pellet/Supernatant 
Control/Induced
Figure 25 - Expression of recombinant BID.
BID was expressed in £  a?//DE3 cells (D) or £. coliDE3 pLysS cells (L) [2.45], 
Approximately 5 pg of the insoluble (pellet; P) and soluble (supernatant; S) fractions from 
control (non-induced; C) and induced (I) cells were run on 10 % SDS-PAGE [2.13]. 
Bands were visualised by Coomassie staining [2.14.1].
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An expression tim e-course was carried out, as show n in Figure 26. M axim al expression of BID 
relative to other cellu lar proteins occurred after 4 hr induction, and this tim e was thus used for large- 
scale expression.
[3.4]Purification
[3.4.1 [Nickel affinity chromatography
BID  was expressed as above [3.3] on a large scale, and the soluble fraction used to purify the 
N -term inally  6 xH is-tagged fusion protein by nickel affinity chrom atography [2.46]. The flow -through, 
w ash and elution fractions w ere retained and analysed by SD S-PA G E [2.13] [Figure 27],
[3.4.2]Removai of poly-histidine tag
T he 6 xHis tag was rem oved from  recom binant BID by digestion w ith throm bin [2.47]. BID pre- and 
post- digestion is show n in Figure 28. It is clear that BID was essentially  com pletely cleaved from the 
6 xHis tag.
[3.4.3]Aberrant mobility on SDS-PAGE
D epending on the polyacrylam ide gel type, BID runs with an apparent m olecular w eight of 24 -  30 kD. 
T his is in com parison w ith its predicted m olecular mass o f 22.2 kD. This is m ost likely due to the 
unusual am ino acid com position o f BID, and especially o f rat BID [Table 2].
[3.5]Characterisation of recombinant BID by ion exchange chromatography
T he BID cleavage products were applied to a M ono-Q  anion exchange colum n [2.12]. Proteins were 
eluted using a gradient from  150 to 500 mM  NaCl [Figure 29]. M ultiple peaks were detected. The 
fractions indicated [Figure 29; 1 -  13] w ere then further analysed by SD S-PA G E  [2.13] [Figure 30], 
Fractions 1 -  3 contained m ultiple species, but fractions 4 -  13 all appeared to contain BID as the m ajor 
protein  specie. The difference in behaviour on FPLC presum ably related to a difference in 
conform ational state or oligom eric form. This may be due to interm olecular disulphide form ation; to 
interm olecular hydrophobic interactions; or to interaction of BID w ith cardiolip in  or o ther m em brane 
lipids from  E. coli (BID binds to cardiolipin and m ono-lyso-cardiolipin [237]).
[3.6]Characterisation of recombinant BID by gel filtration
To investigate the oligom eric form o f the various fractions above, sam ples w ere passed through a gel 
filtration colum n [2.12], and the apparent m olecular mass of protein species recorded. The colum n was 
calibrated  using a m ixture of blue dextran and standard proteins; the calibration  curve is shown in 
Figure 5 (page 44). A selection o f the BID fractions show n in F igure 29 w as then applied to the same 
colum n, and elu ted  under the sam e conditions. By com parison w ith the standards, the apparent 
m olecular m ass o f the BID species present was calculated, as show n in Table 3. A range of oligom ers 
was detected, bu t no BID m onom er was evident.
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Figure 26 - Time-course of Bid expression.
BID was expressed in £. a?//DE3 cells [2.45]. Culture samples were taken at the 
indicated times and the soluble cell fraction run on 10 % SDS-PAGE [2.13]. Bands were 
visualised by Coomassie staining [2.14.1].
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Figure 27 - Purification of BID by nickel affinity chromatography.
A large-scale culture of BID expression strain [2.45] was separated into insoluble 
(pellet; P) and soluble (supernatant; S) fractions. The supernatant was applied to a 
0.5 ml nickel-NTA-agarose column [2.46]. The flow-through (FT) was retained. The 
column was washed 10 times with 35 mM imidazole (W l, W4, W10) and BID was then 
eluted with 4 x 0.5 ml of 250 mM imidazole (El, E2, E3). 10 pi of each fraction was run 
on 10 % SDS-PAGE [2.13], and bands visualised by Coomassie staining [2.14.1]. M -  Size
markers [12.1.1].
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Figure 28 - Removal of the polyhistidine tag from recombinant BID by digestion with
thrombin.
Approximately 1 mg of 6xHis-BID was digested with thrombin [2.47]. 2 pg of the 
cleavage reaction was run on 10 % SDS-PAGE [2.13], and bands visualised by Coomassie 
staining [2.14.1]. Lane 1- Size markers [12.1.1]. Lane 2 - Uncleaved His6-BID.
Lane 3 - Cleaved BID.
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A m ino Acid C haracter
Frequency in 
Vertebrates
Frequency in 
Rat BID
D ifference
Frequency in 
H um an BID
D ifference
Alanine Small nonpolar 7,4% 6.6% -0.8% 6.7%) -0.7%)
Arginine Charged positive 4.2% 7.1% +2.9% 9.2% 5.0%
Asparagine Polar, uncharged 4.4% 6.1% + 1.7% 6.7%) 2.3%
Aspartic Acid Charged negative 5.9% 8.7% +2.8% 7.7%) 1.8%
Cysteine Polar, uncharged 3.3% 0.5% -2.8% 1.5% -1.8%
Glutamate Charged negative 5.8% 8.7% +2.9% 7.2% 1.4%
Glutamine Polar, uncharged 3.7 % 5.1% + 1.4% 4.6% 0.9%
Glycine Small nonpolar 7.4% 5.1% -2.3% 5.1% -2.3%
Histidine Polar, uncharged 2.9% 3.6% +0.7% 2.6%. -0.3%
Isoleucine Large nonpolar 3.8% 3.6% -0.2% 3.6% -0.2%.
Leucine Large nonpolar 7.6% 11.7% +4.1%. 14.4% 6.8%
Lysine Charged positive 7.2% 3.1% -4.1%. 2.1% -5.1%
Methionine Large nonpolar 1.8% 3.6% + 1.8% 2.6%- 0.8%
Phenylalanine Large nonpolar 4.0% 4.6% +0.6% 2.6%. -1.4%
Proline Small nonpolar 5.0% 2.6% -2.4% 3.1% -1.9%
Serine Polar, uncharged 8.1% 7.7% -0.4% 8.7%- 0.6%
Threonine Polar, uncharged 6.2% 3.6%. -2.6% 4.6% -1.6%.
Tryptophan Polar, uncharged 1.3% 0.0%; -1.3% 0.5% -0.8%)
Tyrosine Polar, uncharged 3.3% 1.5% -1.8% 1.5% -1.8%
Valine Large nonpolar 6.8% 6.6% -0.2% 5.1% -1.7%
TOTALS: +ve 11.4% 10.2% -1.2% 11.3% - 0 . 1 %
-ve 11.7% 17.4% 5.7% 14.9%. 3.2%
Polar uncharged 33.2% 28.1 % -5.1% 30.7% -2.5%)
Small nonpolar 19.8% 14.3% -5.5% 14.9%. -4.9%
Large nonpolar 24.0% 30.1% 6.1 % 28.3% 4.3%.
% -ve minus
0.3% 7.2% 3.6%
%+ve
Table 2 - Sequence comparison of rat and human BID, compared to vertebrate averages. 
Both human and rat BID have an excess of negative residues (glutamate and aspartate), 
and are thus predicted to carry a net negative charge.
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Figure 29 - Anion exchange chromatography of thrombin-digest of recombinant BID. 
BID thrombin cleavage products were fractionated by FPLC on an anion exchange column 
[2.12] using a linear gradient from 150 to 500 mM NaCl. The absorption of the eluate at 
280 nm was monitored. 0.5 ml fractions were collected.
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Figure 30 - SDS-PAGE analysis of FPLC peaks.
20 pi of fractions 1 - 1 3  shown in Figure 29 were run on 10 % SDS-PAGE [2.13], and 
bands visualised by Coomassie staining [2.14.1]. Lane 1 - Size markers [12.1.1].
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Fraction
(From Figure 29) W o
Calculated mass 
(kD) Oligomer
Oligomer
(1 S.F)
1
1.99 38.4 1.7 2
3.00 0.63 - -
4
1.80 85.4 3.9 4
1.97 41.8 1.9 2
6
1.80 82.7 3.8 4
1.97 42.7 1.9 2
7
1.69 130.7 (5.9) (6)
1.80 85.4 3.9 4
8
1.68 136.4 (6.2) (6)
1.79 89.1 4.0 4
13 1.07 1635.6 - -
Table 3 - Gel filtration of BID protein.
The apparent molecular mass of the species present in fractions recovered from anion 
exchange chromatography [Figure 30] was calculated by comparison of Ve/V0 values with 
those for the protein standards [2.12]. Brackets indicate the fact that, although alcohol 
dehydrogenase (150 kD) lay on the standard curve [Figure 5], a Superdex 75 column is 
not designed to accurately separate species with masses greater than approximately
80 kD.
[3.7]Generating monomeric BID
The entire purification w as repeated in the presence o f 1 mM D TT to reduce inter-m olecular 
disulphides. The M ono-Q  elution profile obtained is show n in Figure 31. Gel filtration analysis [2.12] 
show ed the first m ajor peak to be m onom eric BID, and the second dim eric BID, presum ably form ed by 
hydrophobic interactions betw een m olecules. The gel filtration profile and apparent m olecular w eights 
are show n in Figure 32. Peak 1 show n in Figure 31 was collected and stored in aliquots at -7 0  °C. 
H ow ever, on storage som e breakdow n of BID was noted (SD S-PA G E; not show n), possibly due to 
residual contam inating  throm bin. Therefore an additional step was introduced, w hereby the first peak 
show n in F igure 31 w as further purified by hydrophobic interaction chrom atography [2.12], In this 
step, the protein was applied to a phenyl Superose colum n, and BID was eluted with a gradient from 
1.7 to 0 M (N H 4 )2 S 0 4  The elution profile is show n in Figure 33; the indicated fraction was collected. 
SD S-PA G E [2.13] confirm ed that the protein fraction indicated in Figure 33 w as essentially  pure BID 
[Figure 34], BID was aliquoted and stored at 0.5 mg/ml at -70 °C, after conversion o f the buffer to 
20 mM K -H EPES, 15 % glycerol, pH 7.4 [2.48]. The final yield o f the BID preparation was 
approxim ately 0.5 mg protein per litre o f culture medium.
[3.8]Generation of tBID
The active form o f BID in vivo  (truncated BID; tBID ) is generated by cleavage of BID at aspartate 59 
by caspase 8  to yield an active 15 kD C -term inal fragm ent and a 7 kD N -term inal fragm ent. The two 
fragm ents are thought to rem ain associated follow ing cleavage [238], R ecom binant BID was incubated 
w ith recom binant caspase 8  (C albiochem ) to produce tBID in vitro  [2.49], The reaction was carried out 
for varying periods, and analysed by SD S-PA G E [2.13] [Figure 35]. As expected, BID was cleaved 
into p 15 and p7 fragm ents in vitro  by caspase 8 .
[3.9]Discussion
[3.9.1 [Purification achieved
T he final BID preparation produced was extrem ely pure, as evidenced by the single species visible on 
hydrophobic interaction chrom atography [Figure 33], SD S-PA G E [Figure 34] and gel filtration [Figure 
36],
[3.9.2]Stability of purified recombinant BID
To verify that the final BID preparation was stable over long-term  storage, a sam ple o f BID was 
thaw ed and analysed by gel filtration im m ediately after freezing. A fter tw o m onths storage, a further 
sam ple w as analysed in the sam e way; the resulting profile was identical [Figure 36].
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Figure 31 - Anion exchange chromatography of thrombin-digest of recombinant BID 
purified in the presence of 1 mM DTT.
DTT was present at every stage up to thrombin cleavage. BID thrombin cleavage 
products were fractionated by FPLC on an anion exchange column [2.12] using a linear 
gradient from 150 to 500 mM NaCl. The absorption of the eluate at 280 nm was
monitored.
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Figure 32 - Gel filtration of BID, purified in the presence of 1 mM DTT.
The peaks labelled 1 and 2 in 
Figure 31 were analysed by gel filtration [2 .1 2 ]. By comparison of Ve/V0 values with 
protein standards [Figure 5], peak 1 was revealed to be monomeric BID, and peak 2 to
be dimeric BID.
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Figure 33 -  Hydrophobic column chromatography elution profile of BID.
BID protein was applied to a hydrophobic interaction column [2.12], and eluted with a 
gradient from 1.7 to 0 M (NH4)2S04 [2.12]. The indicated fraction (pure BID protein; 
0.5 ml) was aliquoted and stored at -70  °C.
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Figure 34 - SDS-PAGE analysis of the BID fraction eluted from the phenyl Superose
column.
5 pi of the indicated fraction [Figure 33] was run on 10 % SDS-PAGE [2.13] and bands 
visualised by Coomassie staining [2.14.1]. BID is > 95% pure, as indicated by the 
absence of any other visible bands on the gel.
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Figure 35 - Cleavage of recombinant p22 BID by caspase 8 in vitro.
BID was incubated with caspase 8 at 20 °C for 0.5 -  24 hr [2.49]. 10 pi of the products 
was run on 18 % SDS-PAGE [2.13], and bands visualised by Coomassie staining [2.14.1].
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Figure 36 - Gel filtration of stored BID protein.
BID was analysed by gel filtration [2.12] either immediately after storing (top trace) or 
after 2 months storage at -70 °C (bottom trace). The two traces were identical. By 
comparison of Ve/V0 values with protein standards [Figure 5], BID was revealed to be
monomeric.
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[3.9.3]Formation of BID multimers
T he form ation o f BID m ultim ers observed during purification is interesting. W hilst the intram olecular 
disulphides presum ably responsible for form ation o f the high-level oligom ers certainly w ould not occur 
in the reducing in tracellu lar environm ent o f the cell, BID dim ers at least nevertheless rem ain after 
purification in the presence o f  D TT to reduce disulphides. H om o-oligom erisation o f tBID  has been 
suggested to be a m echanism  o f activation in vivo  [103], and the speculation that the hom o-dim ers 
observed here m ight represent an activated form  o f BID w arrants further investigation.
[3.9.4]Aberrant mobility on SDS-PAGE
D epending on the gel type, BID runs as a protein of betw een 23 -  30 kD. T his is in contrast to its 
predicted m olecular w eight o f  22 kD. As shown in Table 2 (above), vertebrate proteins contain on 
average approxim ately equal am ounts o f positive (lysine, arginine) and negative (aspartate, glutam ate) 
am ino acids. In contrast, hum an BID has a 3.6 % excess o f negative over positive residues, and the 
figure for rat BID is 7.2 %. U nusual am ino acid com positions such as these are known to influence 
m obility m arkedly on SD S-PA G E, probably due to inhibition of SDS binding [239]. Thus the apparent 
M r of BID on SD S-PA G E  is an overestim ation o f the true value.
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CHAPTER 4 : BID-INDUCED CYTOCHROME C RELEASE FROM ISOLATED 
MITOCHONDRIA -  DEVELOPMENT OF A REPRODUCIBLE PROTOCOL
[4.1]Introduction
O ne of the key roles o f m itochondria in apoptosis is the release o f cytochrom e c from  the inter­
m em brane space into the cytosol in response to pro-apoptotic stim uli delivered by m em bers o f the 
B CL-2 protein fam ily [240]. In order to study this process in an in vitro  system , several groups have 
developed system s to recreate this effect using isolated m itochondria and a range o f BCL-2 proteins. 
The m ajority o f these w orkers have used anim al tissues, for exam ple rat heart [241,242], rat liver 
[24,56,91,108,110,119,243-246], rat brain [242,247] or m ouse liver [57,83,93,102,140,146,233], 
A lternatively, m itochondria have been isolated from  a variety o f cell lines -  H L60 cells [54,248], Rat-1 
cells [249], H eLa cells [99,104,142,243,250-254], 293T cells [114,250], PC 12 cells [254], HEK, 
LoVo, L S I80 and D U 145 cells [99], GT17 cells [247] and KB cells [100]. Finally, som e groups have 
w orked w ith X enopus  egg m itochondria [107,245] or yeast m itochondria [9,233,255], A m ongst the 
above w orkers, 21 groups have induced cytochrom e c release using BID or tBID  proteins 
[54,56,57,93,99,100,102,104,107,110,140,142,146,233,238,242-245,252,253], C ytochrom e c release 
was assayed prim arily  by W estern blot, although som e groups have used an ELISA  system  [91,247], 
Additionally, A ppaix and co-w orkers [241] describe a m ethod to quantify  cytochrom e c levels 
spectrophotom etrically, utilising the Soret (gam m a) peak o f cytochrom e c at 414 nm. H ow ever, the 
sensitivity o f this technique lies only in the low m icrom olar range, and thus requires at least m illigram  
levels of m itochondrial protein. Finally, Petrosillo and co-w orkers [256] have recently  developed a 
very sensitive technique for assaying cytochrom e c, based on reverse-phase HPLC.
[4.2]Development of mitochondrial isolation procedure for cell lines
[4.2.1 [Introduction
Standard techniques for isolating m itochondria from anim al tissue are well established [257], H ow ever 
for cell lines there are a num ber o f alternative possibilities, each w ith their ow n advantages and 
disadvantages. For the purposes o f isolating m itochondria in order to study apoptotic cytochrom e c 
release, several groups have made use o f m echanical hom ogenisers; either D ounce hom ogenisers, 
w hich crush  cells betw een the cylinder wall and plunger, or rotating Potter hom ogenisers, in which 
cells are broken as a result of shear forces betw een the cylinder and a m otorised plunger 
[54,99,114,247,248,250,251], A lternatively, the Polytron hom ogeniser, in which rotating blades 
d isrupt cells, has been used by some [100], Finally, cells have also been broken by passage through a 
sm all-gauge needle; in this case shear forces betw een the m oving cells and the w alls of the needle are 
responsible for disrupting cells [104,142,252,253],
The m ajor consideration for the studies undertaken here w as that m itochondrial preparations made on 
different days should be as sim ilar as possible, so that results could be com pared across m ultiple 
experim ents. C onsequently  the procedure needed to rely as little as possible on hum an error. An 
additional consideration  was that the procedure should be as gentle as possible, in order to m axim ise
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the proportion o f unbroken m itochondria (since perm eabilisation o f the outer m em brane was the 
process to be studied).
[4.2.2]Equipment and strategy
In this study, reproducible cell disruption, yielding largely intact m itochondria, was obtained by forcing 
the cell suspensions through a 21-gauge needle under constant pressure [2.26]. M itochondria were 
isolated from  the cell hom ogenate by differential centrifugation; a flow diagram  of the com plete 
procedure is show n in Figure 7 (page 52). Initially, different conditions w ere investigated, w hereby the 
driving pressure and the num ber o f passes through the needle w ere varied, in order to m axim ise 
m itochondrial yield and integrity.
[4.2.3]Measurement of mitochondrial yield and integrity
T he m itochondrial fraction, as well as unbroken cells, were assayed for m onoam ine oxidase (M AO) 
activity 12.34] and for total protein [2.17.2], M A O  is a protein o f the m itochondrial outer mem brane, 
and so gives a m easure o f the quantity of m itochondria (both broken and intact) present in the fraction. 
In addition, the m itochondrial pellet fraction was assayed for cytochrom e c by W estern blot [2.16], As 
a soluble protein of the inter-m em brane space, cytochrom e c would be released from any broken 
m itochondria; thus the ratio o f cytochrom e c : M AO gives a m easure o f the relative intactness of the 
m itochondrial preparation.
[4.2.4]Effect of driving pressure
The shear stress acting on cells as they pass through the needle is proportional to the velocity of the 
fluid through the needle (assum ing lam inar flow). The fluid velocity is in turn proportional to the 
driving pressure; thus increasing driving pressure will increase the force breaking cells. Cells were 
passed through the needle using driving pressures of 120, 200 or 265 kPa, and the tim e taken for the 
cell suspension to pass through the needle recorded using electronic sensors. The flow rate (Q ) and 
fluid velocity (v) were then calculated based on the volum e o f fluid and the internal d iam eter (I.D .) of 
the needle (0.51 mm for a 21-G auge needle), according to Equation 1 [Table 4].
Table 5 show s the relative yield and intactness of m itochondria isolated at these three pressures. 
Increasing pressure resulted in only a m arginal increase in yield, but produced a m arked fall in 
cytochrom e c recovery (m itochondrial intactness). A driving pressure o f 120 kPa was therefore 
adopted.
[4.2.5]Effect of passage number
In an attem pt to im prove yield, cells were passed through the needle 5, 10 or 20 times at a pressure of 
120 kPa, and w hole-cell and m itochondrial fractions assayed as above [Table 6 ].
Q =
volume Q 4 Q
V =  =  -----------Equation 1 1 i rv 17 t r  71 I.D.time
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Driving pressure (kPa) Time taken (ms) Flow rate (pl/ms) Fluid velocity (m/s)
120 80.7 6.20 30.6
200 54.7 9.15 45.1
265 46.3 10.79 53.2
Table 4 - Flow rates and fluid velocity at the three driving pressures used.
T he tim e taken for the cell suspension to  be forced through th e  need le [2 .26 ] w as 
m easured using electronic sensors. Flow rate and fluid velocity w ere then calculated  
based on th e  volum e o f fluid and the internal diam eter of the needle (0 .51  mm for a 21-
Gauge need le).
Pressure
(kPa)
Fraction
Protein
(mg)
MAO
Activity
(A.U.)
Cytochrome c 
(A.U.)
Yield
(% total MAO recovered 
in mitochondrial fraction)
Relative intactness 
(120 kPa = 1)
120
Cells 0.78 2.75
49.5 1.00
Mitochondria 0.13 2.69 1780
200
Cells 0.65 2.36
49.8 0.89
Mitochondria 0.11 2.34 1379
265
Cells 0.26 1.18
61.7 0.45
Mitochondria 0.11 1.90 571
Table 5 - Effect of driving pressure on the yield and intactness of mitochondria isolated
from B50 cells.
Mitochondria w ere isolated using the procedure described [2 .2 6 ], using three different 
driving pressures. Unbroken cells and th e  mitochondrial fraction w ere assayed  for MAO 
(as a m easure of am ount of both broken and unbroken m itochondria) and cytochrom e c 
(as a m easure of am ount of unbroken mitochondria only). P ercentage yield w as  
calculated a s the percentage of total MAO activity present in the mitochondrial pellet. 
Relative intactness w as calculated as th e  ratio of the am ounts o f cytochrom e c and MAO 
activity in the mitochondrial pellet, relative to  the value for 120 kPa driving pressure. 
MAO activity w as assayed  fluorimetrically by following the release o f a fluorophore from a 
synthetic MAO substrate [2 .3 4 ]. Cytochrom e c w as assayed  by W estern blot [2 .16 ].
A.U. = Arbitrary units
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Passages Fraction
Protein
(mg)
MAO
Activity
(A.U.)
Cytochrome c 
(A.U.)
Yield
(% total MAO recovered in 
mitochondrial fraction)
Relative intactness 
(120 kPa = 1)
5
A 3.54 16.90
30.0 1.00
B 0.31 7.24 3041
10
A 2.61 11.89
52.7 0.52
B 0.40 13.22 2864
20
A 1.48 7.12
69.6 0.49
B 0.53 16.32 3332
Table 6 - Effect of passage  number on the yield and intactness o f mitochondria isolated
from B50 cells.
Mitochondria w ere isolated using the procedure described [2 .2 6 ], using a variable number 
of p a ssa g es through the needle. Unbroken cells and the mitochondrial fraction w ere  
assayed  for MAO (as a m easure of am ount of both broken and unbroken mitochondria) 
and cytochrom e c (as a m easure of am ount of unbroken mitochondria only). Percentage  
yield w as calculated a s th e  percentage of total MAO activity present in the mitochondrial 
pellet. Relative intactness w as calculated as the ratio o f the am ounts o f cytochrom e c 
and MAO activity in th e  mitochondrial pellet, relative to  the value for 120 kPa driving 
pressure. MAO activity w as assayed fluorimetrically by following th e  release of a 
fluorophore from a synthetic MAO substrate [2 .3 4 ]. Cytochrom e c w as assayed  by 
W estern blot [2 .16]. A.U. = Arbitrary units
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Increasing passage num ber had a large effect on yield, increasing from 30 % (5 passes) to 70 % (20 
passes). H ow ever, the m ore im portant param eter is intactness -  m itochondria w ith broken outer 
m em branes (w hilst potentially  acceptable for som e studies) would be o f no use in investigating 
cytochrom e c release from  the inter-m em brane space. A t both 10 and 20 passes, the intactness was less 
than 50 % o f the value at 5 passes. Thus the standard conditions chosen were a driving pressure of 
120 kPa and 5 passes through the needle.
There was low er yield com pared w ith the pressure experim ents above [4.2.4]. This was likely to be 
due to the increased m itochondrial concentration used in these experim ents.
[4.2.6]lntactness
The values given above for intactness o f the m itochondrial preparation are expressed on a relative scale 
since the total am ount of cytochrom e c in the unbroken cells was unknow n. To estim ate the actual 
intactness (i.e. percentage of unbroken m itochondria), both M A O  and cytochrom e c were m easured in 
a sam ple o f unbroken B50 cells, and in a preparation o f m itochondria m ade from these cells under 
standard conditions [Table 7[. C ytochrom e c was enriched 3.5 times in the m itochondrial preparation, 
w hereas M AO w as enriched 4.8 times. Thus the intactness was 3.5 -r 4.8 = 73 %.
[4.2.7]Reproducibility
T o assess the reproducibility  o f the technique, m itochondria were isolated from B50 cell cultures on six 
d ifferent days. Protein and cytochrom e c levels were assayed, and are show n in Figure 37.
C ytochrom e c levels were com parable in all six preparations, indicating that the procedure developed 
for isolation o f m itochondria from  B50 cells is reproducible.
[4.3]Cytochrome c release assay
[4.3.1 [Buffers
Several different buffers are reported in the literature. A m ong these, isosm olarity is m aintained by 
sucrose, mannitol, KCl or som e com bination of these. M ost w orkers have used energised 
m itochondria, with either succinate (com plex II substrate) or m alate/glutam ate (com plex I substrate) as 
fuel. M gC l2, KH 2 P 0 4, PM SF, M g(C 2 H 3 0 2)2, EDTA, EG TA  and NaCl are included in som e buffers 
[57,93,102,258],
Based on a consideration of the work o f the above authors, and others, and also on the basis of 
m aintaining the com position as close as possible to the in vivo in tracellular state, A K Cl-based buffer 
was chosen [2.31.1], containing succinate, rotenone, M gC l2  and inorganic phosphate. KCl was used to 
m aintain isosm olarity, since potassium  is the main intracellular cation in vivo. Succinate was used to 
energise m itochondria, with rotenone included as a com plex I inhibitor. W ithout com plex I inhibition, 
a sufficient N A D + pool is m aintained to convert m alate (generated from  succinate oxiadation, via 
fum arate) to oxaloacetate, which inhibits succinate dehydrogenase. U nder these conditions only a very 
low electron transport flux is possible, and m itochondria are essentially  de-energised. M agnesium  ions 
and inorganic phosphate are reported to be necessary for B ID -induced cytochrom e c release [57].
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[Protein]
(mg/ml)
Cytochrome c 
(A-U./pg protein)
Cytochrome c 
Enrichment
MAO
(A.U./pg protein)
MAO
Enrichment
Intactness
(%)
Whole cells 4.80 0.205
3.52
0.031
4.81 73
Mitochondria 4.85 0.721 0.148
Table 7 - Cytochrome c and MAO levels in unbroken cells and a mitochondrial preparation
made from these cells.
Enrichment was calculated by dividing the MAO or cytochrome c value for the 
mitochondrial preparation [2.26] by the value for whole cells. Intactness was calculated 
by dividing the cytochrome c enrichment by the MAO enrichment. MAO activity was 
assayed fluorimetrically by following the release of a fluorophore from a synthetic MAO 
substrate [2.34]. Cytochrome c was assayed by Western blot [2.16]. A.U. = Arbitrary
units
7
1 2 3 4 5 6 Mean
Preparation number
Figure 37 - Comparison of cytochrome c levels in six different mitochondrial preparations,
made on different days.
Mitochondria were isolated from B50 cells by the procedure developed above [2.26], and 
cytochrome c was assayed by Western blot [2.16]. Values are displayed per mg of 
mitochondrial protein, as a measure of intactness. Mean value error bars are +/- SEM.
A.U. = Arbitrary units
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Finally, EG TA  was included to chelate trace am ounts o f calcium  present follow ing m itochondrial 
isolation, w hich m ight otherw ise induce PT  pore opening. For experim ents using buffered calcium , an 
E G T A -C a2+ buffer pair was constructed using known EGTA pKd values [2.52], Total EGTA 
concentration was m aintained at 2 mM .
[4.3.2] Experimental
The procedure for assaying B ID -induced cytochrom e c release is described above [2.31] (page 57). 
The presence o f caspase 8  does not induce cytochrom e c release independently  of BID  [93,242]. Thus 
to generate tBID  for use in experim ents, full-length BID was incubated w ith caspase 8  [2.49] before 
adding the reaction m ixture (containing cleaved BID  and caspase 8 ) to m itochondria. A lternatively, in 
som e experim ents, a pure tBID  preparation (purified caspase 8 -cleaved recom binant BID; Sigm a) was 
used.
[4.3.3]Analysis
C ytochrom e c release from m itochondria was m easured by W estern blotting [2.16], Q uantification of 
the release required densitom etric analysis of these blots, and it was therefore im portant to ensure that 
the signal obtained was linear over the required range. V arious quantities o f a m itochondrial 
preparation [2.26] were analysed by W estern blot, and values for am ount of cytochrom e c were 
extracted by densitom etry, as in cytochrom e c release assays. V alues are shown in Figure 38. The 
signal is linear w ith increasing [m itochondria].
[4.4]Effect of BID on mitochondria from different tissues
Initial experim ents com pared the capacity of BID (full-length, uncleaved; C H A PT ER  3) to induce the 
release of cytochrom e c from  isolated B50 cell m itochondria [2.26] w ith the effect on those isolated 
from  rat heart and rat liver [2.25]. As show n in Figure 39, m itochondria isolated from  rat heart or liver 
did not give a good response to BID. A considerable am ount o f cytochrom e c w as released over the 
course o f the assay, even w ith no BID added. There was a slow increase in cytochrom e c release over a 
large range o f [BID], and a substantial am ount o f cytochrom e c rem ained un-released at the highest 
[BID] tested (the response plateaus). M itochondria taken from the B50 cell line gave by far the best 
response to BID, with a low background release in absence of tBID , only a sm all am ount o f un­
released cytochrom e c at m axim um  [BID], and a sharp response to increasing [BID ]. This could be 
due to the m ore gentle procedure for isolating m itochondria (no hom ogenisation o f tissue required) 
leading to less disruption o f m itochondrial structure, and also to the hom ogeneous nature of 
m itochondria isolated from cell culture com pared to those from anim al tissue. Thus in all further 
experim ents m itochondria for use in cytochrom e c release studies w ere isolated from  B50 cell cultures.
[4.4.1 [Comparison of cytochrome c release elicited by BID and tBID
tBID  is reported to be considerably m ore potent in releasing cytochrom e c from m itochondria than 
BID. For exam ple, Kim and co-w orkers report a 1 0 - 2 0  fold activation using isolated m itochondria 
[57], w hereas M adesh and co-w orkers report tBID  to be 100-fold more effective in a system  using 
perm eabilised H epG 2 cells [258].
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Figure 38 - Linearity of the assay for cytochrome c in samples taken from cytochrome c
release assays.
Various quantities of a mitochondrial preparation [2.26] were analysed by the same 
procedure used to quantify cytochrome c release (SDS-PAGE [2.13] followed by Western 
blot [2.16], with signals quantified by fluorimetry using the Odyssey system (Li-Cor)). 
The signal is linear with increasing [cytochrome c].
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Figure 39 - BID-induced cytochrome c release, using mitochondria isolated from different
tissues.
Mitochondria were isolated from rat liver (A), rat heart (B) or B50 cells (C), as described 
above [2.25],[2.26]. Cytochrome c release was induced by incubation with various 
quantities of BID (full-length) [3.7] for 30 mins, and mitochondria were then sedimented 
[2.31]. The cytochrome c present in the mitochondria pellet (P) or supernatant (S) was 
assayed by Western blot [2.16]. Percentage cytochrome c release was calculated by 
dividing the cytochrome c reading in the supernatant fraction by the total cytochrome c 
content (pellet plus supernatant), and plotted against BID concentration. Results are 
representative of three independent experiments.
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To investigate the activation by cleavage w ith the BID and tBID  preparations generated here 
[C H A PTER  3], cytochrom e c release assays [2.31] were carried out using the tw o preparations [Figure 
40]. The E C 5 0  for B ID -induced cytochrom e c release was around 140 nM, w hilst for tB ID -induced 
cytochrom e c release the figure was around 10 nM. The activation o f BID by cleavage was thus 14 
tim es; this is in line w ith literature values.
[4.5]Effect of concentration of mitochondria on tBID-induced cytochrome c release
The im portance of controlling the am ount of m itochondria in cytochrom e c release assays was 
investigated by perform ing tB ID -induced cytochrom e c release assays [2.31] with varying am ounts of 
m itochondrial protein.
EC5 0  values w ere derived from  the plots o f [tBID] vs. percentage cytochrom e c release [Figure 41]. 
These w ere then used to plot the effect o f m itochondrial protein concentration on EC 5 0 , as show n in 
Figure 42. EC 5 0  was proportional to concentration o f m itochondria over the range tested. This 
suggests that essentially  all the added tBID was bound to sites on m itochondria. (If this were not so 
then increasing the am ount of m itochondria would result in a less-than-proportional increase in EC™. 
C onsider the case in w hich a negligible am ount of tBID was bound -  then adding more m itochondria 
would not change the free concentration o f tBID, and no additional tBID  w ould be required to achieve 
the same cytochrom e c-releasing effect in the additional m itochondria.) A dditionally, this result 
suggested that there is no positive feedback m echanism  for cytochrom e c release from isolated 
m itochondria, as has been suggested by others [ 137],
[4.6]BID-induced AIF release
In 2003, D iaz and co-w orkers [259] identified an alternative pathw ay of B ID -induced apoptosis. In 
response to addition o f the anti-carcinogenic com pound chlorophyllin, pro-caspase 8  activation led to 
BID  cleavage and B A X /B A K  activation as usual, but cytochrom e c was not released from 
m itochondria. Instead A IF  w as released through the outer m em brane, concom itant with an attenuation 
o f the inner m em brane potential. A IF  translocated to the nucleus and led to cleavage of nuclear lamin 
and subsequent cell death. H ow ever A rnoult and co-w orkers [243] have suggested that A IF release 
occurs dow nstream  of cytochrom e c release, and in fact does not occur at all in m any system s due to 
association w ith the inner mem brane. To investigate this phenom enon, A IF release was assayed by a 
procedure identical to that above [2.31], except using an anti-A IF  antibody rather than an anti­
cytochrom e c antibody for W estern blots [2.16], R epresentative graphs com paring A IF and 
cytochrom e c release induced by BID and tBID are show n in Figure 43. There was no significant 
release o f A IF  paralleling the release of cytochrom e c.
[4.7]Effect of energy state on BID-induced cytochrome c release
Shim izu and co-w orkers [56] have show n previously that BID - or BIK - induced cytochrom e c release 
was respiration-independent. To confirm  this finding, cytochrom e c release was induced by tBID  in 
the presence and absence of succinate as respiratory substrate. (B50 cell m itochondria do not develop a 
m em brane potential in the absence o f succinate; endogenous substrate is consum ed rapidly [157].) The 
response to tB ID  in both cases is show n in Figure 44.
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Figure 40 - BID- and tBID- induced cytochrome c release from B50 mitochondria. 
Mitochondria were isolated from B50 cells as described above [2.26], and cytochrome c 
release induced by addition of BID (A,B) or tBID (B,C), using the procedure described 
[2.31]. Anti-cytochrome c Western blots [2.16] of the mitochondrial fraction (pellet) are 
shown in A and C. Percentage cytochrome c release (B,D) was calculated by dividing the 
cytochrome c reading in each mitochondrial fraction by the maximum cytochrome c 
reading. Results are respresentative of six independent experiments.
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Figure 41 - tBID-induced cytochrome c release from preparations containing different 
amounts of mitochondrial protein.
Cytochrome c release assays were carried out as above [2.31]. (A-D) Four different 
quantities of mitochondria, containing 4, 8, 15 and 31 pg mitochondrial protein, as 
indicated, were added to solutions containing various concentrations of tBID [3.8]. 
Reactions were incubated for 30 mins at 30 °C, and centrifuged to pellet mitochondria. 
Cytochrome c in the mitochondrial pellet was assayed by Western blot [2.16].
(E) Overlay of the cytochrome c release curves taken from A - D .  Results are 
representative of two independent experiments.
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Figure 42 - Effect of [mitochondria] on BID-induced cytochrome c release.
EC50 values are derived from tBID-induced cytochrome c release assays [2.31] with 
varying concentrations of mitochondrial protein [Figure 41]. Values are plotted against 
mitochondrial protein concentration. tBID EC50 is linear with increasing [mitochondrial 
protein], indicating that essentially all tBID is bound to sites on mitochondria.
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Figure 43 - Comparison of cytochrome c and AIF release induced by full-length BID and
by tBID.
A release assay was carried out as above [2.31]. Mitochondria were added to solutions 
containing various concentrations of tBID (A) or BID (B) [CHAPTER 3]. Reactions were 
incubated for 30 mins at 30 °C, and centrifuged to pellet mitochondria [2.31]. The 
mitochondrial pellet was assayed for cytochrome c (x) or AIF (A) by Western blot [2.16], 
showing that tBID and BID are unable to induce AIF release under conditions in which 
cytochrome c is released. Results are representative of two independent experiments.
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Figure 44 - The release of cytochrome c from isolated mitochondria in response to tBID 
occurs at different [tBID] in respiring and non-respiring mitochondria.
A release assay was carried out as above [2.31]. Mitochondria were added to solutions 
containing various concentrations of tBID [3.8]; solutions either contained 5 mM 
succinate (as above; respiring mitochondria; A ) or no succinate (non-respiring 
mitochondria; x). Reactions were incubated for 30 mins at 30 °C, and centrifuged to 
pellet mitochondria [2.31], The mitochondrial pellet was assayed for cytochrome c by 
Western blot [2.16], Results are representative of three independent experiments.
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N on-respiring m itochondria were less sensitive to tB ID -induced cytochrom e c release than respiring 
m itochondria. H ow ever the effect was small (EC 5 0  was increased from  7 nM to around 10 nM) in 
broad agreem ent with published data [56].
[4.8]Effect of exogenous cytochrome c on BID-induced cytochrome c release
C ytochrom e c can induce perturbations in lipid bilayers [260], The release o f a small am ount of 
cytochrom e c from  m itochondria during apoptosis may thus influence the release of the rem aining 
cytochrom e c pool, by affecting bilayer properties. To investigate this possibility in the in vitro  system  
developed here, tBID  was used to induce cytochrom e c release either from  norm al B50 m itochondria, 
or from m itochondria that had been pre-incubated with exogenous cytochrom e c [2.32]. As show n in 
Figure 45, preincubation w ith exogenous cytochrom e c had no effect either on m itochondrial 
cytochrom e c content or on tB ID -induced cytochrom e c release, thus ruling out any feedback 
regulation of cytochrom e c release by this mechanism .
[4.9]Equivalence of commercial and in-house generated tBID
The tBID  used to obtain the data presented above was generated by incubating recom binant BID with 
purified recom binant caspase 8 , and then adding this mixture (containing caspase 8 -cleaved BID (tBID) 
and active caspase 8 ) directly to m itochondria [2.49], This technique has a num ber of potential 
problem s. Firstly, BID is not com pletely cleaved by caspase 8  during the incubation tim es used [3.8] 
so that the tBID  concentration will be slightly less than anticipated. Secondly, BID cleavage will 
continue during incubation o f the preparation w ith m itochondria, changing the tBID  concentration over 
the course of the incubation and thus affecting the kinetics of tB ID -induced cytochrom e c release. And 
finally, although the presence o f caspase 8  has previously been show n not to affect cytochrom e c 
release [93,242] it rem ains possible that its presence m ight have som e effect in the system  used here. 
Thus it was considered preferable to use a com m ercial preparation of purified tBID [2.31.1] in all 
further experim ents. To dem onstrate equivalence of the two preparations, m itochondria were incubated 
either w ith the com m ercial tBID  or with tBID prepared by caspase 8  cleavage o f full-length BID (as 
above) and the cytochrom e c release response com pared. As show n in Figure 46, although the E Q o is 
slightly low er in the case of the com m ercial preparation (perhaps because of incom plete caspase 8  
cleavage o f full-length BID) there is very little difference in response betw een the tw o preparations. 
Thus the com m ercial preparation was used in all further experim ents.
[4.10]Discussion
[4.10.1]Mitochondrial isolation
A procedure was developed to isolate m itochondria from  a B 50 cell line. M itochondria were 
substantially intact, and retained cytochrom e c during isolation. Im portantly, the procedure was 
reproducible, yielding preparations w ith sim ilar contents of cytochrom e c on several different 
occasions.
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Figure 45 - Neither mitochondrial cytochrome c content nor tBID action is affected by 
preincubation with exogenous cytochrome c. 
tBID was used to induce cytochrome c release either from normal B50 mitochondria 
(x) [2.26] or from mitochondria that had been pre-incubated with exogenous 
cytochrome c (A) [2.32], Reactions were incubated for 30 mins at 30 °C, and centrifuged 
to pellet mitochondria [2.31]. The mitochondrial pellet was assayed for cytochrome c by 
Western blot [2.16]. Pre-incubation with cytochrome c had no effect on mitochondrial 
cytochrome c content or on tBID-induced cytochrome c release. Results are 
representative of three independent experiments.
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Figure 46 -  A commercial tBID preparation has a cytochrome c releasing activity 
equivalent to that of the tBID preparation used above.
Cytochrome c release was induced from B50 mitochondria using either a commerical tBID 
preparation [2.31.1] (x) or tBID generated by caspase 8 cleavage of full-length 
recombinant BID [2.49] (A). Reactions were incubated for 30 mins at 30 °C, and 
centrifuged to pellet mitochondria [2.31]. The mitochondrial pellet was assayed for 
cytochrome c by Western blot [2.16]. The cytochrome c release response to the two 
tBID preparations was essentially identical.
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[4.10.2]Cytochrome c release assay
C ytochrom e c release w as induced from m itochondria from various sources using BID and tBID 
proteins. M itochondria isolated from B50 cells gave a better response to BID than those isolated from 
rat heart or rat liver. C ytochrom e c release was assayed by W estern blot; values thus derived were 
show n to accurately reflect m itochondrial cytochrom e c levels, w ith the signal linear over the required 
range. As reported previously, tBID was approxim ately 14 tim es more potent than full-length BID in 
inducing cytochrom e c release. The am ount o f m itochondria used in assays was revealed to be 
im portant; increasing the level o f m itochondrial protein present let to a proportional increase in the 
E C 5 0  for tB ID -induced cytochrom e c release. A dditionally, this result show ed that the m ajority  o f tBID 
protein is bound to sites on m itochondria, rather than free in solution. Energising m itochondria had a 
slightly stim ulatory effect on tBID  action, but the effect was small. Finally, A IF was show n to be 
retained by m itochondria over the course of tBID- and BID- induced cytochrom e c release, and 
exogenous cytochrom e c was dem onstrated to have no effect on m itochondrial cytochrom e c content or 
tB ID -induced cytochrom e c release.
[4.10.3]Equiva!ence of tBID preparations
A com m ercial preparation of tBID  was shown to have the same cytochrom e c-releasing activity as the 
tBID  preparation used above (caspase 8 -cleaved full-length recom binant BID). Since the com m ercial 
preparation had no contam inating caspase 8 , it was decided to use this tBID  stock in all further 
experim ents.
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CHAPTER 5 : ON THE INVOLVEMENT OF THE PERMEABILITY TRANSITION 
PORE IN BID ACTION
[5.1]lntroduction
T here is considerable controversy over the involvem ent o f the perm eability transition pore (PT pore) in 
cytochrom e c release from  m itochondria during apoptosis. On the one hand, PT pore effectors such as 
CSA, C a2+ and bongkrekic acid have been show n to m odulate the m itochondrial apoptotic response, in 
som e system s at least [123,261,262], A dditionally, BCL-2 fam ily m em bers are know n to associate 
w ith PT pore com ponents [108,110], and alterations in levels of these com ponents (A NT and V DA C) 
influence apoptosis [112,114], On the other hand, it is certainly the case in som e system s that 
cytochrom e c release precedes the sw elling and mem brane depolarisation that w ould be predicted to 
accom pany PT  pore opening [53-57], It is also unlikely that sustained PT pore opening occurs early in 
the apoptotic process, since m itochondrial function (or A TP production at least) is necessary for 
com pletion of the active process o f cell dem ise [263],
[5.2]Effect of calcium on tBID action
C a2+ strongly activates PT  pore opening (review ed in [50]). Thus, if PT pore opening is 
m echanistically involved in BID action, exposure to C a2+ should sensitise m itochondria to BID -induced 
cytochrom e c release. M itochondria were incubated with tBID or BID, using the in vitro system  
developed above [CH APTER 4], in the presence cr absence of 0.8 pM  buffered extra-m itochondrial 
free C a2+ [2.52], U nder these conditions a steady state o f C a2+ influx (through the C a2+ uniporter) and 
efflux (through the N a 2 +-C a2+ carrier) is established. At 0.8 pM  external concentration, the internal 
C a2+ concentration is approxim ately 2 pM  (at least in heart m itochondria [264]). Figure 47 show s that 
there was no stim ulatory effect o f C a2+ under these conditions; rather, there was a sm all inhibition. 
This result was in line with those o f Shim izu and co-w orkers [56], who show ed that BID- or BIK- 
induced cytochrom e c release was C a2+ -independent, and suggested PT pore opening did not occur 
during BID -induced cytochrom e c release in this system.
[5.3]Calcein release during tBID-induced cytochrome c release
[5.3.1 [Introduction
N otw ithstanding the results presented in Figure 47, it was possible that PT  pore opening may still be 
involved at som e stage in BID action. Any stim ulatory effect of C a2+ m ight be small, and undetectable 
by the above assay at the C a2+ concentrations used. A lternatively tBID  m ight stim ulate pore opening in 
a C a2+-independent manner. A ccordingly, PT  pore opening was assayed by the release of matrix- 
entrapped calcein [2.28]. This provides a very sensitive m eans o f detecting even very transient periods 
o f pore opening, which will result in release o f the fluorophore into the m edium  [17,57,265].
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Figure 47 - Ca2+ does not stimulate BID or tBID -induced cytochrome c release from
isolated mitochondria.
Mitochondria were incubated with varying concentrations of BID (A) or tBID (B), either in 
Ca2+-free buffer (containing 2 mM EGTA; x) or in buffer supplemented with 0.8 pM Ca2+ 
(buffered with EGTA; A). After 30 mins incubation at 30 °C, mitochondria were separated 
by centrifugation [2.31] and assayed for cytochrome c by Western blot [2.16]. Results 
are representative of five independent experiments.
115
[5.3.2]The effects of Ca2+ and tBID on calcein release
M itochondria w ere loaded w ith calcein [2.28], and then incubated under the sam e conditions as in BID- 
induced cytochrom e c release experim ents [2.31]. In some experim ents, 400  pM  C a2+, 1.2 pM  CSA or 
150 nM  tBID  was added. Calcein release (expressed as % of total entrapped fluorophore) is shown in 
Figure 48. W ith no additions [Figure 48; control] there was a slow loss o f calcein from  m itochondria 
(approxim ately 1 % of the total entrapped per min), probably due to a gradual loss o f integrity of the 
m itochondrial inner m em brane over time. As expected, C a2+ induced rapid loss of calcein, due to 
induction o f PT  pore opening. This effect was inhibited by CSA  (a PT  pore blocker). H ow ever, 
perm eability transition still occurred after around 8  mins under these conditions; this was expected to 
be the case, as CSA  inhibition is overcom e in a tim e-dependent m anner at high [C a2+] [266]. N otably, 
150 nM  tBID  did not induce any calcein loss above the control level (in agreem ent w ith the results of 
Kim and co-w orkers [57]).
[5.3.3]Verifying cytochrome c release
To verify tB ID -induced cytochrom e c release under these conditions, m itochondrial sam ples were also 
assayed for m itochondrial cytochrom e c content by W estern blot [2.16] [Figure 49). C ytochrom e c 
release still occurred in response to tBID  under these conditions. The absence o f any parallel release of 
calcein confirm ed that PT pore opening was not involved in tBID  action. Interestingly, there was no 
release of cytochrom e c from the m itochondria incubated with C a2+, suggesting that PT pore opening 
does not lead to m itochondrial sw elling sufficient to rupture the ou ter m em brane under these 
conditions, or that cytochrom e c is firmly attached to the inner m em brane.
[5.4]The effect of cyclophilin D on apoptosis and mitochondrial cytochrome c release
[5.4.1 [Introduction
Even if pore opening per se  is not involved in B ID -induced cytochrom e c release, the PT pore, or PT 
pore com ponents, m ight still be involved in BID action. For exam ple, the PT pore has been suggested 
to be a binding site for BCL-2 fam ily proteins [108,110], and may additionally facilitate release of a 
sub-population of cytochrom e c during apoptosis [61], To probe further the involvem ent o f the PT 
pore in the system  developed here, the effect o f modulation o f cyclophilin  D levels w as investigated. 
C yclophilin D is the matrix com ponent of the PT pore [Figure 50], and is a PPIase [1.7], H ow ever its 
role in the pore is not clear. It has been suggested either to facilitate the conversion o f the pore to the 
open state, or to stabilise this state [31], C larke and co-w orkers have suggested that cyclophilin D ’s 
PPIase activity is required for pore opening (although not for binding to A N T) [36],
[5.4.2]Cyclophilin D overexpression
A B50 cell line overexpressing cyclophilin D (designated cyclophilin  D (+) cells) had been previously 
produced in our lab [2.42], To check the expression level o f cyclophilin  D, m itochondria were 
prepared from  norm al and over-expressing B 50 cells [2.26], and cyclophilin D levels analysed by 
W estern blot [2.16]. Figure 51 shows that cyclophilin  D is overexpressed approxim ately 10 tim es in 
this cell line.
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Figure 48 - Release of matrix-entrapped calcein from mitochondria is induced by Ca2+ but
not by tBID.
Mitochondria were loaded with calcein by incubating with calcein-AM [2.28].
Mitochondria were then incubated in respiration medium, containing either no 
additions ( ), 400 pM Ca2+ (x), 400 pM Ca2+ + 1.2 pM CSA (+) or tBID (A ) as indicated. 
After incubation for varying times, mitochondria were separated from the assay mixture 
by centrifugation, and calcein in the mitochondrial pellet and supernatant was determined 
fluorimetrically [2.28.2]. Values are presented as calcein released as a percentage of the 
total entrapped calcein at zero time. Results are representative of three independent
experiments.
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Figure 49 - tBID, but not Ca2+, induces cytochrome c release from calcein-loaded
mitochondria.
Sedimented mitochondria taken from the calcein-release experiments [Figure 48] were 
resuspended in sample loading buffer and run on a 10 % SDS-PAGE gel [2.13]. 
Cytochrome c was assayed by Western blot [2.16], in the samples incubated with 
400 pM Ca2+ (x) and in those incubated with tBID (A). Results are representative of 
three independent experiments.
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Figure 50 - Proposed structure of the PT pore.
Cyclophilin D is the matrix component of the pore, and has been suggested either to 
facilitate the conversion of the pore to the open state, or to stabilise this state.
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Figure 51 - Cyclophilin D overexpression in B50 cells carrying the pcDNA 3.1-cyclophilin D
plasmid.
Mitochondria were prepared from control B50 cells and from cells carrying the 
cyclophilin D plasmid, as described above [2.26]. Mitochondrial protein concentration was 
determined [2.17], and either 1, 5, 15 or 60 pg protein loaded on a 10 % SDS-PAGE gel 
[2.13]. After running, cyclophilin D was assayed by Western blot [2.16]. Cyclophilin D is 
overexpressed approximately 10 times in the cyclophilin D(+) cells.
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[5.4.3]Effect of cyclophilin D overexpression on apoptosis in whole cells
The effect o f cyclophilin  D overexpression on w hole-cell apoptosis was investigated by incubating 
control B 50 and cyclophilin D(+) cells with staurosporine. Staurosporine is a broad-spectrum  protein 
kinase inhibitor, know n to strongly induce apoptosis in a num ber of cell types [267]. The tim e-course 
o f caspase activation w as determ ined [2.35], revealing that overexpression of cyclophilin D inhibits 
caspase activation [Figure 52], in agreem ent w ith the results of Li and co-w orkers [157],
[5.4.4]Effect of cyclophilin D overexpression on BID-induced cytochrome c release 
M itochondria isolated from  control or cyclophilin D -overexpressing cells w ere used to assay BID- 
induced cytochrom e c release, as described in C H A PTER  4. C yclophilin  D(+) m itochondria were 
significantly m ore resistant to BID and tBID  action [Figure 53 and Figure 54; p = 0.002 (BID); 
0 .030 (tBID)]. This accords w ith the blunted caspase-activation response to staurosporine, and 
suggests that inhibition of B ID -induced cytochrom e c release m ight be responsible for this effect in 
cyclophilin D(+) cells.
[5.4.5]Effect of cyclophilin D overexpression on mitochondrial protein levels
In the course of the above experim ents, it was observed that levels of som e key mitochondrial proteins 
differ betw een m itochondria isolated from norm al B50 cells and from the cyclophilin  D -overexpressing 
clone. Figure 55 com pares levels o f ANT, M AO and cytochrom e c in these two cell types. Levels of 
both ANT and M AO (relative to m itochondrial protein content) w ere increased to about 150 % of 
control levels in the cyclophilin D(+) m itochondria (p=0.05 (M A O ), p=0.02 (ANT)), whilst 
cytochrom e c levels were equal in the two cell types. Interestingly, this ratio is sim ilar to the ratio of 
the EC5o for tB ID -induced cytochrom e c release in the control and cyclophilin D(+) m itochondria 
[Figure 53] -  approxim ately 50 % more tBID  is required to release cytochrom e c from the clone 
m itochondria. Since EC 5 0  is proportional to the concentration of tBID binding sites [Figure 42] (page 
107), this result may indicate that there are more binding sites per unit of m itochondrial protein in 
cyclophilin  D(+) m itochondria. The effective concentration of tBID at each binding site would thus be 
lower, inhibiting the response to tBID. One way in which this might be achieved is by an decrease in 
m itochondrial size as a result of cyclophilin D overexpression -  the m itochondrial surface area:volum e 
ratio w ould then be increased, and so the area o f m em brane surface presented by a given quantity of 
m itochondrial protein would rise. The surface concentration o f a given quantity  o f tBID  (i.e. 
nm ol/pm 2) w ould then be low er in cyclophilin D(+) m itochondria, potentially  decreasing tBID 
efficacy.
[5.5]Discussion
[5.5.1]PT pore opening during BID-induced cytochrome c release
Based on the lack o f any stim ulatory effect of C a2+ on BID and tBID action, and on the lack of release 
of entrapped calcein during B ID -induced cytochrom e c release, it is clear that PT pore opening is not 
necessary for cytochrom e c release.
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Figure 52 - Caspase activation is inhibited in cells overexpressing cyclophilin D compared
to control B50 cells.
Normal B50 cells (control) and cyclophilin D(+) cells (clone) were incubated with 
staurosporine [2.35]. Cells were extracted at the times indicated after the addition of 
staurosporine, and the cytosolic fractions was assayed for caspase 6 (left) or caspase 8 
(right). The results are expressed as the means + / -  S.E.M. for 5 separate experiments.
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Figure 53 - Cyclophilin D overexpression inhibits BID- and tBID- induced cytochrome c
release.
Mitochondria were isolated either from normal B50 cells or from a B50 cell line 
overexpressing cyclophilin D by approximately 10 times (cyclophilin D(+)), as indicated. 
Mitochondria were incubated with varying concentrations of BID (A) or tBID (B) [2.31]. 
After 30 mins incubation at 30 °C, mitochondria were separated from the assay mixture 
by centrifugation and assayed for cytochrome c by Western blot [2.16]. Results are 
representative of six (A) or four (B) independent experiments.
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Figure 54 - Cyclophilin D overexpression raises the EC50 for cytochrome c release.
Cytochrome c release was induced either by BID (A) or by tBID (B), in several 
independent experiments. Data are means +/- SEM for the following (number of 
independent experiments): Control cells + BID (6); cyclophilin D(+) cells + BID (6); 
Control cells + tBID (4); cyclophilin D(+) cells + tBID (4). The effects of cyclophilin D 
overexpression were statistically significant relative to control cells (p<0.005 for BID, 
panel A; p<0.05 for tBID, panel B).
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Figure 45 - Comparison of MAO, ANT and cytochrome c levels in mitochondria isolated 
from control and cyclophilin D(+) cells.
Mitochondria were isolated from B50 cell cultures on five separate dates. Protein levels 
were calculated per mg total mitochondrial protein, and values are presented as the ratio 
of protein levels in the control mitochondria compared to the cyclophilin D(+) 
mitochondria (clone mitochondria). Mean values are presented ±  standard error.
(A) Mitochondria were assayed for MAO activity by a fluorimetric assay [2.34]. MAO 
activity per unit of mitochondrial protein in control cells was on average 66 % of that in 
the clone cells (p=0.05) (B) Mitochondria were assayed for ANT by Western blot [2.16]. 
Quantity of ANT per unit of mitochondrial protein in control cells was on average 62 % of 
that in the clone cells (p=0.02). (C) Mitochondria were assayed for cytochrome c by 
Western blot [2.16]. There was no statistically significant difference in cytochrome c 
content between the two cell types.
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T his is in d isag reem en t w ith  the  w ork  o f  S corrano  and co -w orkers , w ho  su ggested  tha t tran s ien t pore 
op en in g  w as re sp o n sib le  fo r m o b ilis ing  cy toch rom e c sto res du rin g  ap o p to s is  [17]. T he resu lts  also  
d irec tly  co n trad ic t one  p o p u la r m odel, w h ich  has suggested  ou te r m em brane  ru p tu re  fo llow ing  P T  pore  
op en in g  and  m ito ch o n d ria l sw elling  to  be re sponsib le  fo r cy toch rom e c re lease  [268]. T hey  do  th is  on 
tw o counts: firstly  th e  ca lce in  re lease  experim en ts [5 .3 .2] show  th a t P T  p o re  op en in g  does no t occu r 
du rin g  tB ID -in d u ced  cy toch rom e c re lease ; and  second ly  the fac t th a t cy to ch ro m e c is n o t re leased  
from  m ito ch o n d ria  fo llow ing  C a2+-induced  p o re  op en in g  [5 .3 .3] suggests th a t even  su s ta in ed  pore 
op en in g  w ou ld  be  un ab le  to  re lease  cy toch rom e c du ring  apop to s is.
[4.7.1]lnvolvement o f cyclophilin D
C y cloph ilin  D  o v erex p ress io n  inh ib its caspase  ac tiva tion  in response  to  s tau ro sp o rin e , and  thus c lea rly  
in fluences som e stage  o f  the ap op to tic  p rocess. A dd itiona lly , th e  ab ility  o f  cyc loph ilin  D (+) 
m ito ch o n d ria  to  re lease  cy toch rom e c in response  to  B ID  and  tB ID  is a tten u a ted , suggesting  B ID - 
induced  cy to ch ro m e c re lease  m ay be the stage at w hich  cy c loph ilin  D exerts  its p ro tec tiv e  effect. 
In teresting ly , cy c loph ilin  D o v erexp ression  resu lts  in an increase  in th e  re la tive  abundance  o f  som e 
m itochond ria l p ro te in s  (M A O  and  A N T ), but no t o thers (cy toch rom e c). T h is m ay reflec t an increased  
ava ilab ility  o f  tB ID  b in d in g  sites in these  m itochond ria , w hich  m igh t be  invo lved  in the m echan ism  o f  
cy c loph ilin  D ’s e ffec t on apop to sis .
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CHAPTER 6 : KINETICS OF BID-INDUCED CYTOCHROME C RELEASE
[6.1]lntroduction
The m ajority o f previous work on BID action has assessed cytochrom e c release in a qualitative or 
sem i-quantitative manner, follow ing the appearance or disappearance o f bands on W estern blots o f 
cytosolic or m itochondrial fractions, respectively. H ow ever, G oldstein and co-w orkers have carried 
out a kinetic analysis o f cytochrom e c release in whole cells follow ing induction o f apoptosis by 
staurosporine, actinom ycin D, TN F and ultraviolet C [269]. These authors follow ed release of 
cytochrom e c from individual m itochondria in HeLa cells stably expressing a cytochrom e c-G FP fusion 
protein. A lthough cytochrom e c release from  the whole m itochondrial population occurred over 
several tens of mins, they observed cytochrom e c release from any individual m itochondrion to be a 
rapid event, com plete in around one min. Release was also tem perature insensitive betw een 24 and 
37 °C, indicating that release is a passive process. A side from this work, little has been done to analyse 
the kinetics o f cytochrom e c release from mitochondria. This chapter describes an attem pt to fit a 
kinetic model, derived from  first principles, to experim ental data on cytochrom e c release from isolated 
mitochondria.
BID is believed to release cytochrom e c from mitochondria by inducing the oligom erisation of 
m em brane-associated BAK or BAX m olecules into efflux pores [ l .4.7]. A lthough both BAK and BAX 
are superficially associated with the outer m itochondrial m em brane, it is only BAK that is 
constitutively integrated into the m em brane [74], The trans-m em brane dom ain o f BAX is folded back 
into a pocket form ed by the B H l, 2 and 3 dom ains and is unavailable for m em brane insertion before it 
is released during protein activation in apoptosis [75], Thus m itochondria isolated from non-apoptotic 
cells tend to contain far greater am ounts o f BAK  com pared to BAX [Figure 71, below ], and BID- 
induced release of cytochrom e c from  these m itochondria occurs predom inantly via BAK channels.
[6.2]Time-course of tBID-induced cytochrome c release
[6.2.1 [Introduction
Cytochrom e c release w as induced by the addition o f tBID  to a m itochondrial preparation, and the 
degree o f release w as assayed at several time-points [Figure 56]. Interestingly, although the duration to 
onset o f release varied according to tBID concentration, the shape o f the curve during release did not 
vary greatly. Specifically, the m axim um  rate o f cytochrom e c release (the m axim um  gradient of the 
release curve) appeared to be largely independent o f tBID concentration. This is in keeping with a 
model w hereby cytochrom e c is released from m itochondria through a channel whose opening is 
induced by tBID. tBID determ ines the rate o f opening o f this release channel, but not its properties, 
once opened. The m axim um  efflux rate is an intrinsic property of the channel, and will be determ ined 
by the channel perm eability and by the num ber o f channels per m itochondrion. To develop a com plete 
kinetic m odel, therefore, expressions for cytochrom e c release from  m axim ally perm eabilised 
m itochondria and for tB ID -induced appearance of open channels w ere first obtained separately [6.2.2], 
[6.2.3] and then com bined [6.2.4],
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Figure 56 - Time-course of tBID-induced cycochrome c release at seven different tBID
concentrations.
(A-G) Mitochondria were isolated from B50 cells [2.26] and cytochrome c release induced 
by addition of tBID, to the concentrations indicated. After various times, an aliquot was 
removed and centrifuged to pellet mitochondria [2.31]. Cytochrome c present in the 
mitochondrial fraction was assayed by Western blot [2.16] and is expressed relative to 
the cytochrome c content of mitochondria at the zero time-point. (H) Overlay of the 
cytochrome c release curves for all seven tBID concentrations.
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[6.2.2]Maximal release rate
W hen channel opening is com plete, the rate o f cytochrom e c efflux will be given by:
Equation 2
d[Cytc]  —  = a • [Cytc], 
dt
w here [C ytc] is the fractional am ount o f cytochrom e c rem aining inside m itochondria, and a is a 
constant reflecting the m axim al num ber o f channels and their intrinsic perm eability.
The value o f a defines the progress o f cytochrom e c release when all channels are open; i.e. the shape 
o f the upper portion o f the release curves in Figure 56. Integrating Equation 2 gives:
wheref Cytc], is the fractional internal concentration o f cytochrom e c at som e tim e t, and b is a constant. 
Since [Cytc]t = 1 at t = 0, b = 1 and therefore:
The value of the constant a was determ ined using the release curves show n in Figure 56. The point of 
inflection was determ ined for each tBID concentration, and the release o f  the rem aining  cytochrom e c 
was m odelled from this point up to the point at which 95% was released. If all release channels were 
indeed open at the inflection point and above for each curve and, in addition, if cytochrom e c effluxed 
from a single (or functionally single) pool of cytochrom e c in the interm em brane space, then release 
w ould be first-order, with the value o f a independent o f [tBID] -  i.e. :
six highest tBID concentrations. The curves are indeed linear, with slopes largely independent of 
[tBID], show ing release channels to be substantially open in this region o f the release curves. 
M easurem ent of BAK conform ational change [7.4] subsequently confirm ed this observation. The 
value o f  a approaches 0.19 m in '1.
[6.2.3]Appearance of open channels
The tim e-course o f tB ID -induced release of a functionally single pool o f cytochrom e c, if all channels 
were open from tim e zero, would be as shown in Figure 58. H ow ever, clearly  it is not the case that 
cytochrom e c release channels are m axim ally open im m ediately follow ing induction o f release by 
tBID. C hannels appear in the outer m em brane slowly over time, in a m anner dependent somehow on 
tBID concentration. Ruffolo and co-w orkers [100] and others have provided evidence that the 
cytochrom e c channels form  from BAK  m olecules in the outer m em brane in an auto-catalytic fashion
Equation 3
Equation 4
Equation 5
w here t* and [Cytc]* are defined to be 0  and 1 respectively at the point of inflection. Thus a plot of 
ln([Cytc],*) against t* should be linear with a slope o f -a . These plots are shown in Figure 57 for the
[6.4.2],
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Figure 57 - Determination of the value of the constant a.
(A-F) Release of cytochrome c was analysed after the point of inflection of the curves 
shown in Figure 56. If release channels are essentially completely open after this point, 
release of the remaining cytochrome c should be a first-order process, with rate 
constant a. Thus plots of t* (time elapsed after the point of inflection) against ln(C/C0) 
(where C takes values between 1 and 0, and represents the cytochrome c remaining after 
the point of inflection; i.e. C0= l)  should have gradient m = -a . (G) The relationship 
between [tBID] and the first-order rate constants (negative gradient of the plots in A-F) 
shows that the value of the constant a is approximately 0.19 min'1.
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Figure 58 - Theoretical release of cytochrome c from mitochondria with fully open
channels.
Cytochrome c is assumed to diffuse passively through channels, and the fractional 
amount remaining is therefore described by Equation 4. The value of the constant a was 
determined to be 0.19 m in1 [6.2.2].
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A ccording to this, an activated BH3-only protein such as tBID induces form ation of an ‘open’ 
conform er o f BAK, and these open conform ers then catalyse the conversion of further ‘closed’ 
conform ers into the ‘open’ form. ‘O pen’ m olecules can then self-assem ble into active efflux channels. 
The process is show n in Figure 59, where c and / a r e  constants defining the rates o f tB ID -induced and 
BAK*-induced conform ational changes, respectively.
This model predicts that open channels will form in the m em brane in an exponential fashion, w ith open 
channels appearing slowly at first, and then more and more quickly as the am ount o f ‘open’ conform er 
increases, up to a m axim um  defined by the initial total am ount o f BAK.
M athem atically, the com posite rate constant for channel form ation is:
Equation 6 c + /  • [Open\
where [Open] is the fractional am ount o f open channels, taking values from  0 to 1. The constant c 
defines the initial rate of form ation of open conform ers (dependent on tBID concentration), and /  
defines the rate o f auto-catalysis (an inherent property o f BAK m olecules) [Figure 59]. Open 
conform er form ation is also a first-order process, with the rate of form ation proportional to the am ount 
o f substrate (i.e. closed conform er) rem aining. Thus Equation 7 gives the rate of open conform er 
formation.
Equation 7 d[Open\ _ (c + y  . [oPen\ )• [Closed], 
at
It follows by integration [12.3.1 ], that:
[Open], = 1Equation 8 c + f
c - e [c*n ‘ + f
The appearance of open channels with tim e thus has the form show n in Figure 60, at the predicted 
value o f / =  0.33 m in " 1 [6.3.1] and an arbitrary value o f c = 0.02 min 1 (c is dependent on [tBID]; Figure 
63 below).
[6.2.4]Rate of cytochrome c efflux
A ssum ing the rate o f efflux is proportional to the concentration of open channels, com bining Equation 
2 and Equation 8  gives:
Equation 9
d [ C y t c ] _ (  j_  c + f
dt c . e -|. f
a ■ [Cytc\
Thus, by integration [12.3.2], it follows that:
Equation 10 =
exp a.
f
- t  + (c + f )
V
—  / r l n ( c ^ *  ^  + / )
J  f - { c  + f )  V _J
exp -  a ■ ln(c + / )  
/
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BCL2BCL-X,BID
BAK*
Cyt c
Figure 59 - Model for release of mitochondrial cytochrome c though BAK channels. 
Free tBID induces an open conformer of BAK, which can then induce the conversion of 
other BAK molecules to the open form. Open molecules self-assemble into an active 
efflux pore [BAK]n, through which cytochrome c molecules cross the outer membrane.
Adapted from [100].
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Figure 60 - Appearance of open BAK channels with time.
BAK channel formation was modelled according to the scheme shown in 
Figure 59, with c =  0.02 m in1 and f =  0.33 min'1. Appearance of channels is initially 
exponential with time, but is limited by the availability of substrate (closed BAK 
conformer) at later time-points. The maximum channel activity is defined by the total
initial amount of BAK.
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This gives the predicted m itochondrial cytochrom e c content at any time in term s of the constants a, f  
and c.
[6.2.5]Effect of changes in a, f and c
The constants included in the com plete model are defined in Table 8 . a a n d /s h o u ld  be dependent only 
on characteristics o f the m itochondrial preparation used, and so should not vary w hen fitting the model 
to experim ental data from  any one preparation. The value of c should depend on the tBID  
concentration.
[6.3]Fitting the model to experimental data
[6.3.1 [Deriving the value of the constants c and f
The relationship betw een the value c and the tBID concentration was investigated by fitting curves 
generated by the model above to the experim ental data shown in Figure 56. The value o f a was fixed at 
0.19 m in '1, for the reason discussed above [6.2.2], The values o f /  and c were initially chosen 
arbitrarily. A dditionally, a scaling factor was introduced to take account of the fact that the range of 
release values is frequently less than 1 -  i.e. the response to tBID  plateaus at 90 -  98 % release, and 
there is som e release even at zero time. Thus a predicted release value x  was adjusted to give a new 
value v that was used for com parison with the experim ental value, where:
Equation 11 y  =  rmin +  *  ■ (rm„  -  rmjl))
rmax is the apparent maxim um  release value, when the tBID  response has plateaued, and rmm is the 
apparent m inim um  release value.
An error function was then defined for each tBID  concentration as the sum of the squares of the 
differences betw een experim ental and predicted values for cytochrom e c release. The value o f c was 
then adjusted for each o f the seven tBID  concentrations tested, to m inim ise the value o f this error 
function, thus generating an optim al fit of the model to the experim ental data, for the initial arbitrary 
value of / .  A second error function was then defined as the sum of the error function over all seven 
tBID  concentrations. T he value of the constant /  was then altered, and the fitting process repeated to 
give a new value o f this second error function. Figure 6 1 shows the effect on the second error function 
of changing the value o f / ,  and reveals the optimal value o f / t o  be approxim ately 0.33 m in '1. (The 
change of units from min ‘.M ' 1 to min 1 reflects the use in the model o f fractional B A K  concentrations 
(i.e. the total concentration o f BAK is defined to be 1, and the concentration of ‘closed’ and ‘open’ 
conform er ranges from 0 to 1).) Figure 62 shows the fit betw een experim ental and predicted values for 
this value o f / .  T he derived values for c at the seven tBID concentrations are show n in Figure 63.
[6.3.2] Significance of the relationship between [tBID] and c
It seem s reasonable to suppose that tBID  should affect the value of c  in a linear m anner -  double the 
am ount o f tBID should give tw ice the rate of ‘seeding’ o f open B A K  conform ers. Figure 63 does 
indeed appear to show a linear relationship, apart from  an initial lag.
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Constant Units Definition Determined by
a min 1 Rate constant for cytochrome c efflux, with maximal channel activity (fully open channels)
Characteristics of 
open channel
c m in '1
Rate constant for ‘seeding’ of open BAK conformers -  i.e. for 
tBID-induced conversion o f BAK from closed to open 
conformer
Characteristics of 
tBID action
f M ’.m in '1
Rate constant for auto-catalysis of open BAK conformer 
formation -  i.e. for BAK-induced conversion of new BAK 
molecules from closed to open state
Characteristics of 
channel subunits
Table 8 - Constants included in the model for tBID-induced cytochrome c release
developed above.
0.200
0.200
0.199
0.199
0.198
0.198
0.197
0.197
0.196
0.196
0.195
0.195
x x *
0.26 0.28 0.3 0.32 0.34 0.36 0.38 0.4
f (/min)
0.42
Figure 61 - Determination of the value of the constant f.
The value of /'was adjusted iteratively to minimise the value of the error function defined 
as the sum of the square of the difference between predicted and experimental values 
over all 84 experimental points (12 time-points at 7 different tBID concentrations). The 
change of units from min^.M'1 to min'1 reflects the use in the fitting model of fractional 
BAK concentrations (ranging from 0 to 1), with the sum of concentrations of 'closed' and 
'open' conformer always equal to 1.
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Figure 62 - Comparison of experimental data on tBID-induced cytochrome c release and 
predicted release data from the model developed above.
The values of a and /"were fixed at 0.19 min'1 and 0.33 M^.min'1 respectively, and the 
value of cwas altered to fit the predicted values (A) to the experimental points (x), by a 
least-squares method. (A) 2.2 nM tBID (B) 4.4 nM tBID (C) 6.6 nM tBID (D) 8.8 nM 
tBID (E) 11.1 nM tBID (F) 13.3 nM tBID (G) 19.7 nM tBID.
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Figure 63 - Values of cfor the seven different tBID concentrations, derived by fitting the 
model to the experimental data points of Figure 56.
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The lag may represent sequestering o f tBID  by antiapoptotic BCL2 fam ily proteins such as BCL-2 and 
B CL-X l ; these proteins contain a deep groove form ed by the BH1 and BH2 dom ains, into which the 
BH3 dom ain o f a binding partner can insert [270], This interaction w ould sequester tBID, preventing it 
from  binding to B A K  effectors and stim ulating their conversion to ‘open’ conform ers able to 
oligom erise into active efflux pores [ 101J. A ccording to this, the response to low concentrations 
(< 5 nM ) o f tBID  would be very small, since there would be no free tBID to catalyse BAK 
oligom erisation. A bove 5 nM  tBID or so, the response to tBID  becom es linear; in this region all anti- 
apoptotics w ould be saturated. A lternatively, the sigmoidal relation seen in Figure 63 may reflect 
cooperative behaviour of tBID. In this connection, tBID  oligom ers have been observed in 
mitochondria, and have been causally associated with apoptotic progression [103]. BID  oligom ers 
were also observed during purification of the recom binant protein [3.6].
[6.4] Discussion
[6.4.1 [Summary of the model
A model is described above which predicts the efflux o f cytochrom e c from m itochondria with time, 
follow ing treatm ent w ith tBID. tBID molecules initially catalyse the conversion of BAK m olecules to 
an open state; they do this at a rate proportional to the concentration o f free tBID, and to a constant c. 
‘O pen’ BAK conform ers are able to self-catalyse the conversion of m ore BAK  molecules from a closed 
to an open state; they do this at a rate proportional to the existing concentration of ‘open’ conform ers, 
and to a constant / .  Open BAK conform ers rapidly self-assem ble into channels for cytochrom e c 
efflux, and cytochrom e c diffuses passively through these channels. The rate of efflux is proportional 
to a constant a. The blunted response to small am ounts of tBID  m ay be explained by the presence of 
anti-apoptotic B CL2-fam ily proteins in the outer m em brane. These proteins would initially sequester a 
sm all am ount of tBID, so that a strong response is seen only when they becom e saturated, leaving tBID 
free in the m em brane. The com plete model is represented in Figure 59 (page 131).
[6.4.2]Correspondence with experimental data
The m odel has a good correspondence with the experim ental data presented here [Figure 62], and 
allows calculation of kinetic param eters for tBID action. The model is also entirely consistent w ith the 
work o f R uffolo and co-w orkers [100]. These authors used cross-linkers or trypsin digestion to identify 
the activated conform er of BAK; conversion to this form exposes a novel trypsin site and also rem oves 
the potential for inter-m olecular cross linking of tw o cysteine residues to form a structure with 
increased m obility on SD S-PAG E. They showed that a BID BH3 peptide was able to induce 
conversion o f BAK to the open form, and that these open BAK m olecules could then oligomerise, 
concom itant with release of cytochrom e c from m itochondria. Additionally, by incubating 
m itochondria w ith a synthetic ‘open’ BAK  conform er lacking the inhibitory N -term inus, they showed 
that existing open conform er was able to catalyse conversion of new B A K  m olecules to the open form 
(self-catalysis).
Clearly, how ever, the model developed here is in som e ways speculative, given that there rem ains 
considerable disagreem ent over the precise m echanism s of tBID action and of cytochrom e c efflux.
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For exam ple G oldstein and co-w orkers [269] suggest that the shape o f cytochrom e c efflux curves with 
time m ight be a result o f heterogeneity am ongst the m itochondrial population, with any one 
m itochondrion releasing cytochrom e c very rapidly, but the population as a whole releasing 
cytochrom e c slow ly over time. This is in contrast with the model described above, which assum es a 
hom ogeneous m itochondrial population, with all m itochondria releasing cytochrom e c over a sim ilar 
tim e-course.
[6.4.3]Fitting the model to experimental data
The value o f a m odel for tBID  action is in determ ining the reasons for changes in response to tBID 
under different experim ental conditions. If  the EC 5 0  or shape o f release curve for tBID action is 
changed as a result of the addition of some inhibitor, or the use o f a different m itochondrial 
preparation, the m odel should help to determ ine the reason for this change - i.e. which o f the constants 
a, f  or c have changed - since changing each constant gives a characteristic change in the predicted 
tBID response. C learly though it is ultim ately im possible to make firm  predictions concerning 
mechanistic changes on the basis of inform ation derived from a theoretical model; the effect of one 
change may be masked by that o f  another, and de-convoluting the effects o f several concurrent changes 
is unlikely to be possible given only a lim ited am ount of experim ental data. N evertheless, the model 
described above may certainly suggest or rule out some possibilities in attem pting to explain the effect 
of som e variation in experim ental conditions, and in particular, it can be used to provide information on 
otherwise experim entally  inaccessible param eters (e.g. a). Below [7.3.2] the model is used to analyse 
how CSA affects cytochrom e c release.
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CHAPTER 7 : THE EFFECT OF CYCLOSPORIN A ON CYTOCHROME C 
RELEASE
[7.1]Introduction
Cyclosporin A (CSA) [Figure 64] was First isolated as a m etabolite of the prokaryote Tolypocladium  
inflaturns [l 62]. CSA binds tightly to cyclophilins and inhibits their PPIase activity; the varies 
depending on cyclophilin isoform , from 2-5 nM  for cyclophilins A, B and D, to 300 nM  for 
cyclophilin 40 [163,164]. CSA also strongly inhibits PT pore opening, presum ably by inhibiting 
cyclophilin D [165]. CSA affects other m itochondrial systems, independent o f cyclophilins; for 
exam ple CSA inhibits the calcium  uniporter, albeit only at relatively high concentrations ( 1 - 1 0  pM ) 
[169], CSA also inhibits activity of the cytosolic phosphatase calcineurin, via an unusual m echanism  
involving cyclophilin A. Cyclophilin A is norm ally unable to interact w ith calcineurin, but upon CSA 
binding the binary com plex is able to bind and inhibit the phosphatase; thus as well as inhibiting 
cyclophilin A ’s isom erase activity, CSA concurrently gives a gain-of-function effect [271].
There are num erous reports o f effects of CSA on cell death, and on apoptosis in particular (review ed in 
[164]). Several groups have looked specifically at the effect of CSA on cytochrom e c release from 
isolated mitochondria, with conflicting results. Shimizu and co-w orkers dem onstrated that BID- or 
BIK- induced cytochrom e c release from isolated m itochondria was C SA -insensitive in their 
system  [56]. H ow ever a num ber o f w orkers have shown inhibition by C SA  of BAX- and/or BAK- 
induced cytochrom e c release [ 119,121,179], and Scorrano and co-w orkers [ 17] report inhibition o f the 
analogous process induced by tBID. The latter authors attributed this effect to inhibition by CSA o f a 
process of m itochondrial rem odelling facilitating diffusion of cytochrom e c from intracristal spaces to 
outer m em brane BA X /BA K  pores.
The objectives o f the work presented here w ere firstly to determ ine the effect o f CSA on tBID -induced 
release of cytochrom e c from isolated B50 cell m itochondria and, secondly, to analyse the nature of any 
inhibition using the kinetic model developed in CHA PTER 6 .
[7.2]Effect of CSA on mitochondrial respiration
It has been reported that CSA affects m itochondrial respiration. H okanson and co-w orkers observed an 
18% decrease in succinate/rotenone-stim ulated m itochondrial oxygen consum ption in the presence of 
CSA [172]. In contrast, Zhong and co-w orkers reported that CSA stim ulates a hyperm etabolic state in 
liver cells, inducing a 60 % increase in m itochondrial oxygen consum ption [171]. Since m itochondrial 
cytochrom e c release is affected by m itochondrial inner m em brane potential AT™ [4.7], determ ined in 
part by the rate o f respiration, it was im portant first to check the effect of CSA on A Tm under 
conditions used to m easure BID -induced cytochrom e c release.
M itochondria from norm al B50 cells and from cyclophilin D -over-expressing B50 cells were 
resuspended in respiration buffer containing tetraphenylphosphonium  ion (TPP+) [2.29.4], T PP+ is 
accum ulated by respiring m itochondria according to the m agnitude of A Tm; at equilibrium  the N ernst 
equation describes the distribution:
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Figure 64 - The structure of Cyclosporin A (CSA).
CSA is [R-[R*,R*-(E)]]-cydic(L-alanyl-D- alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N- 
methyl-L-valyl-3-hydroxy-N, 4-dimethyl-L-2-amino-6-octenoyl-L-a-amino-butyryl- N- 
methylglycyl-N- methyl-L-leucyl-L-valyl-N-methyl-L-leucyl). This 11-residue polypeptide 
was originally isolated from Tolypocladium inflaturns. It binds to and inhibits cyclophilins
with a Kd of 2 -  300 nM.
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M itochondria were pre-incubated in respiration buffer [2.31.1] in the absence of the respiratory 
substrate succinate. Subsequent addition of succinate to generate ATm induced rapid TPP+ uptake 
[Figure 65], decreasing the extram itochondrial TPP+ from 1.43 pM  to approxim ately 1.25 pM . This 
was follow ed by a slow progressive loss o f TPP+ over time. N egligible change was induced by 
addition of CSA. Sim ilar data were obtained with m itochondria isolated from  the cyclophilin D 
overexpressing cells. Thus, under the experim ental conditions used to m easure B ID -induced 
cytochrom e c release, changes in ATm induced by C SA  or by cyclophilin D overexpression were very 
small.
[7.3]The effect of CSA on tBID- induced cytochrome c release
[7.3.1 [Cytochrome c release
Cytochrom e c release from  isolated m itochondria was induced by tBID  using the system  developed in 
CH A PTER 4. Experim ents in the presence and absence o f  CSA were conducted in parallel. tBID- 
induced cytochrom e c release was clearly inhibited by CSA [Figure 6 6 ] - over 12 such experim ents, the 
degree of inhibition was variable from preparation to preparation, but overall 1.2 pM  CSA increased 
tBID EC 5 0  by 105 % (standard error 35 %; p =  0.011) [Figure 67]. In contrast, CSA had no effect on 
BID -induced cytochrom e c release [Figure 67]. Inhibition by CSA was surprising -  given that 
cyclophilin D overexpression inhibits BID -induccd cytochrom e c release [5.4.4], CSA would be 
expected to reverse this effect by inhibiting cyclophilin D action.
[7.3.2]Defining the effect of CSA on tBID-induced cytochrome c release
The model developed in C hapter 6  accurately predicts the kinetics o f tB ID -induced cytochrom e c 
release. For a defined m itochondrial preparation, the model may be used to predict the tim e-course of 
cytochrom e c release at a given tBID concentration. M oreover, since the model allow s predictions to 
be m ade about the effect of changing one or more o f the kinetic param eters, it may be used to analyse 
w hich of these constants are affected by CSA.
C ytochrom e c release was induced from a m itochondrial preparation by tBID , in the presence or 
absence o f CSA. Inhibition of tBID -induced cytochrom e c release by C SA  w as confirm ed by assaying 
for cytochrom e c [Figure 6 8 ], The kinetic model w as used to derive values for the relevant param eters 
[Figure 6 8 (A)], which were a =  0.26 m in '1, /  = 0.43 min ' 1 and c - 0 .000988 min"1. The only param eter 
requiring adjustm ent to fit the predicted points to the experim ental points in the presence of CSA 
[Figure 6 8 (B)] was the rate o f seeding o f ‘open’ B A K  conform er by tBID: c was reduced to
0.000161 m in '1. A djustm ent o f either f o r  a w as not able to fit the predicted cytochrom e c release to the 
experim ental data [Figure 6 8 (C ,D )]. In both cases, if the value o f the param eter was adjusted so as to 
fit the predicted cytochrom e c release to the experim ental data at early tim e-points, the model predicted 
release values at later tim e-points that were too low; and vice versa.
+ CSA+ CSA
+ CSA
- CSA
-C S A
+ Succinate + Succinate
5 min 5 min
1.43 ’V
Figure 65 - Neither CSA nor cyclophilin D overexpression affects mitochondrial inner
membrane potential.
A TPP+-sensitive electrode was used to measure membrane potential [2.29].
(A) Calibration with TPP+: B50 mitochondria [2.26] were resuspended in respiration 
buffer [2.31.1]. Aliquots of TPP-CI were added sequentially to 1.43 pM.
(B/C) Mitochondrial respiration was started by addition of succinate (arrow). TPP+ 
accumulation was followed for approximately 15 mins both in control B50 mitochondria 
(B) and cyclophilin D(+) mitochondria (C). 1.2 pM CSA was added after 3 mins where 
indicated. Results are representative of three independent experiments.
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Figure 66 - CSA inhibits tBID-induced cytochrome c release from isolated mitochondria. 
Cytochrome c release [2.31] was induced in the presence (A) or absence (x) of 1.2 pM 
CSA, as indicated. Mitochondria were incubated with varying concentrations of tBID. 
(A) After 30 mins incubation at 30 °C, mitochondria were separated from the assay 
mixture by centrifugation. After Western blotting, the membrane was probed with an 
anti-cytochrome c antibody [2.16]. (B) Fraction cytochrome c remaining in each 
mitochondrial pellet was calculated by dividing the cytochrome c signal from the pellet by 
the maximum cytochrome c reading. Results are representative of twelve independent
experiments.
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Figure 67 - CSA inhibits tBID- but not BID- induced cytochrome c release. 
EC50 values were determined for cytochrome c release, as in Figure 66, over several 
independent experiments (n=6 for BID and n=12 for tBID), in the presence and absence 
of 1.2 pM CSA. Values displayed are the mean increase in EC50 in the presence of 
CSA (%) ± SEM. tBID increases the EC50 value by 105 ± 35 % (p = 0.011).
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Figure 68 - CSA inhibition of tBID-induced cytochrome c release; analyses according to
the kinetic model.
Mitochondria were incubated with 1 nM tBID, with (B,C,D) or without (A) 1.2 pM CSA, 
and an aliquot removed at the indicated times [2.31]. Mitochondria were separated by 
centrifugation and assayed for cytochrome c content by Western blot [2.16] (A and B; x). 
The kinetic model developed in CHAPTER 6 was used to predict cytochrome c release at 
each time-point (A and B; O), using Equation 10 (page 130). The model shows that the 
effect of CSA can be explained by an alteration in the constant c : RMS deviation of 
predicated from experimental points = 0.025 (- CSA), 0.028 (+ CSA). Conversely, the 
effect of CSA is less explicable by a change in the constant a (C) or f  (D). It was 
attempted to fit the predicted release (C and D; A and ) to the experimental data 
obtained in the presence of CSA (C and D; line). (C) Changing the value of a did not 
accurately reflect the effect of CSA. The RMS deviation for an optimum fit was 0.060. 
(D) Changing the value of /"allowed a closer fit to the experimental data (RMS deviation 
0.040), but the fit was less close than that obtained by changing c(RMS deviation 0.028).
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The root-m ean-square (RM S) deviation of predicted values from the experim ental data points was 
0.028 when the predicted values were adjusted by altering c; 0 .060 w hen a was altered, and 0.040 when 
/  was altered. This com pares with an RMS deviation o f 0.025 for the fitting o f the model to the 
experim ental data in the absence o f CSA. It appears, therefore, that CSA  inhibits tBID -induced 
cytochrom e c release by inhibiting tBID -induced conform ational change of BAK. This possibility was 
investigated further in [7.4] below.
[7.4]Assay for BAK conformational change
[7.4.1 [Introduction
R uffolo and co-w orkers [100] describe a technique for assaying the conform ational change in BAK  that 
occurs prior to oligom erisation and cytochrom e c release. The assay relies on the closed conform er 
having no exposed trypsin cleavage sites. Upon conform ational change a site is exposed, so that ‘open’ 
BAK  is digested into fragm ents which are unreactive against a certain BAK  antibody. As discussed 
above, the kinetic model predicts that CSA alters the value o f c, the rate constant for tBID -induced 
conform ational change of BAK. This prediction was therefore checked using this trypsin cleavage 
technique to detect BAK conform ational change induced by tBID in the presence and absence o f CSA.
[7.4.2]Development of assay
The BAK  digestion assay [2.36] was used in this study to reveal the tim e-course of BAK 
conform ational change during tBID -induced cytochrom e c release assays [2.31], Figure 69 show s the 
developm ent of the assay, in which a range of trypsin concentrations and two digestion times were 
com pared for their ability efficiently  to digest BAK only after treatm ent w ith tBID to induce the open 
conform er. W ith 20 mins incubation, som e BAK  was digested even w ithout tBID treatm ent. N o such 
digestion was apparent after 10 mins of trypsin digestion. T herefore a 10 min digestion period with 
0.05 mg/ml trypsin was adopted as standard.
Since the purpose of the assay was to correlate BAK conform ational change with cytochrom e c release, 
it was im portant to verify that no further cytochrom e c release or conform ational change occurred 
during the period of BAK digestion. As shown in Figure 70, 10 mins pre-incubation on ice prior to 
trypsin treatm ent had no effect on either BAK conform ational change or cytochrom e c release, 
confirm ing that both reactions are effectively stopped during the period o f BAK  digestion by trypsin.
In intact cells, BAX translocates to mitochondria during apoptosis, and is also able to oligom erise into 
cytochrom e c efflux pores [8 8 ]; the kinetics o f BAX oligom erisation would not necessarily follow 
those o f BAK. Thus it was im portant to confirm  that there w as no BAX associated with the 
m itochondria used here, and therefore that the efflux pore was com posed o f B A K  molecules. A shown 
in Figure 71, although BAX is present in whole cells, there is indeed none detectably associated with 
the m itochondrial fraction.
Figure 72 shows the correspondence between BAK  conform ational change and cytochrom e c release. 
As predicted by the kinetic model [CHAPTER 6 ], BA K  conform ational change precedes cytochrom e c 
release; at 50 % cytochrom e c release over 85 % of BA K  has been converted to the ‘open’ conformer.
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Figure 69 - Development of a BAK conformation assay : trypsin concentration and
incubation time.
Mitochondria were incubated in respiration buffer [2.31.1] with or without 2 nM tBID.
An aliquot was removed at zero time (O ) and after 30 mins incubation with tBID (x) or 
without tBID (□). The aliquots were then treated with the indicated concentration of 
trypsin at 0 °C, either for 10 mins or for 20 mins. Mitochondria were separated by 
centrifugation and proteins run on SDS-PAGE [2.13]. After transferring to nitrocellulose, 
the blots were probed with an anti-BAK antibody [2.16] which specifically recognises the 
uncleaved BAK molecule (top). The BAK signal was used to calculate % digestion 
(bottom). The data show that with 10 mins incubation, trypsin digests BAK only following
incubation with tBID.
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Figure 70 - Development of a BAK conformation assay : does incubation on ice (during 
trypsin digestion) stop both BAK conformational change and cytochrome c release? 
Mitochondria were incubated in respiration buffer [2.31.1] with 2 nM tBID. Aliquots were 
removed at the indicated times, and digested with trypsin [2.36] either immediately (O ), 
or following 10 mins pre-incubation on ice (x). Mitochondria were then separated by 
centrifugation and proteins run on SDS-PAGE [2.13]. (A) After transferring to 
nitrocellulose, the blots were probed with an anti-BAK antibody which specifically 
recognises the uncleaved BAK molecule [2.16], and the BAK signal used to calculate % 
digestion. (B) Blots were also probed with an anti-cytochrome c antibody to assess
cytochrome c release.
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Figure 71 - BAK, but not BAX, associates with the mitochondrial fraction. 
Mitochondria were isolated from B50 cells [2.26] and the indicated quantity (pg protein) 
run on SDS-PAGE [2.13] together with whole B50 cells, as indicated. Proteins were 
transferred to nitrocellulose by Western blotting [2.16]. (A) The blot was probed with an 
anti-BAK antibody (Upstate), showing that the BAK protein is enriched in the 
mitochondrial fraction (compare lanes 2 and 3). (B) A separate blot was probed with an 
anti-BAX antibody, showing that, although BAK is present in whole cells (lane 2) it is not 
associated with the mitochondrial fraction (lane 1).
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Figure 72 - Development of a BAK conformation assay : correspondence between BAK 
conformational change and cytochrome c release.
Mitochondria were incubated in respiration buffer [2.31.1] with 1.5 nM tBID. Aliquots 
were removed at the indicated times, and digested with trypsin [2.36]. Mitochondria 
were then separated by centrifugation and proteins run on SDS-PAGE [2.13]. (A) After 
transferring to nitrocellulose, the blots were probed with an anti-BAK antibody which 
specifically recognises the uncleaved BAK molecule, and also with an anti-cytochrome c 
antibody, as indicated [2.16]. (B) The BAK and cytochrome c signals from the Western 
blot were used to calculate % BAK conformational change ( ) and % cytochrome c 
release (x) at each time-point.
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[7.4.3]The effects of CSA on BAK conformational change
To confirm  that CSA does inhibit this step of tBID -induced cytochrom e c release, the above technique
[7.4.2] was used to assay for BAK conform ational change [Figure 73]. As expected, the presence of 
CSA inhibited the appearance of the open BAK conform er [Figure 73; com pare (A) with (B)]. 
Strikingly, w ith the values of the kinetic param eters calculated from  the cytochrom e c release data, the 
model accurately predicted the appearance o f open conform er in the presence and absence of CSA.
[7.5]Effect of cyclophilin A
[7.5.1 [Introduction
CSA binds to cytosolic cyclophilin A as well as m itochondrial cyclophilin D. Som e proportion of 
cyclophilin A m ight co-purify with m itochondria through association w ith the outer m em brane, and the 
effect of CSA  m ight represent some interaction w ith cyclophilin A. For exam ple, a cyclophilin A-CSA 
com plex is known to bind and inhibit the protein phosphatase calcineurin; this results in inhibition of 
BAD dephosphorylation and activation, thus inhibiting m itochondrial cytochrom e c release [272]. This 
might explain the inhibition by CSA of a step in tBID -induced cytochrom e c release occurring at the 
outer m itochondrial m em brane (BA K  conform ational change), since the alternative target (i.e. 
cyclophilin D) is present in the matrix, with no access to the outer m em brane.
[7.5.2]Presence of cyclophilin A in mitochondrial preparations
To investigate w hether cyclophilin A was associated w ith the m itochondrial fraction used in BID- 
induced cytochrom e c release experim ents, m itochondrial preparations were analysed for cyclophilin A 
by W estern blot [2.16], As shown in Figure 74, cyclophilin A was detectable in all preparations, at 
approxim ately 1.0 pg/m g m itochondrial protein. In fact, this is considerably more than the estim ated 
content o f cyclophilin D in B50 cell m itochondria (60 ng/m g m itochondrial protein; [157]).
[7.5.3]Effect of exogenous cyclophilin A on tBID-induced cytochrome c release
In an attem pt to probe the involvem ent o f cyclophilin A, tBID -induced cytochrom e c release 
experim ents w ere carried out in the presence or absence o f recom binant cyclophilin A. As show n in 
Figure 75, 5 pg/m g mitochondrial protein or 50 pg/m g m itochondrial protein cyclophilin  A had no 
effect on tB ID -induced cytochrom e c release. However, higher cyclophilin A concentrations inhibited 
cytochrom e c release: as show n in Figure 76, cyclophilin A at 1000 pg /m g  m itochondrial protein raised 
the EC 5 0  from  3 to 5.5 nM (1.8-fold inhibition). In the sam e experim ent, 1.2 pM  CSA had an alm ost 
identical inhibitory effect. Furtherm ore, the effects of cyclophilin  A and CSA  were not additive 
[Figure 76 (C )]. This may suggest that it is a cyclophilin A -CSA  com plex which is exerting an effect 
on tB ID -induced cytochrom e c release. CSA would inhibit release by binding to endogenous 
cyclophilin A, and the binary com plex would interact w ith som e dow n-stream  target. Low 
concentrations o f exogenous cyclophilin A would therefore have no effect, since cyclophilin A would 
presum ably only interact with the target with low affinity in the absence o f CSA. H ow ever at high 
concentrations added cyclophilin A may be able to bind sufficiently well to give inhibition.
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Figure 73 - CSA inhibits tBID-induced conformational change of BAK. 
Mitochondria were incubated in respiration buffer [2.31.1] with 1 nM tBID, with (A) or 
without (B) 1.2 pM CSA. An aliquot was removed at the indicated times, and digested 
with trypsin [2.36]. Mitochondria were separated by centrifugation; proteins were run on 
SDS-PAGE [2.13] and transferred to nitrocellulose [2.16.1]. The blot was probed with an 
anti-BAK antibody [2.16] to assay for undeaved ('closed') BAK (x). The kinetic model was 
used to predict the amount of'open' BAK conformer at each time-point (O ), using 
Equation 8. The dashed line in (B) is the BAK digestion curve taken from (A). The 
digestion data confirms that the effect of CSA is to inhibit the tBID-induced 
conformational change in BAK. Results are representative of three independent
experiments.
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Figure 74 - Cyclophilin A is present in mitochondrial preparations.
A selection of mitochondrial preparations [2.26] (each containing 50 pg of protein) was 
run on SDS-PAGE [2.13] (lanes 2 -  4), along with 150 ng of pure recombinant cyclophilin 
A (lane 1; [2.50]). Proteins were transferred to nitrocellulose and the blot probed with an 
anti-cyclophilin A antibody [2.16]. Cyclophilin A levels were calculated by comparison 
with the reference band, revealing an average value of 1.0 pg/mg mitochondrial protein.
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Figure 75 - Physiological cyclophilin A levels have no effect on tBID-induced cytochrome c
release.
Mitochondria were incubated with 1.7 nM tBID [2.31], either with no exogenous 
cyclophilin A (x) or with 5 pg/mg mitochondrial protein (A) or 50 pg/mg mitochondrial 
protein (0) recombinant cyclophilin A [2.50]. Aliquots were removed at various times, 
and mitochondrial cytochrome c content assayed by Western blot following 
centrifugation [2.16]. Results are representative of four independent experiments.
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Figure 76 - CSA and a high concentration of cyclophilin A inhibit tBID-induced cytochrome 
c release to a similar extent, and in a non-additive fashion.
Recombinant cyclophilin A was prepared as above [2.50]. Mitochondria were incubated 
with varying concentrations of tBID [2.31] either with no additions [(A-C);(x)] or in the 
presence of either cyclophilin A [1000 pg/mg mitochondrial protein; (A)(A)] or CSA 
[1.2 pM; (B)( )] or both [(C)(0)]. After 30 mins incubation at 30 °C, mitochondria were 
separated from the assay mixture by centrifugation and assayed for cytochrome c by 
Western blot [2.16]. The degree of inhibition caused by the additions in each experiment 
was essentially identical. Results are representative of two independent experiments.
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[7.5.4]Effect of cyclophilin A on BID-induced cytochrome c release
As show n in Figure 77, there was no effect o f cyclophilin A (1000 |ng/mg) on B ID -induced cytochrom e 
c release. This correlates with the lack o f any CSA effect on the action of full-length BID [Figure 67],
[7.6]Discussion
[7.6.1]Effect of CSA
CSA inhibited tB ID -induced cytochrom e c release, despite having no effect on m itochondrial 
respiration. It was surprising that CSA should inhibit the tBID effect, given that overexpression of 
cyclophilin D (C SA ’s presum ed target) also inhibited tB ID -induced cytochrom e c release.
[7.6.2]lnhibition of BAK conformational change
The model developed in C hapter 5 allowed prediction of the specific step in tB ID -induced cytochrom e 
c release that was inhibited by CSA, based on Fitting of predicted values to experim ental data points for 
cytochrom e c release. On this basis, CSA appeared to inhibit the conversion o f BAK m olecules from 
the closed to the open conform ation. Specifically, CSA inhibited ‘seeding’ of open conform ers by 
tBID (CSA reduced the value o f the constant c) [Figure 59] (page 131). An assay for BAK 
conform ational change confirm ed that this process was inhibited by CSA.
This result was unexpected; if cyclophilin D was the target o f CSA, then CSA would have been 
expected to inhibit cytochrom e c release through some effect on a matrix system, w hereas BAK 
conform ational change presum ably occurs via a process acting at the outer m em brane. The result is 
also in contrast with the Findings o f Scoranno and co-w orkers [17], w ho suggested that CSA  inhibits 
tBID -induced cytochrom e c release by blocking a process o f m itochondrial rem odelling. This process 
would occur dow nstream  of BAK oligom erisation, and would presum ably be reflected by a change in 
the constant a (the rate constant for cytochrom e c egress through open BAK  pores).
The fact that the action of full-length BID was not inhibited by CSA is in keeping w ith this result. By 
the logic o f Scorrano and co-w orkers, CSA  should inhibit BID  and tBID action to a sim ilar extent 
(since CSA affects a dow n-stream  step). H ow ever if CSA  specifically inhibits tBID -induced 
conform ational change of BAK, then it is conceivable that it does not have any effect of the action of 
fu ll-length  BID (which must presum ably catalyse the change in BAK  via a slightly different 
m echanism , or induce cytochrome c release via a different route).
[7.6.3]Effect of cyclophilin A
It was possible that CSA might be exerting its inhibitory effect on BAK oligom erisation through 
interaction w ith cyclophilin A m olecules associated w ith the m itochondrial outer mem brane. Addition 
of recom binant cyclophilin A did indeed appear to stim ulate tB ID -induced cytochrom e c release, albeit 
only at very high concentrations. Interestingly, the inhibition was alm ost identical in extent to that 
observed in the presence of CSA, suggesting that cyclophilin A m ay be exerting its inhibitory effect 
through interaction with a dow n-stream  target, its interaction with which being strengthened in the 
presence o f CSA.
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Figure 77 - Cyclophilin A does not stimulate BID-induced cytochrome c release. 
Mitochondria were incubated with varying concentrations of full-length BID [2.31] in the 
presence (A) or absence (x) of cyclophilin A [2.50] at 1000 pg/mg mitochondrial protein. 
After 30 mins incubation at 30 °C, mitochondria were separated from the assay mixture 
by centrifugation and assayed for cytochrome c by Western blot [2.16]. Results are 
representative of two independent experiments.
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[7.6.4]Purity of the mitochondrial preparation
A lternatively, since cyclophilin A is thought to be a predom inantly cytosolic protein [150], it is 
possible that the large am ounts detected here m ight simply represent an artifact of the m itochondrial 
isolation technique used, arguing against an involvem ent of cyclophilin A in tB ID -induced cytochrom e 
c release in vivo. In this regard, cyclophilin A, being a positively charged protein at cellular pH [150] 
is predicted to associate w ith intracellular m em branes via electrostatic interactions w ith m em brane 
phospholipids. M itochondria are isolated in a low ionic strength m edium  [2.26] and so peripherally 
associated cyclophilin  A would be found in the m itochondrial fraction. Furtherm ore, any non- 
m itochondrial contam inants (for exam ple endoplasm ic reticulum  or G olgi m em branes) m ight also 
introduce large am ounts o f cyclophilin A to the m itochondrial fraction. W hen incubated in the high 
ionic strength m edium  used for cytochrom e c release experim ents [2.31.1] any electrostatically 
associated cyclophilin  A would be dissociated from m em branes and exist free in aqueous solution.
1 pg  o f cyclophilin A per mg mitochondrial protein would certainly represent a significant com ponent 
if concentrated specifically at m itochondrial m em branes (i.e. if associated w ith m itochondria via 
protein-protein interactions or present as an integral mem brane com ponent), and would be a likely 
candidate for a CSA effector. H ow ever when free in solution this am ount corresponds to ju s t 90 nM 
cyclophilin A, and might be unlikely to exert an effect on m itochondrial m em brane systems. This latter 
situation w ould be the case if cyclophilin A was sim ply pulled dow n into the mitochondrial fraction by 
electrostatic association with non-m itochondrial contam inants, and the purity of the mitochondrial 
preparation is therefore an im portant consideration, which deserves further investigation.
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CHAPTER 8 : THE EFFECTS OF DB25
[8.1 introduction
Several CSA derivatives with varying affinities for cyclophilins have been synthesised. Table 9 shows 
some o f these com pounds, along with their IC 5 0  for cyclophilin D inhibition.
One feature of CSA  action is that, as well as inhibiting the PPIase activity o f cyclophilins by binding to 
the enzym es’ active site, CSA  binding can allow cyclophilins to interact w ith novel dow nstream  targets 
by creating a new binding surface on the C yp-CSA  com plex. As m entioned above, one such 
dow nstream  target is the cytosolic protein phosphatase calcineurin. C yclophilin A is norm ally unable 
to interact with calcineurin, but a cyclophilin A -CSA  com plex binds calcineurin tightly and inhibits its 
phosphatase activity [ 164]. A m ongst the com pounds show n in Table 9, the com pound DB25 
(D -M eA la-3-EtV al-4-CSA ; Figure 78) is particularly interesting, since it inhibits cyclophilins with an 
IC 5 0  close to that o f CSA, but does not perm it interaction with dow nstream  targets such as calcineurin 
(Gregoire V uagniaux, personal com m unication). DB25 thus enables the distinction to be made 
betw een CSA  effects occurring through an ‘enzym e inhibition’ m echanism  and those occurring through 
a ‘gain-of-function’ m echanism .
[8.2]The effects of CSA and DB25
[8.2.1 [Effects on tBID-induced cytochrome c release and BAK conformational change 
The effects o f CSA and DB25 on tBID -induced cytochrom e c release are com pared in Figure 79. 
W hilst CSA com pletely inhibited cytochrom e c release over the tBID concentrations tested, DB25 
instead had a slight stim ulatory effect.
CSA  was shown to inhibit an early stage of tBID -induced cytochrom e c release - tB ID -induced BAK 
conform ational change [7.4.3]. It rem ained possible that DB25 m ight have a sim ilar effect, this being 
m asked by a secondary stim ulatory effect on a later stage of cytochrom e c release. To exclude this 
possibility, m itochondria incubated w ith tBID in the presence and absence o f DB25 were assayed for 
B A K  conform ational change [2.36], A shown in Figure 80, the stim ulatory effect o f DB25 on tBID- 
induced cytochrom e c release was paralleled by a stim ulation o f BAK conform ational change, thus 
show ing the effect of DB25 to be entirely opposite to that of CSA.
Since the effects of CSA and DB25 might simply reflect som e effect o f these com pounds in the 
absence o f tBID , it was im portant to verify that they had no effect p er  se on mitochondrial cytochrom e 
c release. As shown in Figure 81 neither com pound induces cytochrom e c release over a 1 hr 
incubation in respiration buffer.
[8.2.2]Does DB25 inhibit mitochondrial PPIase activity?
To verify that DB25, like CSA, does indeed inhibit m itochondrial PPIase activity, PPIase assays [2.33] 
w ere carried out on an osm otically lysed B50 m itochondrial extract [2.26] in the presence o f either 
CSA  or DB25.
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Name Substituted residue Substituent residue
IC5(J for 
cyclophilin D 
inhibition (nM)
D-M eSer-3-CSA Sarcosine N-methyl-D-serine 2.4
MeVal-4-CSA N-methylleucine N-methylvaline 4.7
CSA - - 6.0
Nva-2-CSA L-a-aminobutyric acid Norvaline 6.4
Val-2-M eBm t(6,7-DH)-l-
CSA
4[R]-4-((E)-2-butenyl)-
4,N-diethyl-L-threonine
(MeBmt)
(4R)-4-butyl-4/N-
dimethyl-L-threonine 7.0
D-Lys(dansyl)-8-CSA D-alanine N-e-dansyl-D-lysine 32.6
D-M eV al-11-CSA (CSH) N-methyl-L-valine N-methyl-D-valine No inhibition
D-MeAla-3-EtVal-4-CSA
(DB25)
Sarcosine and N- 
methylleucine
N-methyl-D-alanine and 
N-ethylvaline Not reported
Table 9 - There exist several Cyclosporin derivatives with differing patterns of interaction
with cyclophilins.
Adapted from [273].
Figure 78 - DB25 (D-MeAla-3-EtVal-4-cyclosporin A).
DB25 inhibits cyclophilins with an IC50 close to that of CSA, but does not permit 
interaction with downstream targets such as calcineurin. Structural differences with CSA 
[Figure 64, page 140] are ringed.
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Figure 79 - The effect of DB25 on tBID-induced cytochrome c release is markedly
different to that of CSA.
Mitochondria were incubated with varying concentrations of tBID in the presence or 
absence of 1.2 pM CSA or DB25 [2.31]. After 30 mins incubation at 30 °C, mitochondria 
were separated from the assay mixture by centrifugation and assayed for cytochrome c 
by Western blot [2.16]. Whilst CSA (A) completely inhibits cytochrome c release over the 
tBID concentrations tested, DB25 ( ) instead has a slight stimulatory effect compared to 
the control conditions (x). Results are representative of two independent experiments.
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Figure 80 - The stimulation of tBID-induced cytochrome c release by DB25 is paralleled by 
a stimulation of BAK conformational change.
B50 mitochondria were incubated in respiration buffer [2.31.1] with varying 
concentrations of tBID, in the presence or absence of 1.2 pM DB25, as indicated.
(A) After 10 mins incubation, trypsin was added, and mitochondria were incubated on ice 
for 10 mins to digest BAK molecules that had undergone conformational change [2.36]. 
Mitochondria were sedimented, and assayed for undigested BAK by Western blot [2.16].
(B) The mitochondrial pellet was also assayed for cytochrome c by Western blot, to 
assess the extent of cytochrome c release induced by tBID. Results are representative of
two independent experiments.
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Figure 81 - Neither CSA nor DB25 cause cytochrome c release from isolated mitochondria
during a 1-hr incubation.
Mitochondria were incubated at 30 °C in respiration buffer [2.31.1] either with no 
additions (x) or in the presence of 1.2 pM CSA ( ) or DB25 (A ). An aliquot was removed 
at various time points. Mitochondria were separated from the assay mixture by 
centrifugation and assayed for cytochrome c by Western blot [2.16].
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A ssum ing the two inhibitors bind reversibly to cyclophilins with simple equilibrium  kinetics, it is 
possible to calculate the IQ for this interaction from the extent o f inhibition at various concentrations of 
inhibitor.
cyclophilin + inhibitor
(Active cyclophilin)
cyclophilin-inhibitor 
(Inactive cyclophilin)
[ £ ] / ]Equation 12
where IQ is the dissociation com plex for the cyclophilin-inhibitor com plex, P is proportion inhibition, 
[I] is the concentration o f free inhibitor, [E] is the concentration o f free cyclophilin, fEI] is the 
concentration o f cyclophilin-inhibitor com plex and [E ] 0  is the total concentration of cyclophilin (i.e. 
bound plus un-bound). The follow ing relationship then follow s [ 12.4]:
Equation 13
[/]„ +[£]„ + K d -  V(-[/]„ -[£]„ -  K d f  -4-[£]„ •[/],
2  • [ £ ] „
This gives predicted values for the proportion inhibition at a given total added inhibitor concentration, 
and so IQ can be calculated by a least-squares fitting algorithm  -  i.e. optim ising the value of IQ to 
minimise the value of X (Ppredicted -  Pmeasured) 2  over all tested inhibitor concentrations. The treatm ent 
depends on having a value for [E]0; this can be calculated by the method o f H enderson [274J, who 
derived the follow ing relationship:
Equation 14 M t l K
( l - p )  Kd
i +
[S]
K
+  [£ ]<
w here [S] is substrate concentration and Km is the M ichaelis constant for the enzym e. Thus a graph of
l
will have y-intercept [E]0. Significant deviation from  linearity[/Jo , , , . r  plotted as a function of 7 ------ r
p  (i-/>)
is observed for points for which P > 0.9, and so this data is excluded from  the analysis.
The relationship of inhibition of m itochondrial PPIase activity to inhibitor concentration, as well as the 
H enderson plot to calculate [E]0, is shown in Figure 82. From these data, IQ values were calculated 
using the above technique to give a value of 2.5 nM  for CSA  and 0.23 nM for DB25. These values
confirm  that DB25 is able to inhibit m itochondrial PPIase activity. In fact, DB25 is a more effective
inhibitor than CSA, the EC 5 0  for inhibition being approxim ately 11 times lower. This increased affinity 
for cyclophilins is presum ably as a result of the m odification at the 3 position of the ring, which is 
predicted to increase apparent binding affinity by favouring the ring conform ation recognised by the 
cyclophilin  CSA  binding site [275],
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Figure 82 - DB25 inhibits mitochondrial PPIase activity with a lower Kd than CSA. 
PPIase assays [2.33] were carried out on a preparation of osmotically lysed B50 
mitochondria [2.26], in the presence of CSA or DB25 as indicated.
(A) The y-intercept of a Henderson plot ( [I]o/P vs. 1/(1-P) ) using the DB25 data 
revealed [E]0 to be 1.4 nM. (B) A plot of % inhibition (P) against [I]0 indicated that 
DB25 (0) inhibited PPIase activity with an 11-fold higher affinity that CSA (x). Lines 
indicate predicted % inhibition using Equation 31 and the calculated values of Kd.
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[8.2.3] Does DB25 inhibit mitochondrial permeability transition?
CSA inhibits m itochondrial perm eability transition by binding to cyclophilin D [165]. To confirm  that 
DB25 had a sim ilar effect on the PT pore via cyclophilin D, pore activity in response to addition of 
calcium  to a B 50 m itochondrial preparation [2.26] was assayed by follow ing m itochondrial swelling 
[2.30]. W hilst addition o f C a2+ resulted in rapid sw elling o f the m itochondrial preparation due to PT 
pore opening [Figure 83(A)] both CSA and DB25 inhibited sw elling follow ing C a2+ addition [Figure 
83(B ,C)]. Thus DB25, like CSA, inhibits PT pore opening, presum ably through interaction with 
m itochondrial cyclophilin D.
[8.2.4]To what extent do CSA and DB25 adsorb to plastic tubes and pipette tips?
CSA and its derivatives are hydrophobic, and are only sparingly soluble in aqueous media -  the 
solubility of CSA is 27.67 pg/m L (23 pM ) at 25°C [276], A ccordingly these com pounds in aqueous 
solution will adsorb to plastic surfaces (tubes, pipette tips etc.). Thus it was im portant to quantify the 
extent to which the different com pounds rem ain in aqueous solution follow ing dilution, since surface 
adsorption would change the effective concentration of inhibitor. In other words, the different effects 
o f DB25 might be due to a different effective concentration of this inhibitor in the reaction buffer 
com pared to that o f CSA, due to an altered aqueous solubility.
PPIase assays [2.33] were carried out on recom binant cyclophilin A, prepared as described above 
[2.50], in the presence of CSA or DB25 added either neat from ethanolic solution, or from a 1.2 pM  
aqueous solution. Both com pounds are highly soluble in ethanol, and so the am ount added directly 
from ethanolic solution will be as calculated. However, when a 1.2 pM  aqueous solution is prepared, 
some proportion of CSA and DB25 will adsorb to the plastic surfaces of the tubes and pipette tips. 
Thus the effective concentration o f inhibitor will be less than 1.2 pM , and the am ount o f inhibitor 
added to the assay mixture will be less than that calculated. From the apparent concentration of 
inhibitor in the diluted aqueous solutions (by com parison of the value w ith that derived following 
addition of ethanolic inhibitor), it was possible to estim ate the proportion of C SA  or DB25 that 
rem ained free in aqueous solution at this concentration. Figure 84 show s the inhibition of recom binant 
cyclophilin  A by CSA and DB25 solutions prepared in this way, together w ith the H enderson plot used 
to derive the value for [E]0; Table 10 shows the derived values.
The affinity o f DB25 for cyclophilin A was approxim ately 14 tim es greater than that of CSA, in broad 
agreem ent w ith the results using mitochondrial PPIase activity [8.2.2], Assum ing that Kd is 
proportional to the concentration of free (non-adsorbed) inhibitor, it was possible to calculate the 
am ount o f inhibitor adsorbed in each case - in the case o f C SA  79 % w as adsorbed, w hilst for DB25 the 
value w as 89 %. Thus the free concentration o f CSA is approxim ately tw ice that of DB25, although 
this w ould presum ably be countered by the 14-fold higher affinity o f DB25 for cyclophilin A. The 
inhibitory effect of DB25 is therefore predicted to be greater  than that of CSA, and a lowered activity 
in aqueous solution is not the explanation for the lack o f any inhibitory effect of DB25 on tBID- 
induced cytochrom e c release.
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Figure 83 - Both DB25 and CSA inhibit mitochondrial permeability transition induced by
Ca2+.
Mitochondria were incubated in respiration buffer [2.31.1], either with no additions (A) or 
with 1 pM CSA (B) or DB25 (C). Absorbance of the mitochondrial suspension was 
recorded at 540 nm to monitor swelling [2.30], At the indicated points, CaCI2 was added 
to 100 to induce opening of the PT pore. (A) Control mitochondria swell rapidly due 
to permeability transition following CaCI2 addition. (B,C) Pre-incubation with either 
CSA (B) or DB25 (C) protects mitochondria from Ca2+-induced permeability transition. 
Results are respresentative of three independent experiments.
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Figure 84 - Cyclosporin A and DB25 both adsorb to the surface of plastic tubes.
PPIase assays [2.33] were carried out on recombinant cyclophilin A [2.50], in the 
presence of either CSA or DB25 added from either ethanolic or 1.2 pM aqueous solutions, 
as indicated. (A) The y-intercept of a Henderson plot ( [I]0/P vs. 1/(1-P )) using the 
ethanolic CSA data revealed [E]0 to be 2.7 nM. (B) A plot of % inhibition (P) against [I]0 
illustrates the relative Kd for ethanolic DB25 (A), aqueous DB25 (x), ethanolic CSA (0) and 
aqueous CSA ( ). Curves indicate predicted % inhibition using Equation 31 and the
calculated values of Kd.
Ethanolic CSA Aqueous CSA Ethanolic DB25 Aqueous DB25
Kd (nM) 3.4 16.3 0.24 2.2
Table 10 -  Apparent Kd values for CSA and DB25 inhibition of recombinant cyclophilin A. 
K<j was calculated as described [8.2.2], from the data presented in Figure 84.
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[8.3]Discussion
CSA has an interesting effect on tBID -induced cytochrom e c release (inhibition o f BAK 
conform ational change), which has not been reported previously [CH APTER 7]. CSA is known to 
affect m ultiple cellular pathw ays, and to exert its effects by different m echanism s. Specifically, CSA 
can, on the one hand, inhibit the catalytic (PPIase) activity o f the cyclophilins - a ‘loss-of-function’ 
mechanism , leading to, for exam ple, blocking o f PT pore opening. On the other hand, CSA can also 
operate by a ‘gain-of-function’ m echanism , as is the case in calcineurin inhibition, w hereby cyclophilin 
A acquires the ability to interact with a dow nstream  target follow ing CSA binding.
The availability o f certain CSA derivatives allows these m echanism s to be distinguished 
experim entally. The com pound DB25 (D -M eA la-3-EtV al-4-CSA ) rem ains a potent inhibitor of PPIase 
activity, but does not support interaction of bound cyclophilins w ith dow nstream  targets. D espite a 
2-fold low er inhibitor concentration in aqueous solution, the 14-fold higher affinity of DB25 for 
cyclophilins indicated that the inhibitory effect of DB25 on m itochondrial cyclophilins should be not 
less than that o f CSA  when added in equal amounts. Despite this fact, DB25 had a m arkedly different 
effect to CSA  on tBID -induced cytochrom e c release; rather than inhibiting tBID action, DB25 
stimulated cytochrom e c release [Figure 79], Based on BAK  digestion assays [Figure 80], this action 
appeared to be at the level of BAK  conform ational change, as is the case for CSA. This result strongly 
suggested that CSA exerts its inhibitory effect via a ‘gain-of-function’ mechanism , rather than by 
cyclophilin inhibition.
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CHAPTER 9 : CYCLOPHILIN D INTERACTION PARTNERS
[9.1[Introduction
From the results presented in C hapter 6 , it seems that cyclophilin D is som ehow  involved in the 
m itochondrial apoptotic pathw ay. C yclophilin D overexpression inhibits B ID -induced cytochrom e c 
release, suggesting it has an inhibitory role [5.4.4], The work o f Lin, Lechleiter, O sada, Tsujim oto, 
G rim m and others [59,156,277] has also im plicated cyclophilin D in apoptotic cell death, but has been 
unable to assign a clear role to this protein. Thus to probe cyclophilin D ’s involvem ent in apoptosis 
further, the identification of cyclophilin D interaction partners was attem pted using pull-dow n assays. 
In all, three different types of pull-dow n were attem pted (sections [9.2], [9.4], [9.5].)
[9.2]Pull-downs from cyclophilin D(+) cells
The cyclophilin D(+) cell line available in the lab [2.42] overexpresses m itochondrial cyclophilin D 
approxim ately 10 tim es [5.4.2], Thus it was attempted to pull dow n interacting proteins from these 
cells using an anti-cyclophilin D antibody, reactive against the epitope SQ N PLV Y LD V G A D  
(corresponding to am ino acids 42-54 o f rat cyclophilin D). A nti-cyclophilin D antibody was 
conjugated to agarose beads [2.22]. Com parison o f the antibody bands from  sam ples taken from the 
supernatant before and after the conjugation reaction [Figure 85; lanes 1 and 2 respectively] indicated 
that approxim ately 50 % of the input antibody was coupled to the beads after incubation. H owever, as 
shown in Figure 8 6 , the resin was unable to pull down any detectable quantity of cyclophilin D from 
the overexpressing cells [2.23]. Thus, although pull-dow n bands were detected (e.g. at 85 kD; lane 3), 
these could not have been pulled down by cyclophilin D, and were considered spurious.
[9.3]Production of epitope-tagged cyclophilin D in B50 cells
M am m alian expression vectors can give transient protein expression levels greater than the 10 times 
achieved with the cyclophilin D(+) cells used above [9.2] [278], A dditionally, antibodies directed 
against epitope tags are typically able to pull down tagged proteins w ith greater affinity than antibodies 
against the target protein [279]. Vectors were generated to code for the cyclophilin  D protein carrying 
three alternative tags: HA, FLAG and triple-FLA G  [2.51].
[9.3.1 [Expression
B 50 cells w ere transiently transfected with the three expression plasm ids [2.39], and HA, FLAG and 
3xFLA G  protein levels in control and transfected cells were com pared by W estern blot [2.16] [Figure 
87], The blots were also probed w ith an anti-A N T antibody (raised against the peptide YDEIKKYV, 
corresponding to the C -term inus o f rat A NT-1; this laboratory) as a loading control [not shown].
A ll three fusion proteins were successfully expressed in the transfected cells. In the case o f the HA and 
3xFLA G  constructs there was little difference betw een 0.25 pg /cm 2 and 0.5 pg /cm 2 of vector. 
H ow ever the FLA G  construct was less well expressed at 2 pg /cm 2 vector.
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Figure 85 - Cyclophilin D antibody was efficiently conjugated to Carbolink™ beads. 
Cyclophilin D antibody was incubated with Carbolink coupling beads [2.22]. Supernatant 
from the coupling reaction was run on SDS-PAGE before (Lane 1) or after (Lane 2) 
incubation, and bands visualised by Coomassie staining. Comparison of the band 
intensity in lanes one and two indicated that approximately 50 % of the antibody was 
coupled to the beads during incubation.
Cyclophilin D Antibody
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Figure 86 - Mitochondrial cyclophilin D was not efficiently pulled down by the anti-
cyclophilin D resin.
The resin prepared above [Figure 85] was incubated with a mitochondrial extract [2.27.1] 
from normal B50 cells (lane 2), or from B50 cells overexpressing mitochondrial 
cyclophilin D (lanes 3 and 4), either in the absence (lane 3) or presence (lane 4) of 5 pM 
CSA. After washing, bound proteins were released using sample loading buffer and run 
on SDS-PAGE [2.13]. Bands were visualised by silver staining [2.15]. There is no band 
corresponding to cyclophilin D (18 kD), which should be much greater in lane 3 than in 
lane 2. Lane 1 -  Anti-cyclophilin D resin alone.
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Figure 87 - Expression of epitope-tagged cyclophilin D proteins in B50 cells.
Cells were transiently transfected [2.39] with an expression plasmid encoding 
cyclophilin D-HA -  Lane 1 (0.25 pg/cm2 culture area) and Lane 2 (0.5 pg/cm2); 
cyclophilin D-FLAG -  Lane 3 (0.25 pg/cm2) and Lane 4 (0.5 pg/cm2); or cyclophilin D- 
3xFLAG -  Lane 5 (0.25 pg/cm2) and Lane 6 (0.5 pg/cm2) and grown for 48 hr. Total 
cellular protein was run on SDS PAGE [2.13] and transferred to nitrocellulose. The blot 
was probed with anti-HA and anti-FLAG antibodies [2.16]. Protein loading was equal 
between lanes, as judged by probing for ANT as a mitochondrial marker [not shown].
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[9.3.2]Mitochondrial localisation
T o verify that the fusion protein was correctly localised to m itochondria, coverslips w ere transfected 
w ith the 3xFLAG  construct [2.39], grown for 48 hr, and then fixed [2.40] and probed with an anti- 
FLA G  antibody [2.41], Cells w ere co-stained either w ith M itoTracker red (before fixation [2.41]) or 
with an anti-A N T antibody (raised against the peptide Y D EIK K Y V , corresponding to the C-term inus 
o f rat A N T-1; this laboratory; after fixation) to reveal the location of m itochondria, as show n in Figure 
8 8 . The 3xFLAG  fusion protein was correctly localised to m itochondria.
[9.3.3]Cross-linking of fusion protein
C ross-linking can reveal the existence o f interaction partners. Incubation with a cross-linking reagent 
such as disuccinim idyl suberate (DSS) links the target protein to an interaction partner; linkage is 
detected by the appearance of a new band on SDS-PAGE, reactive with antibodies directed against the 
target protein. This band corresponds to the cross-linked heterodim er.
B50 cells were transiently transfected w ith the cyclophilin D -HA  expression plasmid [2.39], grow n for 
48 hr, and then incubated with various concentrations of DSS [2.24], As shown in Figure 89 (lane 1), a 
variety of bands are present in the absence of cross-linker. Since the calculated m olecular w eight of 
these bands [Figure 89; arrows] corresponds to m ultiples o f cyclophilin D ’s m onom eric m olecular 
weight, they are likely to represent higher-order cyclophilin D-HA multim ers (from dim ers up to at 
least decam ers). No new bands were apparent follow ing cross-linking [Figure 89, lanes 2 -  11], 
However, the band intensities o f the cyclophilin D-HA  oligom ers increased in the presence o f DSS, 
indicating that they are cross-linkable. To investigate the effect of CSA on the cyclophilin D 
m ultimers, B50 cells w ere again transfected with a cyclophilin D expression plasm id (coding for 
cyclophilin D-3xFLAG ), grown for 48 hr, and then incubated w ith various concentrations o f DSS in 
the presence or absence o f 1.2 pM  CSA [2.24], As shown in Figure 90, CSA did not affect m ultim er 
formation.
A lthough no interaction partners were revealed by this technique, the absence of any clear bands 
indicative o f interaction betw een cyclophilin D and a second protein m ay be due to these bands being 
obscured by the cyclophilin D multimers, or to a lack o f antibody reactivity  o f the cross-linked 
heterodim er.
[9.4JFLAG pull-down from transiently transfected B50 cells
A nti-FLA G  antibody was conjugated to agarose beads [2.22]; approxim ately 50 % of the input 
antibody w as coupled to the beads after incubation [not show n]. A m itochondrial extract [2.27.1] was 
prepared from  cells transiently transfected [2.39] w ith the cyclophilin  D -3xFLA G  plasmid. The extract 
w as incubated with the anti-FLA G -conjugated agarose beads, to pull dow n the tagged cyclophilin D 
protein, along with any interaction partners [2.23]. A sm all am ount o f cyclophilin D -3xFLAG was 
pulled down by the resin [not shown]; how ever no proteins specifically pulled down with the fusion 
protein could be detected. This could be due to the sm all am ount of cyclophilin D -3xFLA G  pulled 
down. In the future, generation o f a stable cyclophilin D -3xFLA G -expressing cell line would allow for 
production o f m uch larger quantities o f fusion protein.
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Figure 88 - The 3xFLAG-tagged fusion protein was correctly localised to mitochondria 
following transient transfection of B50 cells.
Cells were transiently transfected with the cyclophilin D-3xFLAG construct [2.39] and 
grown for 48 hr. (A) Cells were fixed and stained with anti-FLAG and anti-ANT 
antibodies, as described [2.40]; [2.41]. (B) Cells were treated with mitotracker red and 
then fixed and stained with an anti-FLAG antibody.
173
[DSSJ (pM )
154 kD- 
128 kD- 
105 kD-
83 kD-
62 kD-
41 kD-
16 32 64 128 256
m  m  m4H
kD
200
150
100
75
50
37
20 kD- 20
Figure 89 - The cyclophilin D-HA protein oligomerises to form cross-linkable multimers 
that are stable during SDS-PAGE.
B50 cells were transiently transfected with the cyclophilin D-HA expression plasmid
[2.39], and grown for 48 hr. Mitochondria were isolated from the cells [2.26], incubated 
for 20 mins with various concentrations of DSS [2.24], heated in sample loading buffer 
and run on SDS-PAGE [2.13]. After Western blotting, cyclophilin D-HA was detected with
an anti-HA antibody [2.16].
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Figure 90 - The cyclophilin D-3xFLAG protein oligomerises to form cross-linkable 
multimers that are stable during SDS-PAGE and are not disrupted in the presence of CSA. 
B50 cells were transiently transfected with the cyclophilin D-3xFLAG expression plasmid
[2.39], and grown for 48 hr. Mitochondria were isolated from the cells [2.26], and 
incubated for 20 mins with various concentrations of DSS [2.24], with or without 1.2 pM 
CSA as indicated. Cells were then heated in sample loading buffer and run on SDS-PAGE 
[2.13]. After Western blotting, cyclophilin D-3xFLAG was detected with an anti-FLAG
antibody [2.16].
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[9.5]GST-cyclophilin D pull-down from B50 cells
R ather than using endogenously expressed cyclophilin D to pull down interaction partners, it is also 
possible to use bacterially expressed recom binant cyclophilin D to bind proteins. This technique has 
the advantage that it is not lim ited by am ount o f cyclophilin D protein, since large am ounts can be 
expressed in E. coli. A G ST-cyclophilin D fusion protein was expressed, and extracted from the 
bacterial cell extract using G SH-agarose beads [2.18.1], These beads were then incubated with extract 
from a B50 cell m itochondrial preparation [2.18.2], and bound proteins analysed by SD S-PAG E 
[Figure 91]. G ST-cyclophilin D specifically pulled down tw o proteins of approxim ately 18 and 65 kD; 
these interactions were suppressed in the presence of either CSA or DB25.
Since cyclophilin D oligom erises readily [Figure 89], it was thought that the 18 kD protein might be
cyclophilin D (which is approxim ately this size). Therefore extracted proteins were transferred to 
nitrocellulose and the blot probed with an anti-cyclophilin D antibody [not shown]. The antibody did 
not react with the 18 kD protein, indicating that it was not cyclophilin D.
U nfortunately it was not possible to isolate sufficient quantities of the unknow n proteins from B50 cells
to identify them  by mass spectrometry.
[9.6]GST-cyclophilin D pull-down from rat heart mitochondrial matrix extracts
Far greater quantities of protein can be isolated from anim al tissue than from cell lines. Thus 
recom binant G ST-cyclophilin D was used to pull down cyclophilin D interaction partners from a rat 
m itochondrial extract [2.25], in the hope that a sufficient am ount o f the unknown proteins m ight be 
isolated for identification [Figure 92]. Initially a soluble (m atrix) fraction was used [2.27.3].
The 18 kD protein was not pulled down by G ST-cyclophilin D. H owever, Figure 92 shows that there is 
a protein of sim ilar mass to the 65 kD protein identified above, which is pulled down only in the 
absence of CSA (present in lane 2 only). Additionally, tw o proteins, of 200 and 250 kD, were pulled 
down by G ST-cyclophilin D only in the presence of CSA (present in lane 3 only). CSA also slightly 
boosted the intensity o f a 30 kD band in some experim ents [Figure 92, bottom  arrow], but this effect 
was not consistently reproducible.
[9.6.1]Identification of the 200-250 kD proteins
The tw o high m olecular w eight proteins were identified by mass spectrom etry [2.19], The lower band 
corresponded to m yosin heavy chain, and the upper to alpha spectrin [12.2]. These proteins are not 
m itochondrial, and thus represent cytosolic contam ination o f the m itochondrial protein preparation. 
They w ere most likely present as insoluble aggregates which were centrifuged dow n along with the 
agarose beads. The beads seemed to pack down less well after centrifugation in the presence of CSA, 
and so som e of these proteins were rem oved along w ith the supernatant follow ing elution of target 
proteins w ith free GSH. These proteins thus appeared to have been pulled dow n specifically by GST- 
cyclophilin  D in the presence of CSA. R e-centrifuging the eluted fraction and carefully rem oving only 
the top part o f the supernatant elim inated these bands [not shown].
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Figure 91 - GST-cyclophilin D specifically pulled down two proteins from a B50 cell
mitochondrial extract.
Recombinant GST or GST-cyclophilin D [2.18.1] was incubated with a B50 cell 
mitochondrial extract ([2.27.1]; lane 5), and bound proteins pulled down with GSH- 
Agarose [2.18.2]. Lane 1 -  GST + extract. Lane 2 -  GST-cyclophilin D only.
Lane 3 -  GST-cyclophilin D + extract. Lane 4 -  GST-cyclophilin D + extract + 15 pM CSA. 
Arrows indicate the interaction partners, visible in lane 3 alone.
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Figure 92 - GST-cyclophilin D pulled down three proteins from a rat heart mitochondrial
extract.
Recombinant GST-cyclophilin D [2.18.1] was incubated with a rat heart [2.25] 
mitochondrial matrix extract ([2.27.3]; lane 1), and bound proteins pulled down with 
GSH-Agarose [2.18.2]. Lane 2 -  GST-cyclophilin D only. Lane 3 -  GST-cyclophilin D + 
extract. Lane 4 -  GST-cyclophilin D + extract + 15 pM CSA. Lane 5 -  GST + extract. 
Arrows indicate the -60 kD protein (lane 3 only) and the two >200 kD proteins (lane 4 
only) pulled down specifically by GST-cyclophilin D.
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[9.6.2]ldentification of the 54kD protein
The -6 0  kD protein was revealed by mass spectrom etry to be an uncharacterised 524 residue protein of 
m olecular w eight 54 kD, coded for by the rat gene R G D 1305387 [12.2.5]. A homology search using 
BLA ST [280] revealed that the protein contains a predicted short-chain dehydrogenase dom ain and a 
sterol binding domain, as well as four low -com plexity regions, as shown in Figure 93. Searching the 
BLOCKS database [281] showed that the large low -com plexity region betw een residues 298 -  404 has 
hom ology to involucrin.
[9.6.3]Mitochondrial targeting of the 54 kD protein
Since the tw o high-m olecular w eight proteins were found to be cytosolic [9.6.1], it was im portant to 
verify that the 54 kD protein was genuinely m itochondrial. Precursor form s of mitochondrial nuclear- 
encoded proteins contain specific targeting and sorting signals, which m ay be present either internally 
or as cleavable N -term inal signal sequences (reviewed in [282]). The N -term inal sequences are the 
most well characterised; their com m on features include an enrichm ent o f arginine, leucine, serine and 
alanine residues, the presence o f at least two positively charged residues, an absence of acidic residues, 
the ability to form a-helical am phiphilic structures and a high isoelectric point [283], D espite the 
presence of these signals, m itochondrial im port sequences are extrem ely diverse, and can be difficult to 
detect. Additionally, analysis of cytosolic proteins can frequently reveal the presence o f some or all of 
the targeting hallm arks mentioned above. Claros and co-w orkers have developed the M itoProt II 
program  to aid in the prediction o f m itochondrial localisation [283], The algorithm  is based on an 
evaluation o f 47 param eters over a set of 13,039 trainer proteins of known location, and is able to 
predict mitochondrial im port with a success rate o f 93.1%. In the case o f the 54 kD protein, M itoProt 
predicts a probability o f im port to m itochondria of 0.9748, with the cleavage site after lysine 29. Thus 
the 54 kD protein is very likely to be genuinely mitochondrial.
[9.6.4]Role of the 54 kD protein
The SCP2 domain is named after sterol carrier protein 2 (SCP2), in which it was first identified. Based 
on overexpression studies, SCP2 has been proposed to be involved in intracellular cholesterol transport 
in steroidogenic tissues [284], However, there is scant in vitro evidence to suggest a physical 
interaction of SCP2 with cholesterol sufficiently stable to perm it carrying o f the lipid through the 
aqueous phase [285]. On the other hand, the SCP2 lipid binding site can accom m odate a phospholipid 
m olecule upon interaction with mem branes [286,287], and SCP2 has been shown to bind fatty acids 
and long-chain fatty-acyl-CoA s [288], Because of its low affinity, the binding site is occupied by lipid 
only in the presence of m em brane [289].
T he shoit-chain dehydrogenase family contains a wide variety of dehydrogenases, most of which are 
know n to be NAD- or N A D P-dependent oxidoreductases. A lthough little sequence similarity has been 
found in the coenzym e binding domain, there is a large degree of structural similarity, and it has 
therefore been suggested that the fam ily has arisen through gene fusion of a com m on ancestral 
coenzym e binding sequence with various substrate-specific dom ains [290]; in this case the SCP2 
domain.
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Figure 93 - Amino acid sequence of the 54 kD cyclophilin D interaction partner, coded for 
by the uncharacterised rat gene RGD1305387.
The protein contains a predicted short-chain dehydrogenase domain (adh_short) and a 
sterol binding domain (SCP2), as well as four low-complexity regions (light grey).
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The fam ily contains m em bers from a wide range o f species, and is responsible for dehydrogenation o f a 
diverse range o f substrates, including 20-(3-hydroxysteroid, 3-P-hydroxysteroid, 15- 
hydroxyprostaglandin, D -p-hydroxybutyrate, estradiol, corticosteroid, ethanol, sorbitol-6 -phosphate, 
biphenyl-cA -diol and others [290].
As well as the tw o conserved dom ains described above, the 54 kD protein contains a 107 residue region 
of low com plexity, from  am ino acids 298 -  404. This region contains predom inantly glutam ine and 
proline residues, and it is presum ably these prolines that m ediate the interaction with cyclophilin D. 
W ard and co-w orkers [291] have developed the D ISOPRED  algorithm  to predict ordered (structured) 
and disordered (unstructured) regions based on am ino acid sequence data. The algorithm  derives from 
a m achine learning process, with a support vector m achine trained on a set of 750 non-redundant 
sequences with corresponding high resolution X -ray structures. Regions were classified as disordered 
when residues appearing in the sequence records had no associated coordinates in the electron density 
map. D ISO PR ED 2 predicts the m ajority of this region to be unstructured [Figure 94],
The disordered central regional has hom ology to Involucrin, one of a num ber of proteins responsible 
for form ing the highly insoluble cornified cell envelope in term inally differentiated keratinocytes. The 
glutam ine residues are substrates for trans-glutam inases, which cross-link the y-carboxyam ide group of 
these residues to prim ary am ines on target proteins (com m only the e-am ino group of lysine), thus 
form ing insoluble m acrom olecular assem blies [292,293]. A lthough this phenom enon would seem s to 
be unlikely in a m itochondrial setting, the possibility that this central dom ain may be responsible for 
interm olecular cross-linking reactions having some physiological function is intriguing (see 
below) [11.7.3],
G lutam ine-rich tracts also occur in a num ber of other proteins, and are thought in som e cases to occur 
by expansion of CAG repeats by replication slippage [294], CAG  form s a m etastable conform ation, 
and the com plem entary CTG oligom ers form a stable anti-parallel duplex [295]; if  these structures 
form in the nascent DNA lagging strand follow ing prim er slippage, tem plate codons can be replicated 
m ultiple times [Figure 95]. Subsequent mutation o f the CAG  codon generates related codons, for 
exam ple CCG (proline), GAG (glutam ate) and CTG (leucine) and AAG  (lysine), as observed here. 
From the above analysis, the prim ary structure of the 54 kD protein seem s to suggest that its function is 
to catalytically dehydrogenate some lipid specie or species at the inner m itochondrial membrane. 
A lthough the central low -com plexity region may simply be a non-functional result of erroneous 
replication, it is tem pting to speculate that the presence o f a proline-rich m otif serves to tether the 
protein to mitochondrial contact sites via interaction with cyclophilin D. Since contact sites are thought 
to be the route of lipid im port to the inner m em brane [296-298], this w ould bring the catalytic activity 
close to the lipids for which it is required. This m echanism  would assum e either that cyclophilin D 
interacts w ith A N T at contact sites via a non-active site region, or that it dim erises via a non-active site 
region, allowing one active site to bind to ANT and another, on a second molecule, to the 54 kD 
protein. Since CSA occludes the active (PPIase) site o f cyclophilins, the lack of CSA-inhibition of 
cyclophilin D m ultim erisation [Figure 90] suggests that cyclophilin D does indeed dim erise via a non­
active site region.
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Figure 94 - Disorder prediction based on the primary structure of the 54 kD protein, as 
calculated by the DISOPRED algorithm [291].
The protein contains a large predicted disordered region, corresponding to the low 
complexity region between residues 298 and 404. The false-positive cut-off of 0.05 is
indicated by the dashed line.
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Figure 95 - Strand slippage during DNA replication can lead to extension of codon repeats 
with the potential to form stable hairpins.
The nascent lagging strand can dissociate from the template, and re-anneal at a site 3' to 
the dissociation site, within a repeated region. Hairpin formation encourages this event. 
Downstream codons are thus copied for a second time, resulting in codon duplication.
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[9.6.5J54 kD CSA-sensitive band
To further investigate the 54 kD CSA-sensitive band, the experim ent above [Figure 92] was repeated in 
the presence o f varying concentrations of CSA and DB25. As shown in Figure 96, the interaction was 
disrupted by low concentrations of both CSA  and DB25 -  the EC 5 0  was around 500 nM for DB25 and 
around 800 nM  for CSA.
[9.7]GST-cyclophilin Dpull-down from rat heart SMPs
To investigate the interaction of cyclophilin D with m itochondrial inner m em brane proteins, the 
experim ent above [9.6] was repeated using sub-m itochondrial particles prepared from rat heart 
m itochondria [2.27]. G ST-cyclophilin D specifically pulled down a protein of around 30 kD [Figure 
97]. This band was reactive against anti-A N T and anti-V DA C antibodies [not shown], and therefore 
represented the A N T-V D A C com plex present in the m itochondrial m em brane fraction. The interaction 
betw een cyclophilin D and A N T in the inner m em brane has been dem onstrated previously (e.g. [29]). 
To investigate the effect of the tw o cyclophilin D inhibitors on the interaction, the experim ent was 
repeated in the presence o f 1.2 pM  CSA or 1.2 pM  DB25. Both inhibitors reduced the am ount of 
VDAC and ANT pulled down by 60 to 75 % [Figure 98]. Som e w orkers have previously obtained a 
sim ilar result, whereby the cyclophilin D -A N T interaction is disrupted by CSA [36,166]; how ever 
som e have found that this interaction is preserved even in the presence o f CSA [29]. The difference 
may be due to the order of binding, with CSA able to prevent association with A N T w hen pre­
incubated with cyclophilin D (as in this case), but unable to disrupt an existing interaction.
[9.8]Discussion
U nfortunately it was not possible to identify any cyclophilin D interaction partners in the B50 cell line 
in which the cytochrom e c release experim ents were carried out. H ow ever, a previously unknown 
interaction partner was identified in a heart m itochondrial extract. This protein is of a sim ilar size to 
one of the interaction partners pulled down from B50 cells. Based on conserved dom ain identification, 
this 54 kD protein seems likely to have a role in lipid dehydrogenation at the mitochondrial inner 
m em brane. A proline-rich m otif may serve to anchor the protein to m itochondrial contact sites via its 
interaction with cyclophilin D.
A dditionally, the ability of ANT to interact with cyclophilin  D was confirmed. In rat heart 
m itochondria, at least, the 54 kD protein and A NT/V D A C w ere the only proteins detected in pull-down 
experim ents and may therefore com prise the principle binding partners of m itochondrial cyclophilin D.
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Figure 96 - CSA/DB25-sensitive removal of the 54 kD cyclophilin D interaction partner. 
Recombinant GST-cyclophilin D [2.18.1] was incubated with a rat heart mitochondrial 
extract [2.27.1] in the presence of varying concentrations of CSA or DB25, and bound 
proteins pulled down with GSH-Agarose [2.18.2], (A) SDS-PAGE [2.13] and Coomassie 
staining [2.14.1] of pulled down proteins. (B) The 54 kD band was quantified by 
densitometry; the graph shows the decrease in signal strength (disruption of cyclophilin D 
interaction) with increasing CSA (0) or DB25 (x) concentration.
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Figure 97 - GST-cyclophilin D pulls down a 30 kD protein from a mitochondrial membrane
extract.
Recombinant GST-cyclophilin D [2.18.1] was incubated with a rat heart mitochondrial 
SMPs [2.27.2], and bound proteins pulled down with GSH-Agarose [2.18.2]. Proteins 
were run on SDS-PAGE [2.13], and bands visualised by Coomassie staining [2.14.1]. 
Lane 1 -  Pull-down with GST only. Lane 2 -  Pull-down with GST-cyclophilin D.
Lane 3 -  Rat heart SMPs.
□  ANT
□  VDAC
Control
Figure 98 - The interaction of GST-cyclophilin D with the VDAC-ANT complex is disrupted
by CSA and DB25.
ANT and VDAC were pulled down from rat heart mitochondrial SMPs by GST-cyclophilin D 
as in Figure 97, in the presence or absence of 1.2 pM CSA or DB25. ANT and VDAC were 
detected and quantified by Western blot [2.16], and signals used to calculate the degree 
of disruption of the interaction by CSA and DB25.
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CHAPTER 10 : PHOSPHORYLATION CHANGES IN ISOLATED MITOCHONDRIA
[10.1]lntroduction
CSA affects the phosphorylation state of cytosolic proteins by interacting w ith the cytosolic cyclophilin 
isoform  cyclophilin A. The resultant cyclophilin A-CSA com plex specifically inhibits the calm odulin- 
dependent phosphatase calcineurin [271]. It seemed possible that CSA  m ight influence m itochondrial 
protein phosphorylation via an analogous m echanism , involving either adherent cyclophilin A [Figure 
74] or cyclophilin D. M oreover, this m ight relate to why BID -induced cytochrom e c release was 
inhibited by CSA, im plicating a cyclophilin, but was not stim ulated by cyclophilin D overexpression 
[Figure 54] or by addition of cyclophilin A [Figure 75]. Thus it was decided to investigate the effects 
of CSA, DB25 and tBID  on phosphorylation of mitochondrial proteins.
[  10.2f2P labelling of mitochondrial proteins
Protein phosphorylation involves the transfer of a phosphate group from  A TP to serine, threonine or 
tyrosine residues on the target protein. Thus incubation of m itochondria w ith [y-3 2 P]A TP will result in 
labelling of mitochondrial phospho-proteins. A lthough this method has been used by several groups to 
investigate mitochondrial proteins phosphorylation levels (e.g. [215]), it has the disadvantage that 
exogenous A TP will only label proteins to which it has access -  i.e. initially only those of the outer 
m em brane and inter-m em brane space. O bserved changes in phosphorylation levels may thus reflect 
changes in the accessibility o f m itochondrial com partm ents as well as changes in kinase and 
phosphatase activity. For exam ple opening of the PT pore would allow  [y-3 2 P]A TP to enter the matrix, 
leading to labelling of previously inaccessible matrix proteins, despite the fact that pore opening would 
be expected to result in a decrease in matrix protein phosphorylation due to dissipation of the proton 
motive force and matrix ATP levels.
As an alternative, radiolabelled inorganic phosphate can be used to label m itochondrial proteins. For 
labelling of matrix proteins, 32P alone is added to the external m edium. 32P is im ported to the matrix 
via the phosphate carrier, and is then incorporated into matrix A TP by the F 0 F r ATPase. For labelling 
o f internal and external proteins, both 32P and A DP are added to the m edium. Labelled ATP is 
generated internally as before, but in this case the presence of external ADP allows the adenine 
nucleotide translocase to export [y-3 2 P]ATP in antiport w ith A DP, thus generating both internal and 
external pools of labelled ATP.
A s show n in Figure 99, several m itochondrial proteins w ere labelled follow ing incubation with 
respiration buffer plus 32Pj [2.20]. Labelling was essentially com plete at 90 mins, and so this time- 
point was used for further experim ents. No difference in labelling was observed in experim ents with 
and w ithout external A DP [not shown], suggesting that the proteins labelled were largely 
intram itochondrial.
[10.3]The effect of CSA, DB25, tBID and cyclophilin D on phosphorylation levels
M itochondria w ere incubated in respiration buffer plus 32Pj [2.20] as in Figure 99, with or without 
tBID, CSA and DB25.
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Figure 99 - Several mitochondrial proteins are labelled following incubation with 32P, 
Mitochondria were incubated in respiration buffer with 50 pCi/ml 32Pj [2.20] for the 
indicated times, and then heated with sample loading buffer. Proteins were run on 
SDS-PAGE [2.13] and transferred to nitrocellulose [2.16.1]. The blot was exposed to 
phosphorimager screen for 48 hr.
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As shown in Figure 100, none of these additions affected the phosphorylation state o f the labelled 
proteins. Again, no difference in labelling was observed betw een experim ents with and without 
external A D P [not shown].
T o investigate the effect of cyclophilin D on phosphorylation levels, labelling experim ents [2.20] were 
carried out using m itochondria isolated from the cyclophilin D -overexpressing cell line [2.42]. As 
shown in Figure 101(A), a 17 kD protein was specifically labelled in cyclophilin D -overexpressing 
m itochondria; the band was not visible in m itochondria isolated from the control B50 cell line. Since 
cyclophilin D is approxim ately this size, the blot was probed with an anti-cyclophilin D 
antibody [2.16]. H ow ever the 17 kD band did not react, suggesting that it was not cyclophilin D 
[Figure 101(B,C)]. A band corresponding to cyclophilin D is visible in the W estern blot above the 
17 kD band. To investigate the possibility that this 17 kD band m ight represent a phosphorylated 
cyclophilin D protein that was unreactive against the anti-cyclophilin D antibody, the cyclophilin D 
sequence was entered into the NetPhosII program  [299], to predict phosphorylation sites. NetPhosII is 
a neural netw ork-based method for predicting potential phosphorylation sites at serine, threonine or 
tyrosine residues in protein sequences. It predicts non-kinase-specific phosphorylation sites in 
independent sequences with a sensitivity in the range 69 % to 96 %, on the basis of the existence of 
known phosphorylation sites in a large set of trainer proteins. The cyclophilin D epitope recognised by 
the antibody (ab3567; AbCam ) is SQ N PLVY LDV GA D  (residues 42 -  54); the program predicts a 
significant probability of phosphorylation o f both Serine 40 and Tyrosine 48. M odification of either of 
these residues could conceivably inhibit antibody binding, and m ight also influence migration of the 
protein on SD S-PA G E (e.g. [300]). Thus the 17 kD band might possibly represent cyclophilin D.
The investigate the effects of tBID, CSA and DB25 on the phosphorylation level of the 17 kD band, 
mitochondria isolated from the cyclophilin D -overexpressing cell line [2.42] were incubated in 
respiration buffer plus 3 2 P„ with or without these com pounds [2.20]. There was no obvious effect of 
any compound, apart from a slight decrease in intensity o f all the bands following incubation with tBID 
[not shown]. This general decrease in labelling may be due to inhibition of respiration following 
cytochrom e c release in these experiments.
[  10.4] Discussion
M itochondria contain a wide range of protein kinases [206-211] and several m itochondrial enzym es are 
know n to be regulated by phosphorylation; for example pyruvate dehydrogenase and branched-chain u- 
oxoacid dehydrogenase [204,205]. Phosphorylation of a num ber of other soluble and m em brane 
proteins has also been shown [209,212,213]. Given that CSA  is known to regulate cytosolic protein 
phosphorylation levels [271] it was possible that it m ight have a sim ilar function in mitochondria. If 
tBID  were exerting its effects through some phosphorylation-dependent pathway, the effects o f CSA 
m ight thus be m ediated by changes in protein phosphorylation levels.
Incubation of isolated m itochondria with 3 2 P; labelled a variety o f m itochondrial proteins. Initial 
experim ents indicated that neither tBID, CSA nor DB25 were able to influence this labelling pattern. 
H ow ever, when the labelling of mitochondria isolated from a cyclophilin D-overexpressing cell line 
was com pared w ith that of control B50 m itochondria, a novel 17 kD band was apparent.
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Figure 100 - tBID, CSA and DB25 do not affect the phosphorylation level of mitochondrial
proteins.
Mitochondria were incubated in respiration buffer with 50 gCi/ml 32P, [2.20] with 
(lanes 1 - 3) or without (lanes 4 - 6 )  0.65 pM tBID. Cyclophilin D inhibitors were included 
in some experiments: 1.2 pM CSA (lanes 2 and 5) or 1.2 pM DB25 (lanes 3 and 6). After 
incubation for 90 mins, proteins were run on SDS-PAGE [2.13] and transferred to 
nitrocellulose [2.16.1]. The blot was exposed to a phosphorimager screen for 48 hr.
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Figure 101 - A 17 kD protein that is not cyclophilin D is phosphorylated in cyclophilin D
overexpressing cells.
(A) Mitochondria isolated from normal (left) or cyclophilin D-overexpressing cells (right) 
were incubated in respiration buffer with 50 pCi/ml 32Pj [2.20]. After incubation for 90 
mins, proteins were run on SDS-PAGE [2.13] and transferred to nitrocellulose [2.16.1]. 
The blot was exposed to a phosphorimager screen for 48 hr. (B) Subsequently, the blot 
was probed with an anti-cyclophilin D antibody [2.16.2] to reveal the location of 
cyclophilin D. (C) Overlay of the images from the lane loaded with proteins from the 
cyclophilin D-overexpressed mitochondria -  phosphorimager (red) and anti-cyclophilin D 
(green). Cyclophilin D labelled by the antibody runs as a higher molecular weight specie 
than the 17 kD phosphorylated protein.
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Serine predictions
Name Position Context
V
Score Pred
Sequence 15 LGLLSGPRS 0.041
Sequence 19 SGPRSAPLL 0.014
Sequence 25 PLLLSTTRT 0.725 *s*
Sequence 31 TRTCSDGGA 0.986 *S*
Sequence 40 RGANSSSQN 0.858 *S*
Sequence 41 GANSSSQNP 0.141
Sequence 42 ANSSSQNPL 0.055
Sequence 92 GYKGSTFHR 0.003
Sequence 118 TGGKSIYGS 0.977 *s*
Sequence 122 SIYGSRFPD 0.383
Sequence 140 PGVLSMANA 0.114
Sequence 151 NTNGSQFFI 0.061
Sequence 185 KKIESFGSK 0.098
Sequence 188 ESFGSKSGK 0.470
Sequence 190 FGSKSGKTS 0.989 *S*
Sequence 194 SGKTSKKIV 0.930 *S*
Sequence 206 CGQLS---- 0.027
Threonine predictions 
Name Position Context Score Pred
_v_
Sequence 26 LLLSTTRTC 0.056
Sequence 27 LLSTTRTCS 0.015
Sequence 29 STTRTCSDG 0.206
Sequence 73 WPKTAENF 0.084
Sequence 82 RALCTGEKG 0.091
Sequence 93 YKGSTFHRV 0.212
Sequence 109 AGDFTNHNG 0.015
Sequence 114 NHNGTGGKS 0.057
Sequence 130 DENFTLKHV 0.551 *T*
Sequence 148 AGPNTNGSQ 0.028
Sequence 157 FFICTIKTD 0.457
Sequence 160 CTIKTDWLD 0.047
Sequence 193 KSGKTSKKI 0.662 *T*
Sequence 200 KIVITDCGQ 0.036
Tyrosine predictions
Name Position Context
V
Score Pred
Sequence 48 NPLVYLDVG 0. 773 *Y*
Sequence 89 KGFGYKGST 0.294
Sequence 120 GKSIYGSRF 0.142
NetPhos 2.0: predicted phosphorylation sites in Sequence
S e r i n e
Threonine
Tyrosine
T h r e s h o l d
1 0 0
Sequence position
Figure 102 - Prediction of Cyclophilin D phosphorylation sites by the NetPhosII program. 
The rat Cyclophilin D sequence was entered into the NetPhosII program [299]. The 
program predicts non-kinase-specific phosphorylation sites via a neural network 
algorithm; phosphorylation potentials above 0.5 are considered significant. The program 
revealed both Serine 40 and Tyrosine 48 to have a strong probability of phosphorylation, 
which might inhibit antibody binding to the epitope 42SQNPLVYLDVGAD54.
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This band was shown not to be cyclophilin D; how ever beyond this its identity rem ains unknown. 
A lthough CSA was unable to affect the labelling of this protein, a variation in its phosphorylation state 
might nonetheless be related to the inhibition o f cytochrom e c release from these m itochondria. This 
possibility clearly deserves further investigation.
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CHAPTER 11 : DISCUSSION
[  11.1]Overview of the project
Following cloning of the rat bid  gene and expression o f the B ID  protein [CH A PTER 3], a system  was 
developed to assess quantitatively the extent o f m itochondrial cytochrom e c release induced by the 
addition of recom binant BID or tBID to isolated B50 cell m itochondria [C H A PTER  4], In contrast to 
the qualitative m easurem ents of cytochrom e c release made in several o ther studies, this technique was 
able to reveal subtle changes in release progression under different experim ental conditions, thus 
providing a powerful tool to probe the root mechanism s o f release across the m itochondrial outer 
membrane.
The absence of any effect o f calcium  ions on BID -induced cytochrom e c release, together w ith the 
inhibitory effect of cyclophilin D overexpression [CHAPTER 5], indicated that the m itochondrial 
perm eability transition is not involved in BID action, as was suspected from  previously published data. 
This was confirmed by calcein release experim ents, which ruled out even transitory periods of pore 
opening during BID-induced cytochrom e c release. H ow ever the inhibitory effect of cyclophilin D was 
intriguing, and even more so was the failure of CSA to rem ove this inhibition, CSA  instead also being 
inhibitory [CHAPTER 7].
A kinetic model of tBID -induced cytochrom e c release was developed from first principles, which 
accurately predicted the tim e-course of release at various tBID  concentrations [CH APTER 6 ], The 
model is based on tBID -induced cytochrom e c release occurring via a tB ID -induced conform ational 
change in BAK  m olecules resident at the outer m itochondrial m em brane, thus seeding a pool of ‘open’ 
BAK conform ers. These ‘open’ m olecules then auto-catalyse conversion of other BAK m olecules into 
the ‘open’ state, from which they oligom erise into a pore for cytochrom e c efflux. Efflux occurs by 
passive diffusion. For a given cytochrom e c release tim e-course, the m odel provided values o f three 
key kinetic param eters, which together com pletely defined release progression: the rate of tBID- 
induced conform ational change o f BA K  (c), the rate o f B A K -induced conform ational change o f BAK 
if) and the rate of cytochrom e efflux through B A K  channels (a). C ytochrom e c release values 
predicted by the model show ed an excellent correlation with experim ental data. The m odel predicted 
that the locus of CSA inhibition was the BID -induced conform ational change of B A K  at the outer 
m em brane, and this prediction was confirm ed by a direct assay o f B A K  conform ation during BID- 
induced cytochrom e c release [CH APTER 7].
Since the effect of CSA appeared to be at the outer m em brane, rather than in the mitochondrial matrix, 
alternative (non-cyclophilin D) targets w ere considered. Some cyclophilin A was found to be 
associated w ith the B50 m itochondrial fraction, and this was thus a possible m ediator of C SA ’s effects. 
A lthough addition of small am ounts o f recom binant cyclophilin A had no effect on tBID-induced 
cytochrom e c release, addition of large am ounts inhibited release. Interestingly, the inhibitory effect 
was sim ilar in extent and non-additive w ith that of CSA  [CH APTER 7], The effects of CSA contrasted 
w ith those o f a structurally sim ilar analogue, DB25, which binds to and inhibits cyclophilins similarly 
to CSA, but does not perm it interaction w ith dow nstream  targets such as calcineurin. DB25 in fact
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stim ulated  tB ID -induced cytochrom e c release [CH A PTER 8 ], via a stim ulation of tB ID -induced BAK 
conform ational change.
Cyclophilin D pull-downs from mitochondrial extracts w ere unable to identify any proteins interacting 
with cyclophilin D in the presence only of CSA (and not D B25), as m ight be expected in order to 
explain the differing effects of these two com pounds [CH APTER 9]. H ow ever, the previously reported 
[29] interaction of cyclophilin D w ith an A N T-V DA C com plex in a m itochondrial m em brane extract 
was confirmed. Additionally, two novel interaction partners, of approxim ately 18 and 65 kD, were 
identified in a B50 mitochondrial extract. These proteins interacted w ith cyclophilin D only in the 
absence of CSA and DB25. A protein o f sim ilar size to the larger o f these was also pulled dow n from a 
rat heart mitochondrial extract, and identified by mass spectrom etry. This previously uncharacterised 
54 kD protein was analysed com putationally.
Finally, 32P labelling was used in an attem pt to identify changes in m itochondrial phosphorylation 
patterns in response to tBID, CSA and DB25 [CHAPTER 10]. A lthough none of these com pounds 
detectably altered phosphorylation, cyclophilin D overexpression was observed to increase 
phosphorylation of a 17 kD band, the identity o f which rem ains unknown.
[11.2]The pathway of BID- and tBID- induced cytochrome c release
[11.2.1]tBID-induced BAK oligomerisation
Based on the work of Luo, Antonsson, Eskes, Pavlov, Guo, Kuwana, Terrones, Dejean and others 
[7,83-88,93], the follow ing model o f tBID -induced cytochrom e c release has been proposed: BID is 
norm ally present in an inactive form in the cytosol. D uring apoptosis, an active form, tBID, is 
generated by caspase cleavage of BID. tBID translocates to the m itochondrial outer m em brane, where 
it interacts with BAX or BAK to generate an activated ‘open’ conform er. ‘O pen’ conform ers can 
catalyse the conversion of further BA X /BA K  m olecules to the open state. These open conform ers are 
able to self-assemble into a pore w ith transport activity specific for cytochrom e c, through which this 
protein can pass into the cytosol.
The results presented here fully support this model. Firstly, BID  was show n to be activated by caspase 
cleavage - whilst BID induced cytochrom e c release at high concentrations [EC 5 0  typically around 
140 nM ; Figure 40(A)], tBID was far more potent [EC 5 0  typically around 10 nM; Figure 40(B)]. 
Secondly, from the dependence o f tBID E C 5o on the concentration o f m itochondria, it was apparent that 
tBID binds tightly to m itochondria (presum ably the outer m em brane) [Figure 42]. As predicted, tBID 
induced a conformational change in m itochondrially resident BAK  molecules, which preceded the 
release of mitochondrial cytochrom e c stores [Figure 72], Finally, the release of cytochrom e c through 
BAK pores was indeed shown to be specific; another inter-m em brane space protein (AIF) was not 
released during tBID -induced cytochrom e c efflux [Figure 43]. (This said, there is some evidence that 
A IF is peripherally associated w ith the m itochondrial inner m em brane [301], and may not be released 
under any circum stances until these interactions are disrupted follow ing caspase activation, late in 
apoptosis [302]).
195
[11.2.2]An alternative mechanism of cytochrome c release induced by full-length BID? 
V alentijn and co-w orkers [138] propose the existence o f a second pathw ay o f BID action, involving 
translocation of full-length BID to m itochondria. The authors suggest that full-length BID is able to 
induce cytochrom e c release independently o f B A X /B A K  activation. The results of the present study 
suggest that the m echanism  of action of full-length BID  m ay be qualitatively different to that of tBID  -  
i.e. that full-length BID does not simply act as a low er-affinity version o f  tBID. Thus w hilst CSA was 
shown to inhibit tBID action [Figure 6 6 ], this inhibitor had no effect on the action o f full-length BID 
[Figure 67]. Similarly, although addition of high concentrations o f recom binant cyclophilin A 
inhibited tBID action [Figure 76], the same treatm ent had no effect on cytochrom e c release induced by 
the full-length protein [Figure 77], Since CSA and cyclophilin A are believed to act on the process of 
BAK oligom erisation (see below), full-length BID may therefore act independently of BAK. This 
could be checked by testing for conform ational change of BAK  induced by the full-length protein. If, 
as suspected, full-length BID was unable to induce BAK conform ational change, the question of how, 
then, full-length BID is able to induce cytochrom e c efflux would be an intriguing one. Is BID  able to 
form autonom ous pores, as suggested by some [80]? O r is BID  able to induce m em brane 
perm eabilisation by interaction with other outer m em brane system s -  perhaps PT  pore com ponents, as 
suggested by others [111,123]?
[ 11.2.3]lnvolvement of the PT pore
In the literature, a popular model to explain the release of cytochrom e c during apoptosis invokes 
opening o f the PT pore as a m echanism  of outer m em brane perm eabilisation [14]. Osmotic sw elling of 
the m itochondrion following pore opening is predicted to rupture the outer m em brane due to the far 
larger surface area of the convoluted inner m em brane [52]. This m odel has received attention since it 
appeared to provide a simple explanation for the observed phenom enon of integration of m ultiple pro- 
and anti- apoptotic signals at the level o f the mitochondrion, as well a providing a physiological role for 
the mysterious PT pore. There is, how ever, a substantial body o f evidence indicating that the PT pore 
is unlikely to be involved; at least not necessarily so (review ed above [1.3.6]). In a less controversial 
model [17], the PT pore is proposed to be involved not in outer m em brane perm eabilisation per se, but 
rather in a process of cytochrom e c redistribution from  sequestered stores w ithin m itochondrial cristae 
to a more accessible pool, close to the outer m em brane, thus ‘prim ing’ cytochrom e c for release 
through outer membrane channels.
In the present study, the involvem ent of the PT  pore in B ID -induced cytochrom e c release was 
conclusively ruled out, on several grounds: the lack of any stim ulatory effect of calcium  ions on BID 
action [Figure 47]; the inhibition  of apoptosis by cyclophilin D  overexpression (in contrast to the 
stim ulation that would be expected to result in the case o f PT pore involvem ent) [Figure 54]; and, 
categorically, by the lack of release o f m atrix-entrapped calcein during BID -induced cytochrom e c 
release [Figure 48].
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[11.3]Importance of the kinetic model
[11.3.1 [Access to kinetic parameters
The kinetic model of cytochrom e c efflux developed here [C H A PTER  6 ] allows inform ation on 
previously inaccessible param eters to be derived from  quantitative cytochrom e c release data. The 
model makes distinct predictions concerning the effect o f changes at each m odelled stage -  tBID- 
induced conform ational change o f BAK, B AK -induced conform ational change o f B A K  (autocatalysis) 
and efflux of cytochrom e c through BAK  pores (relating to the value of the constants c, f  and a 
respectively). A djusting the values of these three param eters results in an excellent fit of predicted 
release to experim ental release values, and thus the model can be used to derive values o f these 
param eters under different experim ental conditions. This inform ation is norm ally inaccessible in 
cytochrome c release experim ents - for instance there would ordinarily be no way to distinguish the 
effect of an increased rate of BAK  autocatalysis of conform ational change and an increased rate of 
cytochrome c transport through outer m em brane pores (both resulting, as they would, in an apparently 
similar increase in the rate o f cytochrom e c release). The m odel is therefore a pow erful tool in 
deconvoluting the changes in cytochrom e c release observed under different conditions and therefore in 
determ ining the effect of experim ental changes, as dem onstrated by the use o f the model to analyse the 
effects of CSA [CHAPTER 7],
[11.3.2]Use of the model in determining the effect of CSA
In the case o f CSA, cytochrome c release experim ents had show n that CSA inhibits tBID -induced 
cytochrom e c release [Figure 6 6 ]. Published data, discussed in m ore detail below [11.4.1] had 
attributed the effect of CSA to inhibition o f cytochrom e c redistribution within m itochondria, thereby 
restricting access of cytochrom e c to the outer m em brane. H ow ever, analysis of the cytochrom e c 
release data in the presence and absence of CSA according to the kinetic model suggested that rather 
than altering the value of a (the apparent rate constant for cytochrom e c efflux through pores in the 
mem brane; as would be expected for an inhibition of cytochrom e c redistribution), CSA lowered the 
value of c (the rate constant for tB ID -induced conform ational change of BAK) [Figure 6 8 ], A direct 
assay of BAK  conformation supported this view, confirm ing that CSA inhibited a step occurring at the 
outer face of mitochondria [Figure 73], rather than an internal process.
[11.4]The existence of distinct internal pools of cytochrome c
[11.4. IJScorrano’s model
Scorrano and co-workers [17] and others put forw ard a convincing picture o f cytochrome c 
sequestration within m itochondrial cristae. A ccording to their model, the cristae represent a distinct 
com partm ent, separated from the inter-m em brane space by narrow cristae junctions [Figure 103]. 
These junctions present a barrier to diffusion o f solutes, and especially to large m olecules such as 
proteins. A necessary first step in m itochondrial cytochrom e c release was thus proposed to be the 
opening o f these junctions, allow ing efflux of the cytochrom e c stores sequestered within cristae.
197
Outer membrane Inner membrane
Cristae
Cytochrome cO
Narrow cristae junction
Figure 103 -  Sequestration of mitochondrial cytochrome c stores within cristae. 
Recent models of mitochondrial substructure suggest that the cristae are separated from 
the intermembrane space by tight junctions, which prevent free diffusion of solutes and 
proteins [17,18]. Cytochrome c stores have been suggested to be sequestered in these 
spaces, so that they are unavailable for release during apoptosis prior to an active 
alteration of substructural state [20].
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Scorrano’s group measured the proportion o f cytochrom e c present in the interm em brane space and 
cristae com partm ents by com paring the rate o f respiration driven by ascorbate (w hich can reach only 
the IM S store) with that o f TM PD (which, being m em brane-perm eable, can reach all stores). Their 
value of around 15 % for cytochrom e c present in the IMS com pared well with the proportion (16 %) 
that could be released by digitonin solubilisation of the outer m em brane. W hilst tBID could release all 
cytochrome c stores, the authors observed that tBID  in the presence o f CSA  could only release 15 % of 
cytochrome c. They suggested that this am ount represents the IM S store, and therefore that CSA 
inhibits a process of cytochrom e c m obilisation from cristal spaces to the IMS (i.e. a w idening o f the 
cristae junctions). Based on calcein release experim ents, they suggested that this process involves 
transient opening of the PT pore. Their work is supported by the observation that som e IMS proteins 
(AIF and Smac) are indeed released earlier than the bulk of cytochrom e c during apoptosis under some 
conditions [303,304],
In Scorrano’s system, CSA did not inhibit tBID -induced oligom erisation o f BAK, in contrast to the 
results of the present study [Figure 73]. Also, the effect o f tBID  on cristae organisation was show n by 
Scorrano to be independent of BAX  and BAK, thus separating two functions of tBID  -  firstly, 
induction of BAK/BAX oligom erisation (investigated in this study) and secondly, a possible 
reorganisation of mitochondrial substructure. Indeed, the authors show ed that a BH3 mutant o f BID, 
unable to induce BAX/BAK conform ational change, rem ained com petent at inducing calcein release 
(indicative of PT pore opening) and cristae reorganisation.
In the experim ents presented in this study there is no evidence for the existence of a separate store of 
cytochrom e c. Firstly, analysis o f the tim e-course of release does not show a tw o-com ponent efflux; 
rather, the release data is accurately m odelled by assum ing passive diffusion of a single pool of 
cytochrom e c through efflux channels [CH APTER 6 ]. Thus tB ID -induced opening of cristae junctions, 
if  it does occur, must be an extrem ely rapid early process, so that it would not affect the observed 
efflux across the outer m em brane. Secondly, although CSA does indeed inhibit tBID -induced 
cytochrom e c release, there is no evidence that it inhibits the m axim um  am ount of release, but only the 
speed of release of a single pool [7.3]. Finally, regarding the proposed m echanism  of CSA inhibition, 
tBID is shown not to induce even transient PT pore opening in this system  [5.3].
[ 11,4.2]Existence of a two-component cytochrome c store
The lack of any apparent effect of tBID on interm em brane space com partm entalisation in this study 
presum ably reflects either the source o f m itochondria (B50 cells as opposed to mouse liver), or the 
com positions o f the assay media used. Scorrano attem pted to address the problem  of the effect of un- 
physiological buffers by recapitulating some o f the effects on m itochondrial m orphology in whole 
cells. Nevertheless, the generality of Scorrano’s model has been questioned; for exam ple von Ahsen 
and co-w orkers, using electron m icroscopy, detected no change in the internal structure of Xenopus 
m itochondria during BID -induced cytochrom e c release [54], A lso a num ber o f other groups have 
previously been unable to dem onstrate any evidence o f a tw o-com ponent model in intact cells 
[258,269],
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This said, it should be noted that the results o f the present study do not conclusively rule out an effect 
o f CSA on cytochrom e c redistribution. As stated above (page 127), the value o f a describes efflux 
across the outer m em brane of a single or functionally  single  pool o f cytochrom e c. There m ay still be 
tw o (or more than two) distinct pools of cytochrom e c w ithin m itochondria, but if the rate of 
cytochrom e c redistribution am ongst these pools is rapid w ith respect to the rate of m ovem ent across 
the outer mem brane, then the entire cytochrom e c store will behave kinetically as a single pool. Figure 
104(A) shows a hypothetical model of m itochondrial cytochrom e c sequestration w ithin mitochondria. 
The majority of cytochrom e c is held in a large internal pool (Store 2; e.g. cristal spaces), but tBID- 
induced release occurs from  a second, sm aller pool (Store 1; e.g. interm em brane space). Release 
occurs with a rate constant k t. Cytochrom e c can m ove betw een these pools, and, specifically, can 
move by diffusion from  Store 2 to Store 1 with rate constant k3. If k3  is o f sim ilar m agnitude to k |, then 
changes in k3 (potentially induced by addition of an inhibitor such as CSA) will be reflected by a 
change in the kinetics of release [Figure 104(B)]. Conversely, if k3 is large com pared to k |, even a tw o­
fold change in k3 does not alter the kinetics o f cytochrom e c release from Store 1 [Figure 104(C)]. If 
this second scenario is in fact the case in the B50 system investigated here, then CSA  may indeed alter 
cytochrome c redistribution, additionally to its effects on BAK  oligom erisation (as predicted by 
Scorrano and co-w orkers), but this change would not be visible. Further experim ents, directly 
investigating internal redistribution of cytochrom e c stores, would be necessary to investigate this 
possibility.
[11.4.3]Communication between tBID and internal mitochondrial systems
One of the biggest challenges to Scorrano’s model is the fact that tBID, acting at the external surface of 
mitochondria, is proposed to affect the internal structure of the organelle. A signal m ust som ehow be 
transm itted across the outer m em brane, to affect inner m em brane dynam ics. The dem onstration that 
tBID does not insert into the outer mem brane [144,145] show ed that tBID cannot exert any effect via 
physical interaction with a system  internal to mitochondria. Scorrano suggested that the m ediator o f 
tB ID ’s effects on internal structure m ight be the PT pore, w ith tBID proposed to induce transient PT 
pore opening. The inhibition by CSA o f the substructural changes and cytochrom e c release induced 
by tBID was thus proposed to be as a result of PT pore inhibition. This possibility is conclusively ruled 
out in this study by the dem onstration that transient PT pore opening does not occur in B50 cell 
m itochondria treated with tBID [Figure 48].
[  11.5]The effect of CSA at the outer membrane
[11.5.1 [Introduction
Previously the inhibitory effect of CSA on apoptotic cytochrom e c release was assumed to result from 
inhibition o f the PT  pore via cyclophilin D in the m itochondrial matrix [305]; since cyclophilin D is 
the m itochondrial cyclophilin isoform , this was the obvious target o f CSA. The discovery that CSA 
exerts its effect at the outer m itochondrial mem brane was therefore significant.
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Figure 104 - A change in the kinetics of redistribution of distinct cytochrome c stores is 
not necessarily reflected by a change in cytochrome c efflux kinetics.
(A) A hypothetical model of mitochondrial cytochrome c stores. Cytochrome c is stored 
in two distinct compartments (Store 1 and Store 2), and can move between stores by 
diffusion, with rate constants k2 and k3 (which would presumably be equal). The majority 
of cytochrome c (90 %) is in Store 2 under normal conditions, either because the volume 
of Store 2 is greater than that of Store 1, or because cytochrome c is specifically 
associated with the membrane of Store 2. Cytochrome c efflux from mitochondria occurs 
only from store 1, with diffusion rate constant kx. (B) When k3 is similar in magnitude to 
ki, a change in k3 is reflected by a substantial change in efflux progression with time.
(C) When k3 is large compared with klf the two stores behave as 'functionally single' -  
i.e. indistinguishable from a single store of cytochrome c. A change in the value of k3 
does not alter the efflux kinetics.
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Tw o possibilities thus existed : Firstly, CSA m ight indeed by exerting its effects via interaction with 
cyclophilin D in the matrix; this would require som e signal to be transm itted from the matrix to an 
outer m em brane system (BAK), allowing the effect of CSA to be observed at this site. Or, 
alternatively, CSA m ight be acting via an altogether different (non-cyclophilin D) pathw ay, the 
com ponents of which were present at the outer mem brane.
[11.5.2]Communication between matrix and outer membrane
If C SA ’s target is indeed matrix cyclophilin D, then how m ight an effect o f inhibition of this enzym e 
be transmitted to the outer m em brane? One possibility is that BID  binding m ight be affected. This 
would fit with the observation that CSA decreases the value o f the constant c (rate constant for tBID- 
catalysed BAK conform ational change) - inhibition of binding w ould result in a low er effective 
concentration of tBID, which is equivalent to a decrease in c, since:
Equation 15 Rate oc C  • [tBID]
CSA binding to cyclophilin D might have some effect on contact site dynam ics, via an effect on 
cyclophilin D-associated ANT at these sites. It has been proposed that tBID binds to the outer 
membrane at contact sites [139], possibly by targeting cardiolipin [140] (which is enriched at these 
sites) or by targeting a specific m em brane conform ation [306]. Thus a C SA -induced disruption of 
contact site structure and/or function through an effect on cyclophilin D m ight conceivably result in a 
dim inution of tBID -binding potential at the outer mem brane.
[11.5.3]Cyclophilin A-catalysed BAK conformational change
In relation to this second possibility above, cyclophilin A was found to be associated with the 
m itochondrial fraction, thereby presenting a further potential target for CSA in this system. 
C yclophilin A, being a cytosolic enzym e, would be associated w ith the m itochondrial outer mem brane, 
and so would be correctly located to exert an effect on B A K  oligom erisation. In fact, the am ount of 
cyclophilin A present (around 1 p.g/mg m itochondrial protein; Figure 74) was much greater than the 
am ount of cyclophilin D previously observed in B50 m itochondria (60 ng/m g m itochondrial protein; 
[157]).
The role of proline isom erisation in native state conform ational change has been considered previously 
as a method of protein regulation. Pappenberger and co-w orkers have shown the process to be 
energetically  feasible, in some systems at least and, although a substantial kinetic barrier exists, 
k inetically  feasible in the presence of catalysis by cyclophilins [159]. Proteins potentially regulated by 
this m echanism  include the prolactin receptor [160], diphtheria toxin [161], the protein tyrosine kinase 
Itk [307] and the hum an im m unodeficiency virus accessory protein V pr [308]. Interestingly, Schinzel 
and co-w orkers have identified a proline residue (Pro 168) in an unstructured loop of BAX which they 
propose to be involved in regulation o f apoptotic activity [75]. The authors suggest that this residue 
som ehow  regulates release of the C-terminal trans-m em brane dom ain from an internal binding pocket, 
thus directing BAX  activation and targeting o f the norm ally cytosolic protein to the m itochondrial outer 
m em brane. M utagenesis show ed that BAX(AP168), BAX (P168A ), BAX(P168G), and BAX(P168E)
202
were unable to release their transm em brane dom ain in response to apoptotic stim uli, and thus rem ained 
cytosolic follow ing apoptotic stimuli. A sim ilar residue, Pro 185, is present in the BAK  protein (which 
has 24 % sequence identity and 43 % sequence sim ilarity with BAX ). U nlike BAX, BAK is 
constitutively m itochondrial [Figure 71, page 148]; its C -term inal transm em brane dom ain is exposed 
without activation after translation. In keeping w ith this, the above authors were unable to detect any 
changes in BAK association w ith the mitochondrial outer m em brane as a result of mutation o f P ro l85 . 
Nevertheless it is tem pting to speculate that the sam e proline residue m ight be involved in regulation of 
conformational change o f BAK as well as BAX; in the case of B A K  though, the relevant change would 
be conversion of m em brane-integrated BAK to the ‘open’ conform er during activation by tBID , or by 
self-catalysis. M ight this change be regulated by cyclophilins, and in particular by cyclophilin A? 
Further experiments using recom binant BAK  and cyclophilin A are necessary to investigate this 
possibility. Additionally, further studies using cyclophilin A and D knockouts to probe the 
involvement of each might conclusively show which cyclophilin isoform  is responsible for the effects 
of CSA on tBID-induced cytochrom e c release.
[11.5.4]Differences between endogenous and recombinant cyclophilin A
Arguing against cyclophilin A -catalysed BAK conform ational change is the lack o f any stim ulatory 
effect on tBID-induced cytochrom e c release of addition of physiological levels of recom binant 
cyclophilin A. Nevertheless, recom binant cyclophilin A, whilst certainly retaining PPIase activity 
[Figure 84], might be som ehow different to the endogenous protein, and thus unable to substitute 
functionally in the assays carried out above. For exam ple, the cyclophilin  A detected in the 
m itochondrial preparation here [Figure 74, page 151] is presum ably m em brane-associated (perhaps 
through interaction with other m em brane proteins) and so m ay behave functionally differently to added 
cyclophilin A, which would rem ain free in solution. Additionally, cyclophilin A has been shown to be 
a substrate for glutathionylation under some conditions [309], and this m odification was shown by 
circular dichroism  significantly to affect cyclophilin A ’s secondary structure. Furtherm ore, Fratelli and 
co-w orkers have shown cyclophilin A to be heavily glutathionylated even under basal conditions [310], 
suggesting that this may be the predom inant active form o f the enzym e in norm al cells. Recom binant, 
non-glutathionylated enzyme m ight behave functionally differently. A nalysis of mitochondrially- 
associated cyclophilin A by mass spectroscopy to investigate the presence or absence o f the glutathione 
m oiety might help to resolve this issue.
[11.6]The effect of DB25
[11.6.1]Gain-of-function effects of cyclophilin A
W hilst addition o f small amounts o f recom binant cyclophilin A did not affect tBID-induced 
cytochrom e c release, a larger am ount o f exogenous cyclophilin A had an inhibitory effect, identical in 
m agnitude to that of CSA. This result suggested cyclophilin A m ight be the target of CSA, via a ‘gain- 
of-function’ calcineurin-type mechanism . W hilst the affinity o f  free cyclophilin A for downstream 
targets would be low in the absence of CSA, a higher concentration o f cyclophilin A might 
nevertheless be able to substitute functionally for the presence o f this com pound. The involvement of
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calcineurin itself in CSA action was ruled out by the absence o f any external C a2+ (required for 
calcineurin activation) in the cytochrom e c release experim ents (conducted in the presence o f EGTA). 
H ow ever the existence of other interaction partners is a possibility; pull-dow n assays using 
recom binant cyclophilin A in the presence o f CSA m ight be used in the future to identify any such 
proteins.
[11.6.2JDB25 as a non-calcineurin-interacting CSA analogue
Experim ents with the CSA derivative DB25 allowed the m echanism  of CSA inhibition to be 
investigated further [CHAPTER 8 ]. DB25 has m odifications in the 3 and 4 positions o f its ring 
structure when com pared with CSA. The calcineurin binding surface when CSA  is com plexed w ith 
cyclophilin A comprises residues 4 -  8  [311]; the substitution at the 4 position disrupts the binding 
surface and prevents calcineurin interaction. This has been dem onstrated previously fo r a num ber of 
other 4-substituted derivatives; for exam ple M eV al-4-CSA  was show n to retain the ability to inhibit the 
PT pore, but not that of inhibiting calcineurin [312], The cyclophilin binding sites on CSA com prise 
residues 1 -  3 and 9 - 1 1 ,  and the substitution in DB25 at position 3 enhances cyclophilin binding 
relative to CSA. This is desirable because 4-substituted derivates frequently display a low er affinity for 
cyclophilins: for example 4[(E)-2-butenyl]-4,4,(V-trimethyl-L-threonine (M eBm 2 t)-CSA shows only 
1 % o f C SA ’s affinity for cyclophilin D [313], The m echanism  explaining the increased apparent 
affinity o f the 3-substituted com pounds is likely to be partly kinetic. C yclophilins recognise and bind a 
specific CSA conformational state, populated only by a sm all proportion o f CSA m olecules in aqueous 
solution; the rate-lim iting step in complex form ation betw een CSA and cyclophilins is the rate of cis- 
trans isomerisation of CSA at positions 9 and 10 [275]. 3-position-substituted derivatives increase the 
population o f this state, thus accelerating cyclophilin binding, which can otherwise occur extrem ely 
slowly (m inutes to hr). Thus although the extent o f cyclophilin binding at equilibrium  is not affected, 
the observed Kd is frequently higher in the absence o f 3-position substituents since true equilibrium  is 
not attained over the course of typical binding experim ents.
In contrast to CSA, DB25 did not inhibit tBID -induced cytochrom e c release, but instead stim ulated 
release via a stim ulation of tBID -induced BAK  conform ational change [Figure 80]. This result 
suggested that CSA was indeed acting via a ‘gain-of-function’ calcineurin-type m echanism , since 
DB25 retained cyclophilin inhibitory activity [Figure 82], Since cyclophilin D was shown to inhibit 
tBID -induced cytochrome c release [Figure 54], the stim ulatory effect o f DB25 might be as a result of 
cyclophilin  D inhibition (i.e. rem oval o f cyclophilin D ’s inhibitory effect). This stim ulatory effect of 
cyclophilin  D inhibition would presum ably also be present with CSA, but would be counteracted by 
C S A ’s stronger inhibitory effect (not present with DB25). This possibility would imply 
com m unication betw een matrix and outer m em brane, as discussed above [11.5.2], since the effect of 
D B25 is m ediated via BAK at the outer membrane.
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[11.7]Identification of a novel cyclophilin D interaction partner
[11.7.1 ]Domain structure
In attem pting to find a protein responsible for the effects o f cyclophilins and CSA  on tBID -induced 
cytochrom e c release, a novel cyclophilin D interaction partner was identified. This 54 kD proline- and 
glutam ine-rich protein (p54), present in the m itochondrial matrix, was found to associate with 
cyclophilin D in a CSA- and DB25- inhibitable manner. p54 has a short-chain dehydrogenase dom ain 
and a sterol binding domain, and shows significant hom ology to a num ber o f hydroxysteroid 
dehydrogenases, for example estradiol 17P-dehydrogenase. p54 also has four low -com plexity regions, 
rich in proline and glutamine residues, the largest of these being a 107 residue stretch from  am ino acids 
298 -  404. Although this region may have functional significance (see below ) it may also derive from 
polym erase slippage during DNA replication resulting in expansion o f C A G  (glutam ine) codons and 
subsequent mutation [294], as discussed above [9.6.4],
[ 11.7.2]The role of p54 in steroidogenesis
On the basis of its domain structure and its m itochondrial localisation, p54 is likely to have a role in 
steroid processing in the mitochondrial matrix. The first step of steroidogenesis is the transfer of 
cholesterol from the outer m itochondrial m em brane to the inner m em brane - this process is thought to 
occur at contact sites between the inner and outer m em brane [314]. The presence o f a proline-rich tract 
in the centre of p54 could potentially serve to anchor the protein close to the site o f steroid im port via 
interaction with cyclophilin D associated with ANT at contact sites, thus m axim ising its catalytic 
activity. Since p54 appeared to bind to cyclophilin D ’s active site (p54 being dissociated from 
cyclophilin D by CSA [Figure 96]), and since cyclophilin D also interacts w ith A N T via its active site 
[36,166], this mechanism would require at least tw o cyclophilin D m olecules, tethered together via a 
non-active site region, with one bound to p54 and one bound to ANT. D im erisation of cyclophilin D 
via non-active site regions is in fact observed in this study [Figure 90].
Interestingly, CSA can inhibit sterol processing in m itochondria (e.g. 27-hydroxylation of 
cholesterol [173,174], and 25-hydroxylation of vitam in D3 [175]). This fact would fit w ith a model in 
which cyclophilin D serves to anchor p54 to a m em brane site at which it is required for a stage of 
steroid processing, since CSA disrupts the p54-cyclophilin D interaction [Figure 96] and would thus 
dissociate p54 from this site.
[11.7.3]The role of p54 in transglutaminase-catalysed cross-linking reactions
There is an em erging link betw een poly-glutam ine containing proteins, transglutam inases and 
apoptosis. Rodolfo and co-w orkers report that tissue transglutam inase (TG2) has a functional BH3 
dom ain, and interacts with BAX at the outer m itochondrial m em brane during apoptosis [315]. TG2 
selectively accum ulates to high levels during cell death, and cross-links BAK, possibly being 
responsible for the appearance of the high m olecular w eight BAX  aggregates observed late in apoptosis 
[109]. This process m ight represent a stabilisation of BAX channels in the outer mem brane. TG2 is 
also responsible for cross-linking o f other cytosolic proteins during apoptosis; based on its sensitive 
regulation and lim ited substrate specificity, this activity is proposed to be m echanistically involved in
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apoptotic progression, and not sim ply a m eans of preventing leakage o f cellular com ponents prior to 
phagocytosis, as was previously assum ed [316]. The possibility that the 54 kD protein identified here 
might be cross-linked by m itochondrial transglutam inases as part o f a regulatory m echanism  in 
apoptosis is intriguing, and merits further investigation.
[11.8]Binding partners of mitochondrial cyclophilin D
In the course of this study, cyclophilin D has been found to form  at least three types o f m ultim eric 
structure [Figure 105]. Firstly, the interaction o f cyclophilin D w ith A N T  was confirm ed [Figure 97]. 
Secondly, cyclophilin D was found to interact w ith the novel p54 protein [Figure 92]. Both o f these 
interactions were disrupted by either CSA or DB25. Finally, overexpressed m itochondrial cyclophilin 
D was found to oligomerise in vivo  [Figure 89]. The oligom ers w ere not disrupted in the presence of 
CSA [Figure 90] and, since CSA occludes the enzym e’s active site, this suggests that oligom erisation 
occurs via non-active site regions. Further work is necessary to investigate the relative population of 
these cyclophilin D interaction states in intact m itochondria and their functional significance. Are 
complexes formed between ANT and p54 in order to tether the latter to sites of steroid im port, as 
suggested above? Is hom o-oligom erisation a means of enabling this process? How does oligom er 
formation affect the PPIase catalytic function o f the enzym e? Does cyclophilin A also oligom erise, and 
if so, how might this relate to its functions at the outer mitochondrial m em brane?
[11.9]Phosphorylation of mitochondrial proteins
[11.9.1 [Importance of protein phosphorylation in apoptosis
Phosphorylation is a key method o f regulation of cellular protein activity, and no less so in apoptosis. 
For exam ple BAD is activated by dephosphorylation by calcineurin [201,202]; BID is protected from 
cleavage by phosphorylation by casein I and II [135]; the induction o f apoptosis by p53 is regulated 
both positively and negatively by its phosphorylation [317]; and induction of apoptosis by 
staurosporine is by a kinase inhibition m echanism  [267]. CSA is known to influence protein 
phosphorylation through interactions with the calcineurin pathw ay [178], and the profile of C SA ’s 
effects on tBID-induced cytochrom e c release raised the suspicion that CSA  might be acting here via a 
sim ilar mechanism . Clearly calcineurin itself was not involved, since tBID -induced cytochrom e c 
release experim ents were carried out in the absence of calcium . H ow ever a num ber of internal 
m itochondrial proteins are regulated by phosphorylation [209,212,213], and the existence of a 
m itochondrial calcineurin hom ologue is a possiblity. R egulation o f this phosphatase by a mechansim 
analagous to that of CSA and calcineurin might fit w ith the observed effects of CSA.
T o investigate w hether the m echanism  of action of tBID and CSA m ight indeed involve changes in 
phosphorylation state of m itochondrial proteins, proteins were labelled with 32P in the presence or 
absence o f tBID, CSA and DB25. A lthough no changes in phosphorylation state were observed under 
any o f these conditions, it rem ains possible that the changes induced were below the detection limit of 
this assay. D uring the experim ents carried out in this study, protein labelling had not reached steady 
state [Figure 99].
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Figure 105 - Cyclophilin D interaction partners 
Mitochondrial cyclophilin D can interact to form at least three multimeric structures. 
Cyclophilin D is able to dimerise with ANT (left) or with a novel mitochondrial protein, 
p54 (right). Cyclophilin D can also homo-oligomerise (bottom).
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Under these conditions inhibition of phosphatase activity has two effects -  firstly an increase in 
labelling, due to an inhibition o f rem oval of 32P label; but secondly a decrease in labelling due to an 
inhibition of Pj turnover (i.e. inhibition of rem oval of unlabelled Pj). Thus, depending on the kinetics of 
the relevant kinases and phosphatases, changes in phosphatase activity can in fact have no effect 
whatsoever on 32P labelling. Isolation o f m itochondrial phosphatase activity and investigation o f its 
CSA sensitivity in a more well-defined in vitro  system  is required to further probe the involvem ent of 
CSA on this aspect of m itochondrial apoptosis signalling.
[ 11.9.2]Phosphorylation of a 17 kD mitochondrial protein
Despite the absence of any effect of tBID, CSA and DB25, it was observed that phosphorylation of a 
17 kD protein was increased in cyclophilin D overexpressing m itochondria, com pared to w ild-type 
mitochondria. The phosphorylated band was shown to run as a low er m olecular w eight specie than 
cyclophilin D [Figure 101]. H ow ever it is possible that it m ay still correspond to a phosphorylated 
form of cyclophilin D, since phosphorylation may affect m obility on SD S-PAG E. If so, this would 
represent a previously unknown m echanism  of regulation of the m itochondrial cyclophilin isoform, and 
this possibility deserves further study.
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CHAPTER 12 :APPENDIX
[ 12.1]Molecular weight standards 
[12.1.1 JSDS-PAGE
Precision-Plus Dual C olour Protein Standards (B iorad)
kD
250
150
1 0 0
75
50
37
20
15
10
O dyssey M olecular W eight M arker (L iC orl
kD
250 
150
1 0 0  
75
mm 25
*mm 20
15
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Low -R ange R ainbow ™  M olecular W eight M arkers (A m ersham )
kD
45
30
20.1
14.3
6.5
3.5
2.5
[12.1.2] DNA
G eneR uler DNA L adder M ix (Ferm entas)
kB
10000
8000
6000
5000
40 0 0
3500
3000
2500
2000
1500
1200
1031
900
800
700
600
500
400
300
200
100
1  ..... . .  Jm
m m
2 1 0
[12.2]Mass spectrometry data
The data displayed below derives from peptide mass m atching o f LC-M S-M S data against the NCBI 
database, carried out using the M ascot search engine (M atrix Science) [318]. The colum ns are as 
follows:
Query Fragm ent num ber
Observed Experim ental m/z value (m ass.charge ratio)
M W (exp) Experim ental m /z transform ed to a relative m olecular m ass
Delta D ifference (error) betw een the experim ental and calculated (predicted) m asses
Score Score assigned to the peptide match, based on sequence length and delta value
Start Inclusive residue num ber of the first residue o f the m atched sequence (starting w ith 1
for the N -term inal residue o f the intact protein)
Sequence Sequence of the peptide in 1-letter code
End Inclusive residue num ber of the last residue o f the m atched sequence
The ion score is -101og 1 0 (P), where P is the probability that the observed match is a random  event. 
Individual ion scores > 37 indicate identity or extensive hom ology (p<0.05). (This cu t-off depends on 
the database size). Protein score ( ‘total score’) is derived from  ion scores as a non-probabilistic basis 
for ranking protein hits.
[12.2.1]Band 1 -  280 kD Protein 
Tax_ld=10116 Erythroid spectrin alpha
Accession No. Mass (Da) Pi Total Score No. Peptides matched Total Coverage%
IPI00560498 280395.87 4.94 221 10 4
Query Observed z MW(exp) Delta Score Start Sequence End
10 486.78099 2+ 971.547428 -0.017666 10.34 1478 TQLLAELGK 1486
12 516.28674 2+ 1030.558928 -0.006898 19.85 1631 DLTSAGNLLK 1640
15 538.76938 2+ 1075.524208 -0.026695 8.77 1230 VTTLGETAER 1239
17 549.80279 2+ 1097.591028 -0.028219 41.46 709 GLADVQNLLR 718
19 552.8045 2+ 1103.594448 -0.012928 3.33 523 IITLDETATK 532
21 563.80243 2+ 1125.590308 -0.016641 30.14 2169 AYFLDGSLLK 2178
22 598.7981 2+ 1195.581648 -0.042009 40.95 973 VIALYDFEAR 982
26 662.82134 2+ 1323.628128 -0.050095 0.19 9 VLETAEEIQHR 19
27 738.85324 2+ 1475.691928 -0.054776 21.18 1838 G DSG DTLAAT QSLLK 1852
28 883.37849 2+ 1764.742428 -0.085392 21.06 1961 QDTLDASLQSFQQER 1975
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[  12.2.2]Band 2  -  275 kD Protein
Tax_ld=10116 Non-erythroid spectrin beta
Accession No. Mass (Da) Pi Total Score No. Peptides matched Total Coverage%
IPI00555287 274328.49 5.5 772 22 9
Query Observed z MW(exp) Delta Score Start Sequence End
1 394.2068 2+ 786.399048 -0.02446 12.08 824 LAGIEER 830
2 395.72432 2+ 789.434088 -0.015589 14.44 1695 LFQLNR 1700
6 413.2136 2+ 824.412648 -0.016612 4.16 1735 FREFAR 1740
13 446.20208 2+ 890.389608 -0.044856 11.01 1055 EASLGEASK 1063
14 454.22072 2+ 906.426888 -0.017768 19.02 1536 IDDIFER 1542
15 456.77608 2+ 911.537608 -0.017568 32.54 478 VQAVVAVAR 486
16 465.71684 2+ 929.419128 -0.037491 40 1857 QLQEDAAR 1864
18 495.22504 2+ 988.435528 -0.021808 43.83 1741 DTGNIGQER 1749
21 525.77435 2+ 1049.534148 -0.016359 24.07 1902 LVDTGDKFR 1910
22 529.19933 2+ 1056.384108 -0.034059 5.36 682 AFEDEMSGR 690
23 555.27991 2+ 1108.545268 -0.031148 39.23 75 ITDLYTDLR 83
25 573.25977 2+ 1144.504988 -0.022752 23.38 2094 RPPSPEPSAK 2103
26 593.83282 2+ 1185.651088 -0.04575 84.35 2074 LTTLELLEVR 2083
28 621.3326 2+ 1240.650648 -0.042101 31.24 2010 LILEVHQFSR 2019
30 632.32545 2+ 1262.636348 -0.050664 41.12 843 QALQDTLALYK 853
31 632.84974 2+ 1263.684928 -0.0337 45.16 559 HLLGVEDLLQK 569
33 655.802 2+ 1309.589448 -0.036742 7.6 1652 ALVADSHPESER 1663
34 677.359 2+ 1352.703448 -0.037717 52.53 2172 SALPAQSAATLPAR 2185
36 703.83132 2+ 1405.648088 -0.042998 28.4 1462 FMELLEPLNER 1472
37 731.39107 2+ 1460.767588 -0.056219 45 360 GNLEVLLFTIQSK 372
38 574.59139 3+ 1720.752342 -0.063179 16.01 250 LLDPEDISVDHPDEK 264
39 909.9287 2+ 1817.842848 -0.069017 91.29 1543 SQNIITDSSSLNAEAIR 1559
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[12.2.3JBand 3 -  225 kD Protein
Tax_ld=10116 Myosin heavy chain, cardiac muscle alpha isoform
Accession No. Mass (Da) Pi Total Score No. Peptides matched Total Coverage%
IPI00189809 224168.95 5.58 997 32 17
Query Observed z MW(exp) Delta Score Start Sequence End
3 415.7185 2+ 829.422448 -0.022132 4.91 251 IHFGATGK 258
8 430.74164 2+ 859.468728 -0.018806 19.07 1137 LRSDLTR 1143
9 434.71881 2+ 867.423068 -0.021909 12.68 1524 NVHELEK 1530
12 442.21907 2+ 882.423588 -0.036312 31.43 715 ILYGDFR 721
13 445.19887 2+ 888.383188 -0.10842 35.63 444 INATLETK 451
14 455.22701 2+ 908.439468 -0.020813 40.85 407 VGNEYVTK 414
15 462.7314 2+ 923.448248 -0.048105 14.9 1478 SLSTELFK 1485
16 464.70812 2+ 927.401688 -0.021545 4.37 1340 HDCDLLR 1346
17 466.2574 2+ 930.500248 -0.013134 14.32 872 RKELEEK 878
18 480.24375 2+ 958.472948 -0.014235 25.79 553 LYDNHLGK 560
19 486.773 2+ 971.531448 -0.008484 38.22 1263 VKLEEAQR 1270
20 495.75039 2+ 989.486228 -0.017999 36.98 561 SNNFQKPR 568
21 507.74954 2+ 1013.484528 -0.018356 19.75 1320 QLEEEGKAK 1328
24 541.25826 2+ 1080.501968 -0.01799 27.35 1271 SLNDFTTQR 1279
26 568.79834 2+ 1135.582128 -0.041514 4.62 405 VKVGNEYVTK 414
27 576.29987 2+ 1150.585188 -0.035463 15.48 1329 NALAHALQSAR 1339
28 593.25774 2+ 1184.500928 -0.041217 28.05 1774 EQDTSAHLER 1783
30 612.79408 2+ 1223.573608 -0.04097 21.9 1375 TKYETDAIQR 1384
31 619.7738 2+ 1237.533048 -0.024401 31.99 1253 TLEDQANEYR 1262
32 623.32441 2+ 1244.634268 -0.015695 23.5 955 DIDDLELTLAK 965
35 656.87985 2+ 1311.745148 -0.031006 85.53 1866 LQDLVDKLQLK 1876
38 733.37372 2+ 1464.732888 -0.03823 52.18 259 LASADIETYLLEK 271
39 743.85712 2+ 1485.699688 -0.03133 69.47 1399 LQDAEEAVEAVNAK 1412
40 744.83434 2+ 1487.654128 -0.044923 45.98 1117 IEELEEELEAER 1128
42 767.37491 2+ 1532.735268 -0.032905 72.82 1595 VVDSLQTSLDAETR 1608
46 553.29136 3+ 1656.852252 -0.052335 6.3 1292 QLEEKEALISQLTR 1305
47 831.89118 2+ 1661.767808 -0.050322 24.76 979 NLTEEMAGLDEIIAK 993
48 856.41803 2+ 1710.821508 -0.072489 59.83 415 GQSVQQVYYSIGALAK 430
49 859.88446 2+ 1717.754368 -0.064831 23.75 1423 LQNEIEDLMVDVER 1436
52 870.93981 2+ 1739.865068 -0.055495 0.83 726 ILNPAAIPEGQFIDSR 741
53 613.63385 3+ 1837.879722 -0.037224 22.88 1179 DLEEATLQHEATAAALR 1195
54 976.41025 2+ 1950.805948 -0.082068 1.69 617 LMATLFSTYASADTGDSGK 635
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[ 12.2.4]Band 4 -  225 kD Protein
Tax_ld=10116 Myosin heavy chain, cardiac muscle beta isoform
Accession No. Mass (Da) Pi Total Score No. Peptides matched Total Coverage%
IPI00189811 223742.95 5.64 753 22 11
Query Observed z MW (exp) Delta Score Start Sequence End
3 415.7185 2+ 829.422448 -0.022132 4.91 250 IHFGATGK 257
12 442.21907 2+ 882.423588 -0.036312 31.43 713 ILYGDFR 719
13 445.19887 2+ 888.383188 -0.10842 35.63 443 INATLETK 450
14 455.22701 2+ 908.439468 -0.020813 40.85 406 VGNEYVTK 413
15 462.7314 2+ 923.448248 -0.048105 14.9 1476 SLSTELFK 1483
16 464.70812 2+ 927.401688 -0.021545 4.37 1338 HDCDLLR 1344
17 466.2574 2+ 930.500248 -0.013134 14.32 870 RKELEEK 876
18 480.24375 2+ 958.472948 -0.014235 25.79 552 LYDNHLGK 559
20 495.75039 2+ 989.486228 -0.017999 36.98 560 SNNFQKPR 567
26 568.79834 2+ 1135.582128 -0.041514 4.62 404 VKVGNEYVTK 413
27 576.29987 2+ 1150.585188 -0.035463 15.48 1327 NALAHALQSAR 1337
28 593.25774 2+ 1184.500928 -0.041217 28.05 1772 EQDTSAHLER 1781
30 612.79408 2+ 1223.573608 -0.04097 21.9 1373 TKYETDAIQR 1382
32 623.32441 2+ 1244.634268 -0.015695 23.5 953 DIDDLELTLAK 963
35 656.87985 2+ 1311.745148 -0.031006 85.53 1864 LQDLVDKLQLK 1874
38 733.37372 2+ 1464.732888 -0.03823 52.18 258 LASADIETYLLEK 270
39 743.85712 2+ 1485.699688 -0.03133 69.47 1397 LQDAEEAVEAVNAK 1410
40 744.83434 2+ 1487.654128 -0.044923 45.98 1115 IEELEEELEAER 1126
42 767.37491 2+ 1532.735268 -0.032905 72.82 1593 VVDSLQTSLDAETR 1606
49 859.88446 2+ 1717.754368 -0.064831 23.75 1421 LQNEIEDLMVDVER 1434
52 870.93981 2+ 1739.865068 -0.055495 0.83 724 ILNPAAIPEGQFIDSR 739
53 613.63385 3+ 1837.879722 -0.037224 22.88 1177 DLEEATLQHEATAAALR 1193
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[12.2.5]Band 5 - 5 4 k D  Protein
Tax_ld=10116 54 kDa protein
Accession No. Mass (Da) Pi Total Score No. Peptides matched Total Coverage%
IPI00557984 53534.56 6.01 285 6 12
Query Observed z MW (exp) Delta Score Start Sequence End
10 486.26289 2+ 970.511228 -0.03345 50.56 27 DGANIVIAAK 36
11 510.23824 2+ 1018.461928 -0.031129 33.02 388 DSLSDEVVR 396
13 546.25185 2+ 1090.489148 -0.033786 16.99 158 QHCAYTIAK 166
18 676.83386 2+ 1351.653168 -0.038589 55.31 2 LAGCTVFITGASR 14
19 680.35244 2+ 1358.690328 -0.050151 39.26 385 IVKDSLSDEVVR 396
20 903.94952 2+ 1805.884488 -0.056506 61.15 44 LLGTIYTAAEEIEAAGGK 61
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[12.3]Derivation of kinetic analysis equations
[12.3.1 [Formation of open channels with time 
W e begin with:
Equation 16
Using the general result: 
Equation 17
it follows that:
d\Open\ = _ C l o s e d ]  = (f + f  ^ ) .[ C W ] _ 
dt dt
_ d[Closed] _ ^  + y  |j _ j). [Closed]t
dt
Equation 18
I
dx - l
x(vx + w) w
•In
v x + w
r d[Closed] _  r
(c + /  • {l — \Closed\ })• [Closed]t ^
r d[Closed] _  r
J ( — f . \ r i  n  v  & / f 1 4- [ s '  -I- f  V) J[Closed], (- /  • \Cl ose d], + {c  + f } )
- 1
c + f
•In
-  f  [Closed], + {c + / }
•. In
[Closed ], 
-  f  [Closed], + {c  + f }
— k e
[Closed],
. -  f  [Closed], +{c  + f }  
[dosed],
[Closed], [k ■ e^ c+J  ^ + / ] =  c + f
[Closed] =  f + { -----
1 J' k - e {c+f)t+ f
= - t  + g
= (c + f ) t  + h
{(■+f
Since at t=0, [Closed]=l (by definition), it follow s that k = c, and so: 
Equation 19
or alternatively: 
Equation 20
[Closed], =  r ~ r f -----
L h c - e ic+f)t+ f
[Open] = 1 --------C, + f ----
h c • e + f
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[12.3.2]Rate of cytochrome c efflux 
W e begin with:
Equation 21
d[Cytc]
dt
1 - c + f
c - e {c+f)'' + f
a ■ [Cytc\
Thus:
Equation 22
r d\yytc\  = _ a J l _,  c + f  
J [Cytc], c - e {c*n ' + f
dt
J—j a  . i_ .
x 1
Using the general result:
Equation 23
u + v ■ e"" u u- w 
we can integrate Equation 22 as follows:
Equation 24
• ln(w + v - e wx)
ln([Cyfc],) = a ■ - t  + (c + f )  --------2 -----r • ln(c • e ,rtJ *' + / )
f  f - ( c  + f )
+ m
« ex p a ■
(
- t  + {c + f )
V
—  r  T' *n(c • e {'~r" + / )
/  f ( c  + f )
Since at t=0, [C ytc]=l it follows that:
Equation 25
and so:
n =
exp - a \ n ( c  + f )
f
exp
Equation 26 [Cy/c]f =
(
- t  + (c + f )   r* v ln ( c - ,‘+/>'
f  f ( c  + f )
e— +/)
exp - a \ n ( c  + f )
f
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[12.4]Derivation of equations for PPiase inhibition
In the case o f a loose-binding inhibitor, the approxim ation [I]free «  [I]totai holds, and so the follow ing 
relationship can be used to derive a value for by fitting o f predicted values of I to experim ental 
values, using [I]totai for the value o f [I] :
Equation 27
[El]
[El
+  1 =
. \ P  =
where Kj is the dissociation com plex for the cyclophilin-inhibitor com plex, P is proportion inhibition, 
[I] is the concentration of free inhibitor, [E] is the concentration o f free cyclophilin, [El] is the 
concentration of cyclophilin-inhibitor complex and [E ] 0  is the total concentration of cyclophilin (i.e. 
bound plus un-bound). However, in the case of CSA the binding o f inhibitor to enzym e is extrem ely 
tight (in the low nanomolar range; Table 9). Thus [I]free is m uch low er than [I]totab and Equation 27 
cannot be used to derive a value of (since [I]free is unknow n). In this case we can proceed as 
follows:
Equation 28 K d =
[7] ([E]0 - [ E l ] )  
[El]
A t equilibrium , the proportion o f total cyclophilin that is bound to inhibitor is P, and so the 
concentration of cyclophilin-inhibitor com plex, [El], is P [E]0. Thus the concentration of free 
(unbound) cyclophilin, [E], will be (1 -  P) • [E]0. Also, if  [I] 0  is the total added concentration of 
inhibitor, the concentration of free inhibitor, [I] will be [I] 0  - P  [E]0. Thus:
Equation 29
K  _ ( l - / >H £ ] 0 -([/j()- / 3-[£]0) 
[ P ] [ E ] 0 
a-P) ( [ I]o~P[E]0)
K d =
[P]
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Expanding and simplifying, this leaves us with a quadratic in P:
Equation 30 P 2 • ( [ £ ] 0 ) +  P  • ( - [ / ] 0 ~ [ £ ] 0 ~ K d ) +  [ I]0 =0
Thus:
n _ m0 +[£]»+*„ -  Vh /]„-[£]o- ^ ) 2-4-[£]„-[/]„
Equation 31 r  —-------------------------------------------------------------------------------------- -----
2 ■[£]„
219
CHAPTER 13 : REFERENCES
1. Ellis, R. E., Yuan, J. Y., and Horvitz, H. R. (1991) M echanism s and functions o f cell death, A nnu  
Rev Cell Biol 7, 663-698.
2. Kerr, J. F., W yllie, A. H., and Currie, A. R. (1972) A poptosis: a basic biological phenom enon 
with wide-ranging im plications in tissue kinetics, Br. J  C ancer 26, 239-257.
3. Thornberry, N. A. and Lazebnik, Y. (1998) Caspases: enem ies w ithin, Science  281, 1312-1316.
4. Scaffidi, C., Fulda, S., Srinivasan, A., Friesen, C., Li, F., Tom aselli, K. J., D ebatin, K. M., 
Krammer, P. H., and Peter, M. E. (1998) Tw o CD95 (A PO -1/Fas) signaling pathw ays, EM BO  J. 
17, 1675-1687.
5. Zou, H., Li, Y., Liu, X., and W ang, X. (1999) An A PA F-1.cytochrom e c m ultim eric com plex is a 
functional apoptosome that activates procaspase-9, J  B iol Chem  274, 11549-11556.
6 . Van Loo, G., Demol, H., van Gurp, M., H oorelbeke, B., Schotte, P., Beyaert, R., Zhivotovsky, B., 
Gevaert, K., Declercq, W ., V andekerckhove, J., and V andenabeele, P. (2002) A m atrix-assisted 
laser desorption ionization post-source decay (M A LD I-PSD ) analysis o f proteins released from 
isolated liver mitochondria treated with recom binant truncated Bid, Cell Death D iffer  9, 301-308.
7. Antonsson, B., Conti, F., C iavatta, A., M ontessuit, S., Lewis, S., M artinou, I., B ernasconi, L., 
Bernard, A., Mermod, J. J., M azzei, G., M aundrell, K., G am bale, F., Sadoul, R., and M artinou, J. 
C. (1997) Inhibition of Bax channel-form ing activity by Bcl-2, Science  277, 370-372.
8 . Korsmeyer, S. J., Wei, M. C., Saito, M „ W eiler, S., Oh, K. J., and Schlesinger, P. H. (2000) Pro- 
apoptotic cascade activates BID, which oligom erizes BA K  or BAX  into pores that result in the 
release of cytochrome c, Cell Death D iffer 7, 1166-1173.
9. Shimizu, S., Narita, M., and Tsujim oto, Y. (1999) Bcl-2 fam ily proteins regulate the release of 
apoptogenic cytochrom e c by the mitochondrial channel V DA C, N ature  399 ,483-487 .
10. Marzo, I., Brenner, C., Zamzam i, N., Jurgensm eier, J. M ., Susin, S. A., Vieira, H. L., Prevost, M.
C., Xie, Z., M atsuyama, S., Reed, J. C., and Kroemer, G. (1998) Bax and adenine nucleotide 
translocator cooperate in the mitochondrial control of apoptosis, Science. 281, 2027-2031.
11. He, L. and Lemasters, J. J. (2002) Regulated and unregulated mitochondrial perm eability 
transition pores: a new paradigm  of pore structure and function?, FEBS Lett. 512, 1-7.
12. Vander Heiden, M. G., Chandel, N. S., Schumacker, P. T ., and Thom pson, C. B. (1999) Bcl-xL 
prevents cell death follow ing grow th factor w ithdrawal by facilitating mitochondrial A TP/ADP 
exchange, Mol. Cell. 3, 159-167.
13. Basanez, G., Nechushtan, A., Drozhinin, O., Chanturiya, A., Choe, E., Tutt, S., W ood, K. A., Hsu, 
Y., Zim merberg, J., and Youle, R. J. (1999) Bax, but not Bcl-xL, decreases the lifetime of planar 
phospholipid bilayer m em branes at subnanom olar concentrations, Proc N atl A cad  Sci U S A  96, 
5492-5497.
14. Kroemer, G., Zamzami, N., and Susin, S. A. (1997) M itochondrial control o f apoptosis, Immunol. 
Today. 18 ,44-51.
15. D esagher, S. and M artinou, J. C. (2000) M itochondria as the central control point o f apoptosis, 
Trends Cell B iol 10, 369-377.
16. M acFarlane, M. and W illiam s, A. C. (2004) A poptosis and disease: a life or death decision, 
EM BO  Rep. 5, 674-678.
220
17. Scorrano, L., Ashiya, M., Buttle, K., W eiler, S., Oakes, S. A., M annella, C. A., and Korsm eyer, S. 
J. (2002) A distinct pathway rem odels m itochondrial cristae and m obilizes cytochrom e c during 
apoptosis, Dev Cell 2, 55-67.
18. Perkins, G., Renken, C., M artone, M. E., Young, S. J., E llism an, M ., and Frey, T. (1997) E lectron 
tom ography of neuronal m itochondria: three-dim ensional structure and organization of cristae and 
mem brane contacts, J  Struct B iol 119, 260-272.
19. M annella, C. A., Pfeiffer, D. R., Bradshaw, P. C., M oraru, 1.1., Slepchenko, B., Loew, L. M., 
Hsieh, C. E„ Buttle, K., and M arko, M. (2001) T opology o f the m itochondrial inner mem brane: 
dynamics and bioenergetic im plications, IUBM B. Life 52, 93-100.
20. Scorrano, L. (2005) Proteins that fuse and fragm ent m itochondria in apoptosis: con-fissing a 
deadly con-fusion?, J. Bioenerg. Biomembr. 37, 165-170.
21. Bemardi, P. and Azzone, G. F. (1981) Cytochrom e c as an electron shuttle betw een the outer and 
inner mitochondrial mem branes, J  Biol Chem  256, 7187-7192.
22. Tuominen, E. K., W allace, C. J., and Kinnunen, P. K. (2002) Phospholipid-cytochrom e c 
interaction: evidence for the extended lipid anchorage, J  B iol Chem  277, 8822-8826.
23. Zucchi, M. R., Nascim ento, O. R., Faljoni-Alario, A., Prieto, T., and N antes, I. L. (2003) 
M odulation of cytochrome c spin states by lipid acyl chains: a continuous-w ave electron 
param agnetic resonance (CW -EPR) study of haem iron, Biochem  J  370, 671-678.
24. Ott, M., Robertson, J. D., Gogvadze, V., Zhivotovsky, B., and O rrenius, S. (2002) C ytochrom e c 
release from mitochondria proceeds by a tw o-step process, Proc N atl A cad  Sci U S A  99, 1259- 
1263.
25. Lehninger, A. L., Carafoli, E., and Rossi, C. S. (1967) Energy-linked ion m ovem ents in 
mitochondrial systems, Adv. Enzymol. R ela t A reas M ol Biol. 29, 259-320.
26. Hunter, D. R., Haworth, R. A., and Southard, J. H. (1976) R elationship betw een configuration, 
function, and perm eability in calcium -treated m itochondria, J  B iol Chem  251, 5069-5077.
27. Haworth, R. A. and Hunter, D. R. (1979) The C a2+-induced m em brane transition in 
mitochondria. II. Nature of the Ca2+ trigger site, Arch Biochem  B iophys 195, 460-467.
28. Crompton, M. and Costi, A. (1990) A heart m itochondrial C a2(+)-dependent pore o f possible 
relevance to re-perfusion-induced injury. Evidence that A DP facilitates pore interconversion 
between the closed and open states, Biochem  J  266, 33-39.
29. Crompton, M., Virji, S., and W ard, J. M. (1998) Cyclophilin-D  binds strongly to com plexes of the 
voltage-dependent anion channel and the adenine nucleotide translocase to form the perm eability 
transition pore, Eur J  Biochem. 258, 729-735.
30. Brustovetsky, N. and K lingenberg, M. (1996) M itochondrial A D P/A TP carrier can be reversibly 
converted into a large channel by Ca2+, Biochem istry. 35, 8483-8488.
31. Crom pton, M. (2000) M itochondrial interm em brane junctional com plexes and their role in cell 
death, J  Physiol 529 Pt 1, 11-21.
32. Kokoszka, J. E., W aymire, K. G., Levy, S. E., Sligh, J. E., Cai, J., Jones, D. P., M acGregor, G. R., 
and W allace, D. C. (2004) The A DP/ATP translocator is not essential for the mitochondrial 
perm eability transition pore, Nature  427, 461-465.
33. N icholls, D. G. and Crompton, M. (1980) M itochondrial calcium  transport, FEBS Lett 111, 261 - 
268.
221
34. M cStay, G. P., Clarke, S. J., and H alestrap, A. P. (2002) Role o f critical thiol groups on the matrix 
surface of the adenine nucleotide translocase in the m echanism  o f the m itochondrial perm eability 
transition pore, Biochem J  367, 541-548.
35. Costantini, P., Belzacq, A. S., Vieira, H. L., Larochette, N ., de Pablo, M. A., Zam zam i, N., Susin, 
S. A., Brenner, C., and Kroem er, G. (2000) O xidation o f a critical thiol residue of the adenine 
nucleotide translocator enforces Bcl-2-independent perm eability  transition pore opening and 
apoptosis, Oncogene 19, 307-314.
36. Clarke, S. J., McStay, G. P., and Halestrap, A. P. (2002) Sanglifehrin A acts as a potent inhibitor 
o f the mitochondrial perm eability transition and reperfusion injury o f the heart by binding to 
cyclophilin-D at a different site from cyclosporin A, J  B io l Chem  277, 34793-34799.
37. Takuma, K., Phuagphong, P., Lee, E., M ori, K., Baba, A., and M atsuda, T. (2001) A nti-apoptotic 
effect of cGM P in cultured astrocytes: inhibition by cG M P-dependent protein kinase of 
mitochondrial perm eable transition pore, J  B iol Chem  276, 48093-48099.
38. Halestrap, A. P., McStay, G. P., and Clarke, S. J. (2002) The perm eability transition pore 
complex: another view, Biochimie  84, 153-166.
39. Novgorodov, S. A., Gudz, T. I., Brierley, G. P., and Pfeiffer, D. R. (1994) M agnesium  ion 
modulates the sensitivity of the m itochondrial perm eability transition pore to cyclosporin A and 
ADP, Arch Biochem B iophys 311, 219-228.
40. Fontaine, E., Ichas, F„ and Bernardi, P. (1998) A ubiquinone-binding site regulates the 
mitochondrial perm eability transition pore, J  Biol Chem  273, 25734-25740.
41. W alter, L., Nogueira, V., Leverve, X., Heitz, M. P., Bernardi, P., and Fontaine, E. (2000) Three 
classes of ubiquinone analogs regulate the mitochondrial perm eability transition pore through a 
comm on site, J  Biol Chem  275, 29521-29527.
42. Huang, X., Zhai, D., and Huang, Y. (2001) D ependence of perm eability transition pore opening 
and cytochrom e C release from m itochondria on m itochondria energetic status, M ol Cell Biochem  
224 ,1-7 .
43. Isenberg, J. S. and Klaunig, J. E. (2000) Role of the m itochondrial m em brane perm eability 
transition (M PT) in rotenone-induced apoptosis in liver cells, Toxicol. Sci 53, 340-351.
44. Chauvin, C., De Oliveira, F., Ronot, X., M ousseau, M ., Leverve, X., and Fontaine, E. (2001) 
Rotenone inhibits the m itochondrial perm eability transition-induced cell death in U937 and KB 
cells, J  Biol Chem  276,41394-41398.
45. Crompton, M. and Costi, A. (1988) Kinetic evidence for a heart m itochondrial pore activated by 
Ca2+, inorganic phosphate and oxidative stress. A potential m echanism  for m itochondrial 
dysfunction during cellular Ca2+ overload, Eur. J. Biochem. 178,489-501.
46. Bernardi, P. and Petronilli, V. (1996) The perm eability transition pore as a m itochondrial calcium 
release channel: A critical appraisal, Journal o f  B ioenergetics and Biom em branes 28, 131-138.
47. Ichas, F., Jouaville, L. S., and M azat, J. P. (1997) M itochondria are excitable organelles capable 
of generating and conveying electrical and calcium  signals, Cell 89, 1145-1153.
48. A1 Nasser, I. and Crompton, M. (1986) The entrapm ent of the Ca2+ indicator arsenazo III in the 
m atrix space o f rat liver mitochondria by perm eabilization and resealing. Na+-dependent and - 
independent effluxes of C a2+ in arsenazo Ill-loaded mitochondria, Biochem  J  239, 31 -40.
49. A1 N asser, I. and Crom pton, M. (1986) The reversible Ca2+-induced perm eabilization of rat liver 
mitochondria, Biochem  J  239, 19-29.
222
50. Crompton, M. (1999) The m itochondrial perm eability transition pore and its role in cell death, 
Biochem J  341 ( Pt 2), 233-249.
51. Skulachev, V. P. (1996) W hy are m itochondria involved in apoptosis? Perm eability transition 
pores and apoptosis as selective m echanism s to elim inate superoxide-producing m itochondria and 
cell, FEBS Lett 397, 7-10.
52. Zamzam i, N. and Kroemer, G. (2001) The m itochondrion in apoptosis: how Pandora's box opens, 
N at Rev M ol Cell Biol. 2, 67-71.
53. W igdal, S. S., Kirkland, R. A., Franklin, J. L., and H aak-Frendscho, M. (2002) C ytochrom e c 
release precedes m itochondrial m em brane potential loss in cerebellar granule neuron apoptosis: 
lack of mitochondrial swelling, J  N eurochem  82, 1029-1038.
54. von Ahsen, O., Renken, C., Perkins, G., Kluck, R. M ., B ossy-W etzel, E., and N ew m eyer, D. D.
(2000) Preservation of m itochondrial structure and function after Bid- or B ax-m ediated 
cytochrome c release, J  Cell Biol 150, 1027-1036.
55. Kluck, R. M., Bossy-W etzel, E., Green, D. R., and N ew m eyer, D. D. (1997) The release of 
cytochrome c from mitochondria: a primary site for Bcl-2 regulation o f apoptosis, Science 275, 
1132-1136.
56. Shimizu, S. and Tsujimoto, Y. (2000) Proapoptotic B H 3-only Bcl-2 fam ily m em bers induce 
cytochrome c release, but not m itochondrial m em brane potential loss, and do not directly 
modulate voltage-dependent anion channel activity, Proc N atl A cad  Sci U S A  97, 577-582.
57. Kim, T. H., Zhao, Y., Barber, M. J., Kuharsky, D. K., and Yin, X. M. (2000) B id-induced 
cytochrome c release is m ediated by a pathway independent o f m itochondrial perm eability 
transition pore and Bax, J  Biol Chem  275,39474-39481.
58. Gogvadze, V., Robertson, J. D., Enoksson, M., Zhivotovsky, B., and O rrenius, S. (2004) 
M itochondrial cytochrome c release may occur by volum e-dependent m echanism s not involving 
perm eability transition, Biochem  J  378, 213-217.
59. Nakagawa, T., Shimizu, S., W atanabe, T., Yam aguchi, O., Otsu, K., Y am agata, H., Inohara, H., 
Kubo, T., and Tsujimoto, Y. (2005) Cyclophilin D -dependent m itochondrial perm eability 
transition regulates some necrotic but not apoptotic cell death, N ature  434, 652-658.
60. Baines, C. P., Kaiser, R. A., Purcell, N. H., Blair, N. S., O sinska, H., H am bleton, M. A.,
Brunskill, E. W., Sayen, M. R., Gottlieb, R. A., Dorn, G. W ., Robbins, J., and M olkentin, J. D. 
(2005) Loss of cyclophilin D reveals a critical role for m itochondrial perm eability transition in 
cell death, Nature 434, 658-662.
61. Vyssokikh, M. Y. and Brdiczka, D. (2003) The function of com plexes betw een the outer 
mitochondrial mem brane pore (VDAC) and the adenine nucleotide translocase in regulation of 
energy m etabolism and apoptosis, A cta B iochim  Pol. 50, 389-404.
62. Vyssokikh, M., Zorova, L., Zorov, D., H eim lich, G., Jurgensm eier, J., Schreiner, D., and 
Brdiczka, D. (2004) The intra-m itochondrial cytochrom e c distribution varies correlated to the 
form ation of a complex betw een VDAC and the adenine nucleotide translocase: this affects Bax- 
dependent cytochrom e c release, Biochim  B iophys A cta  7644, 27-36.
63. Tsujim oto, Y., Cossm an, J., Jaffe, E., and Croce, C. M. (1985) Involvem ent of the bcl-2 gene in 
hum an follicular lymphoma, Science 228, 1440-1443.
64. Strasser, A., Connor, L„ and Dixit, V. M. (2000) A POPTOSIS SIGNALING, Annual Review  o f 
Biochem istry  69, 217-245.
223
65. Zha, H., A ime-Sempe, C., Sato, T., and Reed, J. C. (1996) Proapoptotic protein Bax 
heterodim erizes with Bcl-2 and hom odim erizes with Bax via a novel dom ain (BH3) distinct from 
BH1 and BH2, J  Biol Chem  271, 7440-7444.
6 6 . Simonen, M., Keller, H., and Heim, J. (1997) The BH3 dom ain o f Bax is sufficient for interaction 
of Bax with itself and with other fam ily m em bers and it is required for induction of apoptosis, Eur 
J  Biochem  249, 85-91.
67. Yin, X. M., Oltvai, Z. N ., and Korsmeyer, S. J. (1994) BH1 and BH 2 dom ains o f Bcl-2 are 
required for inhibition o f apoptosis and heterodim erization w ith Bax, N ature  369, 321-323.
6 8 . Huang, D. C., Adams, J. M., and Cory, S. (1998) The conserved N -term inal B H 4 dom ain of Bcl-2 
homologues is essential for inhibition o f apoptosis and interaction with C ED -4, Embo J  17, 1029- 
1039.
69. Rosse, T„ Olivier, R., M onney, L., Rager, M ., Conus, S., Fellay, I., Jansen, B., and Borner, C.
(1998) Bcl-2 prolongs cell survival after Bax-induced release of cytochrom e c, Nature  391, 496-
499.
70. Oltvai, Z. N., M illiman, C. L., and K orsm eyer, S. J. (1993) Bcl-2 heterodim erizes in vivo w ith a 
conserved homolog, Bax, that accelerates program m ed cell death, Cell 74, 609-619.
71. Degterev, A., Lugovskoy, A., Cardone, M., M ulley, B., W agner, G ., M itchison, T., and Yuan, J.
(2001) Identification o f sm all-m olecule inhibitors o f interaction betw een the BH3 domain and 
Bcl-xL, Nat Cell Biol 3, 173-182.
72. Korsmeyer, S. J., Shutter, J. R., Veis, D. J., Merry, D. E., and O ltvai, Z. N. (1993) Bcl-2/Bax: a 
rheostat that regulates an anti-oxidant pathway and cell death, Semin. C ancer Biol. 4, 327-332.
73. Kaufmann, T., Schlipf, S., Sanz, J., Neubert, K., Stein, R., and Borner, C. (2003) C haracterization 
of the signal that directs Bcl-x(L), but not Bcl-2, to the m itochondrial outer m em brane, J  Cell Biol 
160, 53-64.
74. Griffiths, G. J., Dubrez, L., M organ, C. P., Jones, N. A., W hitehouse, J., Corfe, B. M., Dive, C„ 
and Hickman, J. A. (1999) Cell dam age-induced conform ational changes of the pro-apoptotic 
protein Bak in vivo precede the onset of apoptosis, J  Cell Biol 1 4 4 ,903-914.
75. Schinzel, A., Kaufmann, T., Schuler, M „ M artinalbo, J., Grubb, D., and B orner, C. (2004) 
Conform ational control of Bax localization and apoptotic activity by P r o l 6 8 , J  Cell B iol 164, 
1021-1032.
76. Muchmore, S. W., Sattler, M ., Liang, H., M eadow s, R. P., Harlan, J. E ., Yoon, H. S., Nettesheim,
D., Chang, B. S., Thompson, C. B., W ong, S. L., Ng, S. L., and Fesik, S. W. (1996) X-ray and 
NM R structure of human Bcl-xL, an inhibitor of program m ed cell death, N ature  381, 335-341.
77. Schendel, S. L., Xie, Z., M ontal, M. O., M atsuyam a, S., M ontal, M., and Reed, J. C. (1997) 
Channel formation by antiapoptotic protein Bcl-2, Proc N atl A cad  Sci U S A  94, 5113-5118.
78. M inn, A. J., Velez, P., Schendel, S. L., Liang, H., M uchm ore, S. W., Fesik, S. W., Fill, M., and 
Thompson, C. B. (1997) Bcl-x(L) forms an ion channel in synthetic lipid m em branes, Nature  385, 
353-357.
79. Schlesinger, P. H., Gross, A., Yin, X. M., Y amamoto, K., Saito, M., W aksm an, G., and 
Korsm eyer, S. J. (1997) Com parison of the ion channel characteristics of proapoptotic BAX and 
antiapoptotic BCL-2, Proc N atl A cad  Sci U S A  94, 11357-11362.
80. Schendel, S. L., Azimov, R., Pawlowski, K., Godzik, A., Kagan, B. L., and Reed, J. C. (1999) Ion 
channel activity of the BH3 only Bcl-2 fam ily m em ber, BID, J  B iol Chem  274, 21932-21936.
224
81. Schendel, S. L., Montal, M., and Reed, J. C. (1998) Bcl-2 fam ily proteins as ion-channels, Cell 
D eath D iffer 5, 372-380.
82. Nechushtan, A., Smith, C. L., Lam ensdorf, I., Yoon, S. H., and Youle, R. J. (2001) Bax and Bak 
coalesce into novel m itochondria-associated clusters during apoptosis, J  Cell B iol 153, 1265- 
1276.
83. Eskes, R., Antonsson, B., O sen-Sand, A., M ontessuit, S., R ichter, C., Sadoul, R., M azzei, G., 
Nichols, A., and Martinou, J. C. (1998) B ax-induced cytochrom e C release from  m itochondria is 
independent of the perm eability transition pore but highly dependent on M g2+ ions, J  Cell Biol 
143,217-224.
84. Pavlov, E. V., Priault, M., Pietkiew icz, D., Cheng, E. H., Antonsson, B., M anon, S., K orsm eyer,
S. J., Mannella, C. A., and Kinnally, K. W. (2001) A novel, high conductance channel of 
mitochondria linked to apoptosis in m am m alian cells and Bax expression in yeast, J  Cell B iol 155, 
725-731.
85. Guo, L., Pietkiewicz, D., Pavlov, E. V., Grigoriev, S. M ., K asianow icz, J. J., D ejean, L. M „ 
Korsmeyer, S. J., Antonsson, B., and Kinnally, K. W. (2004) Effects o f cytochrom e c on the 
mitochondrial apoptosis-induced channel MAC, A m  J  Physiol Cell Physiol 286, C l 109-C 1117.
8 6 . Kuwana, T., M ackey, M. R., Perkins, G., Ellism an, M. H., Latterich, M., Schneiter, R., Green, D. 
R., and Newmeyer, D. D. (2002) Bid, Bax, and lipids cooperate to form  supram olecular openings 
in the outer mitochondrial m em brane, Cell 111, 331-342.
87. Terrones, O., Antonsson, B., Yamaguchi, H., W ang, H. G., Liu, J., Lee, R. M ., H errm ann, A., and 
Basanez, G. (2004) Lipidic Pore Form ation by the C oncerted A ction o f Proapoptotic BAX and 
tBID, J  Biol Chem  279, 30081 -30091.
8 8 . Dejean, L. M., M artinez-Caballero, S., Guo, L., Hughes, C., Teijido, O., Ducret, T., Ichas, F., 
Korsmeyer, S. J., Antonsson, B., Jonas, E. A., and Kinnally, K. W. (2005) O ligom eric Bax Is a 
Com ponent of the Putative Cytochrom e c Release Channel M AC, M itochondrial A poptosis- 
induced Channel, M ol Biol Cell 16, 2424-2432.
89. Wei, M. C., Zong, W. X., Cheng, E. H., Lindsten, T., Panoutsakopoulou, V ., Ross, A. J., Roth, K. 
A., M acGregor, G. R., Thom pson, C. B., and Korsm eyer, S. J. (2001) Proapoptotic BAX and 
BAK: a requisite gateway to m itochondrial dysfunction and death, Science 292, 727-730.
90. Zong, W. X., Lindsten, T., Ross, A. J., M acG regor, G. R., and Thom pson, C. B. (2001) BH3-only 
proteins that bind pro-survival Bcl-2 fam ily m em bers fail to induce apoptosis in the absence of 
Bax and Bak, Genes Dev 15, 1481-1486.
91. Heimlich, G., McKinnon, A. D., Bernardo, K., Brdiczka, D., Reed, J. C., Kain, R., Kronke, M., 
and Jurgensmeier, J. M. (2004) Bax-induced cytochrom e c release from m itochondria depends on 
alpha-helices-5 and - 6 , Biochem  J  378, 247-255.
92. Chandra, D., Choy, G., D aniel, P. T., and Tang, D. G. (2005) Bax-dependent Regulation o f Bak 
by Voltage-dependent Anion Channel 2, J  B iol Chem  280, 19051-19061.
93. Luo, X., Budihardjo, I., Zou, H., Slaughter, C., and W ang, X. (1998) Bid, a Bcl2 interacting 
protein, mediates cytochrom e c release from  m itochondria in response to activation of cell surface 
death receptors, Cell 94, 481-490.
94. Datta, S. R., Dudek, H., Tao, X., M asters, S., Fu, H., Gotoh, Y., and Greenberg, M. E. (1997) Akt 
phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery, Cell 91, 
231-241.
95. Sax, J. K., Fei, P., Murphy, M. E., Bernhard, E., Korsm eyer, S. J., and El Deiry, W. S. (2002) BID 
regulation by p53 contributes to chem osensitivity, N at Cell B iol 4, 842-849.
225
96. Oda, E., Ohki, R., M urasawa, H „ Nemoto, J., Shibue, T., Y am ashita, T., Tokino, T., Taniguchi,
T., and Tanaka, N. (2000) Noxa, a BH3-only m em ber of the Bcl-2 fam ily and candidate m ediator 
of p53-induced apoptosis, Science 288, 1053-1058.
97. Yu, J., Zhang, L., Hwang, P. M., K inzler, K. W ., and V ogelstein, B. (2001) PUM A induces the 
rapid apoptosis of colorectal cancer cells, M ol Cell 7, 673-682.
98. Nakano, K. and Vousden, K. H. (2001) PUM A, a novel proapoptotic gene, is induced by p53, M ol 
Cell 7, 683-694.
99. Desagher, S., Osen-Sand, A., Nichols, A., Eskes, R., M ontessuit, S., Lauper, S., M aundrell, K., 
Antonsson, B., and M artinou, J. C. (1999) B id-induced conform ational change o f Bax is 
responsible for mitochondrial cytochrom e c release during apoptosis, J  Cell B iol 144, 891-901.
100. Ruffolo, S. C. and Shore, G. C. (2003) BCL-2 selectively interacts w ith the BID -induced open 
conformer of BAK, inhibiting BAK auto-oligom erization, J  B iol Chem  278, 25039-25045.
101. Cheng, E. H., W ei, M. C., W eiler, S., Flavell, R. A., Mak, T. W ., Lindsten, T., and K orsm eyer, S. 
J. (2001) BCL-2, BCL-X(L) sequester BH3 dom ain-only m olecules preventing BAX- and BAK- 
mediated mitochondrial apoptosis, M ol Cell 8 , 705-711.
102. Wei, M. C., Lindsten, T., M ootha, V. K., W eiler, S., Gross, A., A shiya, M., Thom pson, C. B., and 
Korsmeyer, S. J. (2000) tBID, a mem brane-targeted death ligand, oligom erizes BAK to release 
cytochrome c, Genes D ev  14, 2060-2071.
103. Grinberg, M„ Sarig, R., Zaltsman, Y., Frum kin, D., G ram m atikakis, N., Reuveny, E., and Gross, 
A. (2002) tBID H om ooligom erizes in the m itochondrial m em brane to induce apoptosis, J  Biol 
Chem  277, 12237-12245.
104. Terradillos, O., M ontessuit, S., Huang, D. C., and M artinou, J. C. (2002) D irect addition of Bim L 
to mitochondria does not lead to cytochrom e c release, F EBS Lett 522, 29-34.
105. Letai, A., Bassik, M. C., W alensky, L. D., Sorcinelli, M. D ., W eiler, S., and K orsm eyer, S. J.
(2002) D istinct BH3 dom ains either sensitize or activate m itochondrial apoptosis, serving as
prototype cancer therapeutics, Cancer Cell 2, 183-192.
106. Moreau, C., Cartron, P. F., Hunt, A., M eflah, K., G reen, D. R., Evan, G., V allette, F. M., and Juin,
P. (2003) M inimal BH3 peptides prom ote cell death by antagonizing anti-apoptotic proteins, J
Biol Chem  278, 19426-19435.
107. Kuwana, T., Bouchier-Hayes, L., Chipuk, J. E., Bonzon, C., Sullivan, B. A., Green, D. R., and 
N ewm eyer, D. D. (2005) BH3 dom ains o f BH3-only proteins differentially regulate Bax-mediated 
mitochondrial mem brane perm eabilization both directly and indirectly, M ol Cell 17, 525-535.
108. Sugiyama, T., Shimizu, S., M atsuoka, Y., Yoneda, Y., and Tsujim oto, Y. (2002) A ctivation of 
mitochondrial voltage-dependent anion channel by apro-apoptotic BH3-only protein Bim, 
Oncogene 21, 4944-4956.
109. Capano, M. and Crompton, M. (2002) Biphasic translocation o f Bax to m itochondria, Biochem J  
367, 169-178.
110. Shim izu, S., M atsuoka, Y„ Shinohara, Y., Yoneda, Y., and Tsujim oto, Y. (2001) Essential role of 
voltage-dependent anion channel in various form s of apoptosis in mam malian cells, J  Cell Biol 
152, 237-250.
111. Rostovtseva, T. K., A ntonsson, B., Suzuki, M., Youle, R. J., Colom bini, M., and Bezrukov, S. M.
(2004) Bid, but not Bax, regulates V DAC channels, J  B iol Chem  279, 13575-13583.
226
112. Cheng, E. H., Sheiko, T. V., Fisher, J. K., Craigen, W. J., and K orsm eyer, S. J. (2003) VDA C2
inhibits BAK activation and m itochondrial apoptosis, Science  301, 513-517.
113. Vyssokikh, M. Y., Katz, A., Rueck, A., W uensch, C., D orner, A., Zorov, D. B., and Brdiczka, D. 
(2001) Adenine nucleotide translocator isoform s 1 and 2 are differently distributed in the 
mitochondrial inner mem brane and have distinct affinities to cyclophilin  D, B iochem  J  358, 349- 
358.
114. Bauer, M. K., Schubert, A., Rocks, 0 . ,  and Grim m, S. (1999) A denine nucleotide translocase-1, a 
component o f the perm eability transition pore, can dom inantly  induce apoptosis, J  Cell B iol 147, 
1493-1502.
115. Machida, K., Hayashi, Y., and Osada, H. (2002) A novel adenine nucleotide translocase inhibitor, 
MT-21, induces cytochrome c release by a m itochondrial perm eability  transition-independent 
mechanism, J  Biol Chem  277, 31243-31248.
116. De Giorgi, F., Lartigue, L., Bauer, M. K., Schubert, A., Grim m, S., H anson, G. T., Rem ington, S.
J., Youle, R. J., and Ichas, F. (2002) The perm eability transition pore signals apoptosis by 
directing Bax translocation and multim erization, Faseb J  16, 607-609.
117. Hardie, D. G. and Carling, D. (1997) The A M P-activated protein kinase—fuel gauge o f the 
mammalian cell?, Eur. J. Biochem. 246, 259-273.
118. Capano, M. and Crompton, M. (2006) Bax translocates to m itochondria of heart cells during 
simulated ischaemia: involvem ent of AM P-activated and p38 m itogen-activated protein kinases, 
Biochem. J. 395, 57-64.
119. Narita, M., Shimizu, S., Ito, T., Chittenden, T., Lutz, R. J., M atsuda, H., and Tsujim oto, Y. (1998) 
Bax interacts with the perm eability transition pore to induce perm eability transition and 
cytochrome c release in isolated mitochondria, Proc N atl A cad  Sci U S A  95, 14681-14686.
120. Pastorino, J. G., Tafani, M., Rothman, R. J., M arcinkeviciute, A., Hoek, J. B„ and Farber, J. L.
(1999) Functional consequences of the sustained or transient activation by Bax of the 
mitochondrial perm eability transition pore, J  B iol Chem  274, 31734-31739.
121. Pastorino, J. G., Chen, S. T., Tafani, M., Snyder, J. W ., and Farber, J. L. (1998) The 
overexpression of Bax produces cell death upon induction o f  the m itochondrial perm eability 
transition, J  Biol Chem  273, 7770-7775.
122. W ieckowski, M. R., V yssokikh, M., D ym kowska, D., A ntonsson, B., Brdiczka, D., and W ojtczak, 
L. (2001) Oligomeric C-terminal truncated Bax preferentially releases cytochrom e c but not 
adenylate kinase from m itochondria, outer mem brane vesicles and proteoliposom es, FEBS Lett 
505,453-459.
123. Zamzam i, N., El Hamel, C., M aisse, C., Brenner, C., M unoz-Pinedo, C., Belzacq, A. S., 
Costantini, P., Vieira, H., Loeffler, M., M olle, G., and Kroemer, G. (2000) Bid acts on the 
perm eability transition pore complex to induce apoptosis, O ncogene 19, 6342-6350.
124. W ang, K., Yin, X. M , Chao, D. T., M illiman, C. L., and K orsm eyer, S. J. (1996) BID: a novel 
BH3 dom ain-only death agonist, Genes D ev 10, 2859-2869.
125. Chou, J. J., Li, H., Salvesen, G. S., Yuan, J., and W agner, G. (1999) Solution structure o f BID, an 
intracellular am plifier of apoptotic signaling, Cell 96, 615-624.
126. Esposti, M. D. (2002) The roles of Bid, Apoptosis 7 ,433-440.
127. K rajew ska, M., Zapata, J. M., M einhold-H eerlein, I., Hedayat, H., M onks, A., Bettendorf, H., 
Shabaik, A., Bubendorf, L., Kallioniemi, O. P., Kim, H., Reifenberger, G., Reed, J. C., and 
K rajewski, S. (2002) Expression o f Bcl-2 fam ily m em ber Bid in normal and malignant tissues, 
N eoplasia  4, 129-140.
227
128. Footz, T. K., Birren, B., M inoshim a, S., A sakawa, S., Shim izu, N., Riazi, M. A., and M cDerm id, 
H. E. (1998) The gene for death agonist BID maps to the region o f hum an 22q 11.2 duplicated in 
cat eye syndrome chrom osom es and to mouse chrom osom e 6 , Genomics. 51,472-475.
129. Lee, J. H„ Soung, Y. H „ Lee, J. W., Park, W. S., Kim, S. Y „ Cho, Y. G „ Kim, C. J., Seo, S. H„ 
Kim, H. S., Nam, S. W., Yoo, N. J., Lee, S. H., and Lee, J. Y. (2004) Inactivating m utation o f the 
pro-apoptotic gene BID in gastric cancer, J  Pathol. 202,439-445.
130. Li, H., Zhu, H., Xu, C. J., and Yuan, J. (1998) C leavage o f  BID by caspase 8  m ediates the 
mitochondrial damage in the Fas pathway o f apoptosis, C ell 94, 491-501.
131. Esposti, M. D., Erler, J. T., H ickman, J. A., and Dive, C. (2001) Bid, a w idely expressed 
proapoptotic protein of the Bcl-2 family, displays lipid transfer activity, M ol Cell B iol 21, 7268- 
7276.
132. Tafani, M., Karpinich, N. O., Hurster, K. A., Pastorino, J. G., Schneider, T., Russo, M. A., and 
Farber, J. L. (2002) Cytochrom e c release upon Fas receptor activation depends on translocation 
of full-length bid and the induction o f the mitochondrial perm eability transition, J  B iol Chem  277, 
10073-10082.
133. Zha, J., W eiler, S., Oh, K. J., Wei, M. C., and Korsm eyer, S. J. (2000) Posttranslational N- 
myristoylation of BID as a m olecular switch for targeting m itochondria and apoptosis, Science 
290, 1761-1765.
134. Tan, K. O., Tan, K. M., and Yu, V. C. (1999) A novel BH3-like dom ain in BID is required for 
intram olecular interaction and autoinhibition of pro-apoptotic activity, J  B iol Chem  274, 23687- 
23690.
135. Desagher, S., Osen-Sand, A., M ontessuit, S., M agnenat, E., V ilbois, F., H ochm ann, A., Joum ot, 
L., Antonsson, B., and M artinou, J. C. (2001) Phosphorylation o f bid by casein kinases I and II 
regulates its cleavage by caspase 8 , M ol Cell 8 , 601-611.
136. M cDonnell, J. M., Fushman, D., Milliman, C. L., K orsm eyer, S. J., and Cowburn, D. (1999) 
Solution structure of the proapoptotic molecule BID: a structural basis for apoptotic agonists and 
antagonists, Cell 96, 625-634.
137. Slee, E. A., Keogh, S. A., and M artin, S. J. (2000) C leavage of BID during cytotoxic drug and UV 
radiation-induced apoptosis occurs dow nstream  of the point of Bcl-2 action and is catalysed by 
caspase-3: a potential feedback loop for am plification o f apoptosis-associated m itochondrial 
cytochrome c release, Cell Death D iffer 7, 556-565.
138. Valentijn, A. J. and G ilm ore, A. P. (2004) Translocation of full-length Bid to m itochondria during 
anoikis, J  Biol Chem  279, 32848-32857.
139. Lutter, M., Perkins, G. A., and W ang, X. (2001) The pro-apoptotic Bcl-2 fam ily m em ber tBid 
localizes to mitochondrial contact sites, B M C  Cell Biol 2, 22.
140. Kim, T. H„ Zhao, Y„ Ding, W. X., Shin, J. N „ He, X., Seo, Y. W „ Chen, J., Rabinowich, H„ 
Amoscato, A. A., and Yin, X. M. (2004) B id-cardiolipin interaction at m itochondrial contact site 
contributes to mitochondrial cristae reorganization and cytochrom e C release, M ol Biol Cell 15, 
3061-3072.
141. Hu, X., Han, Z., W yche, J. H., and Hendrickson, E. A. (2003) H elix 6  of tBid is necessary but not 
sufficient for m itochondrial binding activity, A poptosis 8 , 277-289.
142. Liu, J., Durrant, D., Yang, H. S., He, Y., W hitby, F. G., M yszka, D. G., and Lee, R. M. (2005)
The interaction between tB id and cardiolipin or m onolysocardiolipin, Biochem  Biophys Res 
Commun  330, 865-870.
228
143. Yan, L., Miao, Q., Sun, Y., and Yang, F. (2003) tBid form s a pore in the liposom e m em brane, 
EEBS Lett 555, 545-550.
144.
145.
146.
147.
148.
149.
150.
151.
152.
153.
154.
155.
156.
157.
158.
Gong, X. M., Choi, J., Franzin, C. M ., Zhai, D., Reed, J. C., and M arassi, F. M. (2004) 
Conformation o f M em brane-associated Proapoptotic tB id, J  B iol Chem  279, 28954-28960.
Oh, K. J., Barbuto, S., Meyer, N., Kim, R. S., Collier, R. J., and K orsm eyer, S. J. (2005) 
Conformational Changes in BID, a Pro-apoptotic BCL-2 Fam ily M em ber, upon M em brane 
Binding: A SITE-DIRECTED SPIN LABELING  STU D Y , J  B iol Chem  280, 753-767.
Degli Esposti, M. (2002) Sequence and functional sim ilarities betw een pro-apoptotic Bid and 
plant lipid transfer proteins, Biochim  Biophys A cta  1553, 331-340.
Goonesinghe, A., Mundy, E. S., Smith, M., Khosravi-Far, R., M artinou, J. C., and Esposti, M. D.
(2005) Pro-apoptotic Bid induces mem brane perturbation by inserting selected lysolipids into the 
bilayer, Biochem J  387, 109-118.
Handschumacher, R. E., Harding, M. W., R ice, J., Drugge, R. J., and Speicher, D. W. (1984) 
Cyclophilin: a specific cytosolic binding protein for cyclosporin A, Science. 226, 544-547.
Fischer, G., Bang, H., and M ech, C. (1984) [Determination o f enzym atic catalysis for the cis- 
trans-isomerization of peptide binding in proline-containing peptides], Biomed. B iochim  Acta. 43, 
1 1 0 1 - 1 1 1 1 .
Galat, A. (1999) Variations o f sequences and amino acid com positions o f proteins that sustain 
their biological functions: An analysis of the cyclophilin family o f proteins, Arch. Biochem. 
Biophys. 371, 149-162.
Yao, Q., Li, M., Yang, H., Chai, H., Fisher, W., and Chen, C. (2005) Roles of cyclophilins in 
cancers and other organ systems, World J. Surg. 29, 276-280.
Halestrap, A. P. and D avidson, A. M. (1990) Inhibition o f C a2(+)-induced large-am plitude 
swelling o f liver and heart m itochondria by cyclosporin is probably caused by the inhibitor 
binding to m itochondrial-matrix peptidyl-prolyl cis-trans isom erase and preventing it interacting 
with the adenine nucleotide translocase, Biochem  J  268, 153-160.
M cGuinness, O., Yafei, N., Costi, A., and Crom pton, M. (1990) The presence of tw o classes of 
high-affinity cyclosporin A binding sites in mitochondria. Evidence that the m inor com ponent is 
involved in the opening o f an inner-m em brane C a(2+)-dependent pore, E ur J  Biochem  194, 671 - 
679.
Scorrano, L., Nicolli, A., Basso, E., Petronilli, V., and B em ardi, P. (1997) Tw o m odes of 
activation of the perm eability transition pore: the role of m itochondrial cyclophilin, M ol Cell 
Biochem  174, 181-184.
Lin, D. T. and Lechleiter, J. D. (2002) M itochondrial targeted cyclophilin D protects cells from 
cell death by peptidyl prolyl isomerization, J  Biol Chem  277, 31134-31141.
Schubert, A. and Grimm, S. (2004) Cyclophilin D, a com ponent o f the perm eability transition- 
pore, is an apoptosis repressor, Cancer Res 64, 85-93.
Li, Y., Johnson, N., Capano, M., Edwards, M., and Crom pton, M. (2004) Cyclophilin-D  promotes 
the m itochondrial perm eability transition but has opposite effects on apoptosis and necrosis, 
B iochem  J  383, 101-109.
Schinzel, A. C., Takeuchi, O., Huang, Z., Fisher, J. K., Zhou, Z., Rubens, J., Hetz, C., Danial, N. 
N., M oskowitz, M. A., and Korsmeyer, S. J. (2005) Cyclophilin D is a com ponent of 
m itochondrial perm eability transition and m ediates neuronal cell death after focal cerebral 
ischem ia, P roc N atl A cad  Sci U S A  102, 12005-12010.
229
159. Pappenberger, G., Bachmann, A., M uller, R., Aygun, H., Engels, J. W ., and Kiefhaber, T. (2003) 
Kinetic mechanism and catalysis of a native-state prolyl isom erization reaction, J  M ol B iol 326, 
235-246.
160. O'Neal, K. D., Chari, M. V., M cDonald, C. H., Cook, R. G ., Yu-Lee, L. Y., M orrisett, J. D., and 
Shearer, W. T. (1996) M ultiple cis-trans conform ers o f the prolactin  receptor proline-rich m otif 
(PRM) peptide detected by reverse-phase H PLC, CD  and N M R  spectroscopy, B iochem  J  315 ( Pt 
3), 833-844.
161. Johnson, V. G., Nicholls, P. J., Habig, W. H., and Youle, R. J. (1993) T he role of proline 345 in 
diphtheria toxin translocation, J  Biol Chem  268, 3514-3519.
162. Borel, J. F. (1989) Pharm acology o f cyclosporin (Sandim m une). Pharm acological properties in 
vivo Pharmacol.Rev. 41, pp 259-371
163. Wang, M. Z„ Shetty, J. T., Howard, B. A., Campa, M. J., Patz, E. F., Jr., and F itzgerald, M. C. 
(2004) Thermodynamic analysis of cyclosporin a binding to cyclophilin  a in a lung tum or tissue 
lysate, A nal Chem  76, 4343-4348.
164. W aldmeier, P. C., Zim merm ann, K., Qian, T., T intelnot-B lom ley, M., and Lem asters, J. J. (2003) 
Cyclophilin D as a drug target, Curr M ed Chem  10, 1485-1506.
165. Crompton, M., Ellinger, H., and Costi, A. (1988) Inhibition by cyclosporin A o f a Ca2+- 
dependent pore in heart m itochondria activated by inorganic phosphate and oxidative stress, 
Biochem J. 255, 357-360.
166. W oodfield, K., Ruck, A., Brdiczka, D., and Halestrap, A. P. (1998) D irect dem onstration o f a 
specific interaction between cyclophilin-D  and the adenine nucleotide translocase confirm s their 
role in the mitochondrial perm eability transition, Biochem  J. 336, 287-290.
167. Krauskopf, A., Lhote, P., M utter, M., Dufour, J. F„ Ruegg, U. T., and Buetler, T. M. (2003) 
Vasopressin type 1A receptor up-regulation by cyclosporin A in vascular sm ooth m uscle cells is 
mediated by superoxide, J  B iol Chem  278, 41685-41690.
168. Kimchi-Sarfaty, C., Kasir, J., Ambudkar, S. V., and R aham im off, H. (2002) T ransport activity 
and surface expression of the N a+-Ca2+ exchanger NCX1 are inhibited by the 
immunosuppressive agent cyclosporin A and by the nonim m unosuppressive agent PSC 833, J  Biol 
Chem  277,2505-2510.
169. Montero, M., Lobaton, C. D., G utierrez-Fem andez, S., M oreno, A., and Alvarez, J. (2004) 
Calcineurin-independent inhibition o f mitochondrial Ca2+ uptake by cyclosporin A, Br. J  
Pharmacol. 141, 263-268.
170. Smaili, S. S., Stellato, K. A., Burnett, P., Thomas, A. P., and G aspers, L. D. (2001) Cyclosporin A 
inhibits inositol 1,4,5-trisphosphate-dependent Ca2+ signals by enhancing C a2+ uptake into the 
endoplasmic reticulum and mitochondria, J  Biol Chem  276, 23329-23340.
171. Zhong, Z., Li, X., Yamashina, S., von Frankenberg, M., Enom oto, N., Ikejim a, K„ Kolinsky, M., 
Raleigh, J. A., and Thurman, R. G. (2001) Cyclosporin A causes a hyperm etabolic state and 
hypoxia in the liver: prevention by dietary glycine, J  Pharm acol. Exp Ther. 299, 858-865.
172. Hokanson, J. F., M ercier, J. G., and Brooks, G. A. (1995) Cyclosporine A decreases rat skeletal 
m uscle mitochondrial respiration in vitro, Am J  Respir. Crit Care M ed  151, 1848-1851.
173. W inegar, D. A., Salisbury, J. A., Sundseth, S. S., and H awke, R. L. (1996) Effects of cyclosporin 
on cholesterol 27-hydroxylation and LDL receptor activity in H epG2 cells, J  L ipid Res 37, 179-
191.
230
174.
175.
176.
177.
178.
179.
180. 
181.
182.
183.
184.
185.
186.
187.
188.
189.
190.
Princen, H. ML, Meijer, P., W olthers, B. G., Vonk, R. J., and Kuipers, F. (1991) Cyclosporin A 
blocks bile acid synthesis in cultured hepatocytes by specific inhibition of chenodeoxycholic acid 
synthesis, Biochem J  275, 501-505.
Dahlback-Sjoberg, H., Bjorkhem, I., and Princen, H. M. (1993) Selective inhibition of 
mitochondrial 27-hydroxylation of bile acid interm ediates and 25-hydroxylation of vitamin D3 by 
cyclosporin A, Biochem J  293, 203-206.
W u, J., Zhu, Y. H., and Patel, S. B. (1999) C yclosporin-induced dyslipoproteinem ia is associated 
with selective activation of SREBP-2, Am J  Physiol 277, E l 087-E l 094.
Epand, R. M., Epand, R. F., and M cKenzie, R. C. (1987) Effects o f viral chem otherapeutic agents 
on mem brane properties. Studies of cyclosporin A, benzyloxycarbonyl-D -Phe-L-Phe-G ly and 
amantadine, J  Biol Chem  262, 1526-1529.
Matsuda, S. and Koyasu, S. (2000) M echanism s o f action o f cyclosporine, Im m unopharm acology  
47, 119-125.
Jurgensmeier, J. M., Xie, Z., Deveraux, Q., Ellerby, L., B redesen, D., and Reed, J. C. (1998) Bax 
directly induces release of cytochrom e c from isolated m itochondria, Proc N a tl A cad  Sci U S A  
95,4997-5002.
Hales, K. G. and Fuller, M. T. (1997) Developm entally regulated m itochondrial fusion mediated 
by a conserved, novel, predicted GTPase, Cell 90, 121-129.
Hermann, G. J., Thatcher, J. W., Mills, J. P., Hales, K. G ., Fuller, M. T., N unnari, J., and Shaw, J. 
M. (1998) M itochondrial fusion in yeast requires the transm em brane G TPase F zo lp , J  Cell Biol 
143, 359-373.
Sesaki, H. and Jensen, R. E. (2001) U G O l encodes an outer m em brane protein required for 
mitochondrial fusion, J  Cell B iol 152, 1123-1134.
W ong, E. D., W agner, J. A., Scott, S. V., Okreglak, V., H olew inske, T. J., C assidy-Stone, A., and 
Nunnari, J. (2003) The intram itochondrial dynam in-related GTPase, M gm lp , is a com ponent of a 
protein complex that m ediates mitochondrial fusion, J Cell B iol 160, 303-311.
Chen, H., Detmer, S. A., Ewald, A. J., Griffin, E. E., Fraser, S. E., and Chan, D. C. (2003) 
M itofusins M fnl and M fn2 coordinately regulate m itochondrial fusion and are essential for 
embryonic development, J  Cell Biol 160, 189-200.
Shaw, J. M. and Nunnari, J. (2002) M itochondrial dynam ics and division in budding yeast, Trends 
Cell Biol 12, 178-184.
Smirnova, E., Griparic, L., Shurland, D. L., and van der Bliek, A. M. (2001) D ynam in-related 
protein D rpl is required for m itochondrial division in m am m alian cells, M ol Biol Cell 12, 2245- 
2256.
Hinshaw, J. E. (2000) Dynamin and its role in m em brane fission, A nnu Rev Cell D ev B iol 16, 
483-519.
Stowell, M. H., Marks, B., W igge, P., and M cM ahon, H. T. (1999) N ucleotide-dependent 
conform ational changes in dynamin: evidence for a m echanochem ical m olecular spring, N at Cell 
B iol 1, 27-32.
Sweitzer, S. M. and Hinshaw, J. E. (1998) D ynam in undergoes a GTP-dependent conformational 
change causing vesiculation, Cell 93, 1021-1029.
Enriquez, J. A., Cabezas-Herrera, J., Bayona-Bafaluy, M. P., and Attardi, G. (2000) Very rare 
com plem entation between m itochondria carrying different m itochondrial DNA mutations points
231
to intrinsic genetic autonomy of the organelles in cultured hum an cells, J  Biol Chem  275, 11207- 
11215.
191. Frank, S., Gaume, B., Bergm ann-Leitner, E. S., Leitner, W. W ., Robert, E. G., Catez, F., Smith, 
C. L., and Youle, R. J. (2001) The role of dynam in-related protein 1, a m ediator o f mitochondrial 
fission, in apoptosis, Dev Cell 1, 515-525.
192. Karbowski, M., Arnoult, D., Chen, H., Chan, D. C., Smith, C. L., and Y oule, R. J. (2004) 
Quantitation of mitochondrial dynam ics by photolabeling o f individual organelles shows that 
mitochondrial fusion is blocked during the Bax activation phase o f apoptosis, J  Cell B iol 164, 
493-499.
193. Breckenridge, D. G., Stojanovic, M „ M arcellus, R. C., and Shore, G. C. (2003) C aspase cleavage 
product of BAP31 induces mitochondrial fission through endoplasm ic reticulum  calcium  signals, 
enhancing cytochrome c release to the cytosol, J  Cell B iol 160, 1115-1127.
194. Karbowski, M., Lee, Y. J., Gaume, B., Jeong, S. Y., Frank, S., N echushtan, A., Santel, A., Fuller, 
M., Smith, C. L., and Youle, R. J. (2002) Spatial and tem poral association o f Bax with 
mitochondrial fission sites, D rp l, and M fn2 during apoptosis, J  Cell B iol 159, 931-938.
195. Basanez, G. (2002) M em brane fusion: the process and its energy suppliers, Cell M ol Life Sci 59, 
1478-1490.
196. Scorrano, L. (2003) Divide et impera: Ca2+ signals, m itochondrial fission and sensitization to 
apoptosis, Cell Death D iffer 10, 1287-1289.
197. Amutha, B., Gordon, D. M., Gu, Y., and Pain, D. (2004) A novel role o f M gm lp , a dynam in- 
related GTPase, in ATP synthase assembly and cristae form ation/m aintenance, Biochem  J  381, 
19-23.
198. Galigniana, M. D., M orishima, Y., Gallay, P. A., and Pratt, W. B. (2004) Cyclophilin-A  is bound 
through its peptidylprolyl isom erase dom ain to the cytoplasm ic dynein m otor protein com plex, J  
Biol Chem  279, 55754-55759.
199. Tchaicheeyan, O. (2004) Is peptide bond cis/trans isom erization a key stage in the chemo- 
mechanical cycle of motor proteins?, Faseb J  18, 783-789.
200. Simmen, T., Aslan, J. E., Blagoveshchenskaya, A. D., Thom as, L., W an, L., X iang, Y., 
Feliciangeli, S. F., Hung, C. H., Crump, C. M., and Thomas, G. (2005) PA CS-2 controls 
endoplasmic reticulum -m itochondria com m unication and B id-m ediated apoptosis, Embo J  24, 
717-729.
201. W atabe, M. and Nakaki, T. (2004) Rotenone induces apoptosis via activation of bad in human 
dopaminergic SH-SY5Y cells, J  Pharmacol. Exp Ther. 311, 948-953.
202. Springer, J. E., Azbill, R. D., Nottingham, S. A., and Kennedy, S. E. (2000) Calcineurin-m ediated 
BAD dephosphorylation activates the caspase-3 apoptotic cascade in traum atic spinal cord injury, 
J  N eurosci 20, 7246-7251.
203. Lewis, S., Bethell, S. S., Patel, S., M artinou, J. C., and Antonsson, B. (1998) Purification and 
biochem ical properties o f soluble recom binant hum an Bax, Protein Expr P urif 13, 120-126.
204. Bradford, A. P. and Yedman, S. J. (1986) Advances in Protein Phosphatase  3, pp 73-106
205. Sarrouilhe, D. and Baudry, M. (1996) Evidence of true protein kinase CKII activity in 
m itochondria and its sperm ine-m ediated translocation to inner mem brane, Cell M ol B iol (Noisy. - 
le-grand) 42, 189-197.
232
206.
207.
208.
209.
2 10 . 
2 1 1 . 
2 1 2 .
213.
214.
215.
216.
217.
218.
219.
220 . 
221 .
Henriksson, T. and Jergil, B. (1979) Protein kinase activity and endogenous phosphorylation in 
subfractions o f rat liver m itochondria, Biochim  B iophys A cta  588, 380-391.
Kitagawa, Y. and Racker, E. (1982) Purification and characterization o f two protein kinases from 
bovine heart mitochondrial mem brane, J  B iol Chem  257, 4547-4551.
Schwoch, G., Trinczek, B., and Bode, C. (1990) Localization o f catalytic and regulatory subunits 
of cyclic AM P-dependent protein kinases in m itochondria from  various rat tissues, Biochem  J  
270, 181-188.
Technikova-Dobrova, Z., Sardanelli, A. M., Speranza, F., Scacco, S., Signorile, A., Lorusso, V., 
and Papa, S. (2001) Cyclic adenosine m onophosphate-dependent phosphorylation o f m am m alian 
mitochondrial proteins: enzym e and substrate characterization and functional role, Biochem istry  
40, 13941-13947.
Verdanis, A. (1977) Protein kinase activity at the inner m em brane o f m am m alian m itochondria, J  
Biol Chem  252, 807-813.
Signorile, A., Sardanelli, A. M., Nuzzi, R., and Papa, S. (2002) Serine (threonine) phosphatase(s) 
acting on cAM P-dependent phosphoproteins in m am m alian m itochondria, FEBS Lett 512, 91-94.
Papa, S., Sardanelli, A. M., Scacco, S., and Technikova-D obrova, Z. (1999) cA M P-dependent 
protein kinase and phosphoproteins in m am m alian mitochondria. An extension of the cAM P- 
mediated intracellular signal transduction, FEBS Lett 444, 245-249.
Sardanelli, A. M., Technikova-Dobrova, Z., Speranza, F., M azzocca, A., Scacco, S., and Papa, S. 
(1996) Topology of the m itochondrial cA M P-dependent protein kinase and its substrates, FEBS  
Lett 396, 276-278.
Azarashvili, T. S., Tyynela, J., Odinokova, I. V., Grigorjev, P. A., Baumann, M., Evtodienko, Y. 
V., and Saris, N. E. (2002) Phosphorylation o f a peptide related to subunit c of the F0F1- 
ATPase/ATP synthase and relationship to perm eability transition pore opening in m itochondria, J  
Bioenerg. Biomembr. 34, 279-284.
Azarashvili, T., Krestinina, O., Odinokova, I., Evtodienko, Y., and Reiser, G. (2003)
Physiological Ca2+ level and Ca2+-induced Perm eability T ransition Pore control protein 
phosphorylation in rat brain m itochondria, Cell Calcium  34, 253-259.
Sanger, F., Nicklen, S., and Coulson, A. R. (1992) DNA sequencing with chain-term inating 
inhibitors. 1977, Biotechnology 24:104-8., 104-108.
Ruiz-M artinez, M. C., Berka, J., Belenkii, A., Foret, F., M iller, A. W „ and Karger, B. L. (1993) 
DNA sequencing by capillary electrophoresis with replaceable linear polyacrylam ide and laser- 
induced fluorescence detection, A nal Chem  65, 2851-2858.
Laemmli, U. K. (1970) C leavage of structural proteins during the assem bly o f the head of 
bacteriophage T4, Nature 227, 680-685.
Kroger, A. and Klingenberg, M. (1966) On the role of ubiquinone in m itochondria. II. Redox 
reactions of ubiquinone under the control o f oxidative phosphorylation, Biochem  Z  344, 317-336.
Harrington, C. R. (1990) Lowry protein assay containing sodium dodecyl sulfate in microtiter 
plates for protein determinations on fractions from  brain tissue, A nal Biochem  186, 285-287.
Folin, O. and Ciocalteu, V. (1927) On tyrosine and tryptophane determ inations in proteins, J.
Biol. Chem. 73,627-650.
233
222. Pedersen, P. L., Greenawalt, J. W., R eynafarje, B., H ullihen, J., Decker, G. L., Soper, J. W „ and 
Bustamente, E. (1978) Preparation and characterization o f m itochondria and subm itochondrial 
particles of rat liver and liver-derived tissues, M ethods Cell B io l 20, 411-481.
223. Gordon, J. A. (1991) Use of vanadate as protein-phosphotyrosine phosphatase inhibitor, M ethods 
Enzymol. 201, 477-482.
224. Tanveer, A., Virji, S., Andreeva, L., Totty, N. F., H suan, J. J., W ard, J. M., and C rom pton, M. 
(1996) Involvement of cyclophilin D in the activation o f a m itochondrial pore by C a2+ and 
oxidant stress, Eur. J. Biochem. 238, 166-172.
225. Kamo, N., Muratsugu, M., Hongoh, R., and Kobatake, Y. (1979) M em brane potential o f 
mitochondria measured w ith an electrode sensitive to tetraphenyl phosphonium  and relationship 
between proton electrochem ical potential and phosphorylation potential in steady state, J. Membr. 
Biol. 49, 105-121.
226. Kofron, J. L., Kuzmic, P., Kishore, V., Colon-Bonilla, E., and Rich, D. H. (1991) D eterm ination 
of kinetic constants for peptidyl prolyl cis-trans isom erases by an im proved spectrophotom etric 
assay, Biochemistry. 30, 6127-6134.
227. O'Donohue, M. F., Burgess, A. W., W alkinshaw, M. D „ and T reutlein, H. R. (1995) M odeling 
conformational changes in cyclosporin A, Protein Sci 4, 2191 -2202.
228. Zeder-Lutz, G., W enger, R., Van Regenm ortel, M. H., and A ltschuh, D. (1993) Interaction of 
cyclosporin A with an Fab fragm ent or cyclophilin. A ffinity m easurem ents and tim e-dependent 
changes in binding, FEBS Lett 326, 153-157.
229. Kozak, M. (1991) An analysis of vertebrate mRNA sequences: intim ations of translational 
control, J  Cell Biol 115, 887-903.
230. Heman, R., Heuermann, K., and Brizzard, B. (2000) M ultiple epitope tagging of expressed 
proteins for enhanced detection, Biotechniques 28, 789-793.
231. Johnson, N., Khan, A., Virji, S., W ard, J. M., and Crom pton, M. (1999) Im port and processing of 
heart mitochondrial cyclophilin D, Eur J  Biochem  263, 353-359.
232. M ertell, A. E. and Smith, R. M. (1975) Critical Stability C onstants
233. Roucou, X., Montessuit, S., Antonsson, B., and M artinou, J. C. (2002) Bax oligom erization in 
mitochondrial membranes requires tBid (caspase-8 -cleaved Bid) and a m itochondrial protein, 
Biochem J  368, 915-921.
234. Roucou, X., Rostovtseva, T., M ontessuit, S., M artinou, J. C., and A ntonsson, B. (2002) Bid 
induces cytochrome c-im perm eable Bax channels in liposom es, Biochem  J  363, 547-552.
235. M akalowski, W., Zhang, J., and Boguski, M. S. (1996) C om parative analysis o f 1196 orthologous 
mouse and human full-length mRNA and protein sequences, Genome Res  6 , 846-857.
236. Thompson, J. D., Higgins, D. G., and Gibson, T. J. (1994) C LU ST A L  W: im proving the 
sensitivity of progressive multiple sequence alignm ent through sequence weighting, position- 
specific gap penalties and weight matrix choice, N ucleic A cids R es  22, 4673-4680.
237. Esposti, M. D., Cristea, I. M., Gaskell, S. J., Nakao, Y., and Dive, C. (2003) Proapoptotic Bid 
binds to monolysocardiolipin, a new m olecular connection betw een m itochondrial membranes 
and cell death, Cell Death D iffer 10, 1300-1309.
238. Kudla, G., M ontessuit, S., Eskes, R., Berrier, C., M artinou, J. C., Ghazi, A., and Antonsson, B.
(2000) The destabilization of lipid m em branes induced by the C-terminal fragment of caspase 8 - 
cleaved bid is inhibited by the N-terminal fragment, J  B iol Chem  275, 22713-22718.
234
239. Kaufmann, E., Geisler, N., and W eber, K. (1984) SD S-PA G E strongly overestim ates the 
molecular masses of the neurofilam ent proteins, F EBS L ett 170, 81-84.
240. Wang, X. (2001) The expanding role of m itochondria in apoptosis, Genes D ev  15, 2922-2933.
241. Appaix, F„ M inatchy, M., Riva-Lavieille, C., O livares, J., A ntonsson, B., and Saks, V. A. (2000)
Rapid spectrophotometric method for quantitation of cytochrom e c release from  isolated 
mitochondria or perm eabilized cells revisited, Biochim  B iophys A cta  7457, 175-181.
242. Zhai, D., Huang, X., Han, X., and Yang, F. (2000) C haracterization o f tB id-induced cytochrom e c 
release from mitochondria and liposom es, FEBS Lett 472, 293-296.
243. Amoult, D., Parone, P., M artinou, J. C., Antonsson, B., Estaquier, J., and A m eisen, J. C. (2002) 
Mitochondrial release of apoptosis-inducing factor occurs dow nstream  o f cytochrom e c release in 
response to several proapoptotic stimuli, J  Cell B iol 159, 923-929.
244. Eliseev, R. A., Salter, J. D., Gunter, K. K., and Gunter, T. E. (2003) Bcl-2 and tB id proteins
counter-regulate mitochondrial potassium  transport, Biochim  B iophys A cta  7604, 1-5.
245. Kluck, R. M„ Esposti, M. D., Perkins, G., Renken, C., K uwana, T., B ossy-W etzel, E., Goldberg, 
M., Allen, T., Barber, M. J., Green, D. R., and Newm eyer, D. D. (1999) The pro-apoptotic 
proteins, Bid and Bax, cause a limited perm eabilization of the m itochondrial outer mem brane that 
is enhanced by cytosol, J  Cell Biol 147, 809-822.
246. Rodrigues, C. M., Sola, S., Sharpe, J. C., M oura, J. J., and Steer, C. J. (2003) 
Tauroursodeoxycholic acid prevents Bax-induced m em brane perturbation and cytochrom e C 
release in isolated m itochondria, Biochem istry 42, 3070-3080.
247. Polster, B. M., Basanez, G., Young, M „ Suzuki, M., and Fiskum , G. (2003) Inhibition o f Bax-
induced cytochrome c release from neural cell and brain m itochondria by dibucaine and 
propranolol, J  Neurosci 23, 2735-2743.
248. An, J., Chen, Y., and Huang, Z. (2004) Critical upstream  signals of cytochrom e C release induced 
by a novel Bcl-2 inhibitor, J  Biol Chem  279, 19133-19140.
249. Annis, M. G., Zamzami, N., Zhu, W ., Penn, L. Z., Kroemer, G., Leber, B., and A ndrews, D. W.
(2001) Endoplasmic reticulum localized Bcl-2 prevents apoptosis when redistribution of 
cytochrome c is a late event, Oncogene 20, 1939-1952.
250. Yamaguchi, H. and W ang, H. G. (2002) Bcl-X L protects B im EL-induced Bax conform ational 
change and cytochrome C release independent of interacting with Bax or B im EL, J  B iol Chem  
277,41604-41612.
251. Pastorino, J. G., Shulga, N., and Hoek, J. B. (2002) M itochondrial binding of hexokinase II 
inhibits Bax-induced cytochrome c release and apoptosis, J  B iol Chem  277, 7610-7618.
252. Liu, J., W eiss, A., Durrant, D., Chi, N. W., and Lee, R. M. (2004) The cardiolipin-binding domain
of Bid affects mitochondrial respiration and enhances cytochrom e c release, Apoptosis  9, 533-541.
253. Eskes, R., Desagher, S., Antonsson, B., and M artinou, J. C. (2000) Bid induces the 
oligom erization and insertion of Bax into the outer m itochondrial m em brane, M ol Cell B iol 20, 
929-935.
254. Boehning, D., Patterson, R. L., Sedaghat, L., Glebova, N. O ., Kurosaki, T., and Snyder, S. H.
(2003) Cytochrom e c binds to inositol (1,4,5) trisphosphate receptors, amplifying calcium- 
dependent apoptosis, N at Cell B io l ..
235
255.
256.
257.
258.
259.
260. 
261. 
262.
263.
264.
265.
266.
267.
268.
269.
270.
Iverson, S. L„ Enoksson, M.. Gogvadze, V., Ott, M., and O rrenius, S. (2004) C ardiolipin Is Not 
Required for Bax-mediated Cytochrom e c Release from  Y east M itochondria, J  B iol Chem  279, 
1100-1107.
Petrosillo, G., Ruggiero, F. M., Pistolese, M., and Paradies, G. (2004) C a2+-induced reactive 
oxygen species production prom otes cytochrom e c release from  rat liver m itochondria via 
mitochondrial perm eability transition (M PT)-dependent and M PT-independent mechanism s: role 
of cardiolipin, J  Biol Chem  279, 53103-53108.
Pallotti, F. and Lenaz, G. (2001) Isolation and subfractionation o f m itochondria from  anim al 
cells and tissue culture lines M ethods Cell B iol 65, pp 1-35
Madesh, M., Antonsson, B., Srinivasula, S. M., A lnem ri, E. S., and H ajnoczky, G. (2002) Rapid 
kinetics of tBid-induced cytochrom e c and Sm ac/D IA B LO  release and m itochondrial 
depolarization, J  Biol Chem  277, 5651 -5659.
Diaz, G. D., Li, Q., and Dashwood, R. H. (2003) C aspase - 8  and apoptosis-inducing factor mediate 
a cytochrome c-independent pathway of apoptosis in hum an colon cancer cells induced by the 
dietary phytochemical chlorophyllin, Cancer Res 63, 1254-1261.
de Kruijff, B. and Cullis, P. R. (1980) C ytochrom e c specifically induces non-bilayer structures in 
cardiolipin-containing model membranes, Biochim  B iophys A cta  602, 477-490.
Hirsch, T., Marzo, I., and Kroemer, G. (1997) Role o f the m itochondrial perm eability transition 
pore in apoptosis, Biosci. Rep  17, 67-76.
Hail, N., Jr. and Lotan, R. (2000) M itochondrial perm eability transition is a central coordinating 
event in N -(4-hydroxyphenyl)retinam ide-induced apoptosis, C ancer Epidemiol. B iom arkers Prev. 
9, 1293-1301.
Nicotera, P. and Leist, M. (1997) Energy supply and the shape of death in neurons and lym phoid 
cells, Cell Death and Differentiation  4, 435-442.
Crompton, M. (1990) The Role of Ca2+ in the Function and D ysfunction o f H eart M itochondria, in 
Calcium and the Heart (Langer, G. A., Ed.) pp 167-198, Raven Press.
Rodrigues, C. M „ Fan, G., W ong, P. Y., Kren, B. T., and Steer, C. J. (1998) U rsodeoxycholic acid 
may inhibit deoxycholic acid-induced apoptosis by m odulating m itochondrial transm em brane 
potential and reactive oxygen species production, M ol M ed  4, 165-178.
Bemardi, P. (1999) M itochondrial transport of cations: channels, exchangers, and perm eability 
transition, Physiol Rev 79, 1127-1155.
Bertrand, R., Solary, E., O 'Connor, P., Kohn, K. W ., and Pom m ier, Y. (1994) Induction o f a 
comm on pathway of apoptosis by staurosporine, Exp Cell R es  211, 314-321.
M artinou, J. C., Desagher, S., and Antonsson, B. (2000) C ytochrom e c release from mitochondria: 
all or nothing, N at Cell Biol 2, E41-E43.
Goldstein, J. C., W aterhouse, N. J., Juin, P., Evan, G. I., and Green, D. R. (2000) The coordinate 
release of cytochrome c during apoptosis is rapid, com plete and kinetically invariant, N at Cell 
B iol 2, 156-162.
M inn, A. J., Kettlun, C. S., Liang, H., K elekar, A., V ander H eiden, M. G., Chang, B. S., Fesik, S. 
W ., Fill, M., and Thompson, C. B. (1999) Bcl-xL regulates apoptosis by heterodim erization- 
dependent and -independent mechanism s, Em bo J 18, 632-643.
236
271. Liu, J., Farmer, J. D., Jr., Lane, W. S., Friedm an, J., W eissm an, I., and Schreiber, S. L. (1991) 
Calcineurin is a common target of cyclophilin-cyclosporin A and FK BP-FK 506 com plexes, Cell 
6 6 , 807-815.
272. W ang, H. G., Pathan, N., Ethell, I. M., Krajew ski, S., Y am aguchi, Y., Shibasaki, F., M cKeon, F., 
Bobo, T., Franke, T. F., and Reed, J. C. (1999) C a2+-induced apoptosis through calcineurin 
dephosphorylation o f BAD, Science. 284, 339-343.
273. Nicolli, A., Basso, E., Petronilli, V., W enger, R. M., and B em ardi, P. (1996) Interactions o f 
cyclophilin with the m itochondrial inner m em brane and regulation o f the perm eability  transition 
pore, and cyclosporin A-sensitive channel, J  B iol Chem  271, 2185-2192.
274. Henderson, P. J. (1972) A linear equation that describes the steady-state kinetics o f enzym es and 
subcellular particles interacting w ith tightly bound inhibitors, Biochem . J. 127, 321-333.
275. Zeder-Lutz, G., Van Regenm ortel, M. H., W enger, R., and A ltschuh, D. (1994) Interaction of 
cyclosporin A and two cyclosporin analogs with cyclophilin: relationship betw een structure and 
binding, J. Chromatogr. B  Biomed. Appl. 662, 301-306.
276. Ismailos, G., Reppas, C., D ressm an, J. B., and M acheras, P. (1991) U nusual solubility behaviour 
of cyclosporin A in aqueous m edia, J  Pharm. Pharmacol. 43, 287-289.
277. Machida, K. and Osada, H. (2003) M olecular interaction betw een cyclophilin D and adenine 
nucleotide translocase in cytochrom e c release: does it determ ine w hether cytochrom e c release is 
dependent on perm eability transition or not?, Ann. N. Y. A cad  Sci 1010, 182-185.
278. MacGregor, G. R. and Caskey, C. T. (1989) C onstruction o f plasm ids that express E. coli beta- 
galactosidase in mam malian cells, N ucleic A cids Res. 17, 2365.
279. Heman, R., Heuermann, K., and Brizzard, B. (2000) M ultiple epitope tagging of expressed 
proteins for enhanced detection, Biotechniques. 28, 789-793.
280. Altschul, S. F., Madden, T. L., Schaffer, A. A., Zhang, J., Zhang, Z., M iller, W „ and Lipm an, D. 
J. (1997) Gapped BLAST and PSI-BLAST: a new generation o f protein database search 
programs, Nucleic Acids Res. 25, 3389-3402.
281. Henikoff, S. and Henikoff, J. G. (1994) Protein fam ily classification based on searching a 
database of blocks, Genomics. 19, 97-107.
282. Kiebler, M., Becker, K., Pfanner, N., and N eupert, W. (1993) M itochondrial protein import: 
specific recognition and mem brane translocation o f preproteins, J  M em br Biol. 135, 191-207.
283. Claros, M. G. and Vincens, P. (1996) Com putational method to predict m itochondrially im ported 
proteins and their targeting sequences, E ur J  Biochem  241, 779-786.
284. Fuchs, M., Lammert, F., W ang, D. Q., Paigen, B., Carey, M. C., and Cohen, D. E. (1998) Sterol 
carrier protein 2  participates in hypersecretion of biliary cholesterol during gallstone formation in 
genetically gallstone-susceptible mice, B iochem  J. 336, 33-37.
285. van Amerongen, A., Demel, R. A., W esterm an, J., and W irtz, K. W. (1989) Transfer of 
cholesterol and oxysterol derivatives by the nonspecific lipid transfer protein (sterol carrier 
protein 2): a study on its mode of action, Biochim  Biophys Acta. 7004, 36-43.
286. Nichols, J. W. (1987) Binding of fluorescent-labeled phosphatidylcholine to rat liver nonspecific 
lipid transfer protein, J  Biol Chem. 262, 14172-14177.
287. Gadella, T. W., Jr., Bastiaens, P. I., Visser, A. J., and W irtz, K. W. (1991) Shape and lipid- 
binding site of the nonspecific lipid-transfer protein (sterol carrier protein 2 ): a steady-state and 
tim e-resolved fluorescence study, Biochem istry. 30, 5555-5564.
237
288. Frolov, A., Cho, T. H., Billheimer, J. T., and Schroeder, F. (1996) Sterol carrier protein-2, a new 
fatty acyl coenzyme A -binding protein, J  B iol Chem. 271, 31878-31884.
289. Gadella, T. W., Jr. and W irtz, K. W. (1994) Phospholipid binding and transfer by the nonspecific 
lipid-transfer protein (sterol carrier protein 2). A kinetic m odel, E ur J  Biochem. 220, 1019-1028.
290. Jornvall, H., Persson, B., Krook, M., Atrian, S., G onzalez-D uarte, R., Jeffery, J., and Ghosh, D. 
(1995) Short-chain dehydrogenases/reductases (SDR), B iochem istry. 34, 6003-6013.
291. W ard, J. J., McGuffin, L. J., Bryson, K., Buxton, B. F., and Jones, D. T. (2004) The D ISO PR ED  
server for the prediction of protein disorder, Bioinform atics. 20, 2138-2139.
292. Folk, J. E. and Finlayson, J. S. (1977) The epsilon-(gam m a-glutam yl)lysine crosslink and the 
catalytic role of transglutaminases, Adv. Protein Chem. 31:1-133., 1-133.
293. Thacher, S. M. and Rice, R. H. (1985) K eratinocyte-specific transglutam inase o f cultured human 
epidermal cells: relation to cross-linked envelope form ation and term inal differentiation, Cell. 40, 
685-695.
294. W ells, R. D. (1996) M olecular basis of genetic instability o f triplet repeats, J  B iol Chem. 271, 
2875-2878.
295. Smith, G. K., Jie, J., Fox, G. E., and Gao, X. (1995) D N A  CTG  triplet repeats involved in 
dynamic mutations of neurologically related gene sequences form stable duplexes, N ucleic Acids 
Res. 23,4303-4311.
296. Ardail, D., Lerme, F., and Louisot, P. (1991) Involvem ent o f contact sites in phosphatidylserine 
import into liver mitochondria, J  Biol Chem  266, 7978-7981.
297. Kemer, J. and Hoppel, C. (2000) Fatty acid im port into m itochondria, Biochim  B iophys Acta. 
1486, 1-17.
298. Tuller, G. and Daum, G. (1995) Im port of sterols into m itochondria of the yeast Saccharom yces 
cerevisiae, FEBS Lett. 372, 29-32.
299. Blom, N., Gammeltoft, S., and Brunak, S. (1999) Sequence and structure-based prediction of 
eukaryotic protein phosphorylation sites, J. Mol. Biol. 294, 1351-1362.
300. Lehman, J. A., Calvo, V., and Gom ez-Cam bronero, J. (2003) M echanism  of ribosom al p70S6 
kinase activation by granulocyte macrophage colony-stim ulating factor in neutrophils: 
cooperation of a M EK-related, THR421/SER424 kinase and a rapam ycin-sensitive, m-TOR- 
related THR389 kinase, J. Biol. Chem. 278, 28130-28138.
301. Amoult, D., Parone, P., M artinou, J. C., Antonsson, B., Estaquier, J., and Am eisen, J. C. (2002) 
Mitochondrial release of apoptosis-inducing factor occurs dow nstream  o f cytochrom e c release in 
response to several proapoptotic stimuli, J. Cell Biol. 159, 923-929.
302. A moult, D., Gaume, B., Karbowski, M., Sharpe, J. C., Cecconi, F., and Youle, R. J. (2003) 
M itochondrial release of AIF and EndoG requires caspase activation dow nstream  of Bax/Bak- 
m ediated permeabilization, EM BO J. 22,4385-4399.
303. Chauhan, D., Hideshima, T„ Rosen, S., Reed, J. C., K harbanda, S., and A nderson, K. C. (2001) 
Apaf-1/cytochrom e c-independent and Sm ac-dependent induction o f apoptosis in m ultiple 
m yeloma (MM) cells, J. Biol. Chem. 276, 24453-24456.
304. Ferri, K. F„ Jacotot, E., Blanco, J., Este, J. A., Zam zam i, N ., Susin, S. A ., Xie, Z., Brothers, G., 
Reed, J. C., Penninger, J. M., and Kroemer, G. (2000) A poptosis control in syncytia induced by 
the HIV type 1-envelope glycoprotein complex: role o f m itochondria and caspases, J. Exp. Med. 
192, 1081-1092.
238
305. Soriano, M. E., Nicolosi, L., and Bem ardi, P. (2004) D esensitization of the perm eability transition 
pore by cyclosporin a prevents activation of the m itochondrial apoptotic pathw ay and liver 
damage by tum or necrosis factor-alpha, J. Biol. Chem. 279, 36803-36808.
306. Epand, R. F., Martinou, J. C., Fom allaz-M ulhauser, M., H ughes, D. W., and Epand, R. M. (2002) 
The apoptotic protein tBid prom otes leakage by altering m em brane curvature, J  B iol Chem  277, 
32632-32639.
307. Brazin, K. N., Mallis, R. J., Fulton, D. B., and A ndreotti, A. H. (2002) R egulation o f the tyrosine 
kinase Itk by the peptidyl-prolyl isomerase cyclophilin A, Proc. Natl. Acad. Sci. U. S. A. %19;99, 
1899-1904.
308. Bruns, K., Fossen, T., W ray, V., Henklein, P., Tessmer, U., and Schubert, U. (2003) Structural 
characterization of the HIV-1 V pr N terminus: evidence o f cis/trans-proline isom erism , J. Biol. 
Chem. 278, 43188-43201.
309. Ghezzi, P., Casagrande, S., M assignan, T., Basso, M., Bellacchio, E., M ollica, L., B iasini, E., 
Tonelli, R., Eberini, I., G ianazza, E., Dai, W. W., Fratelli, M ., Salm ona, M., Sherry, B., and 
Bonetto, V. (2006) Redox regulation of cyclophilin A by glutathionylation, Proteom ics. 6 , 817- 
825.
310. Fratelli, M., Demol, H., Puype, M., Casagrande, S., Eberini, I., Salm ona, M., Bonetto, V., 
M engozzi, M., Duffieux, F., M iclet, E., Bachi, A., V andekerckhove, J., G ianazza, E., and Ghezzi, 
P. (2002) Identification by redox proteomics of glutathionylated proteins in oxidatively stressed 
human T lym phocytes, Proc. Natl. Acad. Sci. U. S. A. 99, 3505-3510.
311. Papageorgiou, C., Florineth, A., and Mikol, V. (1994) Im proved binding affinity for cyclophilin A 
by a cyclosporin derivative singly modified at its effector dom ain, J. Med. Chem. 37, 3674-3676.
312. Schreier, M. H., Baumann, G., and Zenke, G. (1993) Inhibition o f T-cell signaling pathw ays by 
immunophilin drug complexes: are side effects inherent to im m unosuppressive properties?, 
Transplant. Proc. 25, 502-507.
313. Mikol, V., Kallen, J., and W alkinshaw, M. D. (1994) The X -ray structure o f (M eB m 2t)l- 
cyclosporin complexed w ith cyclophilin A provides an explanation for its anom alously high 
immunosuppressive activity, Protein Eng. 7, 597-603.
314. Thomson, M. (2003) Does cholesterol use the m itochondrial contact site as a conduit to the 
steroidogenic pathway?, Bioessays 25, 252-258.
315. Rodolfo, C., Mormone, E., M atarrese, P., Ciccosanti, F., Farrace, M. G., G arofano, E., Piredda,
L., Fimia, G. M., M alomi, W., and Piacentini, M. (2004) T issue transglutam inase is a 
multifunctional BH3-only protein, J. Biol. Chem. 279, 54783-54792.
316. Melino, G. and Piacentini, M. (1998) 'Tissue' transglutam inase in cell death: a dow nstream  or a 
multifunctional upstream effector?, FEBS Lett. 430, 59-63.
317. Haupt, S., Berger, M., Goldberg, Z., and Haupt, Y. (2003) A poptosis - the p53 netw ork, J  Cell Sci 
116,4077-4085.
318. Perkins, D. N., Pappin, D. J., Creasy, D. M., and Cottrell, J. S. (1999) P robability-based protein 
identification by searching sequence databases using mass spectrom etry data, Electrophoresis. 20, 
3551-3567.
239
